# EDGAR Filing Document

**Accession Number:** 0001786108
**File Stem:** 0001193125-25-265807
**Filing Date:** 2025-11
**Character Count:** 562105
**Document Hash:** 29afdf1e6432f66ca105286d37a1186d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-265807.hdr.sgml**: 20251105

**ACCESSION NUMBER**: 0001193125-25-265807

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 88

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251105

**DATE AS OF CHANGE**: 20251105

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Trinity Capital Inc.
- **CENTRAL INDEX KEY:** 0001786108

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39958
- **FILM NUMBER:** 251451880

**BUSINESS ADDRESS:**
- **STREET 1:** 1 N. 1ST ST.
- **STREET 2:** 3RD FLOOR
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85004
- **BUSINESS PHONE:** 480.374.5350

**MAIL ADDRESS:**
- **STREET 1:** 1 N. 1ST ST.
- **STREET 2:** 3RD FLOOR
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85004

?xml version='1.0' encoding='ASCII'? 10-Q

[**<u>**Table of Contents**</u>**](#toc_page)

PRewhwwrecw20112

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

------

**FORM** 10-Q

------

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2025

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-39958

------

TRINITY CAPITAL INC.

(Exact name of registrant as specified in its charter)

------

Maryland 35-2670395 <br> (State or other jurisdiction of incorporation ororganization) (IRS Employer Identification No.)

---

| | |
|:---|:---|
| &nbsp;&nbsp;**1 N. 1**<sup>st</sup> **Street**<br>Suite 302<br>Phoenix**,** Arizona | &nbsp;&nbsp;85004 |
| &nbsp;&nbsp;(Address of principal executive offices) | &nbsp;&nbsp;(Zip Code) |

---

**(**480**)** 374-5350

(Registrant's telephone number, including area code)

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.001 per share | TRIN | Nasdaq Global Select Market |
| 7.875% Notes Due 2029 | TRINZ | Nasdaq Global Select Market |
| 7.875% Notes Due 2029 | TRINI | Nasdaq Global Select Market |

---

**Securities registered pursuant to Section 12(g) of the Act: None**

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act:

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of November 3, 2025, the registrant had 75,683,355 shares of common stock ($0.001 par value per share) outstanding.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2025**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | **PAGE** <br>**NO.** |
| [**<u>PART I</u>**](#financial_information) | [**<u>FINANCIAL INFORMATION</u>**](#financial_information) | 3 |
| [<u>Item 1.</u>](#consolidated_financial_statements) | [<u>Consolidated Financial Statements</u>](#consolidated_financial_statements) | 3 |
|  | [<u>Consolidated Statements of Assets and Liabilities as of September 30, 2025 (unaudited) and December 31, 2024</u>](#consolidated_statements_of_assets_and_li) | 3 |
|  | [<u>Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024 (unaudited)</u>](#consolidatedstatementofoperations_972774) | 4 |
|  | [<u>Consolidated Statements of Changes in Net Assets for the Three and Nine Months Ended September 30, 2025 and 2024 (unaudited)</u>](#statements_of_changes_in_net_assets) | 5 |
|  | [<u>Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 (unaudited)</u>](#statementofcashflows) | 7 |
|  | [<u>Consolidated Schedule of Investments as of September 30, 2025 (unaudited)</u>](#soi_debt_cp) | 9 |
|  | [<u>Consolidated Schedule of Investments as of December 31, 2024</u>](#py_soi) | 39 |
|  | [<u>Notes to Consolidated Financial Statements (unaudited)</u>](#notes_to_consolidated_financial) | 70 |
| [<u>Item 2.</u>](#item2managementsdiscussionandanalysisoff) | [<u>Management's Discussion and Analysis of Financial Condition and Results of Operations</u>](#item2managementsdiscussionandanalysisoff) | 117 |
| [<u>Item 3.</u>](#quantitative_and_qualitative_disclosures) | [<u>Quantitative and Qualitative Disclosures About Market Risk</u>](#quantitative_and_qualitative_disclosures) | 135 |
| [<u>Item 4.</u>](#item4) | [<u>Controls and Procedures</u>](#item4) | 136 |
| [**<u>PART II</u>**](#partii) | [**<u>OTHER INFORMATION</u>**](#partii) | 136 |
| [<u>Item 1.</u>](#legal_proceedings) | [<u>Legal Proceedings</u>](#legal_proceedings) | 136 |
| [<u>Item 1A.</u>](#risk_factors) | [<u>Risk Factors</u>](#risk_factors) | 137 |
| [<u>Item 2.</u>](#unregisteredsalesofequity) | [<u>Unregistered Sales of Equity Securities and Use of Proceeds</u>](#unregisteredsalesofequity) | 138 |
| [<u>Item 3.</u>](#defaultsofseniorsecurities) | [<u>Defaults Upon Senior Securities</u>](#defaultsofseniorsecurities) | 138 |
| [<u>Item 4.</u>](#minesafetydisclosures) | [<u>Mine Safety Disclosures</u>](#minesafetydisclosures) | 138 |
| [<u>Item 5.</u>](#otherinformation) | [<u>Other Information</u>](#otherinformation) | 138 |
| [<u>Item 6.</u>](#item6exhibits_543184) | [<u>Exhibits</u>](#item6exhibits_543184) | 138 |
| [**<u>SIGNATURES</u>**](#signature) |  | 140 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

# PART I: FINANCIAL INFORMATION

# Item 1. Consolidated Financial Statements
**TRINITY CAPITAL INC.**

**Consolidated Statements of Assets and Liabilities**

**(In thousands, except share and per share data)**

---

| | | |
|:---|:---|:---|
|  | **September 30,** | **December 31,** |
|  | **2025** | **2024** |
|  | (Unaudited) |  |
| **ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments at fair value: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control investments (cost of $102,382 and $82,391, respectively) | $116743 | $89249 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliate investments (cost of $57,095 and $34,309, respectively) | 50153 | 34727 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Control / Non-Affiliate investments (cost of $2,045,286 and $1,643,526, respectively) | 2025465 | 1601594 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investments (cost of $2,204,763 and $1,760,226, respectively) | 2192361 | 1725570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 9467 | 9627 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest receivable | 19464 | 16542 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred credit facility costs | 6263 | 6586 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 19380 | 15916 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total assets** | $**2246935** | $**1774241** |
| **LIABILITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;KeyBank Credit Facility | $481600 | $113000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unsecured Notes, net of $10,858 and $10,327, respectively, of unamortized deferred financing costs and premium/discount | 693041 | 764673 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution payable | 38244 | 31451 |
| &nbsp;&nbsp;&nbsp;&nbsp;Security deposits | 4413 | 8472 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, accrued expenses and other liabilities | 31373 | 33663 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | **1248671** | **951259** |
| Commitments and contingencies (Note 6) |  |  |
| **NET ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.001 par value per share (200,000,000 authorized, 74,988,962 and 61,669,059 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively) | 75 | 62 |
| &nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital in excess of par | 1015057 | 829626 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributable earnings/(accumulated deficit) | (16868) | (6706) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total net assets** | **998264** | **822982** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities and net assets** | $**2246935** | $**1774241** |
| **NET ASSET VALUE PER SHARE** | $**13.31** | $**13.35** |

---

See accompanying notes to unaudited consolidated financial statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Statements of Operations**

**(In thousands, except share and per share data)**

**(Unaudited)** 

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| **INVESTMENT INCOME:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and dividend income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control investments | $2809 | $2287 | $7567 | $6223 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliate investments | 1866 | 940 | 4116 | 1806 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Control / Non-Affiliate investments | 67900 | 55964 | 190278 | 152390 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest and dividend income | 72575 | 59191 | 201961 | 160419 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fee and other income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliate investments | 731 | 807 | 2020 | 2509 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Control / Non-Affiliate investments | 2244 | 1768 | 6436 | 3931 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total fee and other income | 2975 | 2575 | 8456 | 6440 |
| **Total investment income** | 75550 | 61766 | 210417 | 166859 |
| **EXPENSES:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense and other debt financing costs | 20981 | 16868 | 56681 | 42896 |
| &nbsp;&nbsp;&nbsp;&nbsp;Compensation and benefits | 13388 | 11528 | 36522 | 31336 |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 1936 | 1296 | 5750 | 3354 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 2590 | 2221 | 7303 | 6241 |
| &nbsp;&nbsp;&nbsp;Total gross expenses | 38895 | 31913 | 106256 | 83827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Allocated expenses to Trinity Capital Adviser, LLC | (955) | (126) | (1871) | (126) |
| **Total net expenses** | 37940 | 31787 | 104385 | 83701 |
| **NET INVESTMENT INCOME/(LOSS) BEFORE TAXES** | 37610 | 29979 | 106032 | 83158 |
| &nbsp;&nbsp;&nbsp;&nbsp;Excise tax expense | 644 | 619 | 1881 | 1897 |
| **NET INVESTMENT INCOME** | 36966 | 29360 | 104151 | 81261 |
| **NET REALIZED GAIN/(LOSS) FROM INVESTMENTS:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Control investments |  |  |  | (3916) |
| &nbsp;&nbsp;&nbsp;&nbsp;Affiliate investments | (19039) |  | (19039) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Control / Non-Affiliate investments | (986) | (13880) | (11402) | (15100) |
| **Net realized gain/(loss) from investments** | (20025) | (13880) | (30441) | (19016) |
| **NET CHANGE IN UNREALIZED APPRECIATION/(DEPRECIATION) FROM INVESTMENTS:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Control investments | (411) | 1151 | 7503 | 7407 |
| &nbsp;&nbsp;&nbsp;&nbsp;Affiliate investments | 308 | 1516 | (2153) | 3442 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Control / Non-Affiliate investments | 10807 | 6253 | 17084 | (3356) |
| **Net change in unrealized appreciation/(depreciation) from investments** | 10704 | 8920 | 22434 | 7493 |
| **NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS** | $**27645** | $**24400** | $**96144** | $**69738** |
| NET INVESTMENT INCOME PER SHARE - BASIC | $**0.52** | $**0.54** | $**1.56** | $**1.61** |
| NET INVESTMENT INCOME PER SHARE - DILUTED | $**0.52** | $**0.52** | $**1.56** | $**1.54** |
| NET CHANGE IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC | $**0.39** | $**0.45** | $**1.44** | $**1.38** |
| NET CHANGE IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - DILUTED | $**0.39** | $**0.43** | $**1.44** | $**1.33** |
| WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC | **71467831** | **54412566** | **66677623** | **50455373** |
| WEIGHTED AVERAGE SHARES OUTSTANDING - DILUTED | **71467831** | **58373696** | **66677623** | **54416503** |

---

See accompanying notes to unaudited consolidated financial statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Statements of Changes in Net Assets**

**(In thousands, except share and per share data)**

**(Unaudited)**

**Three Months Ended September 30, 2025:**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  |  |  | **Distributable** |  |
|  |  |  | **Paid In Capital** | **Earnings /** |  |
|  | **Common Stock** | **Common Stock** | **in Excess of** | **(Accumulated** | **Total** |
|  | **Shares** | **Par Value** | **Par Value** | **Deficit)** | **Net Assets** |
| **Balance as of June 30, 2025** | 69574146 | $70 | $929767 | $(6269) | $923568 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock pursuant to distribution reinvestment plan | 22729 |  | 330 |  | 330 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  |  | 3073 |  | 3073 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of restricted stock awards | 151366 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock, net of issuance costs | 5318978 | 5 | 82946 |  | 82951 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retired and forfeited shares of restricted stock | (78257) |  | (1059) |  | (1059) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions to stockholders |  |  |  | (38244) | (38244) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase/(decrease) in net assets resulting from operations |  |  |  | 27645 | 27645 |
| **Balance as of September 30, 2025** | 74988962 | $75 | $1015057 | $(16868) | $998264 |

---

**Three Months Ended September 30, 2024:**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  |  |  | **Distributable** |  |
|  |  |  | **Paid In Capital** | **Earnings /** |  |
|  | **Common Stock** | **Common Stock** | **in Excess of** | **(Accumulated** | **Total** |
|  | **Shares** | **Par Value** | **Par Value** | **Deficit)** | **Net Assets** |
| **Balance as of June 30, 2024** | 51849429 | $52 | $708529 | $(28542) | $680039 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock pursuant to distribution reinvestment plan | 23559 |  | 333 |  | 333 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  |  | 2835 |  | 2835 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of restricted stock awards | 103356 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock, net of issuance costs | 5723189 | 6 | 79378 |  | 79384 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retired and forfeited shares of restricted stock | (57493) |  | (799) |  | (799) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions to stockholders |  |  |  | (29397) | (29397) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase/(decrease) in net assets resulting from operations |  |  |  | 24400 | 24400 |
| **Balance as of September 30, 2024** | 57642040 | $58 | $790276 | $(33539) | $756795 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Nine Months Ended September 30, 2025:**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  |  |  | **Distributable** |  |
|  |  |  | **Paid In Capital** | **Earnings /** |  |
|  | **Common Stock** | **Common Stock** | **in Excess of** | **(Accumulated** | **Total** |
|  | **Shares** | **Par Value** | **Par Value** | **Deficit)** | **Net Assets** |
| **Balance as of December 31, 2024** | 61669059 | $62 | $829626 | $(6706) | $822982 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock pursuant to distribution reinvestment plan | 64150 |  | 930 |  | 930 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  |  | 8876 |  | 8876 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of restricted stock awards | 485094 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock, net of issuance costs | 13013562 | 13 | 194919 |  | 194932 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retired and forfeited shares of restricted stock | (242903) |  | (3522) |  | (3522) |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital in connection with Convertible Notes Redemption |  |  | (15772) |  | (15772) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions to stockholders |  |  |  | (106306) | (106306) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase/(decrease) in net assets resulting from operations |  |  |  | 96144 | 96144 |
| **Balance as of September 30, 2025** | 74988962 | $75 | $1015057 | $(16868) | $998264 |

---

**Nine Months Ended September 30, 2024:**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  |  |  | **Distributable** |  |
|  |  |  | **Paid In Capital** | **Earnings /** |  |
|  | **Common Stock** | **Common Stock** | **in Excess of** | **(Accumulated** | **Total** |
|  | **Shares** | **Par Value** | **Par Value** | **Deficit)** | **Net Assets** |
| **Balance as of December 31, 2023** | 46323712 | $46 | $633740 | $(22627) | $611159 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock pursuant to distribution reinvestment plan | 69593 |  | 991 |  | 991 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  |  | 8178 |  | 8178 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of restricted stock awards | 869747 | 1 | (1) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock, net of issuance costs | 10600529 | 11 | 150547 |  | 150558 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retired and forfeited shares of restricted stock | (221541) |  | (3179) |  | (3179) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions to stockholders |  |  |  | (80650) | (80650) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase/(decrease) in net assets resulting from operations |  |  |  | 69738 | 69738 |
| **Balance as of September 30, 2024** | 57642040 | $58 | $790276 | $(33539) | $756795 |

---

See accompanying notes to unaudited consolidated financial statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Statements of Cash Flows**

**(In thousands)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** |
| **Cash flows provided by/(used in) operating activities:** |  |  |
| &nbsp;&nbsp;Net increase/(decrease) in net assets resulting from operations | $96144 | $69738 |
| &nbsp;&nbsp;Adjustments to reconcile net increase/(decrease) in net assets resulting from operation to net cash provided by/(used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase of investments, net of deferred fees | (1046394) | (924758) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales and paydowns of investments | 607846 | 527269 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized (appreciation)/depreciation from investments | (22434) | (7493) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized (gain)/loss from investments | 30441 | 19016 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accretion of original issue discounts and end of term payments on investments | (36431) | (25716) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred financing costs | 3653 | 3757 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 8876 | 8178 |
| &nbsp;&nbsp;Change in operating assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(Increase)/Decrease in interest receivable | (2922) | (5741) |
| &nbsp;&nbsp;&nbsp;&nbsp;(Increase)/Decrease in other assets | (2926) | 1497 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase/(Decrease) in security deposits | (4059) | (2894) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase/(Decrease) in accounts payable, accrued expenses and other liabilities | (2290) | 1832 |
| **Net cash provided by/(used in) operating activities** | (370496) | (335315) |
| **Cash flows provided by/(used in) investing activities:** |  |  |
| &nbsp;&nbsp;Disposal/(Acquisition) of fixed assets | (357) | (284) |
| **Net cash provided by/(used in) investing activities** | (357) | (284) |
| **Cash flows provided by/(used in) financing activities** |  |  |
| &nbsp;&nbsp;Issuance of common stock, net of issuance costs | 194932 | 150558 |
| &nbsp;&nbsp;Retirement of employee shares | (3522) | (3179) |
| &nbsp;&nbsp;Cash distributions paid | (98582) | (73422) |
| &nbsp;&nbsp;Issuance of Unsecured Notes, net of issuance costs | 127021 | 218416 |
| &nbsp;&nbsp;Repayment of Unsecured Notes | (217756) | (30000) |
| &nbsp;&nbsp;Borrowings under Credit Facility | 1164200 | 670400 |
| &nbsp;&nbsp;Repayments under Credit Facility | (795600) | (593400) |
| **Net cash provided by/(used in) financing activities** | 370693 | 339373 |
| **Net increase/(decrease) in cash, cash equivalents and restricted cash** | (160) | 3774 |
| **Cash, cash equivalents and restricted cash at beginning of period** | 9627 | 4761 |
| **Cash, cash equivalents and restricted cash at end of period** | $9467 | $8535 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** |
| **Supplemental and non-cash investing and financing activities:** |  |  |
| &nbsp;&nbsp;Cash paid for interest | $48394 | $22996 |
| &nbsp;&nbsp;Income tax, including excise tax, paid | 2722 | 2599 |
| &nbsp;&nbsp;Distribution payable | 38244 | 29397 |
| &nbsp;&nbsp;Distributions reinvested | 930 | 991 |

---

See accompanying notes to unaudited consolidated financial statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States** | **Debt Securities- United States** | **Debt Securities- United States** | **Debt Securities- United States** |  |  |  |  |  |
| ***<u>Artificial Intelligence & Automation</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Applied Digital Corporation | Equipment Financing | March 13, 2024 | October 1, 2025 | Fixed interest rate 19.0%; EOT 0.0% | $449 | $448 | $454 | (9)(10)(14) |
|  | Equipment Financing | March 25, 2024 | March 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | 2989 | 2988 | 3043 | (9)(10)(14)(19) |
|  | Equipment Financing | April 24, 2024 | April 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | 1739 | 1739 | 1772 | (9)(10)(14)(19) |
|  | Equipment Financing | May 28, 2024 | May 1, 2026 | Fixed interest rate 16.0%; EOT 0.0% | 826 | 826 | 840 | (9)(10)(14) |
|  | Equipment Financing | June 21, 2024 | April 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | 2816 | 2817 | 2870 | (9)(10)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Applied Digital Corporation |  |  |  |  | 8819 | 8818 | 8979 |  |
| &nbsp;&nbsp;&nbsp;Augmented Reality Concepts, Inc. | Secured Loan | June 17, 2024 | June 18, 2029 | Variable interest rate SOFR 3 Month Term + 7.3%; EOT 0.0% | $14145 | $13917 | $14201 | (8)(14)(19)(22) |
| &nbsp;&nbsp;&nbsp;Cirrascale Cloud Services, LLC | Equipment Financing | June 27, 2024 | September 1, 2026 | Fixed interest rate 12.7%; EOT 4.0% | $10811 | $11599 | $11665 | (9)(14)(19) |
|  | Equipment Financing | October 22, 2024 | April 1, 2027 | Fixed interest rate 10.2%; EOT 5.0% | 10483 | 11149 | 11159 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Cirrascale Cloud Services, LLC |  |  |  |  | 21294 | 22748 | 22824 |  |
| &nbsp;&nbsp;&nbsp;D-Wave Quantum Inc. | Equipment Financing | August 1, 2025 | September 1, 2028 | Fixed interest rate 10.8%; EOT 4.0% | $308 | $300 | $300 | (14)(19)(22) |
| &nbsp;&nbsp;&nbsp;K2View Inc. | Secured Loan | May 30, 2025 | June 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 2.5% | $15000 | $14757 | $14993 | (8) |
| &nbsp;&nbsp;&nbsp;Sortera Technologies, Inc. | Equipment Financing | February 11, 2025 | March 1, 2028 | Fixed interest rate 12.5%; EOT 4.0% | $4583 | $4442 | $4502 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Swimlane, Inc. | Secured Loan | May 28, 2025 | June 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 2.3% | $11400 | $11184 | $11355 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Tquila Automation, Inc | Secured Loan | July 2, 2025 | August 1, 2030 | Variable interest rate Prime + 5.0% or Floor rate 12.3%; EOT 3.0% | $6600 | $6512 | $6512 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;Uniphore Technologies Inc. | Secured Loan | September 30, 2025 | October 1, 2030 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.0% | $36000 | $35057 | $35057 | (8)(14)(19) |
| **Sub-total: Artificial Intelligence & Automation (11.9%)\*** | **Sub-total: Artificial Intelligence & Automation (11.9%)\*** | **Sub-total: Artificial Intelligence & Automation (11.9%)\*** |  |  | $**118149** | $**117735** | $**118723** |  |
| ***<u>Biotechnology</u>*** | ***<u>Biotechnology</u>*** | ***<u>Biotechnology</u>*** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pendulum Therapeutics, Inc. | Secured Loan | December 31, 2021 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | $4292 | $4296 | $4291 | (8)(14) |
|  | Secured Loan | February 28, 2022 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | 4581 | 4574 | 4573 | (8)(14) |
|  | Secured Loan | March 30, 2022 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | 4722 | 4710 | 4712 | (8)(14) |
|  | Secured Loan | May 6, 2022 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | 5000 | 4974 | 4982 | (8)(14) |
|  | Secured Loan | June 17, 2022 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | 5000 | 4974 | 4982 | (8)(14) |
|  | Secured Loan | February 1, 2024 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | 1405 | 1398 | 1366 | (8)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Pendulum Therapeutics, Inc. |  |  |  |  | 25000 | 24926 | 24906 |  |
| &nbsp;&nbsp;&nbsp;Taysha Gene Therapies, Inc. | Secured Loan | August 7, 2025 | September 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 5.0% | $48000 | $47974 | $48828 | (8)(14)(19) |
| **Sub-total: Biotechnology (7.4%)\*** |  |  |  |  | $**73000** | $**72900** | $**73734** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Connectivity</u>*** | ***<u>Connectivity</u>*** | ***<u>Connectivity</u>*** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;AST & Science, LLC | Equipment Financing | June 27, 2025 | June 1, 2030 | Fixed interest rate 12.4%; EOT 9.0% | $14985 | $15006 | $15195 | (9)(10)(14)(19) |
|  | Equipment Financing | June 30, 2025 | June 1, 2030 | Fixed interest rate 12.5%; EOT 9.0% | 2437 | 2440 | 2471 | (9)(10)(14)(19) |
|  | Equipment Financing | September 26, 2025 | October 1, 2030 | Fixed interest rate 12.4%; EOT 9.0% | 6600 | 6554 | 6554 | (10)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total AST & Science, LLC |  |  |  |  | 24022 | 24000 | 24220 |  |
| &nbsp;&nbsp;&nbsp;Tarana Wireless, Inc. | Secured Loan | September 23, 2024 | October 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 12.5%; EOT 4.0% | $14800 | $14350 | $14575 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Vertical Communications, Inc. | Secured Loan | August 23, 2021 | November 1, 2026 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 23.8% | $12600 | $15768 | $14422 | (8)(23) |
|  | Secured Loan | July 16, 2025 | October 31, 2025 | Fixed interest rate 11.5%; EOT 0.0% | 1000 | 998 | 1000 | (23) |
|  | Secured Loan | September 9, 2025 | October 31, 2025 | Fixed interest rate 11.5%; EOT 0.0% | 500 | 497 | 500 | (23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Vertical Communications, Inc. |  |  |  |  | 14100 | 17263 | 15922 |  |
| **Sub-total: Connectivity (5.5%)\*** |  |  |  |  | $**52922** | $**55613** | $**54717** |  |
| ***<u>Consumer Products & Services</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Bobbie Baby, Inc. | Equipment Financing | September 11, 2025 | October 1, 2028 | Fixed interest rate 11.5%; EOT 3.0% | $12900 | $12665 | $12666 | (14)(19) |
| &nbsp;&nbsp;&nbsp;Ogee, Inc. | Secured Loan | February 14, 2023 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | $4700 | $4804 | $4789 | (8)(14)(19) |
|  | Secured Loan | September 29, 2023 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 4700 | 4786 | 4800 | (8)(14)(19) |
|  | Secured Loan | August 1, 2024 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 4700 | 4724 | 4703 | (8)(14)(19) |
|  | Secured Loan | July 18, 2025 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 4700 | 4018 | 4018 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Ogee, Inc. |  |  |  |  | 18800 | 18332 | 18310 |  |
| &nbsp;&nbsp;&nbsp;Quip NYC, Inc. | Secured Loan | September 30, 2025 | September 1, 2028 | Variable interest rate Prime + 9.0% or Floor rate 12.3%; EOT 0.0% | 3656 | 3655 | 3657 | (8) |
| &nbsp;&nbsp;&nbsp;Rinse, Inc. | Secured Loan | May 10, 2022 | June 1, 2027 | Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.8% | $2846 | $2991 | $3009 | (8)(14) |
|  | Secured Loan | September 22, 2023 | October 1, 2028 | Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.8% | 3629 | 3675 | 3733 | (8)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Rinse, Inc. |  |  |  |  | 6475 | 6666 | 6742 |  |
| &nbsp;&nbsp;&nbsp;UnTuckIt, Inc. | Secured Loan | January 16, 2020 | December 1, 2025 | Fixed interest rate 12.0%; EOT 5.0% | $1320 | $2315 | $2302 |  |
| **Sub-total: Consumer Products & Services (4.4%)\*** |  |  |  |  | $**43151** | $**43633** | $**43677** |  |
| ***<u>Diagnostics & Tools</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Rapid Micro Biosystems, Inc. | Secured Loan | August 8, 2025 | September 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 4.0% | $18200 | $17617 | $17617 | (8)(14)(19) |
| **Sub-total: Diagnostics & Tools (1.8%)\*** |  |  |  |  | $**18200** | $**17617** | $**17617** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Education Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Edblox, Inc. | Secured Loan | March 19, 2024 | April 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.8%; EOT 2.5% | $15000 | $14992 | $13369 | (8)(9) |
| &nbsp;&nbsp;&nbsp;Medical Sales Training Holding Company | Secured Loan | March 18, 2021 | December 31, 2025 | Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 6.3% | $5175 | $5547 | $3549 | (8)(18) |
|  | Secured Loan | July 21, 2021 | December 31, 2025 | Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 6.3% | 1825 | 1944 | 1251 | (8)(18) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Medical Sales Training Holding Company |  |  |  |  | 7000 | 7491 | 4800 |  |
| &nbsp;&nbsp;&nbsp;Yellowbrick Learning, Inc. | Secured Loan | February 1, 2021 | March 1, 2026 | Fixed interest rate 2.0%; EOT 5.0% | $7500 | $7875 | $7142 |  |
|  | Secured Loan | August 10, 2021 | March 1, 2026 | Fixed interest rate 2.0%; EOT 5.0% | 2500 | 2625 | 2381 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Yellowbrick Learning, Inc. |  |  |  |  | 10000 | 10500 | 9523 |  |
| **Sub-total: Education Technology (2.8%)\*** |  |  |  |  | $**32000** | $**32983** | $**27692** |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Alt Lending SPV II, LLC | Secured Loan | July 8, 2025 | July 8, 2028 | Variable interest rate SOFR 1 Month Term + 9.0%; EOT 0.0% | $12394 | $11915 | $11915 | (8)(10)(12)(21) |
| &nbsp;&nbsp;&nbsp;Beam Technologies, Inc. | Secured Loan | August 30, 2024 | October 1, 2029 | Variable interest rate Prime + 2.8% or Floor rate 11.0%+PIK Fixed Interest Rate 1.5%; EOT 2.0% | $29705 | $30290 | $30030 | (8)(9)(14)(15)(19) |
|  | Secured Loan | June 25, 2025 | October 1, 2029 | Variable interest rate Prime + 2.8% or Floor rate 11.0%+PIK Fixed Interest Rate 1.5%; EOT 2.0% | 2379 | 2428 | 2409 | (8)(9)(14)(15)(19) |
|  | Secured Loan | August 7, 2025 | December 31, 2029 | Fixed interest rate 0.0%; EOT 0.0% | 395 | 395 | 395 | (9)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Beam Technologies, Inc. |  |  |  |  | 32479 | 33113 | 32834 |  |
| &nbsp;&nbsp;&nbsp;Busbot, Inc. | Secured Loan | April 1, 2024 | October 1, 2026 | Variable interest rate SOFR 1 Month Term + 11.5%; EOT 0.0% | $10322 | $10238 | $10238 | (8)(10)(12)(21) |
| &nbsp;&nbsp;&nbsp;Centivo Corporation | Secured Loan | July 31, 2024 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | $3794 | $3742 | $3790 | (8)(9)(14)(15)(19) |
|  | Secured Loan | December 20, 2024 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 3779 | 3624 | 3645 | (8)(9)(14)(15)(19) |
|  | Secured Loan | February 3, 2025 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 3775 | 3632 | 3657 | (8)(9)(14)(15)(19) |
|  | Secured Loan | May 20, 2025 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 7528 | 7229 | 7284 | (8)(9)(14)(15)(19) |
|  | Secured Loan | June 13, 2025 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 3761 | 3607 | 3636 | (8)(9)(14)(15)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Centivo Corporation |  |  |  |  | 22637 | 21834 | 22012 |  |
| &nbsp;&nbsp;&nbsp;Cherry Technologies, Inc. | Secured Loan | March 29, 2024 | April 1, 2029 | Variable interest rate Prime + 2.5% or Floor rate 9.5%; EOT 2.0% | $7235 | $7508 | $7402 | (8)(9)(14)(19) |
|  | Secured Loan | July 31, 2024 | April 1, 2029 | Variable interest rate Prime + 2.5% or Floor rate 9.5%; EOT 2.0% | 7235 | 7513 | 7392 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Cherry Technologies, Inc. |  |  |  |  | 14470 | 15021 | 14794 |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tilt Finance, Inc. (dba Empower Financial, Inc.) | Secured Loan | October 13, 2023 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | $11622 | $11652 | $11774 | (8)(9)(14)(19) |
|  | Secured Loan | January 5, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 2902 | 2860 | 2896 | (8)(9)(14)(19) |
|  | Secured Loan | February 8, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 4353 | 4288 | 4341 | (8)(9)(14)(19) |
|  | Secured Loan | April 9, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 4348 | 4189 | 4230 | (8)(9)(14)(19) |
|  | Secured Loan | May 15, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 14495 | 14702 | 14958 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Tilt Finance, Inc. (dba Empower Financial, Inc.) |  |  |  |  | 37720 | 37691 | 38199 |  |
| &nbsp;&nbsp;&nbsp;Gravie, Inc. | Secured Loan | June 4, 2024 | July 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 13.0%; EOT 2.5% | $15980 | $15829 | $15545 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Inshur, Inc. | Secured Loan | June 10, 2025 | July 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 2.5% | $25000 | $24598 | $24815 | (8) |
| &nbsp;&nbsp;&nbsp;Kafene, Inc. | Secured Loan | January 5, 2024 | February 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 13.0%; EOT 1.0% | $12500 | $12628 | $12711 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Kard Financial, Inc. | Secured Loan | September 10, 2025 | October 1, 2030 | Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 2.0% | $6020 | $5848 | $5848 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;Lendflow, Inc. | Secured Loan | April 24, 2025 | May 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 12.0%; EOT 2.7% | $2040 | $2009 | $2041 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Mesa Financial, Inc. | Secured Loan | August 29, 2024 | February 28, 2027 | Variable interest rate SOFR 1 Month Term + 10.3% or Floor rate 13.0%; EOT 0.0% | $12041 | $11922 | $11922 | (8)(10)(12)(21) |
| &nbsp;&nbsp;&nbsp;Mesa Financing I, LLC | Secured Loan | May 7, 2025 | May 7, 2028 | Variable interest rate SOFR 1 Month Term + 10.8% or Floor rate 12.8%; EOT 0.0% | $5920 | $5788 | $5913 | (8)(10)(12)(21) |
| &nbsp;&nbsp;&nbsp;One Million Metrics (dba Kinetic) | Secured Loan | August 25, 2025 | September 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 12.0%; EOT 3.0% | $6450 | $6262 | $6262 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;Parafin SPV 2, LLC | Secured Loan | February 22, 2024 | December 21, 2026 | Variable interest rate SOFR 1 Month Term + 10.8% or Floor rate 12.8%; EOT 0.0% | $23806 | $23634 | $23634 | (8)(10)(12)(21) |
| &nbsp;&nbsp;&nbsp;Parafin SPV 3, LLC | Secured Loan | July 25, 2024 | January 25, 2027 | Variable interest rate SOFR 1 Month Term + 10.8% or Floor rate 13.8%; EOT 0.0% | $15928 | $15808 | $15808 | (8)(10)(12)(21) |
| &nbsp;&nbsp;&nbsp;PatientFi, Inc. | Secured Loan | March 14, 2025 | April 1, 2030 | Variable interest rate Prime + 3.5% or Floor rate 10.5%; EOT 2.5% | $5700 | $5600 | $5641 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Slope Tech, Inc. | Secured Loan | October 5, 2022 | February 27, 2026 | Variable interest rate SOFR 1 Month Term + 11.8% or Floor rate 11.8%; EOT 0.0% | $3497 | $3477 | $3477 | (8)(10)(12)(21) |
| &nbsp;&nbsp;&nbsp;Thrivory, Inc. | Secured Loan | September 9, 2025 | October 1, 2027 | Variable interest rate SOFR 1 Month Term + 10.5% or Floor rate 2.0%; EOT 0.0% | $3960 | $3893 | $3893 | (8)(10)(12)(21) |
| &nbsp;&nbsp;&nbsp;Under Technologies, Inc. | Secured Loan | September 13, 2024 | June 1, 2029 | Variable interest rate Prime + 3.8% or Floor rate 12.0%; EOT 4.3% | $7400 | $7354 | $7486 | (8)(9)(14)(19) |
|  | Secured Loan | November 27, 2024 | June 1, 2029 | Variable interest rate Prime + 3.8% or Floor rate 12.0%; EOT 4.3% | 7400 | 7334 | 7384 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Under Technologies, Inc. |  |  |  |  | 14800 | 14688 | 14870 |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Wisetack, Inc. | Secured Loan | November 14, 2024 | December 1, 2029 | Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 2.5% | $12150 | $12049 | $12218 | (8)(9)(14)(19) |
| **Sub-total: Finance and Insurance (29.5%)\*** |  |  |  |  | $**295814** | $**293845** | $**294590** |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;DrinkPak, LLC | Equipment Financing | February 17, 2023 | September 1, 2026 | Fixed interest rate 12.9%; EOT 7.0% | $4192 | $5182 | $5195 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Emergy, Inc. | Equipment Financing | December 15, 2021 | July 1, 2026 | Fixed interest rate 12.7%; EOT 11.5% | $3183 | $3992 | $786 | (18) |
|  | Equipment Financing | December 13, 2022 | July 1, 2027 | Fixed interest rate 9.4%; EOT 11.5% | 6183 | 6970 | 1372 | (9)(18) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Emergy, Inc. |  |  |  |  | 9366 | 10962 | 2158 |  |
| **Sub-total: Food and Agriculture Technologies (0.7%)\*** |  |  |  |  | $**13558** | $**16144** | $**7353** |  |
| ***<u>Green Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Commonwealth Fusion Systems, LLC | Equipment Financing | June 16, 2023 | July 1, 2030 | Fixed interest rate 13.0%; EOT 10.0% | $3111 | $3292 | $3366 | (9)(14)(19) |
|  | Equipment Financing | June 27, 2024 | July 1, 2030 | Fixed interest rate 13.2%; EOT 10.0% | 9003 | 9282 | 9513 | (9)(14)(19) |
|  | Equipment Financing | January 14, 2025 | July 1, 2029 | Fixed interest rate 11.2%; EOT 6.0% | 11003 | 11145 | 11238 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Commonwealth Fusion Systems, LLC | &nbsp;&nbsp;&nbsp;&nbsp;Total Commonwealth Fusion Systems, LLC |  |  |  | 23117 | 23719 | 24117 |  |
| &nbsp;&nbsp;&nbsp;Electric Hydrogen Co. | Equipment Financing | September 12, 2022 | April 1, 2026 | Fixed interest rate 9.0%; EOT 10.0% | $329 | $529 | $521 | (14) |
|  | Equipment Financing | December 22, 2023 | January 1, 2029 | Fixed interest rate 12.5%; EOT 15.0% | 3315 | 3687 | 3646 | (9)(14)(19) |
|  | Equipment Financing | June 27, 2024 | January 1, 2029 | Fixed interest rate 12.6%; EOT 15.0% | 2718 | 2938 | 2936 | (9)(14)(19) |
|  | Equipment Financing | September 19, 2024 | October 1, 2028 | Fixed interest rate 12.5%; EOT 15.0% | 1643 | 1765 | 1753 | (9)(14)(19) |
|  | Equipment Financing | November 14, 2024 | December 1, 2028 | Fixed interest rate 11.9%; EOT 15.0% | 394 | 419 | 415 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Electric Hydrogen Co. |  |  |  |  | 8399 | 9338 | 9271 |  |
| &nbsp;&nbsp;&nbsp;Form Energy Inc. | Equipment Financing | October 21, 2024 | November 1, 2027 | Fixed interest rate 12.7%; EOT 3.0% | $23611 | $23714 | $24013 | (9)(14)(19) |
|  | Equipment Financing | December 12, 2024 | January 1, 2028 | Fixed interest rate 12.5%; EOT 3.0% | 6327 | 6321 | 6392 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Form Energy Inc. | &nbsp;&nbsp;&nbsp;&nbsp;Total Form Energy Inc. |  |  |  | 29938 | 30035 | 30405 |  |
| &nbsp;&nbsp;&nbsp;Hi-Power, LLC | Equipment Financing | September 30, 2022 | April 1, 2026 | Fixed interest rate 14.7%; EOT 1.0% | $733 | $774 | $790 | (14) |
| &nbsp;&nbsp;&nbsp;SeaOn Global, LLC | Equipment Financing | June 16, 2022 | July 1, 2026 | Fixed interest rate 9.3%; EOT 11.0% | $1457 | $2173 | $2116 |  |
|  | Equipment Financing | August 17, 2022 | September 1, 2026 | Fixed interest rate 9.3%; EOT 11.0% | 851 | 1189 | 1160 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total SeaOn Global, LLC |  |  |  |  | 2308 | 3362 | 3276 |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Footprint International Holding, Inc. | Secured Loan | February 18, 2022 | March 1, 2027 | Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.5% | $11129 | $11456 | $10921 | (8)(14) |
|  | Secured Loan | April 20, 2022 | March 1, 2027 | Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.5% | 11129 | 11441 | 10903 | (8)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Footprint International Holding, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;Total Footprint International Holding, Inc. |  |  |  | 22258 | 22897 | 21824 |  |
| **Sub-total: Green Technology (9.0%)\*** |  |  |  |  | $**86753** | $**90125** | $**89683** |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;B.Well Connected Health, Inc. | Secured Loan | April 10, 2025 | May 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 3.0% | $5700 | $5625 | $5707 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Lightning Step Technologies, LLC | Secured Loan | August 6, 2025 | August 6, 2030 | Variable interest rate SOFR 3 Month Term + 7.4%; EOT 0.0% | $9000 | $8822 | $8822 | (8) |
| &nbsp;&nbsp;&nbsp;Moxe Health Corporation | Secured Loan | December 29, 2023 | January 1, 2028 | Variable interest rate Prime + 5.5% or Floor rate 13.0%; EOT 4.8% | $12500 | $12698 | $12692 | (8) |
| &nbsp;&nbsp;&nbsp;Paytient Technologies, Inc. | Secured Loan | May 27, 2025 | June 1, 2030 | Variable interest rate Prime + 3.8% or Floor rate 10.8%; EOT 3.0% | $8125 | $7956 | $8021 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;PurpleLab, Inc. | Secured Loan | September 24, 2025 | October 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 11.5%; EOT 2.0% | $21500 | $21016 | $21016 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;RXAnte, Inc. | Secured Loan | November 21, 2022 | December 1, 2027 | Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5% | $8612 | $8771 | $8822 | (8)(9)(14)(15)(19) |
|  | Secured Loan | April 14, 2023 | December 1, 2027 | Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5% | 2863 | 2899 | 2968 | (8)(9)(14)(15)(19) |
|  | Secured Loan | October 19, 2023 | December 1, 2027 | Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5% | 2834 | 2866 | 2919 | (8)(9)(14)(15)(19) |
|  | Secured Loan | September 9, 2024 | December 1, 2027 | Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5% | 2798 | 2826 | 2879 | (8)(9)(14)(15)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total RXAnte, Inc. |  |  |  |  | 17107 | 17362 | 17588 |  |
| &nbsp;&nbsp;&nbsp;TMRW Life Sciences, Inc. | Secured Loan | April 29, 2022 | May 1, 2027 | Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 5.8% | $5000 | $5222 | $4933 | (8)(14) |
|  | Secured Loan | March 3, 2023 | May 1, 2027 | Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 5.8% | 15000 | 15667 | 14799 | (8)(14) |
|  | Secured Loan | December 8, 2023 | May 1, 2027 | Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 5.8% | 10000 | 10445 | 9866 | (8)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total TMRW Life Sciences, Inc. |  |  |  |  | 30000 | 31334 | 29598 |  |
| &nbsp;&nbsp;&nbsp;WorkWell Prevention & Care Inc. | Secured Loan | December 31, 2022 | January 1, 2027 | Variable interest rate Prime + 5.0% or Floor rate 6.0%; EOT 0.0% | $500 | $500 | $500 | (8)(23) |
| **Sub-total: Healthcare Technology (10.4%)\*** |  |  |  |  | $**104432** | $**105313** | $**103944** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Human Resource Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Nomad Health, Inc. | Secured Loan | June 12, 2024 | September 1, 2027 | Fixed interest rate 10.0%; EOT 0.0% | $500 | $500 | $381 | (18)(23) |
|  | Secured Loan | September 30, 2025 | January 1, 2028 | Fixed interest rate 7.5%; EOT 0.0% | 11401 | 11401 | 7533 | (14)(18)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Nomad Health, Inc. |  |  |  |  | 11901 | 11901 | 7914 |  |
| **Sub-total: Human Resource Technology (0.8%)\*** |  |  |  |  | $**11901** | $**11901** | $**7914** |  |
| ***<u>Industrials</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;3DEO, Inc. | Equipment Financing | February 1, 2025 | February 1, 2028 | Fixed interest rate 0.1%; EOT 2.2% | $1871 | $1890 | $1859 | (14) |
| **Sub-total: Industrials (0.2%)\*** |  |  |  |  | $**1871** | $**1890** | $**1859** |  |
| ***<u>Marketing, Media, and Entertainment</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Angel Studios, Inc. | Secured Loan | September 8, 2025 | October 1, 2030 | Variable interest rate Prime + 6.0% or Floor rate 13.5%; EOT 2.0% | $38400 | $34448 | $34448 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;Drone Racing League, Inc. | Secured Loan | October 17, 2022 | December 1, 2025 | Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.5% | $2417 | $2659 | $2649 | (8) |
| &nbsp;&nbsp;&nbsp;Grabit Interactive Media, Inc. | Secured Loan | April 8, 2022 | November 1, 2026 | Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 2.5% | $2001 | $2100 | $2077 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Incontext Solutions, Inc. | Secured Loan | September 1, 2025 | June 1, 2026 | Fixed interest rate 12.0%; EOT 0.0% | $1150 | $1150 | $1126 |  |
| &nbsp;&nbsp;&nbsp;Rarefied Atmosphere, Inc. | Secured Loan | May 6, 2025 | June 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 2.0% | $41645 | $40929 | $41562 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Vox Media Holdings, Inc. | Secured Loan | October 18, 2022 | November 1, 2027 | Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5% | $10506 | $10518 | $10440 | (8)(9)(14)(19) |
|  | Secured Loan | December 29, 2022 | January 1, 2028 | Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5% | 5251 | 5254 | 5220 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Vox Media Holdings, Inc. |  |  |  |  | 15757 | 15772 | 15660 |  |
| **Sub-total: Marketing, Media, and Entertainment (9.8%)\*** | **Sub-total: Marketing, Media, and Entertainment (9.8%)\*** | **Sub-total: Marketing, Media, and Entertainment (9.8%)\*** | **Sub-total: Marketing, Media, and Entertainment (9.8%)\*** |  | $**101370** | $**97058** | $**97522** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Apiject Holdings, Inc. | Equipment Financing | June 24, 2024 | July 1, 2028 | Fixed interest rate 12.6%; EOT 7.5% | $14654 | $15154 | $15226 | (9)(14)(19) |
|  | Equipment Financing | September 30, 2024 | October 1, 2028 | Fixed interest rate 12.7%; EOT 7.5% | 6219 | 6340 | 6351 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Apiject Holdings, Inc. |  |  |  |  | 20873 | 21494 | 21577 |  |
| &nbsp;&nbsp;&nbsp;Cagent Vascular, Inc. | Secured Loan | January 24, 2025 | February 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 3.0% | $3150 | $3133 | $3161 | (8)(9)(19) |
| &nbsp;&nbsp;&nbsp;Elucent Medical, Inc. | Secured Loan | October 31, 2024 | November 30, 2029 | Variable interest rate Prime + 3.8% or Floor rate 11.3%; EOT 3.3% | $12150 | $12027 | $12254 | (8)(9)(19) |
| &nbsp;&nbsp;&nbsp;Lightforce Orthodontics, Inc. | Secured Loan | August 6, 2024 | August 6, 2029 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0% | $28200 | $28072 | $28460 | (8)(14)(19) |
|  | Secured Loan | September 25, 2024 | August 6, 2029 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0% | 4700 | 4678 | 4743 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Lightforce Orthodontics, Inc. |  |  |  |  | 32900 | 32750 | 33203 |  |
| &nbsp;&nbsp;&nbsp;Nalu Medical, Inc | Secured Loan | July 3, 2025 | August 1, 2030 | Variable interest rate Prime + 3.0% or Floor rate 10.0%; EOT 4.0% | $15300 | $15129 | $15129 | (8)(19)(22) |
| &nbsp;&nbsp;&nbsp;Neurolens, Inc. | Secured Loan | September 29, 2023 | October 1, 2028 | Variable interest rate Prime + 3.5% or Floor rate 11.5%; EOT 3.0% | $20000 | $20115 | $20823 | (8) |
|  | Secured Loan | January 21, 2025 | October 1, 2028 | Variable interest rate Prime + 3.5% or Floor rate 11.5%; EOT 3.0% | 15000 | 14956 | 14895 | (8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Neurolens, Inc. |  |  |  |  | 35000 | 35071 | 35718 |  |
| &nbsp;&nbsp;&nbsp;Neuros Medical, Inc. | Secured Loan | August 10, 2023 | September 1, 2027 | Variable interest rate Prime + 6.0% or Floor rate 14.3%; EOT 4.5% | $6000 | $6122 | $6146 | (8)(9)(14) |
|  | Secured Loan | August 30, 2024 | September 1, 2027 | Variable interest rate Prime + 6.0% or Floor rate 14.3%; EOT 4.5% | 3000 | 3026 | 3012 | (8)(9)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Neuros Medical, Inc. |  |  |  |  | 9000 | 9148 | 9158 |  |
| &nbsp;&nbsp;&nbsp;Okami Medical, Inc. | Secured Loan | June 24, 2025 | July 1, 2030 | Variable interest rate Prime + 3.8% or Floor rate 10.5%; EOT 2.0% | $4400 | $4321 | $4358 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;Restor3d, Inc. | Secured Loan | June 4, 2024 | July 4, 2028 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.3% | $3995 | $3998 | $4121 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Shoulder Innovations, Inc. | Secured Loan | August 7, 2023 | September 1, 2028 | Variable interest rate Prime + 3.5% or Floor rate 11.0%; EOT 3.0% | $11250 | $11589 | $11446 | (8)(9)(14) |
| &nbsp;&nbsp;&nbsp;Vital Connect, Inc. | Secured Loan | July 3, 2024 | July 3, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0% | $27650 | $27706 | $28122 | (8)(9)(14)(19) |
|  | Secured Loan | March 21, 2025 | July 3, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0% | 7900 | 7871 | 7993 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Vital Connect, Inc. |  |  |  |  | 35550 | 35577 | 36115 |  |
| **Sub-total: Medical Devices (18.7%)\*** | **Sub-total: Medical Devices (18.7%)\*** | **Sub-total: Medical Devices (18.7%)\*** | **Sub-total: Medical Devices (18.7%)\*** |  | $**183568** | $**184237** | $**186240** |  |
| ***<u>Multi-Sector Holdings</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Senior Credit Corp 2022 LLC | Secured Loan | January 30, 2023 | December 5, 2028 | Fixed interest rate 8.5%; EOT 0.0% | $12885 | $12885 | $12885 | (10)(23) |
| **Sub-total: Multi-Sector Holdings (1.3%)\*** | **Sub-total: Multi-Sector Holdings (1.3%)\*** | **Sub-total: Multi-Sector Holdings (1.3%)\*** | **Sub-total: Multi-Sector Holdings (1.3%)\*** |  | $**12885** | $**12885** | $**12885** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cellares Corporation | Equipment Financing | August 2, 2024 | September 1, 2029 | Fixed interest rate 12.0%; EOT 4.5% | $3906 | $3971 | $4038 | (14)(19) |
|  | Equipment Financing | January 10, 2025 | February 1, 2030 | Fixed interest rate 12.2%; EOT 4.5% | 5386 | 5428 | 5434 | (14)(19) |
|  | Equipment Financing | January 29, 2025 | February 1, 2030 | Fixed interest rate 12.5%; EOT 4.5% | 3291 | 3314 | 3319 | (14)(19) |
|  | Secured Loan | August 2, 2024 | February 1, 2027 | Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 4.0% | 47000 | 47282 | 48061 | (8)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Cellares Corporation |  |  |  |  | 59583 | 59995 | 60852 |  |
| &nbsp;&nbsp;&nbsp;Metabolon, Inc. | Secured Loan | March 28, 2024 | April 1, 2029 | Variable interest rate Prime + 2.5% or Floor rate 10.0%+PIK Fixed Interest Rate 3.0%; EOT 4.8% | $44122 | $43821 | $44406 | (8)(15) |
|  | Secured Loan | October 1, 2024 | April 1, 2029 | Variable interest rate Prime + 2.5% or Floor rate 10.0%+PIK Fixed Interest Rate 3.0%; EOT 4.8% | 5152 | 5136 | 5127 | (8)(15) |
|  | Secured Loan | January 6, 2025 | April 1, 2029 | Variable interest rate Prime + 2.5% or Floor rate 10.0%+PIK Fixed Interest Rate 3.0%; EOT 4.8% | 2556 | 2534 | 2530 | (8)(15) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Metabolon, Inc. |  |  |  |  | 51830 | 51491 | 52063 |  |
| &nbsp;&nbsp;&nbsp;Upward Health, Inc. | Secured Loan | August 6, 2024 | September 1, 2029 | Variable interest rate Prime + 4.3% or Floor rate 12.8%; EOT 3.0% | $5875 | $5783 | $5912 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Renalogic Holdings, Inc. | Secured Loan | June 30, 2025 | June 30, 2030 | Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0% | $63341 | $62139 | $62411 | (8)(20) |
| &nbsp;&nbsp;&nbsp;Velentium, Inc. | Secured Loan | May 24, 2024 | May 24, 2029 | Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 5.3% | $8500 | $8497 | $8440 | (8)(9)(14) |
| **Sub-total: Other Healthcare Services (19.0%)\*** | **Sub-total: Other Healthcare Services (19.0%)\*** | **Sub-total: Other Healthcare Services (19.0%)\*** | **Sub-total: Other Healthcare Services (19.0%)\*** |  | $**189129** | $**187905** | $**189678** |  |
| ***<u>Real Estate Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Homelight Lending, Inc. | Secured Loan | October 15, 2021 | June 1, 2026 | Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.5% | $2065 | $2289 | $2258 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Knockaway, Inc. | Secured Loan | September 29, 2023 | September 1, 2028 | Fixed interest rate 10.2%; EOT 0.0% | $23644 | $21257 | $20567 | (8)(14)(23) |
|  | Secured Loan | May 14, 2025 | May 14, 2027 | Fixed interest rate 4.0%; EOT 0.0% | 1600 | 1600 | 1626 | (16)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Knockaway, Inc. |  |  |  |  | 25244 | 22857 | 22193 |  |
| &nbsp;&nbsp;&nbsp;Knockaway Trinity Holdings, LLC | Secured Loan | December 6, 2023 | December 27, 2026 | Variable interest rate SOFR 1 Month Term + 9.3% or Floor rate 13.8%; EOT 0.0% | $17953 | $17943 | $17943 | (8)(10)(12)(21)(23) |
| &nbsp;&nbsp;&nbsp;Maxwell Financial Labs, Inc. | Secured Loan | September 30, 2021 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 13.5%; EOT 5.0% | $15000 | $15034 | $14346 | (8)(14) |
|  | Secured Loan | October 2, 2024 | October 2, 2026 | Fixed interest rate 6.0%; EOT 0.0% | 187 | 187 | 199 | (16) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Maxwell Financial Labs, Inc. |  |  |  |  | 15187 | 15221 | 14545 |  |
| &nbsp;&nbsp;&nbsp;Orchard Technologies, Inc. | Secured Loan | January 1, 2024 | January 1, 2029 | Variable interest rate Prime + 10.0% or Floor rate 17.0%; EOT 4.0% | $28540 | $29572 | $24592 | (8) |
| **Sub-total: Real Estate Technology (8.2%)\*** | **Sub-total: Real Estate Technology (8.2%)\*** | **Sub-total: Real Estate Technology (8.2%)\*** | **Sub-total: Real Estate Technology (8.2%)\*** |  | $**88989** | $**87882** | $**81531** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Software as a Service ("SaaS")</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cpacket Networks, Inc. | Secured Loan | January 29, 2024 | February 1, 2029 | Variable interest rate Prime + 4.8% or Floor rate 12.0%+PIK Fixed Interest Rate 1.3%; EOT 3.0% | $20671 | $20681 | $20970 | (8)(9)(14)(15) |
| &nbsp;&nbsp;&nbsp;Eyelit Technologies, Inc. | Secured Loan | November 4, 2024 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0% | $3250 | $3197 | $3313 | (8)(14)(19)(20)(22) |
|  | Secured Loan | December 27, 2024 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0% | 5720 | 5623 | 5831 | (8)(14)(19)(20)(22) |
|  | Secured Loan | June 20, 2025 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0% | 650 | 638 | 670 | (8)(14)(19)(20)(22) |
|  | Secured Loan | September 10, 2025 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0% | 1625 | 1593 | 1593 | (8)(14)(19)(20)(22) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Eyelit Technologies, Inc. |  |  |  |  | 11245 | 11051 | 11407 |  |
| &nbsp;&nbsp;&nbsp;Hometown Ticketing, Inc. | Secured Loan | November 25, 2024 | November 25, 2029 | Variable interest rate SOFR 3 Month Term + 7.7%; EOT 0.0% | $24723 | $24311 | $24782 | (8)(19) |
| &nbsp;&nbsp;&nbsp;CCP InterGalactic Buyer, LLC | Secured Loan | September 15, 2025 | September 15, 2030 | Variable interest rate SOFR 3 Month Term + 5.5%; EOT 0.0% | $7500 | $7362 | $7362 | (8)(20) |
| &nbsp;&nbsp;&nbsp;ServiceTrade, Inc. | Secured Loan | August 15, 2024 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.5%; EOT 0.0% | $17250 | $16997 | $17206 | (8)(14)(19)(20)(22) |
|  | Secured Loan | May 2, 2025 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.8%; EOT 0.0% | 1380 | 1357 | 1386 | (8)(14)(19)(20)(22) |
|  | Secured Loan | June 3, 2025 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.8%; EOT 0.0% | 1380 | 1356 | 1385 | (8)(14)(19)(20)(22) |
|  | Secured Loan | September 22, 2025 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | 1380 | 1355 | 1355 | (8)(14)(19)(20)(22) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total ServiceTrade, Inc. |  |  |  |  | 21390 | 21065 | 21332 |  |
| &nbsp;&nbsp;&nbsp;Silk Technologies, Inc. | Secured Loan | November 4, 2024 | December 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 1.5% | $16200 | $15912 | $15910 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;SOCi, Inc. | Secured Loan | October 3, 2024 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0% | $35828 | $35179 | $34863 | (8)(14)(19)(20) |
|  | Secured Loan | December 30, 2024 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0% | 3265 | 3203 | 3179 | (8)(14)(19)(20) |
|  | Secured Loan | April 23, 2025 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0% | 1641 | 1608 | 1637 | (8)(14)(19)(20) |
|  | Secured Loan | August 5, 2025 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0% | 1727 | 1691 | 1691 | (8)(14)(19)(20) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total SOCi, Inc. |  |  |  |  | 42461 | 41681 | 41370 |  |
| &nbsp;&nbsp;&nbsp;Steno Agency, Inc. | Secured Loan | June 21, 2024 | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | $3740 | $3671 | $3786 | (8)(9)(14)(19) |
|  | Secured Loan | January 2, 2025 | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | 3650 | 3656 | 3707 | (8)(9)(14)(19) |
|  | Secured Loan | May 16, 2025 | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | 3650 | 3505 | 3551 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Steno Agency, Inc. |  |  |  |  | 11040 | 10832 | 11044 |  |
| &nbsp;&nbsp;&nbsp;Ticketure | Secured Loan | July 25, 2025 | July 25, 2030 | Variable interest rate SOFR 3 Month Term + 6.3%; EOT 0.0% | $25000 | $24525 | $24525 | (8)(20) |
| &nbsp;&nbsp;&nbsp;Xytech Systems, LLC | Secured Loan | February 26, 2025 | February 26, 2030 | Variable interest rate SOFR 3 Month Term + 6.0%; EOT 0.0% | $37600 | $36966 | $38137 | (8)(19)(20) |
|  | Secured Loan | July 2, 2025 | February 26, 2030 | Variable interest rate SOFR 3 Month Term + 6.0%; EOT 0.0% | 1880 | 1845 | 1845 | (8)(19)(20) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Xytech Systems, LLC |  |  |  |  | 39480 | 38811 | 39982 |  |
| **Sub-total: SaaS (21.9%)\*** |  |  |  |  | $**219710** | $**216231** | $**218684** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Astranis Space Technology Corporation | Equipment Financing | April 13, 2023 | May 1, 2027 | Fixed interest rate 12.1%; EOT 6.5% | $5699 | $6367 | $6179 | (9)(14)(19) |
|  | Equipment Financing | September 27, 2024 | October 1, 2028 | Fixed interest rate 13.8%; EOT 6.5% | 9526 | 10122 | 9815 | (9)(14)(19) |
|  | Equipment Financing | September 27, 2024 | October 1, 2027 | Fixed interest rate 12.6%; EOT 4.0% | 2049 | 2032 | 2049 | (9)(14)(19) |
|  | Equipment Financing | August 25, 2025 | September 1, 2028 | Fixed interest rate 11.6%; EOT 4.0% | 4653 | 4620 | 4620 | (14)(19) |
|  | Secured Loan | August 25, 2025 | August 25, 2030 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 4.0% | 48000 | 45941 | 45941 | (8)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Astranis Space Technology Corporation |  |  |  |  | 69927 | 69082 | 68604 |  |
| &nbsp;&nbsp;&nbsp;Impulse Space, Inc. | Equipment Financing | June 18, 2024 | July 1, 2027 | Fixed interest rate 12.7%; EOT 3.0% | $529 | $538 | $547 | (9)(14)(19)(22) |
|  | Equipment Financing | September 13, 2024 | October 1, 2027 | Fixed interest rate 12.5%; EOT 3.0% | 422 | 425 | 432 | (9)(14)(19)(22) |
|  | Equipment Financing | December 27, 2024 | January 1, 2028 | Fixed interest rate 12.9%; EOT 3.0% | 419 | 418 | 428 | (9)(14)(19)(22) |
|  | Equipment Financing | February 12, 2025 | March 1, 2028 | Fixed interest rate 12.6%; EOT 3.0% | 480 | 477 | 482 | (9)(14)(19)(22) |
|  | Equipment Financing | June 25, 2025 | July 1, 2028 | Fixed interest rate 12.8%; EOT 3.0% | 588 | 578 | 586 | (9)(14)(19)(22) |
|  | Equipment Financing | September 25, 2025 | October 1, 2028 | Fixed interest rate 12.8%; EOT 3.0% | 3931 | 3840 | 3840 | (14)(19)(22) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Impulse Space, Inc. |  |  |  |  | 6369 | 6276 | 6315 |  |
| &nbsp;&nbsp;&nbsp;Kymeta Corporation | Secured Loan | July 3, 2024 | August 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 3.0% | $7900 | $7704 | $7901 | (8)(9)(14)(19) |
|  | Secured Loan | June 11, 2025 | August 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 3.0% | 7900 | 7857 | 7929 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Kymeta Corporation |  |  |  |  | 15800 | 15561 | 15830 |  |
| &nbsp;&nbsp;&nbsp;Rocket Lab USA, Inc. | Equipment Financing | December 29, 2023 | January 1, 2029 | Fixed interest rate 14.8%; EOT 1.0% | $21834 | $21523 | $22872 | (9)(10)(14)(19)(22) |
|  | Equipment Financing | March 20, 2025 | April 1, 2030 | Fixed interest rate 12.3%; EOT 1.0% | 11955 | 11946 | 12215 | (9)(10)(14)(19)(22) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Rocket Lab USA, Inc. |  |  |  |  | 33789 | 33469 | 35087 |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Slingshot Aerospace, Inc. | Secured Loan | July 12, 2024 | August 1, 2029 | Variable interest rate Prime + 5.5% or Floor rate 14.0%; EOT 3.0% | $23700 | $23499 | $23907 | (8)(9)(14)(19) |
|  | Secured Loan | August 7, 2024 | April 30, 2026 | Fixed interest rate 10.0%; EOT 0.0% | 500 | 500 | 559 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Slingshot Aerospace, Inc. |  |  |  |  | 24200 | 23999 | 24466 |  |
| **Sub-total: Space Technology (15.1%)\*** |  |  |  |  | $**150085** | $**148387** | $**150302** |  |
| ***<u>Supply Chain Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Macrofab, Inc. | Secured Loan | July 21, 2023 | August 1, 2027 | Variable interest rate Prime + 5.5% or Floor rate 13.3%; EOT 4.5% | $19495 | $20307 | $19035 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Nucleus RadioPharma, Inc. | Equipment Financing | June 4, 2024 | June 1, 2027 | Fixed interest rate 11.8%; EOT 4.0% | $266 | $275 | $279 | (9)(14) |
|  | Equipment Financing | December 23, 2024 | January 1, 2028 | Fixed interest rate 12.3%; EOT 4.0% | 1322 | 1340 | 1352 | (9)(14) |
|  | Equipment Financing | September 9, 2025 | October 1, 2028 | Fixed interest rate 12.0%; EOT 4.0% | 1652 | 1636 | 1636 | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Nucleus RadioPharma, Inc. |  |  |  |  | 3240 | 3251 | 3267 |  |
| **Sub-total: Supply Chain Technology (2.2%)\*** |  |  |  |  | $**22735** | $**23558** | $**22302** |  |
| ***<u>Transportation Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;EVO Transportation & Energy Services, Inc. | Equipment Financing | May 2, 2025 | May 1, 2028 | Fixed interest rate 4.5%; EOT 12.0% | $2917 | $3007 | $2743 | (19) |
|  | Equipment Financing | May 23, 2025 | June 1, 2028 | Fixed interest rate 4.7%; EOT 12.0% | 2248 | 2307 | 2107 | (19) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total EVO Transportation & Energy Services, Inc. |  |  |  |  | 5165 | 5314 | 4850 |  |
| &nbsp;&nbsp;&nbsp; NextCar Holding Company, Inc. | Secured Loan | December 14, 2021 | December 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | $1830 | $2092 | $437 | (8)(18) |
|  | Secured Loan | December 15, 2021 | December 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 2274 | 2379 | 543 | (8)(18) |
|  | Secured Loan | February 23, 2022 | December 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 2843 | 2974 | 679 | (8)(18) |
|  | Secured Loan | March 16, 2022 | December 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 3411 | 3569 | 814 | (8)(18) |
|  | Secured Loan | April 18, 2022 | December 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 2843 | 2974 | 679 | (8)(18) |
|  | Secured Loan | April 18, 2022 | December 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 2843 | 2974 | 679 | (8)(18) |
|  | Secured Loan | May 17, 2022 | December 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 5685 | 5948 | 1357 | (8)(18) |
|  | Secured Loan | June 22, 2022 | December 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 2843 | 2974 | 679 | (8)(18) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total NextCar Holding Company, Inc. |  |  |  |  | 24572 | 25884 | 5867 |  |
| &nbsp;&nbsp;&nbsp;Get Spiffy, Inc. | Secured Loan | July 14, 2023 | January 14, 2028 | Variable interest rate Prime + 4.5% or Floor rate 12.3%; EOT 6.0% | $9332 | $9569 | $8287 | (8)(9) |
|  | Equipment Financing | July 14, 2023 | February 1, 2027 | Fixed interest rate 12.1%; EOT 4.0% | 194 | 206 | 199 | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Get Spiffy, Inc. |  |  |  |  | 9526 | 9775 | 8486 |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Uveye, Inc. | Equipment Financing | December 26, 2024 | January 1, 2028 | Fixed interest rate 11.9%; EOT 1.0% | $15689 | $15654 | $15754 | (14) |
|  | Equipment Financing | March 28, 2025 | April 1, 2028 | Fixed interest rate 11.9%; EOT 1.0% | 4310 | 4289 | 4314 | (14) |
|  | Equipment Financing | May 15, 2025 | June 1, 2028 | Fixed interest rate 11.6%; EOT 1.0% | 1112 | 1105 | 1111 | (14) |
|  | Equipment Financing | June 25, 2025 | July 1, 2028 | Fixed interest rate 11.9%; EOT 1.0% | 3558 | 3531 | 3553 | (14) |
|  | Equipment Financing | August 13, 2025 | September 1, 2028 | Fixed interest rate 11.6%; EOT 1.0% | 9226 | 9142 | 9142 | (14) |
|  | Equipment Financing | September 26, 2025 | October 1, 2028 | Fixed interest rate 11.9%; EOT 1.0% | 6145 | 6082 | 6082 | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Uveye, Inc. |  |  |  |  | 40040 | 39803 | 39956 |  |
| &nbsp;&nbsp;&nbsp;Zuum Transportation, Inc. | Secured Loan | December 17, 2021 | January 1, 2027 | Variable interest rate Prime + 6.0% or Floor rate 10.8%; EOT 2.5% | $4682 | $4776 | $4451 | (8) |
| **Sub-total: Transportation Technology (6.4%)\*** |  |  |  |  | $**83985** | $**85552** | $**63610** |  |
| **Total: Debt Securities- United States (186.7%)\*** |  |  |  |  | $**1904207** | $**1903394** | $**1864257** |  |
| **Debt Securities- Canada** |  |  |  |  |  |  |  |  |
| ***<u>Construction Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Nexii, Inc. | Secured Loan | July 24, 2024 | July 1, 2027 | Fixed interest rate 10.0%; EOT 0.0% | $365 | $365 | $307 | (10)(23) |
| **Sub-total: Construction Technology (0.0%)\*** | **Sub-total: Construction Technology (0.0%)\*** | **Sub-total: Construction Technology (0.0%)\*** | **Sub-total: Construction Technology (0.0%)\*** |  | $**365** | $**365** | $**307** |  |
| ***<u>Real Estate Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Maple Raptor Acquisition Inc. (dba Rentsync) | Secured Loan | April 28, 2025 | April 26, 2030 | Variable interest rate CORRA 3 Month Term + 9.4%; EOT 0.0% | $19806 | $19402 | $20157 | (8)(10)(20) |
| **Sub-total: Real Estate Technology (2.0%)\*** | **Sub-total: Real Estate Technology (2.0%)\*** | **Sub-total: Real Estate Technology (2.0%)\*** | **Sub-total: Real Estate Technology (2.0%)\*** |  | $**19806** | $**19402** | $**20157** |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Earthdaily Constellation Holdings, LP | Equipment Financing | June 10, 2025 | January 1, 2029 | Fixed interest rate 13.5%; EOT 7.0% | $17765 | $17419 | $17610 | (9)(10)(14)(19) |
|  | Equipment Financing | August 28, 2025 | March 1, 2029 | Fixed interest rate 13.9%; EOT 7.0% | 3420 | 3317 | 3317 | (10)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Earthdaily Constellation Holdings, LP |  |  |  |  | 21185 | 20736 | 20927 |  |
| **Sub-total: Space Technology (2.1%)\*** | **Sub-total: Space Technology (2.1%)\*** | **Sub-total: Space Technology (2.1%)\*** | **Sub-total: Space Technology (2.1%)\*** |  | $**21185** | $**20736** | $**20927** |  |
| ***<u>Supply Chain Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;GoFor Delivers, Inc. | Secured Loan | June 28, 2024 | July 1, 2028 | Variable interest rate Prime + 3.5% or Floor rate 12.0%; EOT 2.5% | $6000 | $6062 | $5900 | (8)(10)(23) |
| **Sub-total: Supply Chain Technology (0.6%)\*** | **Sub-total: Supply Chain Technology (0.6%)\*** | **Sub-total: Supply Chain Technology (0.6%)\*** | **Sub-total: Supply Chain Technology (0.6%)\*** |  | $**6000** | $**6062** | $**5900** |  |
| **Total: Debt Securities- Canada (4.7%)\*** | **Total: Debt Securities- Canada (4.7%)\*** |  |  |  | $**47356** | $**46565** | $**47291** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- Europe** | **Debt Securities- Europe** |  |  |  |  |  |  |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Unmind LTD | Secured Loan | July 8, 2025 | August 1, 2029 | Variable interest rate Prime + 3.8% or Floor rate 11.3%; EOT 3.0% | $19500 | $19016 | $19016 | (8)(10) |
| **Sub-total: Healthcare Technology (1.9%)\*** |  |  |  |  | $**19500** | $**19016** | $**19016** |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;CMR Surgical Limited | Secured Loan | March 24, 2025 | April 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 4.0% | $29375 | $29161 | $29942 | (8)(10)(14)(19) |
| **Sub-total: Medical Devices (3.0%)\*** | **Sub-total: Medical Devices (3.0%)\*** | **Sub-total: Medical Devices (3.0%)\*** | **Sub-total: Medical Devices (3.0%)\*** |  | $**29375** | $**29161** | $**29942** |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Zandivio PLC | Secured Loan | October 30, 2024 | May 1, 2029 | Variable interest rate Prime + 5.3% or Floor rate 13.8%; EOT 2.5% | $28200 | $27790 | $28141 | (8)(10)(14)(19) |
| **Sub-total: Other Healthcare Services (2.8%)\*** | **Sub-total: Other Healthcare Services (2.8%)\*** | **Sub-total: Other Healthcare Services (2.8%)\*** | **Sub-total: Other Healthcare Services (2.8%)\*** |  | $**28200** | $**27790** | $**28141** |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;All.Space Networks, Limited. | Secured Loan | August 22, 2022 | September 1, 2027 | Variable interest rate Prime + 7.0% or Floor rate 11.5%; EOT 2.5% | $7936 | $8109 | $7894 | (8)(10) |
| **Sub-total: Space Technology (0.8%)\*** | **Sub-total: Space Technology (0.8%)\*** |  |  |  | $**7936** | $**8109** | $**7894** |  |
| **Total: Debt Securities- Europe (8.5%)\*** | **Total: Debt Securities- Europe (8.5%)\*** |  |  |  | $**85011** | $**84076** | $**84993** |  |
| **Total: Debt Securities (200.0%)\*** | **Total: Debt Securities (200.0%)\*** |  |  |  | $**2036574** | $**2034035** | $**1996541** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States** |  |  |  |  |  |  |  |  |  |
| ***<u>Artificial Intelligence & Automation</u>*** | ***<u>Artificial Intelligence & Automation</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Ambient Photonics, Inc. | Warrant | July 27, 2022 | July 27, 2032 | Common Stock | 15976 | $5.50 | $48 | $— |  |
| &nbsp;&nbsp;&nbsp;D-Wave Quantum Inc. | Warrant | August 1, 2025 | August 1, 2035 | Common Stock | 13585 | $16.05 | $184 | $287 | (19)(22) |
| Everalbum, Inc. | Warrant | January 16, 2020 | July 29, 2026 | Class A Common Stock | 851063 | $0.10 | $25 | $— | (17) |
| &nbsp;&nbsp;&nbsp;Hologram, Inc. | Warrant | January 31, 2020 | January 27, 2030 | Common Stock | 193054 | $0.26 | $49 | $82 |  |
| &nbsp;&nbsp;&nbsp;K2View Inc. | Warrant | May 30, 2025 | May 30, 2035 | Ordinary | 252050 | $1.38 | $150 | $114 | (17) |
| &nbsp;&nbsp;&nbsp;Sortera Technologies, Inc. | Warrant | February 11, 2025 | February 11, 2035 | Common Stock | 38319 | $5.23 | $286 | $314 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Swimlane, Inc. | Warrant | May 28, 2025 | May 28, 2037 | Preferred Series B | 2176343 | $0.19 | $151 | $145 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Tquila Automation, Inc | Warrant | July 2, 2025 | July 2, 2037 | Common Stock | 32247 | $0.81 | $41 | $35 | (19) |
| &nbsp;&nbsp;&nbsp;Uniphore Technologies Inc. | Warrant | September 30, 2025 | September 30, 2035 | Common Stock | 604703 | $2.40 | $653 | $639 | (19) |
| **Sub-Total: Artificial Intelligence & Automation (0.2%)\*** | **Sub-Total: Artificial Intelligence & Automation (0.2%)\*** | **Sub-Total: Artificial Intelligence & Automation (0.2%)\*** |  |  |  |  | $**1587** | $**1616** |  |
| ***<u>Biotechnology</u>*** | ***<u>Biotechnology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pendulum Therapeutics, Inc. | Warrant | January 16, 2020 | October 9, 2029 | Preferred Series B | 55263 | $1.90 | $43 | $36 | (17) |
|  | Warrant | June 1, 2020 | July 15, 2030 | Preferred Series B | 36842 | $1.90 | 36 | 24 | (17) |
|  | Warrant | December 31, 2021 | December 31, 2031 | Preferred Series C | 322251 | $3.24 | 118 | 146 | (17) |
|  | Warrant | February 5, 2024 | February 5, 2034 | Common Stock | 1143690 | $1.03 | 588 | 962 |  |
|  | Warrant | May 30, 2025 | May 30, 2035 | Preferred Series C | 914565 | $0.01 | 1880 | 1934 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Pendulum Therapeutics, Inc. |  |  |  |  |  |  | 2665 | 3102 |  |
| **Sub-Total: Biotechnology (0.3%)\*** | **Sub-Total: Biotechnology (0.3%)\*** | **Sub-Total: Biotechnology (0.3%)\*** |  |  |  |  | $**2665** | $**3102** |  |
| ***<u>Connectivity</u>*** | ***<u>Connectivity</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tarana Wireless, Inc. | Warrant | June 30, 2021 | June 30, 2031 | Common Stock | 5027629 | $0.19 | $967 | $1666 |  |
|  | Warrant | September 23, 2024 | September 23, 2034 | Common Stock | 2094922 | $0.51 | 695 | 495 | (9)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Tarana Wireless, Inc. |  |  |  |  |  |  | 1662 | 2161 |  |
| &nbsp;&nbsp;&nbsp;Vertical Communications, Inc. | Warrant | January 16, 2020 | July 11, 2026 | Preferred Series A | 828479 | $1.00 | $— | $— | (11)(17)(23) |
| &nbsp;&nbsp;&nbsp;viaPhoton, Inc. | Warrant | March 31, 2022 | March 31, 2032 | Common Stock | 15839 | $0.60 | $22 | $21 |  |
| **Sub-Total: Connectivity (0.2%)\*** | **Sub-Total: Connectivity (0.2%)\*** | **Sub-Total: Connectivity (0.2%)\*** |  |  |  |  | $**1684** | $**2182** |  |
| ***<u>Construction Technology</u>*** | ***<u>Construction Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Project Frog, Inc. | Warrant | January 16, 2020 | February 28, 2027 | Preferred Series AA-1 | 211649 | $0.19 | $9 | $— | (17)(23) |
|  | Warrant | January 16, 2020 | February 28, 2027 | Common Stock | 180340 | $0.19 | 9 |  | (23) |
|  | Warrant | August 3, 2021 | December 31, 2031 | Preferred Series CC | 250000 | $0.01 | 20 | 2 | (17)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Project Frog, Inc. |  |  |  |  |  |  | 38 | 3 |  |
| **Sub-total: Construction Technology (0.0%)\*** |  |  |  |  |  |  | $**38** | $**3** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Consumer Products & Services</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;BaubleBar, Inc. | Warrant | January 16, 2020 | March 29, 2027 | Preferred Series C | 531806 | $1.96 | $639 | $10 | (17) |
|  | Warrant | January 16, 2020 | April 20, 2028 | Preferred Series C | 60000 | $1.96 | 72 | 1 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total BaubleBar, Inc. |  |  |  |  |  |  | 711 | 11 |  |
| &nbsp;&nbsp;&nbsp;Bobbie Baby, Inc. | Warrant | September 12, 2025 | September 12, 2035 | Common Stock | 94943 | $4.05 | $126 | $112 | (19) |
| &nbsp;&nbsp;&nbsp;Boosted eCommerce, Inc. | Warrant | December 14, 2020 | December 14, 2030 | Preferred Series A-1 | 759263 | $0.84 | $259 | $— | (17) |
| &nbsp;&nbsp;&nbsp;Happiest Baby, Inc. | Warrant | January 16, 2020 | May 16, 2029 | Common Stock | 182554 | $0.33 | $193 | $3 |  |
| &nbsp;&nbsp;&nbsp;Madison Reed, Inc. | Warrant | January 16, 2020 | March 23, 2027 | Preferred Series C | 194553 | $2.57 | $185 | $326 | (17) |
|  | Warrant | January 16, 2020 | July 18, 2028 | Common Stock | 43158 | $0.99 | 71 | 100 |  |
|  | Warrant | January 16, 2020 | June 30, 2029 | Common Stock | 36585 | $1.23 | 56 | 81 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Madison Reed, Inc. |  |  |  |  |  |  | 312 | 507 |  |
| &nbsp;&nbsp;&nbsp;Ogee, Inc. | Warrant | February 14, 2023 | February 14, 2033 | Preferred Series A-3 | 243668 | $0.68 | $54 | $624 | (17)(19) |
|  | Warrant | September 29, 2023 | February 14, 2033 | Preferred Series A-3 | 243668 | $0.68 | 49 | 624 | (17)(19) |
|  | Warrant | August 1, 2024 | August 1, 2034 | Preferred Series A-3 | 243668 | $0.68 | 104 | 624 | (17)(19) |
|  | Warrant | July 18, 2025 | August 1, 2034 | Preferred Series A-3 | 243668 | $0.68 | 780 | 624 | (17)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Ogee, Inc. |  |  |  |  |  |  | 987 | 2496 |  |
| &nbsp;&nbsp;&nbsp;Portofino Labs, Inc. | Warrant | December 31, 2020 | December 31, 2030 | Common Stock | 99148 | $1.53 | $160 | $64 |  |
|  | Warrant | April 1, 2021 | April 1, 2031 | Common Stock | 39912 | $1.46 | 99 | 27 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Portofino Labs, Inc. |  |  |  |  |  |  | 259 | 91 |  |
| &nbsp;&nbsp;&nbsp;Quip NYC, Inc. | Warrant | March 9, 2021 | March 9, 2031 | Common Stock | 10833 | $48.46 | $203 | $— |  |
| &nbsp;&nbsp;&nbsp;Rinse, Inc. | Warrant | May 10, 2022 | May 10, 2032 | Preferred Series C | 278761 | $1.13 | $118 | $268 | (17) |
| &nbsp;&nbsp;&nbsp;SI Tickets, Inc. | Warrant | May 11, 2022 | May 11, 2032 | Common Stock | 53029 | $2.52 | $162 | $— |  |
| &nbsp;&nbsp;&nbsp;Super73, Inc. | Warrant | December 31, 2020 | December 31, 2030 | Common Stock | 177305 | $3.16 | $105 | $1 |  |
| &nbsp;&nbsp;&nbsp;Trendly, Inc. | Warrant | January 16, 2020 | August 10, 2026 | Preferred Series A | 245506 | $1.14 | $222 | $18 | (17) |
| &nbsp;&nbsp;&nbsp;Whoop, Inc. | Warrant | May 17, 2023 | May 17, 2033 | Common Stock | 2393845 | $0.43 | $1099 | $3512 | (9)(19) |
| **Sub-total: Consumer Products & Services (0.7%)\*** |  |  |  |  |  |  | $**4756** | $**7019** |  |
| ***<u>Diagnostics & Tools</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Rapid Micro Biosystems, Inc. | Warrant | August 8, 2025 | August 8, 2035 | Common Stock | 162985 | $3.35 | $443 | $446 | (19) |
| **Sub-total: Diagnostics & Tools (0.0%)\*** |  |  |  |  |  |  | $**443** | $**446** |  |
| ***<u>Education Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Edblox, Inc. | Warrant | March 19, 2024 | March 19, 2034 | Common Stock | 111458 | $1.71 | $152 | $— | (9) |
| &nbsp;&nbsp;&nbsp;Medical Sales Training Holding Company | Warrant | March 18, 2021 | March 18, 2031 | Common Stock | 130853 | $7.74 | $108 | $— |  |
|  | Warrant | April 17, 2024 | April 17, 2034 | Common Stock | 32493 | $7.74 | 73 |  |  |
|  | Warrant | December 18, 2024 | December 18, 2034 | Common Stock | 21444 | $7.74 | 4 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Medical Sales Training Holding Company |  |  |  |  |  |  | 185 |  |  |
| &nbsp;&nbsp;&nbsp;Yellowbrick Learning, Inc. | Warrant | January 16, 2020 | September 30, 2028 | Common Stock | 222222 | $0.90 | $120 | $10 |  |
| **Sub-Total: Education Technology (0.0%)\*** |  |  |  |  |  |  | $**457** | $**10** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Alt Platform Inc. | Warrant | July 8, 2025 | July 8, 2035 | Common Stock | 256692 | $0.74 | $310 | $302 | (10)(12)(21) |
| &nbsp;&nbsp;&nbsp;Beam Technologies, Inc. | Warrant | August 30, 2024 | August 30, 2034 | Common Stock | 47479 | $17.28 | $629 | $377 | (9)(19) |
|  | Warrant | August 7, 2025 | August 7, 2032 | Preferred Series F Prime | 4083 | $0.00 | 148 | 194 | (9)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Beam Technologies, Inc. |  |  |  |  |  |  | 777 | 571 |  |
| &nbsp;&nbsp;&nbsp;Bestow, Inc. | Warrant | August 1, 2024 | August 1, 2034 | Preferred Series C-2 | 349793 | $0.01 | $1987 | $2362 | (17) |
| &nbsp;&nbsp;&nbsp;Centivo Corporation | Warrant | July 31, 2024 | July 31, 2034 | Common Stock | 80578 | $0.76 | $67 | $99 | (9)(19) |
|  | Warrant | December 20, 2024 | July 31, 2034 | Common Stock | 80577 | $0.76 | 189 | 99 | (9)(19) |
|  | Warrant | February 3, 2025 | July 31, 2034 | Common Stock | 80578 | $0.76 | 164 | 99 | (9)(19) |
|  | Warrant | May 20, 2025 | July 31, 2034 | Common Stock | 161157 | $0.76 | 290 | 198 | (9)(19) |
|  | Warrant | June 13, 2025 | July 31, 2034 | Common Stock | 80578 | $0.76 | 145 | 99 | (9)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Centivo Corporation |  |  |  |  |  |  | 855 | 594 |  |
| &nbsp;&nbsp;&nbsp;DailyPay, Inc. | Warrant | September 30, 2020 | September 30, 2030 | Common Stock | 89264 | $3.00 | $151 | $1572 |  |
| &nbsp;&nbsp;&nbsp;Tilt Finance, Inc. (dba Empower Financial, Inc.) | Warrant | October 13, 2023 | October 13, 2033 | Common Stock | 404893 | $1.43 | $953 | $3298 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Eqis Capital Management, Inc. | Warrant | June 15, 2022 | June 15, 2032 | Preferred Class B | 904000 | $0.01 | $10 | $88 | (17) |
| &nbsp;&nbsp;&nbsp;Gravie, Inc. | Warrant | June 4, 2024 | June 4, 2034 | Common Stock | 123816 | $2.68 | $293 | $9 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Inshur, Inc. | Warrant | June 10, 2025 | June 10, 2035 | Common Stock | 32049 | $6.05 | $234 | $205 |  |
| &nbsp;&nbsp;&nbsp;Kafene, Inc. | Warrant | January 5, 2024 | January 5, 2034 | Common Stock | 44448 | $4.03 | $58 | $541 |  |
| &nbsp;&nbsp;&nbsp;Kard Financial, Inc. | Warrant | September 10, 2025 | September 10, 2035 | Common Stock | 210899 | $1.36 | $249 | $238 | (19) |
| &nbsp;&nbsp;&nbsp;One Million Metrics (dba Kinetic) | Warrant | August 25, 2025 | August 25, 2035 | Common Stock | 168871 | $0.51 | $134 | $118 | (19) |
| &nbsp;&nbsp;&nbsp;Lendflow, Inc. | Warrant | April 24, 2025 | April 24, 2035 | Common Stock | 85778 | $0.70 | $79 | $108 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Mesa Financial, Inc. | Warrant | August 29, 2024 | August 29, 2034 | Common Stock | 62422 | $0.73 | $28 | $41 | (10)(12)(21) |
| &nbsp;&nbsp;&nbsp;Mesa Financing I, LLC | Warrant | May 7, 2025 | May 7, 2035 | Common Stock | 22519 | $0.01 | $8 | $14 | (10)(12)(21) |
|  | Warrant | June 25, 2025 | May 7, 2035 | Common Stock | 61926 | $0.01 | 21 | 38 | (10)(12)(21) |
|  | Warrant | July 31, 2025 | May 7, 2035 | Common Stock | 28148 | $0.01 | 11 | 17 | (10)(12)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Mesa Financing I, LLC |  |  |  |  |  |  | 40 | 69 |  |
| &nbsp;&nbsp;&nbsp;Parafin, Inc. | Warrant | February 16, 2024 | February 16, 2034 | Common Stock | 24616 | $7.09 | $118 | $357 | (10)(12)(21) |
|  | Warrant | July 25, 2024 | July 25, 2034 | Common Stock | 24641 | $7.09 | 108 | 357 | (10)(12)(21) |
|  | Warrant | December 23, 2024 | December 23, 2034 | Common Stock | 3657 | $11.14 | 49 | 47 | (10)(12)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Parafin, Inc. |  |  |  |  |  |  | 275 | 761 |  |
| &nbsp;&nbsp;&nbsp;PatientFi, Inc. | Warrant | March 14, 2025 | March 14, 2035 | Preferred Series B | 60995 | $3.10 | $84 | $108 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;RealtyMogul, Co. | Warrant | January 16, 2020 | December 18, 2027 | Preferred Series B | 954979 | $0.95 | $285 | $946 | (17) |
| &nbsp;&nbsp;&nbsp;Slope Tech, Inc. | Warrant | September 14, 2022 | September 14, 2032 | Common Stock | 90971 | $0.88 | $109 | $445 | (10)(12)(21) |
|  | Warrant | August 30, 2023 | August 30, 2033 | Common Stock | 21303 | $0.88 | 112 | 104 | (10)(12)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Slope Tech, Inc. |  |  |  |  |  |  | 221 | 549 |  |
| &nbsp;&nbsp;&nbsp;Thrivory, Inc. | Warrant | September 9, 2025 | September 9, 2035 | Common Stock | 484952 | $0.01 | $18 | $14 | (10)(12)(21) |
| &nbsp;&nbsp;&nbsp;Under Technologies, Inc. | Warrant | May 3, 2024 | May 3, 2034 | Common Stock | 76133 | $2.90 | $210 | $189 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Wisetack, Inc. | Warrant | November 14, 2024 | November 14, 2034 | Common Stock | 111153 | $1.58 | $102 | $113 | (9)(19) |
| **Sub-Total: Finance and Insurance (1.3%)\*** |  |  |  |  |  |  | $**7353** | $**12796** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Athletic Brewing Company, LLC | Warrant | October 28, 2022 | October 28, 2032 | Preferred Class B | 3741 | $140.21 | $287 | $440 | (17) |
| &nbsp;&nbsp;&nbsp;DrinkPak, LLC | Warrant | September 13, 2022 | September 13, 2032 | Common Stock | 2387 | $19.12 | $7 | $53 | (9) |
|  | Warrant | February 17, 2023 | February 17, 2033 | Common Stock | 12010 | $18.89 | 26 | 270 | (9)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total DrinkPak, LLC |  |  |  |  |  |  | 33 | 323 |  |
| Emergy, Inc. | Warrant | October 5, 2022 | October 5, 2032 | Common Stock | 4051 | $39.60 | $181 | $— | (9) |
| &nbsp;&nbsp;&nbsp;GrubMarket, Inc. | Warrant | June 15, 2020 | June 15, 2030 | Common Stock | 405000 | $1.10 | $115 | $7525 |  |
| &nbsp;&nbsp;&nbsp;Intelligent Brands, Inc. (f.k.a. PSB Holdings, Inc.) | Warrant | January 16, 2020 | October 5, 2027 | Common Stock | 103636 | $21.42 | $111 | $— |  |
|  | Warrant | December 31, 2020 | December 29, 2032 | Common Stock | 33348 | $3.17 | 546 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Intelligent Brands, Inc. |  |  |  |  |  |  | 657 |  |  |
| The Fynder Group, Inc. | Warrant | October 14, 2020 | October 14, 2030 | Common Stock | 36445 | $0.49 | $68 | $11 |  |
| Zero Acre Farms, Inc. | Warrant | December 23, 2022 | December 23, 2032 | Class A Common Stock | 20181 | $2.13 | $79 | $2 | (17) |
| **Sub-Total: Food and Agriculture Technologies (0.8%)\*** | **Sub-Total: Food and Agriculture Technologies (0.8%)\*** |  |  |  |  |  | $**1420** | $**8301** |  |
| ***<u>Green Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Bolb, Inc. | Warrant | October 12, 2021 | October 12, 2031 | Common Stock | 181784 | $0.07 | $35 | $— |  |
| &nbsp;&nbsp;&nbsp;Edeniq, Inc. | Warrant | January 16, 2020 | December 23, 2026 | Preferred Series B | 2685501 | $0.22 | $— | $593 | (11)(17)(23) |
|  | Warrant | January 16, 2020 | December 23, 2026 | Preferred Series B | 2184672 | $0.01 |  | 930 | (11)(17)(23) |
|  | Warrant | January 16, 2020 | June 29, 2027 | Preferred Series C | 5106972 | $0.44 |  | 281 | (11)(17)(23) |
|  | Warrant | January 16, 2020 | November 2, 2028 | Preferred Series C | 3850294 | $0.01 |  | 1816 | (11)(17)(23) |
|  | Warrant | November 29, 2021 | November 29, 2031 | Preferred Series D | 154906320 | $0.01 | 7 | 8525 | (17)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Edeniq, Inc. |  |  |  |  |  |  | 7 | 12145 |  |
| &nbsp;&nbsp;&nbsp;Footprint International Holding, Inc. | Warrant | February 14, 2020 | February 14, 2030 | Common Stock | 38171 | $0.31 | $9 | $— |  |
|  | Warrant | February 18, 2022 | February 18, 2032 | Common Stock | 77524 | $0.01 | 4246 |  |  |
|  | Warrant | June 23, 2022 | June 23, 2032 | Common Stock | 14624 | $0.01 | 359 |  |  |
|  | Warrant | October 31, 2024 | October 31, 2034 | Preferred Class F | 250 | $25000.00 |  |  | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Footprint International Holding, Inc. |  |  |  |  |  |  | 4614 |  |  |
| &nbsp;&nbsp;&nbsp;Form Energy Inc. | Warrant | October 21, 2024 | October 21, 2034 | Common Stock | 85556 | $8.03 | $796 | $606 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Mainspring Energy, Inc. | Warrant | January 16, 2020 | July 9, 2029 | Common Stock | 140186 | $1.15 | $283 | $253 |  |
|  | Warrant | November 20, 2020 | November 20, 2030 | Common Stock | 81294 | $1.15 | 226 | 147 |  |
|  | Warrant | March 18, 2022 | March 18, 2032 | Common Stock | 137692 | $1.66 | 344 | 237 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Mainspring Energy, Inc. |  |  |  |  |  |  | 853 | 637 |  |
| &nbsp;&nbsp;&nbsp;RTS Holding, Inc. | Warrant | December 10, 2021 | December 10, 2031 | Preferred Series C | 2314 | $205.28 | $75 | $64 | (9)(17) |
|  | Warrant | October 10, 2022 | October 10, 2032 | Preferred Series D | 917 | $196.50 | 87 | 29 | (9)(17) |
|  | Warrant | January 19, 2024 | January 19, 2034 | Preferred Series D-1 | 2876 | $203.47 | 418 | 92 | (9)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total RTS Holding, Inc. |  |  |  |  |  |  | 580 | 185 |  |
| **Sub-Total: Green Technology (1.4%)\*** |  |  |  |  |  |  | $**6885** | $**13573** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;B.Well Connected Health, Inc. | Warrant | April 10, 2025 | April 10, 2035 | Common Stock | 64777 | $0.79 | $108 | $81 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Dentologie Enterprises, Inc. | Warrant | October 14, 2022 | October 14, 2034 | Common Stock | 51632 | $0.76 | $66 | $101 | (9) |
| &nbsp;&nbsp;&nbsp;Exer Holdings, LLC | Warrant | November 19, 2021 | November 19, 2031 | Common Stock | 281 | $527.51 | $93 | $4 |  |
| &nbsp;&nbsp;&nbsp;Hospitalists Now, Inc. | Warrant | January 16, 2020 | March 30, 2026 | Preferred Series D-2 | 135807 | $5.89 | $71 | $14 | (17) |
|  | Warrant | January 16, 2020 | December 6, 2026 | Preferred Series D-2 | 750000 | $5.89 | 391 | 78 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Hospitalists Now, Inc. |  |  |  |  |  |  | 462 | 92 |  |
| &nbsp;&nbsp;&nbsp;Lark Technologies, Inc. | Warrant | September 30, 2020 | September 30, 2030 | Common Stock | 76231 | $1.76 | $177 | $13 |  |
|  | Warrant | June 30, 2021 | June 30, 2031 | Common Stock | 79325 | $1.76 | 258 | 13 |  |
|  | Warrant | December 22, 2022 | December 22, 2032 | Common Stock | 97970 | $2.49 | 58 | 14 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Lark Technologies, Inc. |  |  |  |  |  |  | 493 | 40 |  |
| &nbsp;&nbsp;&nbsp;Moxe Health Corporation | Warrant | December 29, 2023 | December 29, 2033 | Preferred Series B | 155438 | $3.62 | $135 | $62 | (17) |
| &nbsp;&nbsp;&nbsp;Paytient Technologies, Inc. | Warrant | May 27, 2025 | May 27, 2035 | Common Stock | 31216 | $1.01 | $43 | $42 | (9)(19) |
| &nbsp;&nbsp;&nbsp;PurpleLab, Inc. | Warrant | September 24, 2025 | September 24, 2035 | Common Stock | 10157 | $23.09 | $273 | $286 | (19) |
| &nbsp;&nbsp;&nbsp;RXAnte, Inc. | Warrant | November 21, 2022 | November 21, 2032 | Preferred A | 16517 | $10.00 | $89 | $183 | (9)(17)(19) |
|  | Warrant | April 7, 2023 | November 21, 2032 | Preferred A | 5518 | $10.00 | 25 | 61 | (9)(17)(19) |
|  | Warrant | October 17, 2023 | November 21, 2032 | Preferred A | 5506 | $10.00 | 37 | 61 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total RXAnte, Inc. |  |  |  |  |  |  | 151 | 305 |  |
| &nbsp;&nbsp;&nbsp;TMRW Life Sciences, Inc. | Warrant | April 29, 2022 | April 29, 2032 | Preferred Class A | 268983 | $2.09 | $80 | $3 | (17) |
|  | Warrant | March 3, 2023 | April 29, 2032 | Preferred Class A | 268983 | $2.09 | 80 | 3 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total TMRW Life Sciences, Inc. |  |  |  |  |  |  | 160 | 6 |  |
| &nbsp;&nbsp;**Sub-Total: Healthcare Technology (0.1%)\*** |  |  |  |  |  |  | $**1984** | $**1019** |  |
| ***<u>Human Resource Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;BetterLeap, Inc. | Warrant | April 20, 2022 | April 20, 2032 | Common Stock | 88435 | $2.26 | $38 | $4 |  |
| **Sub-Total: Human Resource Technology (0.0%)\*** |  |  |  |  |  |  | $**38** | $**4** |  |
| ***<u>Industrials</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;3DEO, Inc. | Warrant | February 23, 2022 | February 23, 2032 | Common Stock | 37218 | $1.81 | $93 | $— |  |
| **Sub-total: Industrials (0.0%)\*** |  |  |  |  |  |  | $**93** | $**—** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Marketing, Media, and Entertainment</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Angel Studios, Inc. | Warrant | September 8, 2025 | September 11, 2030 | Common Stock | 561670 | $7.29 | $3645 | $1720 | (19) |
| &nbsp;&nbsp;&nbsp;Drone Racing League, Inc. | Warrant | October 17, 2022 | October 17, 2032 | Common Stock | 253824 | $6.76 | $375 | $— |  |
| &nbsp;&nbsp;&nbsp;Firefly Systems, Inc. | Warrant | January 29, 2020 | January 29, 2030 | Common Stock | 133147 | $1.14 | $282 | $171 |  |
| &nbsp;&nbsp;&nbsp;Grabit Interactive Media, Inc. | Warrant | April 8, 2022 | April 8, 2034 | Preferred Series A | 142828 | $1.00 | $40 | $42 | (17) |
| &nbsp;&nbsp;&nbsp;Incontext Solutions, Inc. | Warrant | January 16, 2020 | September 28, 2028 | Common Stock | 2219 | $220.82 | $34 | $— |  |
| &nbsp;&nbsp;&nbsp;PebblePost, Inc. | Warrant | May 7, 2021 | May 7, 2031 | Common Stock | 657343 | $0.52 | $68 | $393 |  |
| &nbsp;&nbsp;&nbsp;Rarefied Atmosphere, Inc. | Warrant | May 6, 2025 | May 6, 2037 | Common Stock | 174032 | $7.35 | $571 | $557 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Vox Media Holdings, Inc. | Warrant | June 25, 2025 | June 25, 2035 | Class A Common Stock | 1580142 | $0.37 | $464 | $455 | (9)(17)(19) |
| **Sub-Total: Marketing, Media, and Entertainment (0.3%)\*** | **Sub-Total: Marketing, Media, and Entertainment (0.3%)\*** | **Sub-Total: Marketing, Media, and Entertainment (0.3%)\*** |  |  |  |  | $**5479** | $**3338** |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Apiject Holdings, Inc. | Warrant | June 24, 2024 | June 24, 2034 | Common Stock | 937604 | $0.99 | $612 | $459 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Convergent Dental, Inc. | Warrant | April 21, 2023 | April 21, 2033 | Preferred Series D | 446982 | $1.61 | $493 | $127 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Delphinus, Inc. | Warrant | June 27, 2023 | June 27, 2033 | Preferred Series E | 294288 | $0.69 | $29 | $18 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Elucent Medical, Inc. | Warrant | October 31, 2024 | October 31, 2034 | Preferred Series C-2 | 1628141 | $0.30 | $144 | $343 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Lightforce Orthodontics, Inc. | Warrant | August 6, 2024 | August 6, 2034 | Preferred Series D | 62627 | $18.01 | $249 | $72 | (17)(19) |
|  | Warrant | September 25, 2024 | August 6, 2034 | Preferred Series D | 10438 | $18.01 | 37 | 12 | (17)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Lightforce Orthodontics, Inc. |  |  |  |  |  |  | 286 | 84 |  |
| &nbsp;&nbsp;&nbsp;Nalu Medical, Inc | Warrant | July 3, 2025 | July 3, 2035 | Preferred Series E | 71043 | $4.85 | $115 | $108 | (17)(19)(22) |
| &nbsp;&nbsp;&nbsp;Neuros Medical, Inc. | Warrant | August 10, 2023 | August 10, 2033 | Preferred Series C | 798085 | $0.38 | $71 | $49 | (9)(17) |
|  | Warrant | August 30, 2024 | August 10, 2033 | Preferred Series C | 399042 | $0.38 | 39 | 25 | (9)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Neuros Medical, Inc. |  |  |  |  |  |  | 110 | 74 |  |
| &nbsp;&nbsp;&nbsp;Okami Medical, Inc. | Warrant | June 24, 2025 | June 24, 2035 | Preferred Series F-1 | 38529 | $2.86 | $46 | $52 | (19) |
| &nbsp;&nbsp;&nbsp;Restor3d, Inc. | Warrant | June 4, 2024 | June 4, 2034 | Preferred Series A | 95688 | $5.01 | $51 | $152 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;Shoulder Innovations, Inc. | Warrant | August 7, 2023 | August 7, 2033 | Preferred Series D | 32684 | $10.33 | $120 | $281 | (9)(17) |
| **Sub-Total: Medical Devices (0.2%)\*** |  |  |  |  |  |  | $**2006** | $**1698** |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cellares Corporation | Warrant | August 2, 2024 | August 2, 2034 | Common Stock | 243868 | $4.77 | $841 | $1332 | (19) |
| &nbsp;&nbsp;&nbsp;Upward Health, Inc. | Warrant | August 6, 2024 | August 6, 2034 | Class A Common Stock | 763137 | $0.28 | $251 | $951 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;Metabolon, Inc. | Warrant | March 28, 2024 | March 28, 2034 | Preferred Series 3 | 2288461 | $0.65 | $644 | $247 | (17) |
|  | Warrant | October 1, 2024 | March 28, 2034 | Preferred Series 3 | 384615 | $0.65 | 33 | 42 | (17) |
|  | Warrant | January 6, 2025 | March 28, 2034 | Preferred Series 3 | 192308 | $0.65 | 23 | 21 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Metabolon, Inc. |  |  |  |  |  |  | 700 | 310 |  |
| &nbsp;&nbsp;&nbsp;Velentium, Inc. | Warrant | May 24, 2024 | May 24, 2034 | Preferred Class B | 7958 | $53.40 | $129 | $113 | (9)(17) |
| **Sub-Total: Other Healthcare Services (0.3%)\*** |  |  |  |  |  |  | $**1921** | $**2706** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Real Estate Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Homelight Lending, Inc. | Warrant | June 23, 2022 | June 23, 2032 | Common Stock | 5434 | $18.40 | $1 | $7 |  |
| &nbsp;&nbsp;&nbsp;Knockaway, Inc. | Warrant | January 16, 2020 | May 24, 2029 | Common Stock | 880 | $85.27 | $208 | $— | (23) |
|  | Warrant | November 10, 2021 | November 10, 2031 | Common Stock | 16350 | $2.20 | 265 |  | (23) |
|  | Warrant | September 29, 2023 | September 29, 2033 | Common Stock | 2804355 | $0.01 |  | 1 | (23) |
|  | Warrant | December 6, 2023 | December 6, 2033 | Preferred Series AA | 457778 | $0.01 |  | 1 | (10)(12)(17)(21)(23) |
|  | Warrant | September 16, 2024 | September 16, 2034 | Preferred Series BB | 93951849 | $0.00 | 2391 | 904 | (17)(23) |
|  | Warrant | September 27, 2023 | September 27, 2033 | Preferred Series AA-1 | 5084804 | $0.09 |  |  | (17)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Knockaway, Inc. |  |  |  |  |  |  | 2864 | 906 |  |
| &nbsp;&nbsp;&nbsp;Maxwell Financial Labs, Inc. | Warrant | October 8, 2020 | October 8, 2030 | Common Stock | 106735 | $0.29 | $21 | $13 |  |
|  | Warrant | December 22, 2020 | December 22, 2030 | Common Stock | 110860 | $0.29 | 34 | 14 |  |
|  | Warrant | September 30, 2021 | September 30, 2031 | Common Stock | 79135 | $1.04 | 148 | 6 |  |
|  | Warrant | May 10, 2024 | May 10, 2034 | Common Stock | 303562 | $0.27 | 83 | 38 |  |
|  | Warrant | July 1, 2024 | May 10, 2034 | Common Stock | 303562 | $0.27 | 91 | 38 |  |
|  | Warrant | January 1, 2025 | May 10, 2034 | Common Stock | 308162 | $0.27 | 13 | 39 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Maxwell Financial Labs, Inc. |  |  |  |  |  |  | 390 | 148 |  |
| &nbsp;&nbsp;&nbsp;Orchard Technologies, Inc. | Warrant | February 12, 2024 | February 12, 2034 | Preferred Series 1 | 228000 | $0.01 | $— | $84 | (17) |
|  | Warrant | February 12, 2025 | February 12, 2034 | Preferred Series 1 | 228000 | $0.01 | 126 | 84 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Orchard Technologies, Inc. |  |  |  |  |  |  | 126 | 168 |  |
| **Sub-Total: Real Estate Technology (0.1%)\*** |  |  |  |  |  |  | $**3381** | $**1229** |  |
| ***<u>SaaS</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;All Seated, Inc. | Warrant | February 28, 2022 | February 28, 2032 | Common Stock | 5101 | $15.72 | $22 | $— |  |
| &nbsp;&nbsp;&nbsp;Cart.com, Inc. | Warrant | November 17, 2023 | November 17, 2033 | Common Stock | 31572 | $15.87 | $440 | $744 | (9) |
| Cpacket Networks, Inc. | Warrant | January 29, 2024 | January 29, 2034 | Class B Common | 499366 | $0.36 | $166 | $96 | (9)(17) |
| Crowdtap, Inc. | Warrant | January 16, 2020 | December 16, 2025 | Preferred Series B | 442233 | $1.09 | $42 | $627 | (17) |
|  | Warrant | January 16, 2020 | December 11, 2027 | Preferred Series B | 100000 | $1.09 | 9 | 142 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Crowdtap, Inc. |  |  |  |  |  |  | 51 | 769 |  |
| &nbsp;&nbsp;&nbsp;Gtxcel, Inc. | Warrant | January 16, 2020 | August 30, 2026 | Preferred Series D | 1000000 | $0.21 | 83 |  | (17) |
| &nbsp;&nbsp;&nbsp;Lucidworks, Inc. | Warrant | January 16, 2020 | June 27, 2026 | Preferred Series D | 619435 | $0.77 | $806 | $440 | (17) |
| &nbsp;&nbsp;&nbsp;Reciprocity, Inc. | Warrant | September 25, 2020 | September 25, 2030 | Common Stock | 114678 | $4.17 | $99 | $— |  |
|  | Warrant | April 29, 2021 | April 29, 2031 | Common Stock | 57195 | $4.17 | 54 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Reciprocity, Inc. |  |  |  |  |  |  | 153 |  |  |
| &nbsp;&nbsp;&nbsp;Silk Technologies, Inc. | Warrant | November 4, 2024 | November 4, 2034 | Common Stock | 204760 | $1.98 | $433 | $304 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Smartly, Inc. | Warrant | May 16, 2022 | May 16, 2034 | Common Stock | 48097 | $1.10 | $84 | $86 |  |
| &nbsp;&nbsp;&nbsp;Steno Agency, Inc. | Warrant | June 21, 2024 | June 21, 2034 | Common Stock | 55818 | $1.98 | $136 | $181 | (9)(19) |
|  | Warrant | May 16, 2025 | June 21, 2034 | Common Stock | 54476 | $1.98 | 164 | 177 | (9)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Steno Agency, Inc. |  |  |  |  |  |  | 300 | 358 |  |
| &nbsp;&nbsp;&nbsp;The Tomorrow Companies, Inc. | Warrant | December 14, 2022 | December 14, 2032 | Common Stock | 26124 | $1.70 | $49 | $14 | (9) |
| **Sub-Total: SaaS (0.3%)\*** |  |  |  |  |  |  | $**2587** | $**2811** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Astranis Space Technology Corporation | Warrant | April 13, 2023 | April 13, 2033 | Common Stock | 85644 | $7.89 | $83 | $281 | (9)(19) |
|  | Warrant | September 27, 2024 | September 27, 2034 | Common Stock | 156677 | $2.27 | 683 | 717 | (9)(19) |
|  | Warrant | June 26, 2025 | June 26, 2035 | Common Stock | 39557 | $0.01 | 191 | 206 | (9)(19) |
|  | Warrant | August 25, 2025 | August 25, 2035 | Common Stock | 439662 | $2.33 | 1671 | 2006 | (19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Astranis Space Technology Corporation |  |  |  |  |  |  | 2628 | 3210 |  |
| &nbsp;&nbsp;&nbsp;Axiom Space, Inc. | Warrant | May 28, 2021 | May 28, 2031 | Common Stock | 1773 | $169.24 | $121 | $19 |  |
|  | Warrant | May 28, 2021 | May 28, 2031 | Common Stock | 882 | $340.11 | 39 | 3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Axiom Space, Inc. |  |  |  |  |  |  | 160 | 22 |  |
| &nbsp;&nbsp;&nbsp;Hermeus Corporation | Warrant | August 9, 2022 | August 9, 2032 | Common Stock | 19286 | $6.24 | $144 | $145 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Impulse Space, Inc. | Warrant | June 18, 2024 | June 18, 2034 | Common Stock | 32877 | $1.91 | $133 | $843 | (9)(19)(22) |
| &nbsp;&nbsp;&nbsp;Slingshot Aerospace, Inc. | Warrant | July 12, 2024 | July 12, 2034 | Common Stock | 328416 | $0.46 | $400 | $459 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Kymeta Corporation | Warrant | July 3, 2024 | July 3, 2034 | Common Stock | 3995407 | $0.11 | $331 | $229 | (9)(19) |
| **Sub-Total: Space Technology (0.5%)\*** |  |  |  |  |  |  | $**3796** | $**4908** |  |
| ***<u>Supply Chain Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Macrofab, Inc. | Warrant | January 14, 2025 | July 21, 2035 | Common Stock | 311176 | $0.01 | $166 | $2 |  |
|  | Warrant | January 14, 2025 | January 29, 2034 | Preferred C-1 | 392157 | $0.01 | 254 | 125 | (17) |
|  | Warrant | January 14, 2025 | April 11, 2036 | Common Stock | 161006 | $0.01 | 64 | 1 |  |
|  | Warrant | January 14, 2025 | July 21, 2035 | Preferred C-1 | 311177 | $0.01 | 166 | 99 | (17) |
|  | Warrant | January 14, 2025 | April 11, 2036 | Preferred C-1 | 161007 | $0.01 | 64 | 52 | (17) |
|  | Warrant | January 14, 2025 | January 14, 2035 | Preferred C-1 | 247173 | $0.01 | 151 | 78 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Macrofab, Inc. |  |  |  |  |  |  | 865 | 357 |  |
| &nbsp;&nbsp;&nbsp;Nucleus RadioPharma, Inc. | Warrant | June 4, 2024 | June 4, 2034 | Common Stock | 43636 | $1.99 | $69 | $14 | (9) |
| **Sub-Total: Supply Chain Technology (0.0%)\*** |  |  |  |  |  |  | $**934** | $**371** |  |
| ***<u>Transportation Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Get Spiffy, Inc. | Warrant | July 14, 2023 | July 14, 2033 | Common Stock | 874527 | $0.70 | $408 | $— | (9) |
| &nbsp;&nbsp;&nbsp;NextCar Holding Company, Inc. | Warrant | December 14, 2021 | December 14, 2026 | Class A Common | 6211 | $64.42 | 35 |  | (13) |
|  | Warrant | February 23, 2022 | February 23, 2027 | Class A Common | 486 | $64.42 | 3 |  | (13) |
|  | Warrant | March 16, 2022 | March 16, 2027 | Class A Common | 583 | $64.42 | 3 |  | (13) |
|  | Warrant | April 18, 2022 | April 18, 2027 | Class A Common | 5336 | $64.42 | 7 |  | (13) |
|  | Warrant | September 29, 2022 | September 29, 2027 | Preferred Stock | 1224752 | $0.22 | 170 |  | (13)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total NextCar Holding Company, Inc. |  |  |  |  |  |  | 218 |  |  |
| &nbsp;&nbsp;&nbsp;Uveye, Inc. | Warrant | December 26, 2024 | December 26, 2034 | Preferred Ordinary | 476031 | $4.38 | $539 | $393 | (17) |
| &nbsp;&nbsp;&nbsp;Zuum Transportation, Inc. | Warrant | April 30, 2024 | April 30, 2034 | Common Stock | 41271 | $4.34 | $95 | $52 |  |
| **Sub-Total: Transportation Technology (0.0%)\*** |  |  |  |  |  |  | $**1260** | $**445** |  |
| **Total: Warrant Investments- United States (6.8%)\*** |  |  |  |  |  |  | $**50767** | $**67577** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- Canada** |  |  |  |  |  |  |  |  |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Earthdaily Constellation Holdings, LP | Warrant | June 10, 2025 | June 10, 2035 | Class B Common Stock | 1775329 | $0.81 | $993 | $1219 | (9)(10)(17)(19) |
| **Sub-Total: Space Technology (0.1%)\*** |  |  |  |  |  |  | $**993** | $**1219** |  |
| **Total: Warrant Investments- Canada (0.1%)\*** |  |  |  |  |  |  | $**993** | $**1219** |  |
| **Warrant Investments- Europe** |  |  |  |  |  |  |  |  |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Unmind LTD | Warrant | July 7, 2025 | July 7, 2035 | Ordinary | 122340 | 149.02 | $518 | $527 | (10)(17) |
| **Sub-Total: Healthcare Technology (0.1%)\*** |  |  |  |  |  |  | $**518** | $**527** |  |
| ***<u>Industrials</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Aledia, Inc. | Warrant | March 31, 2022 | March 31, 2032 | Ordinary | 11771 | 149.02 | $130 | $119 | (10)(17) |
| **Sub-Total: Industrials (0.0%)\*** |  |  |  |  |  |  | $**130** | $**119** |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;CMR Surgical Limited | Warrant | March 24, 2025 | March 24, 2030 | Ordinary | 7520 | 0.01 | $122 | $125 | (10)(17)(19) |
| **Sub-Total: Medical Devices (0.0%)\*** |  |  |  |  |  |  | $**122** | $**125** |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Zandivio PLC | Warrant | October 29, 2024 | October 29, 2034 | Common Stock | 132042 | 0.01 | $771 | $516 | (10)(19) |
| **Sub-Total: Other Healthcare Services (0.1%)\*** |  |  |  |  |  |  | $**771** | $**516** |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;All.Space Networks, Limited. | Warrant | August 19, 2022 | August 19, 2032 | Common Stock | 71203 | $21.79 | $113 | $— | (10) |
|  | Warrant | August 22, 2024 | August 22, 2034 | Common Stock | 35601 | $8.90 | 1 |  | (10) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total All.Space Networks, Limited. |  |  |  |  |  |  | 114 |  |  |
| **Sub-Total: Space Technology (0.0%)\*** |  |  |  |  |  |  | $**114** | $**—** |  |
| **Total: Warrant Investments- Europe (0.1%)\*** |  |  |  |  |  |  | $**1655** | $**1287** |  |
| **Total: Warrant Investments- (7.0%)\*** |  |  |  |  |  |  | $**53415** | $**70083** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Shares / Principal** | **Series** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Equity Investments- United States** |  |  |  |  |  |  |  |
| ***<u>Artificial Intelligence & Automation</u>*** | ***<u>Artificial Intelligence & Automation</u>*** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cabernet AI, Inc. | Equity | February 27, 2025 | $500 | SAFE Note | $500 | $500 | (17) |
| **Sub-Total: Artificial Intelligence & Automation (0.1%)\*** |  |  |  |  | $**500** | $**500** |  |
| ***<u>Connectivity</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tarana Wireless, Inc. | Equity | March 16, 2022 | 611246 | Preferred Series 6 | $500 | $419 | (17) |
| &nbsp;&nbsp;&nbsp;Vertical Communications, Inc. | Equity | January 16, 2020 | 3892485 | Preferred Series 1 | $— | $— | (11)(17)(23) |
|  | Equity | January 16, 2020 | $5500 | Convertible Note | 3966 |  | (16)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Vertical Communications, Inc. |  |  |  |  | 3966 |  |  |
| &nbsp;&nbsp;&nbsp;viaPhoton Inc. | Equity | May 23, 2024 | $740 | SAFE Note | $370 | $370 | (17) |
| **Sub-Total: Connectivity (0.1%)\*** |  |  |  |  | $**4836** | $**789** |  |
| ***<u>Construction Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Project Frog, Inc. | Equity | January 16, 2020 | 4383497 | Preferred Series AA-1 | $352 | 6 | (17)(23) |
|  | Equity | January 16, 2020 | 3401678 | Preferred Series BB | 1333 | 11 | (17)(23) |
|  | Equity | August 3, 2021 | 6633486 | Common Stock | 1684 | 6 | (23) |
|  | Equity | August 3, 2021 | 3129887 | Preferred Series CC | 1253 | 32 | (17)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Project Frog, Inc. |  |  |  |  | 4622 | 55 |  |
| **Sub-Total: Construction Technology (0.0%)\*** |  |  |  |  | $**4622** | $**55** |  |
| ***<u>Consumer Products & Services</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Portofino Labs, Inc. | Equity | November 1, 2021 | 256291 | Preferred Series B-1 | $500 | $530 | (17) |
| &nbsp;&nbsp;&nbsp;Quip NYC, Inc. | Equity | August 17, 2021 | 3321 | Common Stock | $500 | $— |  |
| &nbsp;&nbsp;&nbsp;Rinse, Inc. | Equity | December 30, 2024 | 290242 | Preferred Series D | $500 | $547 | (17) |
| **Sub-Total: Consumer Products & Services (0.1%)\*** |  |  |  |  | $**1500** | $**1077** |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Centivo Corporation | Equity | December 20, 2024 | 128393 | Preferred Series B-1 | $375 | $320 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;Dynamics, Inc. | Equity | January 16, 2020 | 17726 | Preferred Series A | $390 | $— | (17) |
| &nbsp;&nbsp;&nbsp;Tilt Finance, Inc. (dba Empower Financial, Inc.) | Equity | May 16, 2024 | 2810235 | Preferred Series C | $20000 | $30037 | (17) |
|  | Equity | May 15, 2024 | 300285 | Common Stock | 4023 | 2816 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Tilt Finance, Inc. (dba Empower Financial, Inc.) |  |  |  |  | 24023 | 32853 |  |
| &nbsp;&nbsp;&nbsp;Mesa Financing I, LLC | Equity | September 17, 2025 | $500 | SAFE Note | $500 | $500 | (10)(12)(17)(21) |
| &nbsp;&nbsp;&nbsp;Openly Holdings Corp. | Equity | May 9, 2023 | 44725 | Preferred Series D-1 | $500 | $516 | (17) |
| &nbsp;&nbsp;&nbsp;Slope Tech, Inc. | Equity | June 20, 2023 | 64654 | Preferred Series A-3 | $500 | $513 | (10)(12)(17)(21) |
| &nbsp;&nbsp;Upgrade Master Pass - Thru Trust, Series 2025-ST5 (Estimated Yield 15.08%, maturity July 15, 2030) | Equity | August 11, 2025 | $7000 | Series Certificate | $6506 | $6506 | (10)(12)(17)(21) |
| **Sub-Total: Finance and Insurance (4.1%)\*** |  |  |  |  | $**32794** | $**41208** |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Emergy, Inc. | Equity | June 28, 2021 | 7595 | Common Stock | $500 | $— |  |
| &nbsp;&nbsp;&nbsp;Athletic Brewing Company, LLC | Equity | August 1, 2024 | 1214 | Preferred Class B | $283 | $261 | (9)(17)(19) |
| **Sub-Total: Food and Agriculture Technologies (0.0%)\*** |  |  |  |  | $**783** | $**261** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Shares / Principal** | **Series** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Equity Investments- United States, Continued** |  |  |  |  |  |  |  |
| ***<u>Green Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Crusoe Energy Systems LLC | Equity | November 6, 2024 | 11140 | Preferred Series D-1 | $325 | $340 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;Edeniq, Inc. | Equity | January 16, 2020 | 7807499 | Preferred Series B | $— | $3397 | (11)(17)(23) |
|  | Equity | January 16, 2020 | 3657487 | Preferred Series C |  | 1760 | (11)(17)(23) |
|  | Equity | January 16, 2020 | 133766138 | Preferred Series D |  | 9027 | (11)(17)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Edeniq, Inc. |  |  |  |  |  | 14184 |  |
| &nbsp;&nbsp;&nbsp;Electric Hydrogen Co. | Equity | April 6, 2023 | 87112 | Preferred Series C | $500 | $437 | (17) |
| &nbsp;&nbsp;&nbsp;Mainspring Energy, Inc. | Equity | March 30, 2022 | 65614 | Preferred Series E-1 | $500 | $231 | (17) |
| &nbsp;&nbsp;&nbsp;RTS Holding, Inc. | Equity | July 5, 2022 | 2035 | Preferred Series E-1D | $334 | $400 | (9)(17) |
|  | Equity | February 15, 2023 | 1966 | Preferred Series E-1D1 | 405 | 398 | (9)(17) |
|  | Equity | February 7, 2025 | 2054 | Preferred Series E-1 | 328 | 340 | (9)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total RTS Holding, Inc. |  |  |  |  | 1067 | 1138 |  |
| **Sub-Total: Green Technology (1.6%)\*** |  |  |  |  | $**2392** | $**16330** |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Dentologie Enterprises, Inc. | Equity | August 3, 2023 | 72338 | Preferred Series B-1 | $300 | $260 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Emerald Cloud Lab, Inc. | Equity | June 3, 2022 | 499999 | Preferred Series A | $500 | $77 | (17) |
|  | Equity | April 29, 2024 | 617890 | Preferred Series B-1 | 129 | 75 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Emerald Cloud Lab, Inc. |  |  |  |  | 629 | 152 |  |
| &nbsp;&nbsp;&nbsp;Lark Technologies, Inc. | Equity | August 19, 2021 | 32416 | Preferred Series D | $500 | $101 | (17) |
| &nbsp;&nbsp;&nbsp;WorkWell Prevention & Care Inc. | Equity | January 16, 2020 | 7000000 | Common Stock | $51 | $— | (23) |
|  | Equity | January 16, 2020 | 3450 | Preferred Series P | 3450 |  | (17)(23) |
|  | Equity | January 16, 2020 | $3170 | Convertible Note | 3219 |  | (16)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total WorkWell Prevention & Care Inc. |  |  |  |  | 6720 |  |  |
| **Sub-Total: Healthcare Technology (0.1%)\*** |  |  |  |  | $**8149** | $**513** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Shares / Principal** | **Series** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Equity Investments- United States, Continued** |  |  |  |  |  |  |  |
| ***<u>Human Resource Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Nomad Health, Inc. | Equity | May 27, 2022 | 37920 | Common Stock | $500 | $— | (23) |
|  | Equity | September 30, 2025 | 16314426 | Preferred Series AA-1 | 3781 | 3781 | (23) |
|  | Equity | September 30, 2025 | 2392230 | Preferred Series AAA | 1000 | 661 | (23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Nomad Health, Inc. |  |  |  |  | 5281 | 4442 |  |
| **Sub-Total: Human Resource Technology (0.4%)\*** |  |  |  |  | $**5281** | $**4442** |  |
| ***<u>Industrials</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Digilens, Inc. | Equity | July 29, 2023 | 21730 | Preferred Series A-1 | $13 | $19 | (17) |
|  | Equity | September 18, 2024 | 9498 | Preferred Series A-1 | 8 | 9 | (17) |
|  | Equity | January 12, 2024 | 12205 | Preferred Series A-1 | 7 | 11 | (17) |
|  | Equity | March 24, 2025 | 4489 | Preferred Series A-1 | 4 | 4 | (17) |
|  | Equity | October 10, 2023 | 6332 | Preferred Series A-1 | 4 | 6 | (17) |
|  | Equity | May 6, 2024 | 4117 | Preferred Series A-1 | 4 | 4 | (17) |
|  | Equity | June 9, 2024 | 2617 | Preferred Series A-1 | 2 | 2 | (17) |
|  | Equity | May 20, 2024 | 126641 | Preferred Series A-1 | 110 | 114 | (17) |
|  | Equity | March 26, 2025 | 73873 | Preferred Series A-1 | 65 | 66 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Digilens, Inc. |  |  |  |  | 217 | 235 |  |
| **Sub-Total: Industrials (0.0%)\*** |  |  |  |  | $**217** | $**235** |  |
| ***<u>Multi-Sector Holdings</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;AZ-VC Fund I, LLC | Equity | June 30, 2022 |  | Preferred | $570 | $571 | (7)(10)(17) |
| &nbsp;&nbsp;&nbsp;Direct Lending 2025 LLC | Equity | September 24, 2025 |  | Preferred | $22350 | $22350 | (7)(10)(17)(23) |
| &nbsp;&nbsp;&nbsp;Senior Credit Corp 2022 LLC | Equity | January 30, 2023 |  | Preferred | $5522 | $5878 | (7)(10)(17)(23) |
| &nbsp;&nbsp;&nbsp;Eagle Point Trinity Senior Secured Lending Company (fka EPT 16 LLC) | Equity | June 28, 2024 |  | Preferred | $10000 | $10176 | (7)(10)(17)(23) |
| &nbsp;&nbsp;&nbsp;Trinity Capital Adviser, LLC | Equity | June 28, 2024 |  | Preferred | $1 | $9586 | (17)(23) |
| **Sub-Total: Multi-Sector Holdings (4.9%)\*** |  |  |  |  | $**38443** | $**48561** |  |
| ***<u>Real Estate Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Knockaway, Inc. | Equity | March 30, 2022 | 30458 | Common Stock | $501 | $— | (23) |
|  | Equity | September 29, 2023 | 2956224 | Preferred Series AA | 250 | 6 | (17)(23) |
|  | Equity | September 16, 2024 | 97866510 | Preferred Series BB | 2500 | 951 | (17)(23) |
|  | Equity | September 7, 2023 | 3409997 | Preferred Series AA-1 |  | 2 | (17)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Knockaway Inc. |  |  |  |  | 3251 | 959 |  |
| &nbsp;&nbsp;&nbsp;Orchard Technologies, Inc. | Equity | August 6, 2021 | 2938 | Preferred Series 2 | $29 | $— | (17) |
|  | Equity | March 16, 2023 | 97060 | Preferred Series 1 | 971 | 37 | (17) |
|  | Equity | January 24, 2025 | 3009 | Preferred Series 1 | 1 | 1 | (17) |
|  | Equity | January 24, 2025 | $10900 | SAFE Note | 5 | 5 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Orchard Technologies, Inc. |  |  |  |  | 1006 | 43 |  |
| &nbsp;&nbsp;&nbsp;Maxwell Financial Labs, Inc | Equity | January 22, 2021 | 84998 | Preferred Series B | $313 | $64 | (17) |
|  | Equity | May 10, 2024 | 229972 | Preferred Series B-1 | 365 | 261 | (17) |
|  | Equity | October 2, 2024 | 32839 | Preferred Series B-2 | 121 | 126 | (17) |
|  | Equity | October 2, 2024 | 17804 | Common Stock | 66 | 3 |  |
|  | Equity | September 11, 2025 | 294171 | Preferred Series B-2 | 868 | 1131 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Maxwell Financial Labs, Inc |  |  |  |  | 1733 | 1585 |  |
| **Sub-Total: Real Estate Technology (0.3%)\*** |  |  |  |  | $**5990** | $**2587** |  |
| ***<u>SaaS</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cart.com, Inc. | Equity | April 17, 2024 | 11533 | Preferred Series C | $500 | $569 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Smartly, Inc. | Equity | March 29, 2023 | 136388 | Preferred Series B | $500 | $546 | (17) |
| &nbsp;&nbsp;&nbsp;The Tomorrow Companies, Inc. | Equity | July 5, 2023 | 108088 | Preferred Series E-1 | $325 | $208 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Dahlia Clipper SPV, L.P. | Equity | July 25, 2025 | n/a | Preferred SPV Member Units | $2000 | $2019 | (17) |
| **Sub-total: SaaS (0.3%)\*** |  |  |  |  | $**3325** | $**3342** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Shares / Principal** | **Series** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Equity Investments- United States, Continued** |  |  |  |  |  |  |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Astranis Space Technology Corporation | Equity | April 5, 2023 | 13685 | Series C Prime Preferred | $300 | $151 | (9)(17) |
|  | Equity | March 19, 2024 | 64223 | Preferred Series D | 600 | 628 | (9)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Astranis Space Technology Corporation |  |  |  |  | 900 | 779 |  |
| &nbsp;&nbsp;&nbsp;Axiom Space, Inc. | Equity | January 18, 2023 | 3624 | Preferred Series C-1 | $521 | $428 | (17) |
| &nbsp;&nbsp;&nbsp;Hadrian Automation, Inc. | Equity | March 29, 2022 | 53154 | Preferred A-4 | $500 | $522 | (17) |
|  | Equity | December 11, 2023 | 31831 | Preferred B-1 | 300 | 313 | (9)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Hadrian Automation, Inc. |  |  |  |  | 800 | 835 |  |
| &nbsp;&nbsp;&nbsp;Impulse Space, Inc. | Equity | August 30, 2024 | 23240 | Preferred Series B | $325 | $690 | (9)(17)(19) |
|  | Equity | May 9, 2025 | 8503 | Preferred Series C | 325 | 329 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Impulse Space, Inc. |  |  |  |  | 650 | 1019 |  |
| **Sub-total: Space Technology (0.3%)\*** |  |  |  |  | $**2871** | $**3061** |  |
| ***<u>Supply Chain Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Macrofab, Inc. | Equity | January 30, 2024 | 247173 | Preferred C-1 | $500 | $81 | (17) |
| **Sub-total: Supply Chain Technology (0.0%)\*** |  |  |  |  | $**500** | $**81** |  |
| ***<u>Transportation Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Get Spiffy, Inc. | Equity | April 14, 2025 | 16024208 | Preferred Series A-2 | $31 | $44 | (9)(17) |
| &nbsp;&nbsp;&nbsp;NextCar Holding Company, Inc. | Equity | April 18, 2023 | 2688971 | Preferred Series A-6 | $— | $— | (17) |
| **Sub-total: Transportation Technology (0.0%)\*** |  |  |  |  | $**31** | $**44** |  |
| **Total: Equity Investments- United States (12.3%)\*** |  |  |  |  | $**112234** | $**123086** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Shares / Principal** | **Series** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Equity Investments- Canada** |  |  |  |  |  |  |  |
| ***<u>Construction Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Nexii, Inc. | Equity | July 24, 2024 | 6126 | Preferred Series A-1 | $3049 | $164 | (10)(17)(23) |
|  | Equity | July 24, 2024 | 50000 | Preferred Series A-1 | 1370 | 1340 | (10)(17)(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Nexii, Inc. |  |  |  |  | 4419 | 1504 |  |
| **Sub-Total: Construction Technology (0.2%)\*** |  |  |  |  | $**4419** | $**1504** |  |
| ***<u>Supply Chain Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;GoFor Delivers, Inc. | Equity | June 28, 2024 | 194329 | Series 2 Seed | $660 | $1147 | (10)(23) |
| **Sub-total: Supply Chain Technology (0.1%)\*** |  |  |  |  | $**660** | $**1147** |  |
| **Total: Equity Investments- Canada (0.3%)\*** |  |  |  |  | $**5079** | $**2651** |  |
| **Total: Equity Investments (12.6%)\*** |  |  |  |  | $**117313** | $**125737** |  |
| **Total Investment in Securities (219.6%)\*** |  |  |  |  | $**2204763** | $**2192361** |  |
| **Cash and Cash Equivalents** |  |  |  |  |  |  |  |
| Goldman Sachs Financial Square Government Institutional Fund |  |  |  |  | $191 | $191 |  |
| Other cash accounts |  |  |  |  | 9276 | 9276 |  |
| **Cash and Cash Equivalents (0.9%)\*** |  |  |  |  | 9467 | 9467 |  |
| ***Total Portfolio Investments and Cash and Cash Equivalents (220.6%) of net assets)*** |  |  |  |  | $**2214230** | $**2201828** |  |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  |  | **Notional Amount** |  | **Notional Amount** |  |
| **Foreign Currency Forward Contracts** | **Settlement Date** | **Counterparty** | **to be Sold** | **Transaction** | **to be Purchased** | **Fair Value** |
| Canadian Dollars (CAD) | April 29, 2026 | Canadian Imperial Bank of Commerce | CAD 26,762 | Sold | $19584 | $181 |
| **Total Foreign Currency Forward (0.0%)\*** |  |  |  |  | $**19584** | $**181** |

---

\* Value as a percent of net assets

<sup>(1)</sup> All portfolio companies are located in North America or Europe. As of September 30, 2025, Trinity Capital Inc. (the "Company") had nine foreign domiciled portfolio companies, four of which are based in Canada and five of which are based in Europe. As of September 30, 2025, these foreign domiciled portfolio investments represented 13.8% of total net asset value based on fair value. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the "Securities Act"). These investments are generally subject to certain limitations on resale and may be deemed to be "restricted securities" under the Securities Act.

<sup>(2)</sup> All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted.

<sup>(3)</sup> Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds as part of the Formation Transactions (both terms as defined in "Note 1 – Organization and Basis of Presentation"), the investment date is January 16, 2020, the date of the Formation Transactions.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

<sup>(4)</sup> Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term ("EOT") payment, or additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair value, generally subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the term of the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Company's current debt securities.

<sup>(5)</sup> Principal is net of repayments, if any, as per the terms of the debt instrument's contract.

<sup>(6)</sup> Except as noted, all investments were valued at fair value as determined in good faith by the Company's Board of Directors (the "Board") using Level 3 inputs.

<sup>(7)</sup> Asset is valued at fair value as determined in good faith by the Company's Board using Level 1 and Level 2 inputs.

<sup>(8)</sup> The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. As of September 30, 2025, the U.S. Prime Rate ("Prime") was 7.25%, the Secured Overnight Financing Rate ("SOFR") 30 Day Forward Rate was 4.13%, the SOFR 3-Month Term Rate was 3.97%, and the Canadian Overnight Repo Rate Average ("CORRA") 3-Month Term rate was 2.45%.

<sup>(9)</sup> Senior Credit Corp 2022 LLC owns an additional portion of this security. See "Note 12 – Related Party Transactions" for further discussion.

<sup>(10)</sup> Indicates a "non-qualifying asset" under section 55(a) of the Investment Company Act of 1940, as amended (the "1940 Act"). The Company's percentage of non-qualifying assets at fair value represents 16.5% of the Company's total assets as of September 30, 2025. Qualifying assets must represent at least 70% of the Company's total assets at the time of acquisition of any additional non-qualifying assets.

<sup>(11)</sup> Investment has zero cost basis as it was purchased at a fair value of zero as part of the Formation Transactions (as defined in "Note 1 – Organization and Basis of Presentation").

<sup>(12)</sup> Investment is a secured loan warehouse facility collateralized by interest in specific assets that meet the eligibility requirements under the facility during the warehouse period. Repayment of the facility will occur over the amortizing period unless otherwise prepaid.

<sup>(13)</sup> Company has been issued warrants with pricing and number of shares dependent upon a future round of equity issuance by the portfolio company.

<sup>(14)</sup> Investment is pledged as collateral supporting amounts outstanding under the Company's credit facility with KeyBank, National Association (the "KeyBank Credit Facility"). See "Note 5 – Borrowings" for more information.

<sup>(15)</sup> Interest on this loan includes a payment-in-kind ("PIK") provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally collected through amortization, is recorded on an accrual basis to the extent such amounts are expected to be collected.

<sup>(16)</sup> Convertible notes represent investments through which the Company will participate in future equity rounds at preferential rates. There are no principal or interest payments made against the note unless conversion does not occur.

<sup>(17)</sup> Preferred stock represents investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.

<sup>(18)</sup> Investment is on non-accrual status as of September 30, 2025 and is therefore considered non-income producing.

<sup>(19)</sup> Eagle Point Trinity Senior Secured Lending Company (fka EPT 16 LLC) owns an additional portion of this security. See "Note 12 – Related Party Transactions" for further discussion.

<sup>(20)</sup> Investment has an unfunded commitment as of September 30, 2025 (see "Note 6 – Commitments and Contingencies"). The fair value of the investment includes the impact of the fair value of any unfunded commitments.

<sup>(21)</sup> Borrower is a wholly owned, special purpose vehicle subsidiary of named portfolio company.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**September 30, 2025**

**(In thousands, except share and per share data)**

**(Unaudited)**

<sup>(22)</sup> Direct Lending 2025 LLC owns an additional portion of this security. See "Note 12-Related Party Transactions" for further discussion.

<sup>(23)</sup> This investment is deemed to be a "Control Investment" or an "Affiliate Investment." The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. The 1940 Act defines Control Investments as investments in companies in which the Company owns beneficially, either directly or indirectly, more than 25% of the voting securities, or maintains greater than 50% of the board representation. Affiliate Investments are defined by the 1940 Act as investments in companies in which the Company owns beneficially, either directly or indirectly, between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. Fair value as of September 30, 2025, along with transactions during the nine months ended September 30, 2025 in these control and affiliate investments are as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  | **Net change in** |  |  |
|  |  |  |  |  | **Unrealized** |  |  |
|  | **Fair Value at** | **Gross** | **Gross** | **Realized** | **(Depreciation)/** | **Fair Value at** | **Interest and** |
|  | **December 31, 2024** | **Additions** <sup>(1)</sup> | **Reductions** <sup>(2)</sup> | **Gain/(Loss)** | **Appreciation** | **September 30, 2025** | **Dividend Income** |
| ***For the Nine Months Ended September 30, 2025*** |  |  |  |  |  |  |  |
| **Control Investments** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Edeniq, Inc. | $18105 | $— | $— | $— | $8222 | $26327 | $— |
| &nbsp;&nbsp;&nbsp;Project Frog, Inc. | 44 |  |  |  | 13 | 57 |  |
| &nbsp;&nbsp;&nbsp;Vertical Communications, Inc. | 16608 | 3071 | (1328) |  | (2428) | 15923 | 1201 |
| &nbsp;&nbsp;&nbsp;WorkWell Prevention and Care Inc. | 500 |  |  |  |  | 500 | 47 |
| &nbsp;&nbsp;&nbsp;Knockaway, Inc. | 49141 | 35945 | (40047) |  | (3039) | 42000 | 6319 |
| &nbsp;&nbsp;&nbsp;Direct Lending 2025 LLC |  | 22350 |  |  |  | 22350 |  |
| &nbsp;&nbsp;&nbsp;Trinity Capital Adviser, LLC | 4851 |  |  |  | 4735 | 9586 |  |
| **Total Control Investments** | $89249 | $61366 | $(41375) | $— | $7503 | $116743 | $7567 |
| **Affiliate Investments** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Eagle Point Trinity Senior Secured Lending Company (fka EPT 16 LLC) | 9215 | 785 |  |  | 176 | 10176 | 808 |
| &nbsp;&nbsp;&nbsp;GoFor Delivers, Inc. | 6441 | 34 |  |  | 572 | 7047 | 574 |
| &nbsp;&nbsp;&nbsp;Nexii, Inc. | 3997 |  |  |  | (2186) | 1811 | 28 |
| &nbsp;&nbsp;&nbsp;Nomad Health, Inc. <sup>(3)</sup> | 28868 | 1162 | 1773 | (19039) | (407) | 12356 |  |
| &nbsp;&nbsp;&nbsp;Senior Credit Corp 2022 LLC | 19071 |  |  |  | (308) | 18763 | 2706 |
| **Total Affiliate Investments** | $67592 | $1981 | $1773 | $(19039) | $(2153) | $50153 | $4116 |
| **Total Control and Affiliate Investments** | $156841 | $63347 | $(39602) | $(19039) | $5350 | $166896 | $11683 |

---

------

<sup>(1)</sup> Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.

<sup>(2)</sup> Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

<sup>(3)</sup> The portfolio company was designated as an affiliate investment during the three months ended September 30, 2025, and the interest and dividend income presented represents amounts earned during that period.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States** | **Debt Securities- United States** | **Debt Securities- United States** | **Debt Securities- United States** |  |  |  |  |  |
| ***<u>Artificial Intelligence & Automation</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Ambient Photonics, Inc. | Secured Loan | July 28, 2022 | July 1, 2025 | Variable interest rate Prime + 6.0% or Floor rate 9.5%; EOT 4.0% | $1003 | $1175 | $1184 | (8) |
|  | Secured Loan | November 17, 2022 | May 1, 2025 | Variable interest rate Prime + 6.0% or Floor rate 9.5%; EOT 4.0% | 947 | 1131 | 939 | (8) |
|  | Secured Loan | December 20, 2022 | June 1, 2025 | Variable interest rate Prime + 6.0% or Floor rate 9.5%; EOT 4.0% | 175 | 204 | 177 | (8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Ambient Photonics, Inc. |  |  |  |  | 2125 | 2510 | 2300 |  |
| &nbsp;&nbsp;&nbsp;Applied Digital Corporation | Equipment Financing | March 13, 2024 | October 1, 2025 | Fixed interest rate 19.0%; EOT 0.0% | $4190 | $4191 | $4270 | (9)(10)(14) |
|  | Equipment Financing | March 25, 2024 | March 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | 6975 | 6978 | 7162 | (9)(10)(14)(19) |
|  | Equipment Financing | April 24, 2024 | April 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | 3711 | 3714 | 3814 | (9)(10)(14)(19) |
|  | Equipment Financing | May 28, 2024 | May 1, 2026 | Fixed interest rate 16.0%; EOT 0.0% | 1657 | 1657 | 1700 | (9)(10)(14) |
|  | Equipment Financing | June 21, 2024 | April 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | 6011 | 6016 | 6178 | (9)(10)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Applied Digital Corporation |  |  |  |  | 22544 | 22556 | 23124 |  |
| &nbsp;&nbsp;&nbsp;Augmented Reality Concepts, Inc. | Secured Loan | June 17, 2024 | June 18, 2029 | Variable interest rate SOFR 3 Month Term + 7.3%; EOT 0.0% | $19270 | $18894 | $19404 | (8)(19) |
| &nbsp;&nbsp;&nbsp;Cirrascale Cloud Services, LLC | Equipment Financing | June 27, 2024 | September 1, 2026 | Fixed interest rate 12.7%; EOT 4.0% | $18771 | $19170 | $19371 | (9)(19) |
|  | Equipment Financing | October 22, 2024 | April 1, 2027 | Fixed interest rate 10.2%; EOT 5.0% | 19838 | 20041 | 20041 | (19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Cirrascale Cloud Services, LLC |  |  |  |  | 38609 | 39211 | 39412 |  |
| **Sub-total: Artificial Intelligence & Automation (10.2%)\*** | **Sub-total: Artificial Intelligence & Automation (10.2%)\*** | **Sub-total: Artificial Intelligence & Automation (10.2%)\*** |  |  | $**82548** | $**83171** | $**84240** |  |
| ***<u>Biotechnology</u>*** | ***<u>Biotechnology</u>*** | ***<u>Biotechnology</u>*** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pendulum Therapeutics, Inc. | Secured Loan | December 31, 2021 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | $4292 | $4468 | $4453 | (8)(14) |
|  | Secured Loan | February 28, 2022 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | 4581 | 4757 | 4747 | (8)(14) |
|  | Secured Loan | March 30, 2022 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | 4722 | 4899 | 4891 | (8)(14) |
|  | Secured Loan | May 6, 2022 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | 5000 | 5177 | 5173 | (8)(14) |
|  | Secured Loan | June 17, 2022 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | 5000 | 5177 | 5173 | (8)(14) |
|  | Secured Loan | February 1, 2024 | July 1, 2026 | Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0% | 1405 | 1089 | 1053 | (8)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Pendulum Therapeutics, Inc. |  |  |  |  | 25000 | 25567 | 25490 |  |
| &nbsp;&nbsp;&nbsp;Taysha Gene Therapies, Inc. | Secured Loan | November 13, 2023 | December 1, 2028 | Variable interest rate Prime + 4.5% or Floor rate 12.8%; EOT 5.0% | $30000 | $30195 | $30949 | (8)(9)(14) |
| **Sub-total: Biotechnology (6.9%)\*** |  |  |  |  | $**55000** | $**55762** | $**56439** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Connectivity</u>*** | ***<u>Connectivity</u>*** | ***<u>Connectivity</u>*** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tarana Wireless, Inc. | Secured Loan | September 23, 2024 | October 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 12.5%; EOT 4.0% | $14800 | $14058 | $14283 | (8)(9)(19) |
| &nbsp;&nbsp;&nbsp;Vertical Communications, Inc. | Secured Loan | August 23, 2021 | March 1, 2026 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 23.8% | $12600 | $15521 | $15521 | (8)(21) |
| **Sub-total: Connectivity (3.6%)\*** |  |  |  |  | $**27400** | $**29579** | $**29804** |  |
| ***<u>Consumer Products & Services</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Eterneva, Inc. | Equipment Financing | November 24, 2021 | June 1, 2026 | Fixed interest rate 7.8%; EOT 11.5% | $227 | $250 | $223 |  |
|  | Equipment Financing | March 16, 2022 | October 1, 2026 | Fixed interest rate 8.1%; EOT 11.5% | 376 | 392 | 353 | (14) |
|  | Equipment Financing | June 17, 2022 | January 1, 2027 | Fixed interest rate 11.9%; EOT 11.5% | 1139 | 1141 | 1014 | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Eterneva, Inc. |  |  |  |  | 1742 | 1783 | 1590 |  |
| &nbsp;&nbsp;&nbsp;Molekule Group, Inc. | Equipment Financing | June 19, 2020 | March 31, 2025 | Fixed interest rate 8.8%; EOT 10.0% | $312 | $595 | $218 | (18) |
|  | Equipment Financing | September 29, 2020 | March 31, 2025 | Fixed interest rate 12.3%; EOT 10.0% | 273 | 347 | 191 | (18) |
|  | Equipment Financing | December 18, 2020 | March 31, 2025 | Fixed interest rate 11.9%; EOT 10.0% | 473 | 584 | 331 | (18) |
|  | Equipment Financing | August 25, 2021 | March 31, 2025 | Fixed interest rate 11.3%; EOT 10.0% | 385 | 454 | 270 | (18) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Molekule Group, Inc. |  |  |  |  | 1443 | 1980 | 1010 |  |
| &nbsp;&nbsp;&nbsp;Ogee, Inc. | Secured Loan | February 14, 2023 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | $4700 | $4752 | $4736 | (8)(14)(19) |
|  | Secured Loan | September 29, 2023 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 4700 | 4722 | 4751 | (8)(14)(19) |
|  | Secured Loan | August 1, 2024 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 4700 | 4612 | 4620 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Ogee, Inc. |  |  |  |  | 14100 | 14086 | 14107 |  |
| &nbsp;&nbsp;&nbsp;Portofino Labs, Inc. | Secured Loan | April 1, 2021 | November 1, 2025 | Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 6.0% | $1064 | $1150 | $1176 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Quip NYC, Inc. | Secured Loan | March 9, 2021 | April 1, 2026 | Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0% | $7778 | $8237 | $8264 | (8)(14) |
|  | Secured Loan | February 10, 2022 | April 1, 2026 | Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0% | 1111 | 1179 | 1185 | (8)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Quip NYC, Inc. |  |  |  |  | 8889 | 9416 | 9449 |  |
| &nbsp;&nbsp;&nbsp;Rinse, Inc. | Secured Loan | May 10, 2022 | June 1, 2027 | Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.8% | $3849 | $3954 | $3984 | (8)(14) |
|  | Secured Loan | September 22, 2023 | October 1, 2028 | Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.8% | 4000 | 3997 | 4068 | (8)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Rinse, Inc. |  |  |  |  | 7849 | 7951 | 8052 |  |
| &nbsp;&nbsp;&nbsp;SI Tickets, Inc. | Secured Loan | May 11, 2022 | September 1, 2026 | Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 3.0% | $1928 | $1986 | $1939 | (8)(14) |
| &nbsp;&nbsp;&nbsp;UnTuckIt, Inc. | Secured Loan | January 16, 2020 | December 1, 2025 | Fixed interest rate 12.0%; EOT 5.0% | $5051 | $5951 | $5859 |  |
| &nbsp;&nbsp;&nbsp;VitaCup, Inc. | Secured Loan | June 23, 2021 | January 1, 2026 | Variable interest rate Prime + 7.5% or Floor rate 11.5%; EOT 5.0% | $6000 | $6128 | $5842 | (8)(14) |
| **Sub-total: Consumer Products & Services (6.0%)\*** |  |  |  |  | $**48066** | $**50431** | $**49024** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Digital Assets Technology and Services</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cleanspark, Inc. | Equipment Financing | April 22, 2022 | May 1, 2025 | Fixed interest rate 10.3%; EOT 5.0% | $2522 | $3511 | $3493 | (10)(14) |
| **Sub-total: Digital Assets Technology and Services (0.4%)\*** |  |  |  |  | $**2522** | $**3511** | $**3493** |  |
| ***<u>Education Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Edblox, Inc. | Secured Loan | March 19, 2024 | April 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.8%; EOT 2.5% | $15000 | $14848 | $13712 | (8)(9)(14) |
| &nbsp;&nbsp;&nbsp;Medical Sales Training Holding Company | Secured Loan | March 18, 2021 | April 1, 2025 | Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 6.3% | $5175 | $5531 | $5300 | (8) |
|  | Secured Loan | July 21, 2021 | August 1, 2025 | Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 6.3% | 1825 | 1938 | 1759 | (8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Medical Sales Training Holding Company |  |  |  |  | 7000 | 7469 | 7059 |  |
| &nbsp;&nbsp;&nbsp;Yellowbrick Learning, Inc. | Secured Loan | February 1, 2021 | March 1, 2026 | Fixed interest rate 2.0%; EOT 5.0% | $7500 | $7876 | $6683 |  |
|  | Secured Loan | August 10, 2021 | March 1, 2026 | Fixed interest rate 2.0%; EOT 5.0% | 2500 | 2625 | 2229 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Yellowbrick Learning, Inc. |  |  |  |  | 10000 | 10501 | 8912 |  |
| **Sub-total: Education Technology (3.6%)\*** |  |  |  |  | $**32000** | $**32818** | $**29683** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beam Technologies, Inc. | Secured Loan | August 30, 2024 | April 1, 2027 | Variable interest rate PRIME + 2.8% or Floor rate 11.0%+PIK Fixed Interest Rate 1.5%; EOT 2.0% | $34956 | $34130 | $34579 | (8)(15)(19) |
| &nbsp;&nbsp;&nbsp;Bestow, Inc. | Secured Loan | August 1, 2024 | December 1, 2027 | Variable interest rate Prime + 6.0% or Floor rate 13.0%; EOT 1.5% | $40000 | $38342 | $38122 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Busbot, Inc. | Secured Loan | April 1, 2024 | October 1, 2026 | Variable interest rate SOFR 30 Day Forward + 11.5% or Floor rate 13.5%; EOT 0.0% | $8630 | $8482 | $8482 | (8)(10)(12) |
| &nbsp;&nbsp;&nbsp;Centivo Corporation | Secured Loan | July 31, 2024 | August 1, 2029 | Variable interest rate PRIME + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | $3765 | $3677 | $3735 | (8)(9)(15)(19) |
|  | Secured Loan | December 20, 2024 | August 1, 2029 | Variable interest rate PRIME + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 3751 | 3528 | 3528 | (8)(9)(15)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Centivo Corporation |  |  |  |  | 7516 | 7205 | 7263 |  |
| &nbsp;&nbsp;&nbsp;Cherry Technologies, Inc. | Secured Loan | March 29, 2024 | April 1, 2029 | Variable interest rate PRIME + 4.5% or Floor rate 12.0%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | $14577 | $14504 | $15000 | (8)(9)(14)(15)(19) |
|  | Secured Loan | July 31, 2024 | April 1, 2029 | Variable interest rate PRIME + 4.5% or Floor rate 12.0%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 14530 | 14437 | 14924 | (8)(9)(14)(15)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Cherry Technologies, Inc. |  |  |  |  | 29107 | 28941 | 29924 |  |
| &nbsp;&nbsp;&nbsp;Empower Financial, Inc. | Secured Loan | October 13, 2023 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | $11622 | $11514 | $11663 | (8)(9)(14)(19) |
|  | Secured Loan | January 5, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 2902 | 2809 | 2856 | (8)(9)(14)(19) |
|  | Secured Loan | February 8, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 4353 | 4210 | 4281 | (8)(9)(14)(19) |
|  | Secured Loan | April 9, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 4348 | 4078 | 4142 | (8)(9)(14)(19) |
|  | Secured Loan | May 15, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 14495 | 14591 | 14895 | (8)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Empower Financial, Inc. |  |  |  |  | 37720 | 37202 | 37837 |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Eqis Capital Management, Inc. | Secured Loan | June 15, 2022 | July 1, 2026 | Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 3.0% | $6809 | $7019 | $6610 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Gravie, Inc. | Secured Loan | June 4, 2024 | July 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 13.0%; EOT 2.5% | $15980 | $15662 | $15796 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Kafene, Inc. | Secured Loan | January 5, 2024 | February 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.0%; EOT 1.0% | $12500 | $12403 | $12582 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Mesa Financial, Inc. | Secured Loan | August 29, 2024 | February 28, 2027 | Variable interest rate SOFR 30 Day Forward + 10.3% or Floor rate 12.3%; EOT 0.0% | $9861 | $9665 | $9665 | (8)(10)(12) |
| &nbsp;&nbsp;&nbsp;Pagaya Structured Products LLC | Secured Loan | August 23, 2024 | August 23, 2025 | Fixed interest rate 20.0%; EOT 0.0% | $13814 | $13712 | $13712 | (10) |
| &nbsp;&nbsp;&nbsp;Parafin SPV 2, LLC | Secured Loan | February 22, 2024 | December 21, 2026 | Variable interest rate SOFR 1 Month Term + 10.8% or Floor rate 12.8%; EOT 0.0% | $24600 | $24252 | $24252 | (8)(10)(12) |
| &nbsp;&nbsp;&nbsp;Parafin SPV 3, LLC | Secured Loan | July 25, 2024 | January 25, 2027 | Variable interest rate SOFR 1 Month Term + 10.8% or Floor rate 13.8%; EOT 0.0% | $16452 | $16220 | $16220 | (8)(10)(12) |
| &nbsp;&nbsp;&nbsp;Slope Tech, Inc. | Secured Loan | October 5, 2022 | February 27, 2026 | Variable interest rate SOFR 1 Month Term + 11.8% or Floor rate 11.8%; EOT 0.0% | $1823 | $1742 | $1742 | (8)(10)(12) |
| &nbsp;&nbsp;&nbsp;Under Technologies, Inc. | Secured Loan | September 13, 2024 | June 1, 2029 | Variable interest rate PRIME + 3.8% or Floor rate 12.0%; EOT 4.3% | $9400 | $9223 | $9369 | (8)(19) |
|  | Secured Loan | November 27, 2024 | June 1, 2029 | Variable interest rate PRIME + 3.8% or Floor rate 12.0%; EOT 4.3% | 9400 | 9191 | 9191 | (8)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Under Technologies, Inc. |  |  |  |  | 18800 | 18414 | 18560 |  |
| &nbsp;&nbsp;&nbsp;Wisetack, Inc. | Secured Loan | November 14, 2024 | December 1, 2029 | Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 2.5% | $14100 | $13862 | $13862 | (8)(19) |
| **Sub-total: Finance and Insurance (35.1%)\*** |  |  |  |  | $**292668** | $**287253** | $**289208** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Bowery Farming, Inc. | Secured Loan | September 10, 2021 | September 10, 2026 | Variable interest rate SOFR 1 Month Term + 10.0% or Floor rate 1.0%; EOT 0.0% | $7652 | $6938 | $57 | (8)(18) |
| &nbsp;&nbsp;&nbsp; Daring Foods, Inc. | Equipment Financing | March 8, 2022 | April 1, 2025 | Fixed interest rate 9.5%; EOT 7.5% | $215 | $385 | $381 | (14) |
|  | Equipment Financing | April 29, 2022 | May 1, 2025 | Fixed interest rate 10.2%; EOT 7.5% | 126 | 201 | 199 | (14) |
|  | Equipment Financing | July 6, 2022 | August 1, 2025 | Fixed interest rate 10.9%; EOT 7.5% | 99 | 132 | 131 | (14) |
|  | Equipment Financing | August 25, 2022 | September 1, 2025 | Fixed interest rate 12.1%; EOT 7.5% | 267 | 342 | 341 | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Daring Foods, Inc. |  |  |  |  | 707 | 1060 | 1052 |  |
| &nbsp;&nbsp;&nbsp;DrinkPak, LLC | Equipment Financing | February 17, 2023 | September 1, 2026 | Fixed interest rate 12.9%; EOT 7.0% | $7274 | $8033 | $8074 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Emergy, Inc. | Equipment Financing | December 15, 2021 | July 1, 2026 | Fixed interest rate 11.2%; EOT 11.5% | $3711 | $4520 | $3668 | (14) |
|  | Equipment Financing | December 13, 2022 | July 1, 2027 | Fixed interest rate 8.8%; EOT 11.5% | 6744 | 7531 | 5930 | (9)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Emergy, Inc. |  |  |  |  | 10455 | 12051 | 9598 |  |
| **Sub-total: Food and Agriculture Technologies (2.3%)\*** |  |  |  |  | $**26088** | $**28082** | $**18781** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Green Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Commonwealth Fusion Systems, LLC | Equipment Financing | June 16, 2023 | July 1, 2030 | Fixed interest rate 13.0%; EOT 10.0% | $3450 | $3565 | $3665 | (9)(14)(19) |
|  | Equipment Financing | June 27, 2024 | July 1, 2030 | Fixed interest rate 13.2%; EOT 10.0% | 9979 | 10021 | 10333 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Commonwealth Fusion Systems, LLC | &nbsp;&nbsp;&nbsp;&nbsp;Total Commonwealth Fusion Systems, LLC |  |  |  | 13429 | 13586 | 13998 |  |
| &nbsp;&nbsp;&nbsp;Crusoe Energy Systems LLC | Equipment Financing | March 1, 2024 | March 1, 2029 | Fixed interest rate 12.7%; EOT 0.0% | $8098 | $8034 | $8237 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;Dandelion Energy, Inc. | Equipment Financing | June 25, 2024 | July 1, 2025 | Fixed interest rate 15.9%; EOT 0.0% | $1361 | $1349 | $1378 | (9)(14) |
| &nbsp;&nbsp;&nbsp;Electric Hydrogen Co. | Equipment Financing | September 12, 2022 | April 1, 2026 | Fixed interest rate 9.0%; EOT 10.0% | $797 | $974 | $956 | (14) |
|  | Equipment Financing | December 22, 2023 | January 1, 2029 | Fixed interest rate 12.5%; EOT 15.0% | 3908 | 4125 | 4125 | (9)(14)(19) |
|  | Equipment Financing | June 27, 2024 | January 1, 2029 | Fixed interest rate 12.6%; EOT 15.0% | 3203 | 3276 | 3321 | (9)(14)(19) |
|  | Equipment Financing | September 19, 2024 | October 1, 2028 | Fixed interest rate 12.5%; EOT 15.0% | 1967 | 1989 | 2004 | (9)(14)(19) |
|  | Equipment Financing | November 14, 2024 | December 1, 2028 | Fixed interest rate 11.9%; EOT 15.0% | 870 | 874 | 874 | (14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Electric Hydrogen Co. |  |  |  |  | 10745 | 11238 | 11280 |  |
| &nbsp;&nbsp;&nbsp;Form Energy Inc. | Equipment Financing | October 21, 2024 | November 1, 2027 | Fixed interest rate 12.7%; EOT 3.0% | $35626 | $34946 | $34946 | (19) |
|  | Equipment Financing | December 12, 2024 | January 1, 2028 | Fixed interest rate 12.5%; EOT 3.0% | 9400 | 9185 | 9185 | (19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Form Energy Inc. | &nbsp;&nbsp;&nbsp;&nbsp;Total Form Energy Inc. |  |  |  | 45026 | 44131 | 44131 |  |
| &nbsp;&nbsp;&nbsp;Hi-Power, LLC | Equipment Financing | September 30, 2021 | April 1, 2025 | Fixed interest rate 12.4%; EOT 1.0% | $601 | $670 | $680 | (14) |
|  | Equipment Financing | September 30, 2022 | April 1, 2026 | Fixed interest rate 14.7%; EOT 1.0% | 1737 | 1769 | 1779 | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Hi-Power, LLC |  |  |  |  | 2338 | 2439 | 2459 |  |
| &nbsp;&nbsp;&nbsp;SeaOn Global, LLC | Equipment Financing | June 16, 2022 | July 1, 2026 | Fixed interest rate 9.3%; EOT 11.0% | $2817 | $3450 | $3332 |  |
|  | Equipment Financing | August 17, 2022 | September 1, 2026 | Fixed interest rate 9.3%; EOT 11.0% | 1496 | 1788 | 1737 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total SeaOn Global, LLC |  |  |  |  | 4313 | 5238 | 5069 |  |
| &nbsp;&nbsp;&nbsp;Footprint International Holding, Inc. | Secured Loan | February 18, 2022 | March 1, 2027 | Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.5% | $15838 | $15722 | $15382 | (8)(14) |
|  | Secured Loan | April 20, 2022 | March 1, 2027 | Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.5% | 15838 | 15689 | 15345 | (8)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Footprint International Holding, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;Total Footprint International Holding, Inc. |  |  |  | 31676 | 31411 | 30727 |  |
| &nbsp;&nbsp;&nbsp;Mainspring Energy, Inc. | Secured Loan | March 18, 2022 | October 1, 2026 | Fixed interest rate 11.0%; EOT 3.8% | $19488 | $20347 | $20126 | (14) |
| **Sub-total: Green Technology (16.7%)\*** |  |  |  |  | $**136474** | $**137773** | $**137405** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Lark Technologies, Inc. | Secured Loan | September 30, 2020 | April 1, 2025 | Variable interest rate Prime + 8.3% or Floor rate 11.5% or ceiling rate of 13.5%; EOT 4.0% | $659 | $856 | $853 | (8)(14) |
|  | Secured Loan | June 30, 2021 | January 1, 2026 | Variable interest rate Prime + 8.3% or Floor rate 11.5% or ceiling rate of 13.5%; EOT 4.0% | 2041 | 2212 | 2187 | (14) |
|  | Secured Loan | July 7, 2023 | January 1, 2028 | Variable interest rate Prime + 8.3% or Floor rate 11.5% or ceiling rate of 13.5%; EOT 4.0% | 5000 | 5039 | 5094 | (8)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Lark Technologies, Inc. |  |  |  |  | 7700 | 8107 | 8134 |  |
| &nbsp;&nbsp;&nbsp;Moxe Health Corporation | Secured Loan | December 29, 2023 | January 1, 2028 | Variable interest rate Prime + 5.5% or Floor rate 13.0%; EOT 4.8% | $12500 | $12512 | $12439 | (8) |
| &nbsp;&nbsp;&nbsp;RXAnte, Inc. | Secured Loan | November 21, 2022 | December 1, 2027 | Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5% | $8516 | $8601 | $8658 | (8)(9)(14)(15)(19) |
|  | Secured Loan | April 14, 2023 | December 1, 2027 | Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5% | 2831 | 2832 | 2932 | (8)(9)(14)(15)(19) |
|  | Secured Loan | October 19, 2023 | December 1, 2027 | Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5% | 2803 | 2797 | 2873 | (8)(9)(14)(15)(19) |
|  | Secured Loan | September 9, 2024 | December 1, 2027 | Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5% | 2767 | 2756 | 2830 | (8)(9)(14)(15)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total RXAnte, Inc. |  |  |  |  | 16917 | 16986 | 17293 |  |
| &nbsp;&nbsp;&nbsp;TMRW Life Sciences, Inc. | Secured Loan | April 29, 2022 | May 1, 2027 | Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0% | $5000 | $5127 | $4799 | (8)(14) |
|  | Secured Loan | March 3, 2023 | May 1, 2027 | Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0% | 15000 | 15309 | 15007 | (8)(14) |
|  | Secured Loan | December 8, 2023 | May 1, 2027 | Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0% | 10000 | 10131 | 10129 | (8)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total TMRW Life Sciences, Inc. |  |  |  |  | 30000 | 30567 | 29935 |  |
| &nbsp;&nbsp;&nbsp;WorkWell Prevention & Care Inc. | Secured Loan | December 31, 2022 | January 1, 2027 | Variable interest rate Prime + 5.0% or Floor rate 6.0%; EOT 0.0% | $500 | $500 | $500 | (8)(21) |
| **Sub-total: Healthcare Technology (8.3%)\*** |  |  |  |  | $**67617** | $**68672** | $**68301** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Human Resource Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Nomad Health, Inc. | Secured Loan | March 29, 2022 | December 1, 2026 | Variable interest rate Prime + 5.5% or Floor rate 9.3%; EOT 4.0% | $31416 | $32287 | $28390 | (8)(14)(15) |
|  | Secured Loan | June 12, 2024 | December 1, 2026 | Fixed interest rate 10.0%; EOT 0.0% | 500 | 500 | 478 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Nomad Health, Inc. |  |  |  |  | 31916 | 32787 | 28868 |  |
| **Sub-total: Human Resource Technology (3.5%)\*** |  |  |  |  | $**31916** | $**32787** | $**28868** |  |
| ***<u>Industrials</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;3DEO, Inc. | Equipment Financing | February 23, 2022 | February 1, 2025 | Fixed interest rate 0.0%; EOT 9.0% | $1256 | $1567 | $1517 | (14) |
|  | Equipment Financing | April 12, 2022 | February 1, 2025 | Fixed interest rate 0.0%; EOT 9.0% | 675 | 816 | 796 | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total 3DEO, Inc. |  |  |  |  | 1931 | 2383 | 2313 |  |
| &nbsp;&nbsp;&nbsp;Formlogic Corporation | Equipment Financing | December 28, 2023 | January 1, 2028 | Fixed interest rate 12.1%; EOT 1.5% | $4017 | $4014 | $1718 | (9)(14)(18) |
|  | Equipment Financing | April 25, 2024 | May 1, 2028 | Fixed interest rate 12.1%; EOT 1.5% | 350 | 347 | 149 | (9)(14)(18) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Formlogic Corporation |  |  |  |  | 4367 | 4361 | 1867 |  |
| **Sub-total: Industrials (0.5%)\*** |  |  |  |  | $**6298** | $**6744** | $**4180** |  |
| ***<u>Marketing, Media, and Entertainment</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Drone Racing League, Inc. | Secured Loan | October 17, 2022 | December 1, 2025 | Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.5% | $8360 | $8449 | $8123 | (8) |
| &nbsp;&nbsp;&nbsp;Grabit Interactive Media, Inc. | Secured Loan | April 8, 2022 | November 1, 2026 | Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 2.5% | $3115 | $3193 | $3130 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Incontext Solutions, Inc. | Secured Loan | January 16, 2020 | September 1, 2025 | Fixed interest rate 11.8%; EOT 11.4% | $1388 | $2538 | $2332 |  |
| &nbsp;&nbsp;&nbsp;PebblePost, Inc. | Secured Loan | May 7, 2021 | June 1, 2026 | Variable interest rate Prime + 8.8% or Floor rate 11.5%; EOT 3.8% | $7478 | $7886 | $7871 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Vox Media Holdings, Inc. | Secured Loan | October 18, 2022 | November 1, 2027 | Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5% | $10506 | $10599 | $10768 | (8)(9)(14)(19) |
|  | Secured Loan | December 29, 2022 | January 1, 2028 | Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5% | 5251 | 5286 | 5371 | (8)(9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Vox Media Holdings, Inc. |  |  |  |  | 15757 | 15885 | 16139 |  |
| **Sub-total: Marketing, Media, and Entertainment (4.6%)\*** | **Sub-total: Marketing, Media, and Entertainment (4.6%)\*** | **Sub-total: Marketing, Media, and Entertainment (4.6%)\*** | **Sub-total: Marketing, Media, and Entertainment (4.6%)\*** |  | $**36098** | $**37951** | $**37595** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Apiject Holdings, Inc. | Equipment Financing | June 24, 2024 | July 1, 2028 | Fixed interest rate 12.6%; EOT 7.5% | $17847 | $17773 | $17982 | (9)(14)(19) |
|  | Equipment Financing | September 30, 2024 | October 1, 2028 | Fixed interest rate 12.7%; EOT 7.5% | 7438 | 7314 | 7371 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Apiject Holdings, Inc. |  |  |  |  | 25285 | 25087 | 25353 |  |
| &nbsp;&nbsp;&nbsp;Convergent Dental, Inc. | Secured Loan | April 21, 2023 | May 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 13.5%; EOT 5.5% | $12000 | $12074 | $12215 | (8)(9)(14) |
|  | Secured Loan | February 29, 2024 | May 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 13.5%; EOT 5.5% | 6000 | 5997 | 6137 | (8)(9)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Convergent Dental, Inc. |  |  |  |  | 18000 | 18071 | 18352 |  |
| &nbsp;&nbsp;&nbsp;Elucent Medical, Inc. | Secured Loan | October 31, 2024 | November 30, 2029 | Variable interest rate PRIME + 3.8% or Floor rate 11.3%; EOT 3.3% | $14100 | $13822 | $13822 | (8)(19) |
| &nbsp;&nbsp;&nbsp;Lightforce Orthodontics, Inc. | Secured Loan | August 6, 2024 | August 6, 2029 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0% | $28200 | $27803 | $28052 | (8)(19) |
|  | Secured Loan | September 25, 2024 | August 6, 2029 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0% | 4700 | 4633 | 4675 | (8)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Lightforce Orthodontics, Inc. |  |  |  |  | 32900 | 32436 | 32727 |  |
| &nbsp;&nbsp;&nbsp;Neurolens, Inc. | Secured Loan | September 29, 2023 | October 1, 2028 | Variable interest rate Prime + 3.5% or Floor rate 11.5%; EOT 3.0% | $20000 | $20000 | $20706 | (8) |
| &nbsp;&nbsp;&nbsp;Neuros Medical, Inc. | Secured Loan | August 10, 2023 | September 1, 2027 | Variable interest rate Prime + 6.0% or Floor rate 14.3%; EOT 4.5% | $6000 | $6034 | $6032 | (8)(9)(14) |
|  | Secured Loan | August 30, 2024 | September 1, 2027 | Variable interest rate Prime + 6.0% or Floor rate 14.3%; EOT 4.5% | 3000 | 2961 | 2926 | (8)(9)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Neuros Medical, Inc. |  |  |  |  | 9000 | 8995 | 8958 |  |
| &nbsp;&nbsp;&nbsp;Restor3d, Inc. | Secured Loan | June 4, 2024 | July 4, 2028 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.3% | $11985 | $11895 | $12006 | (8)(9)(19) |
| &nbsp;&nbsp;&nbsp;Shoulder Innovations, Inc. | Secured Loan | August 7, 2023 | September 1, 2028 | Variable interest rate Prime + 3.5% or Floor rate 11.5%; EOT 3.0% | $11250 | $11245 | $11426 | (8)(9)(14) |
| &nbsp;&nbsp;&nbsp;Vital Connect, Inc. | Secured Loan | July 3, 2024 | July 3, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0% | $27650 | $27504 | $27745 | (8)(9)(19) |
| **Sub-total: Medical Devices (20.8%)\*** | **Sub-total: Medical Devices (20.8%)\*** | **Sub-total: Medical Devices (20.8%)\*** | **Sub-total: Medical Devices (20.8%)\*** |  | $**170170** | $**169055** | $**171095** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Multi-Sector Holdings</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Senior Credit Corp 2022 LLC | Secured Loan | January 30, 2023 | December 5, 2028 | Fixed interest rate 8.5%; EOT 0.0% | $12885 | $12885 | $12885 | (10)(14)(21) |
| **Sub-total: Multi-Sector Holdings (1.6%)\*** | **Sub-total: Multi-Sector Holdings (1.6%)\*** | **Sub-total: Multi-Sector Holdings (1.6%)\*** | **Sub-total: Multi-Sector Holdings (1.6%)\*** |  | $**12885** | $**12885** | $**12885** |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cellares Corporation | Equipment Financing | August 2, 2024 | September 1, 2029 | Fixed interest rate 12.0%; EOT 4.5% | $4467 | $4477 | $4555 | (19) |
|  | Secured Loan | August 2, 2024 | February 1, 2027 | Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 4.0% | 47000 | 46411 | 47219 | (8)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Cellares Corporation |  |  |  |  | 51467 | 50888 | 51774 |  |
| &nbsp;&nbsp;&nbsp;Metabolon, Inc. | Secured Loan | March 28, 2024 | April 1, 2029 | Variable interest rate PRIME + 2.5% or Floor rate 10.0%+PIK Fixed Interest Rate 3.0%; EOT 4.8% | $43141 | $42389 | $42382 | (8)(15) |
|  | Secured Loan | October 1, 2024 | April 1, 2029 | Variable interest rate PRIME + 2.5% or Floor rate 10.0%+PIK Fixed Interest Rate 3.0%; EOT 4.8% | 5038 | 4972 | 4972 | (8)(15) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Metabolon, Inc. |  |  |  |  | 48179 | 47361 | 47354 |  |
| &nbsp;&nbsp;&nbsp;Upward Health, Inc. | Secured Loan | August 6, 2024 | September 1, 2029 | Variable interest rate Prime + 4.3% or Floor rate 12.8%; EOT 3.0% | $5875 | $5707 | $5833 | (8)(9)(19) |
| &nbsp;&nbsp;&nbsp;Velentium, Inc. | Secured Loan | May 24, 2024 | May 24, 2029 | Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 4.0% | $8500 | $8379 | $8445 | (8)(9)(14) |
| **Sub-total: Other Healthcare Services (13.8%)\*** | **Sub-total: Other Healthcare Services (13.8%)\*** | **Sub-total: Other Healthcare Services (13.8%)\*** | **Sub-total: Other Healthcare Services (13.8%)\*** |  | $**114021** | $**112335** | $**113406** |  |
| ***<u>Real Estate Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Homelight Lending, Inc. | Secured Loan | October 15, 2021 | June 1, 2026 | Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.5% | $3900 | $4129 | $3999 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Knockaway, Inc. | Secured Loan | September 29, 2023 | September 1, 2028 | Fixed interest rate 10.2%; EOT 0.0% | $23644 | $19920 | $19159 | (8)(14)(21) |
| &nbsp;&nbsp;&nbsp;Knockaway Trinity Holdings, LLC | Secured Loan | December 6, 2023 | December 27, 2026 | Variable interest rate SOFR 30 Day Forward + 9.0% or Floor rate 13.5%; EOT 0.0% | $25000 | $24981 | $24981 | (8)(10)(12)(21) |
| &nbsp;&nbsp;&nbsp;Maxwell Financial Labs, Inc. | Secured Loan | September 30, 2021 | April 1, 2026 | Variable interest rate Prime + 6.0% or Floor rate 10.0%; EOT 5.0% | $15000 | $15486 | $15052 | (8)(14) |
|  | Secured Loan | October 2, 2024 | October 2, 2026 | Fixed interest rate 6.0%; EOT 0.0% | 187 | 187 | 187 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Maxwell Financial Labs, Inc. |  |  |  |  | 15187 | 15673 | 15239 |  |
| &nbsp;&nbsp;&nbsp;Orchard Technologies, Inc. | Secured Loan | January 1, 2024 | January 1, 2029 | Variable interest rate Prime + 8.0% or Floor rate 15.0%; EOT 3.0% | $28540 | $28765 | $24662 | (8)(14) |
| **Sub-total: Real Estate Technology (10.7%)\*** | **Sub-total: Real Estate Technology (10.7%)\*** | **Sub-total: Real Estate Technology (10.7%)\*** | **Sub-total: Real Estate Technology (10.7%)\*** |  | $**96271** | $**93468** | $**88040** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Software as a Service ("SaaS")</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;BackBlaze, Inc. | Equipment Financing | March 29, 2021 | April 1, 2025 | Fixed interest rate 7.5%; EOT 11.5% | $198 | $518 | $510 | (14) |
| &nbsp;&nbsp;&nbsp;Cpacket Networks, Inc. | Secured Loan | January 29, 2024 | February 1, 2029 | Variable interest rate PRIME + 4.8% or Floor rate 12.0%+PIK Fixed Interest Rate 1.3%; EOT 3.0% | $20478 | $20316 | $20532 | (8)(9)(14)(15) |
| &nbsp;&nbsp;&nbsp;Eyelit Technologies, Inc. | Secured Loan | November 4, 2024 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0% | $4500 | $4413 | $4413 | (8)(19)(20) |
|  | Secured Loan | December 27, 2024 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0% | 7920 | 7764 | 7764 | (8)(19)(20) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Eyelit Technologies, Inc. |  |  |  |  | 12420 | 12177 | 12177 |  |
| &nbsp;&nbsp;&nbsp;Hometown Ticketing, Inc. | Secured Loan | November 25, 2024 | November 25, 2029 | Variable interest rate SOFR 3 Month Term + 7.7%; EOT 0.0% | $24910 | $24422 | $24422 | (8)(19) |
| &nbsp;&nbsp;&nbsp;ServiceTrade, Inc. | Secured Loan | August 15, 2024 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.5%; EOT 0.0% | $23500 | $23091 | $23720 | (8)(19)(20) |
| &nbsp;&nbsp;&nbsp;Silk Technologies, Inc. | Secured Loan | November 4, 2024 | December 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 1.5% | $18800 | $18309 | $18309 | (8)(19) |
| &nbsp;&nbsp;&nbsp;SOCi, Inc. | Secured Loan | October 3, 2024 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0% | $36100 | $35326 | $35326 | (8)(19) |
|  | Secured Loan | December 30, 2024 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0% | 3290 | 3216 | 3216 | (8)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total SOCi, Inc. |  |  |  |  | 39390 | 38542 | 38542 |  |
| &nbsp;&nbsp;&nbsp;Steno Agency, Inc. | Secured Loan | June 21, 2024 | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | $3740 | $3621 | $3744 | (8)(9)(14)(19) |
| **Sub-total: SaaS (17.2%)\*** |  |  |  |  | $**143436** | $**140996** | $**141956** |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Astranis Space Technology Corporation | Equipment Financing | April 13, 2023 | November 1, 2026 | Fixed interest rate 12.1%; EOT 5.0% | $7611 | $8099 | $8201 | (9)(14)(19) |
|  | Equipment Financing | September 27, 2024 | April 1, 2028 | Fixed interest rate 12.4%; EOT 5.5% | 10911 | 10388 | 10557 | (9)(14)(19) |
|  | Equipment Financing | September 27, 2024 | October 1, 2027 | Fixed interest rate 12.6%; EOT 4.0% | 2693 | 2563 | 2603 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Astranis Space Technology Corporation |  |  |  |  | 21215 | 21050 | 21361 |  |
| &nbsp;&nbsp;&nbsp;Axiom Space, Inc. | Secured Loan | May 28, 2021 | June 1, 2026 | Variable interest rate Prime + 6.0% or Floor rate 9.3%; EOT 2.5% | $15000 | $15641 | $15530 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Hadrian Automation, Inc. | Equipment Financing | March 2, 2022 | September 1, 2025 | Fixed interest rate 12.6%; EOT 0.0% | $126 | $126 | $129 | (14) |
|  | Equipment Financing | May 6, 2022 | November 1, 2025 | Fixed interest rate 12.9%; EOT 0.0% | 1497 | 1495 | 1522 | (14) |
|  | Equipment Financing | July 15, 2022 | January 1, 2026 | Fixed interest rate 14.3%; EOT 0.0% | 1192 | 1191 | 1215 | (14) |
|  | Equipment Financing | September 30, 2022 | March 1, 2026 | Fixed interest rate 15.2%; EOT 0.0% | 2290 | 2289 | 2347 | (9)(14) |
|  | Equipment Financing | December 22, 2022 | June 1, 2026 | Fixed interest rate 16.1%; EOT 0.0% | 612 | 608 | 632 | (9)(14) |
|  | Equipment Financing | December 22, 2022 | December 1, 2026 | Fixed interest rate 16.4%; EOT 0.0% | 274 | 273 | 284 | (9)(14)(19) |
|  | Equipment Financing | March 29, 2023 | March 1, 2027 | Fixed interest rate 15.7%; EOT 0.0% | 877 | 875 | 903 | (9)(14)(19) |
|  | Equipment Financing | September 28, 2023 | September 1, 2027 | Fixed interest rate 17.7%; EOT 0.0% | 468 | 467 | 485 | (9)(14)(19) |
|  | Equipment Financing | June 27, 2024 | June 1, 2028 | Fixed interest rate 17.6%; EOT 0.0% | 1273 | 1268 | 1307 | (9)(14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Hadrian Automation, Inc. |  |  |  |  | 8609 | 8592 | 8824 |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Impulse Space, Inc. | Equipment Financing | June 18, 2024 | July 1, 2027 | Fixed interest rate 12.7%; EOT 3.0% | $1143 | $1133 | $1155 | (9)(14)(19) |
|  | Equipment Financing | September 13, 2024 | October 1, 2027 | Fixed interest rate 12.5%; EOT 3.0% | 901 | 887 | 907 | (9)(14)(19) |
|  | Equipment Financing | December 27, 2024 | January 1, 2028 | Fixed interest rate 12.9%; EOT 3.0% | 1077 | 1051 | 1051 | (14)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Impulse Space, Inc. |  |  |  |  | 3121 | 3071 | 3113 |  |
| &nbsp;&nbsp;&nbsp;Kymeta Corporation | Secured Loan | July 3, 2024 | August 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 3.0% | $7900 | $7575 | $7783 | (8)(9)(19) |
| &nbsp;&nbsp;&nbsp;Rocket Lab USA, Inc. | Equipment Financing | December 29, 2023 | January 1, 2029 | Fixed interest rate 12.8%; EOT 1.0% | $45649 | $44992 | $46466 | (9)(10)(14) |
| &nbsp;&nbsp;&nbsp;Slingshot Aerospace, Inc. | Secured Loan | July 12, 2024 | August 1, 2029 | Variable interest rate Prime + 5.5% or Floor rate 14.0%; EOT 3.0% | $23700 | $23233 | $23750 | (8)(9)(19) |
|  | Secured Loan | August 7, 2024 | April 30, 2025 | Fixed interest rate 10.0%; EOT 0.0% | 500 | 500 | 524 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Slingshot Aerospace, Inc. |  |  |  |  | $24200 | $23733 | $24274 |  |
| &nbsp;&nbsp;&nbsp;Space Perspective, Inc. | Secured Loan | March 3, 2022 | July 1, 2026 | Variable interest rate Prime + 7.8% or Floor rate 11.0%; EOT 5.0% | $2936 | $3021 | $1637 | (8)(14)(18) |
| **Sub-total: Space Technology (15.7%)\*** |  |  |  |  | $**128630** | $**127675** | $**128988** |  |
| ***<u>Supply Chain Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Macrofab, Inc. | Secured Loan | July 21, 2023 | August 1, 2027 | Variable interest rate Prime + 5.5% or Floor rate 13.3%; EOT 4.0% | $19495 | $19448 | $19220 | (8)(14) |
| &nbsp;&nbsp;&nbsp;Nucleus RadioPharma, Inc. | Equipment Financing | June 4, 2024 | June 1, 2027 | Fixed interest rate 11.8%; EOT 4.0% | $364 | $366 | $373 | (9)(14) |
|  | Equipment Financing | December 23, 2024 | January 1, 2028 | Fixed interest rate 12.3%; EOT 4.0% | 2000 | 1980 | 1980 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Nucleus RadioPharma, Inc. |  |  |  |  | $2364 | $2346 | $2353 |  |
| **Sub-total: Supply Chain Technology (2.6%)\*** |  |  |  |  | $**21859** | $**21794** | $**21573** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** | **Debt Securities- United States, Continued** |  |  |  |  |  |
| ***<u>Transportation Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; NextCar Holding Company, Inc. | Secured Loan | December 14, 2021 | March 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | $2927 | $3188 | $926 | (8) |
|  | Secured Loan | December 15, 2021 | March 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 2274 | 2379 | 720 | (8)(18) |
|  | Secured Loan | February 23, 2022 | March 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 2843 | 2974 | 900 | (8)(18) |
|  | Secured Loan | March 16, 2022 | March 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 3411 | 3569 | 1080 | (8)(18) |
|  | Secured Loan | April 18, 2022 | March 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 2843 | 2974 | 900 | (8)(18) |
|  | Secured Loan | April 18, 2022 | March 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 2843 | 2974 | 900 | (8)(18) |
|  | Secured Loan | May 17, 2022 | March 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 5685 | 5948 | 1800 | (8)(18) |
|  | Secured Loan | June 22, 2022 | March 31, 2025 | Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% | 2843 | 2974 | 900 | (8)(18) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total NextCar Holding Company, Inc. |  |  |  |  | 25669 | 26980 | 8126 |  |
| &nbsp;&nbsp;&nbsp;Get Spiffy, Inc. | Secured Loan | July 14, 2023 | January 14, 2028 | Variable interest rate Prime + 4.5% or Floor rate 12.3%; EOT 6.0% | $9000 | $9127 | $7763 | (8)(9)(14) |
|  | Equipment Financing | July 14, 2023 | February 1, 2027 | Fixed interest rate 12.1%; EOT 4.0% | 291 | 292 | 274 | (9)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Get Spiffy, Inc. |  |  |  |  | 9291 | 9419 | 8037 |  |
| &nbsp;&nbsp;&nbsp;Uveye, Inc. | Equipment Financing | December 26, 2024 | January 1, 2028 | Fixed interest rate 11.9%; EOT 1.0% | $20217 | $20011 | $20011 |  |
| &nbsp;&nbsp;&nbsp;Zuum Transportation, Inc. | Secured Loan | December 17, 2021 | January 1, 2027 | Variable interest rate Prime + 6.0% or Floor rate 10.8%; EOT 2.5% | $5000 | $5065 | $4737 | (8)(14) |
| **Sub-total: Transportation Technology (5.0%)\*** |  |  |  |  | $**60177** | $**61475** | $**40911** |  |
| **Total: Debt Securities- United States (189.1%)\*** |  |  |  |  | $**1592144** | $**1594217** | $**1555875** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Maturity Date** | **Interest Rate** <sup>(4)</sup> | **Principal <br>Amount** <sup>(5)</sup> | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Debt Securities- Canada** |  |  |  |  |  |  |  |  |
| ***<u>Construction Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Nexii, Inc. | Secured Loan | July 24, 2024 | July 1, 2027 | Fixed interest rate 10.0%; EOT 0.0% | $365 | $365 | $375 | (10) |
| **Sub-total: Construction Technology (0.0%)\*** | **Sub-total: Construction Technology (0.0%)\*** | **Sub-total: Construction Technology (0.0%)\*** | **Sub-total: Construction Technology (0.0%)\*** |  | $**365** | $**365** | $**375** |  |
| ***<u>Supply Chain Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;GoFor Delivers, Inc. | Secured Loan | June 28, 2024 | July 1, 2028 | Variable interest rate Prime + 3.5% or Floor rate 12.0%; EOT 2.5% | $6000 | $6027 | $5769 | (8)(10)(21) |
| **Sub-total: Supply Chain Technology (0.7%)\*** | **Sub-total: Supply Chain Technology (0.7%)\*** | **Sub-total: Supply Chain Technology (0.7%)\*** | **Sub-total: Supply Chain Technology (0.7%)\*** |  | $**6000** | $**6027** | $**5769** |  |
| **Total: Debt Securities- Canada (0.7%)\*** | **Total: Debt Securities- Canada (0.7%)\*** |  |  |  | $**6365** | $**6392** | $**6144** |  |
| **Debt Securities- Europe** | **Debt Securities- Europe** |  |  |  |  |  |  |  |
| ***<u>Industrials</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Aledia, Inc. | Equipment Financing | March 31, 2022 | April 1, 2025 | Fixed interest rate 9.0%; EOT 7.0% | $1701 | $2971 | $2947 | (10)(14) |
|  | Equipment Financing | June 30, 2022 | July 1, 2025 | Fixed interest rate 9.7%; EOT 7.0% | 218 | 298 | 297 | (10)(14) |
|  | Equipment Financing | August 5, 2022 | September 1, 2025 | Fixed interest rate 10.7%; EOT 7.0% | 379 | 480 | 478 | (10)(14) |
|  | Equipment Financing | September 30, 2022 | October 1, 2025 | Fixed interest rate 12.0%; EOT 7.0% | 680 | 838 | 838 | (10)(14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Aledia, Inc. |  |  |  |  | 2978 | 4587 | 4560 |  |
| **Sub-total: Industrials (0.6%)\*** |  |  |  |  | $**2978** | $**4587** | $**4560** |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Zandivio PLC | Secured Loan | October 30, 2024 | May 1, 2029 | Variable interest rate PRIME + 5.3% or Floor rate 13.8%; EOT 2.5% | $28200 | $27426 | $27426 | (8)(10)(19) |
| **Sub-total: Other Healthcare Services (3.3%)\*** | **Sub-total: Other Healthcare Services (3.3%)\*** | **Sub-total: Other Healthcare Services (3.3%)\*** | **Sub-total: Other Healthcare Services (3.3%)\*** |  | $**28200** | $**27426** | $**27426** |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;All.Space Networks, Limited. | Secured Loan | August 22, 2022 | September 1, 2027 | Variable interest rate Prime + 7.0% or Floor rate 11.5%; EOT 2.5% | $8219 | $8339 | $8126 | (8)(10) |
| **Sub-total: Space Technology (1.0%)\*** | **Sub-total: Space Technology (1.0%)\*** |  |  |  | $**8219** | $**8339** | $**8126** |  |
| **Total: Debt Securities- Europe (4.9%)\*** | **Total: Debt Securities- Europe (4.9%)\*** |  |  |  | $**39397** | $**40352** | $**40112** |  |
| **Total: Debt Securities (194.7%)\*** | **Total: Debt Securities (194.7%)\*** |  |  |  | $**1637906** | $**1640961** | $**1602131** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States** |  |  |  |  |  |  |  |  |  |
| ***<u>Artificial Intelligence & Automation</u>*** | ***<u>Artificial Intelligence & Automation</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Ambient Photonics, Inc. | Warrant | July 27, 2022 | July 27, 2032 | Common Stock | 15976 | $5.50 | $47 | $1 |  |
| &nbsp;&nbsp;&nbsp;Everalbum, Inc. | Warrant | January 16, 2020 | July 29, 2026 | Preferred Class A Common Stock | 851063 | $0.10 | $25 | $19 | (17) |
| &nbsp;&nbsp;&nbsp;Hologram, Inc. | Warrant | January 31, 2020 | January 27, 2030 | Common Stock | 193054 | $0.26 | $49 | $188 |  |
| &nbsp;&nbsp;&nbsp;Presto Automation, Inc. | Warrant | January 16, 2020 | April 28, 2027 | Preferred Series A | 402679 | $0.37 | $185 | $— | (7)(17) |
|  | Warrant | January 16, 2020 | July 28, 2027 | Common Stock | 170993 | $5.85 | 28 |  | (7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Presto Automation, Inc. |  |  |  |  |  |  | 213 |  |  |
| **Sub-Total: Artificial Intelligence & Automation (0.0%)\*** | **Sub-Total: Artificial Intelligence & Automation (0.0%)\*** | **Sub-Total: Artificial Intelligence & Automation (0.0%)\*** |  |  |  |  | $**334** | $**208** |  |
| ***<u>Biotechnology</u>*** | ***<u>Biotechnology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pendulum Therapeutics, Inc. | Warrant | January 16, 2020 | October 9, 2029 | Preferred Series B | 55263 | $1.90 | $43 | $44 | (17) |
|  | Warrant | June 1, 2020 | July 15, 2030 | Preferred Series B | 36842 | $1.90 | 36 | 30 | (17) |
|  | Warrant | December 31, 2021 | December 31, 2031 | Preferred Series C | 322251 | $3.24 | 118 | 194 | (17) |
|  | Warrant | February 5, 2024 | February 5, 2034 | Common Stock | 1143690 | $1.03 | 588 | 1129 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Pendulum Therapeutics, Inc. |  |  |  |  |  |  | 785 | 1397 |  |
| **Sub-Total: Biotechnology (0.2%)\*** | **Sub-Total: Biotechnology (0.2%)\*** | **Sub-Total: Biotechnology (0.2%)\*** |  |  |  |  | $**785** | $**1397** |  |
| ***<u>Connectivity</u>*** | ***<u>Connectivity</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tarana Wireless, Inc. | Warrant | June 30, 2021 | June 30, 2031 | Common Stock | 5027629 | $0.19 | $967 | $2701 |  |
|  | Warrant | September 23, 2024 | September 23, 2034 | Common Stock | 2094922 | $0.51 | 695 | 722 | (9)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Tarana Wireless, Inc. |  |  |  |  |  |  | 1662 | 3423 |  |
| &nbsp;&nbsp;&nbsp;Vertical Communications, Inc. | Warrant | January 16, 2020 | July 11, 2026 | Preferred Series A | 828479 | $1.00 | $— | $— | (11)(17)(21) |
| &nbsp;&nbsp;&nbsp;viaPhoton, Inc. | Warrant | March 31, 2022 | March 31, 2032 | Common Stock | 15839 | $0.60 | $22 | $1 |  |
| **Sub-Total: Connectivity (0.4%)\*** | **Sub-Total: Connectivity (0.4%)\*** | **Sub-Total: Connectivity (0.4%)\*** |  |  |  |  | $**1684** | $**3424** |  |
| ***<u>Construction Technology</u>*** | ***<u>Construction Technology</u>*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Project Frog, Inc. | Warrant | January 16, 2020 | February 28, 2027 | Preferred Series AA-1 | 211649 | $0.19 | $9 | $— | (17)(21) |
|  | Warrant | January 16, 2020 | February 28, 2027 | Common Stock | 180340 | $0.19 | 9 |  | (21) |
|  | Warrant | August 3, 2021 | December 31, 2031 | Preferred Series CC | 250000 | $0.01 | 20 | 2 | (17)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Project Frog, Inc. |  |  |  |  |  |  | 38 | 2 |  |
| **Sub-total: Construction Technology (0.0%)\*** |  |  |  |  |  |  | $**38** | $**2** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Consumer Products & Services</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;BaubleBar, Inc. | Warrant | January 16, 2020 | March 29, 2027 | Preferred Series C | 531806 | $1.96 | $638 | $33 | (17) |
|  | Warrant | January 16, 2020 | April 20, 2028 | Preferred Series C | 60000 | $1.96 | 72 | 4 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total BaubleBar, Inc. |  |  |  |  |  |  | 710 | 37 |  |
| &nbsp;&nbsp;&nbsp;Boosted eCommerce, Inc. | Warrant | December 14, 2020 | December 14, 2030 | Preferred Series A-1 | 759263 | $0.84 | $259 | $— | (17) |
| &nbsp;&nbsp;&nbsp;Eterneva, Inc. | Warrant | September 30, 2024 | September 30, 2034 | Common Stock | 833333 | $0.48 | $421 | $477 |  |
| &nbsp;&nbsp;&nbsp;Happiest Baby, Inc. | Warrant | January 16, 2020 | May 16, 2029 | Common Stock | 182554 | $0.33 | $193 | $35 |  |
| &nbsp;&nbsp;&nbsp;Madison Reed, Inc. | Warrant | January 16, 2020 | March 23, 2027 | Preferred Series C | 194553 | $2.57 | $185 | $169 | (17) |
|  | Warrant | January 16, 2020 | July 18, 2028 | Common Stock | 43158 | $0.99 | 71 | 59 |  |
|  | Warrant | January 16, 2020 | June 30, 2029 | Common Stock | 36585 | $1.23 | 56 | 47 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Madison Reed, Inc. |  |  |  |  |  |  | 312 | 275 |  |
| &nbsp;&nbsp;&nbsp;Ogee, Inc. | Warrant | February 14, 2023 | February 14, 2033 | Preferred Series A-3 | 243668 | $0.68 | $54 | $303 | (17)(19) |
|  | Warrant | September 29, 2023 | September 29, 2033 | Preferred Series A-3 | 243668 | $0.68 | 49 | 303 | (17)(19) |
|  | Warrant | August 1, 2024 | August 1, 2034 | Preferred Series A-3 | 243668 | $0.68 | 104 | 303 | (17)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Ogee, Inc. |  |  |  |  |  |  | 207 | 909 |  |
| &nbsp;&nbsp;&nbsp;Portofino Labs, Inc. | Warrant | December 31, 2020 | December 31, 2030 | Common Stock | 99148 | $1.53 | $160 | $62 |  |
|  | Warrant | April 1, 2021 | April 1, 2031 | Common Stock | 39912 | $1.46 | 99 | 26 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Portofino Labs, Inc. |  |  |  |  |  |  | 259 | 88 |  |
| &nbsp;&nbsp;&nbsp;Quip NYC, Inc. | Warrant | March 9, 2021 | March 9, 2031 | Common Stock | 10833 | $48.46 | $203 | $— |  |
| &nbsp;&nbsp;&nbsp;Rinse, Inc. | Warrant | May 10, 2022 | May 10, 2032 | Preferred Series C | 278761 | $1.13 | $118 | $454 | (17) |
| &nbsp;&nbsp;&nbsp;SI Tickets, Inc. | Warrant | May 11, 2022 | May 11, 2032 | Common Stock | 53029 | $2.52 | $162 | $— |  |
| &nbsp;&nbsp;&nbsp;Super73, Inc. | Warrant | December 31, 2020 | December 31, 2030 | Common Stock | 177305 | $3.16 | $105 | $58 |  |
| &nbsp;&nbsp;&nbsp;Trendly, Inc. | Warrant | January 16, 2020 | August 10, 2026 | Preferred Series A | 245506 | $1.14 | $222 | $1 | (17) |
| &nbsp;&nbsp;&nbsp;VitaCup, Inc. | Warrant | June 23, 2021 | June 23, 2031 | Preferred Series C | 68996 | $2.79 | $9 | $— | (17) |
|  | Warrant | November 22, 2023 | November 22, 2033 | Common Stock | 51225 | $0.41 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total VitaCup, Inc. |  |  |  |  |  |  | 9 |  |  |
| &nbsp;&nbsp;&nbsp;Whoop, Inc. | Warrant | May 17, 2023 | May 17, 2033 | Common Stock | 2393845 | $0.43 | $1099 | $2275 | (9)(19) |
| **Sub-total: Consumer Products & Services (0.6%)\*** |  |  |  |  |  |  | $**4279** | $**4609** |  |
| ***<u>Education Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Edblox, Inc. | Warrant | March 19, 2024 | March 19, 2034 | Common Stock | 111458 | $1.71 | $152 | $24 |  |
| &nbsp;&nbsp;&nbsp;Medical Sales Training Holding Company | Warrant | March 18, 2021 | March 18, 2031 | Common Stock | 130853 | $7.74 | $108 | $23 |  |
|  | Warrant | April 17, 2024 | April 17, 2034 | Common Stock | 32493 | $7.74 | 73 | 6 |  |
|  | Warrant | December 18, 2024 | December 18, 2034 | Common Stock | 21444 | $7.74 | 4 | 4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Medical Sales Training Holding Company |  |  |  |  |  |  | 185 | 33 |  |
| &nbsp;&nbsp;&nbsp;Yellowbrick Learning, Inc. | Warrant | January 16, 2020 | September 30, 2028 | Common Stock | 222222 | $0.90 | $120 | $— |  |
| **Sub-Total: Education Technology (0.0%)\*** |  |  |  |  |  |  | $**457** | $**57** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beam Technologies, Inc. | Warrant | August 30, 2024 | August 30, 2034 | Common Stock | 56494 | $17.28 | $749 | $702 | (19) |
| &nbsp;&nbsp;&nbsp;Bestow, Inc. | Warrant | August 1, 2024 | August 1, 2034 | Preferred Series C-2 | 349793 | $0.01 | $1987 | $1624 | (17) |
| &nbsp;&nbsp;&nbsp;Busbot, Inc. | Warrant | April 1, 2024 | April 1, 2034 | Common Stock | 44133 | $0.96 | $85 | $31 |  |
| &nbsp;&nbsp;&nbsp;Centivo Corporation | Warrant | July 31, 2024 | July 31, 2034 | Common Stock | 161155 | $0.76 | $256 | $369 | (9)(19) |
| &nbsp;&nbsp;&nbsp;DailyPay, Inc. | Warrant | September 30, 2020 | September 30, 2030 | Common Stock | 89264 | $3.00 | $151 | $1516 |  |
| &nbsp;&nbsp;&nbsp;Empower Financial, Inc. | Warrant | October 13, 2023 | October 13, 2033 | Common Stock | 404893 | $1.43 | $953 | $1534 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Eqis Capital Management, Inc. | Warrant | June 15, 2022 | June 15, 2032 | Preferred Class B | 904000 | $0.01 | $10 | $87 | (17) |
| &nbsp;&nbsp;&nbsp;Gravie, Inc. | Warrant | June 4, 2024 | June 4, 2034 | Common Stock | 123816 | $2.68 | $293 | $257 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Kafene, Inc. | Warrant | January 5, 2024 | January 5, 2034 | Common Stock | 44448 | $4.03 | $58 | $429 |  |
| &nbsp;&nbsp;&nbsp;Mesa Financial, Inc. | Warrant | August 29, 2024 | August 29, 2034 | Common Stock | 62422 | $0.73 | $28 | $27 | (10) |
| &nbsp;&nbsp;&nbsp;Parafin, Inc. | Warrant | February 16, 2024 | February 16, 2034 | Common Stock | 24616 | $7.09 | $118 | $321 | (10) |
|  | Warrant | July 25, 2024 | July 25, 2034 | Common Stock | 24641 | $7.09 | 108 | 321 | (10) |
|  | Warrant | December 23, 2024 | December 23, 2034 | Common Stock | 3657 | $11.14 | 49 | 43 | (10) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Parafin, Inc. |  |  |  |  |  |  | 275 | 685 |  |
| &nbsp;&nbsp;&nbsp;RealtyMogul, Co. | Warrant | January 16, 2020 | December 18, 2027 | Preferred Series B | 954979 | $0.95 | $285 | $1386 | (17) |
| &nbsp;&nbsp;&nbsp;Slope Tech, Inc. | Warrant | September 14, 2022 | September 14, 2032 | Common Stock | 90971 | $0.88 | $109 | $476 | (10) |
|  | Warrant | August 30, 2023 | August 30, 2033 | Common Stock | 21303 | $0.88 | 112 | 112 | (10) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Slope Tech, Inc. |  |  |  |  |  |  | 221 | 588 |  |
| &nbsp;&nbsp;&nbsp;Under Technologies, Inc. | Warrant | May 3, 2024 | May 3, 2034 | Common Stock | 96710 | $2.90 | $267 | $243 | (19) |
| &nbsp;&nbsp;&nbsp;Wisetack, Inc. | Warrant | November 14, 2024 | November 14, 2034 | Common Stock | 128992 | $1.58 | $119 | $118 | (19) |
| **Sub-Total: Finance and Insurance (1.2%)\*** |  |  |  |  |  |  | $**5737** | $**9596** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Athletic Brewing Company, LLC | Warrant | October 28, 2022 | October 28, 2032 | Preferred Class B | 3741 | $140.21 | $287 | $490 | (17) |
| &nbsp;&nbsp;&nbsp;Bowery Farming, Inc. | Warrant | January 16, 2020 | June 10, 2029 | Common Stock | 68863 | $5.08 | $410 | $— |  |
|  | Warrant | December 22, 2020 | December 22, 2030 | Common Stock | 29925 | $6.24 | 160 |  |  |
|  | Warrant | September 10, 2021 | September 10, 2028 | Common Stock | 21577 | $0.01 | 617 |  |  |
|  | Warrant | December 29, 2023 | December 29, 2030 | Common Stock | 114725 | $0.01 | 29 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Bowery Farming, Inc. |  |  |  |  |  |  | 1216 | $— |  |
| &nbsp;&nbsp;&nbsp;Daring Foods, Inc. | Warrant | April 8, 2021 | April 8, 2031 | Common Stock | 68100 | $0.27 | $106 | $55 |  |
| &nbsp;&nbsp;&nbsp;DrinkPak, LLC | Warrant | September 13, 2022 | September 13, 2032 | Common Stock | 2387 | $19.12 | $7 | $59 | (9) |
|  | Warrant | February 17, 2023 | February 17, 2033 | Common Stock | 12010 | $18.89 | 26 | 296 | (9)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total DrinkPak, LLC |  |  |  |  |  |  | 33 | 355 |  |
| &nbsp;&nbsp;&nbsp;Emergy, Inc. | Warrant | October 5, 2022 | October 5, 2032 | Common Stock | 4051 | $39.60 | $181 | $— | (9) |
| &nbsp;&nbsp;&nbsp;GrubMarket, Inc. | Warrant | June 15, 2020 | June 15, 2030 | Common Stock | 405000 | $1.10 | $115 | $4256 |  |
| &nbsp;&nbsp;&nbsp;Intelligent Brands, Inc. (f.k.a. PSB Holdings, Inc.) | Warrant | January 16, 2020 | October 5, 2027 | Common Stock | 103636 | $14.47 | $111 | $— |  |
|  | Warrant | December 31, 2020 | December 29, 2032 | Common Stock | 33348 | $3.17 | 546 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Intelligent Brands, Inc. |  |  |  |  |  |  | 657 |  |  |
| &nbsp;&nbsp;&nbsp;The Fynder Group, Inc. | Warrant | October 14, 2020 | October 14, 2030 | Common Stock | 36445 | $0.49 | $68 | $23 |  |
| &nbsp;&nbsp;&nbsp;Zero Acre Farms, Inc. | Warrant | December 23, 2022 | December 23, 2032 | Class A Common Stock | 20181 | $2.13 | $79 | $8 | (17) |
| **Sub-Total: Food and Agriculture Technologies (0.6%)\*** | **Sub-Total: Food and Agriculture Technologies (0.6%)\*** |  |  |  |  |  | $**2742** | $**5187** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Green Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Bolb, Inc. | Warrant | October 12, 2021 | October 12, 2031 | Common Stock | 181784 | $0.07 | $35 | $— |  |
| &nbsp;&nbsp;&nbsp;Edeniq, Inc. | Warrant | January 16, 2020 | December 23, 2026 | Preferred Series B | 2685501 | $0.22 | $— | $506 | (11)(17)(21) |
|  | Warrant | January 16, 2020 | December 23, 2026 | Preferred Series B | 2184672 | $0.01 |  | 855 | (11)(17)(21) |
|  | Warrant | January 16, 2020 | June 29, 2027 | Preferred Series C | 5106972 | $0.44 |  | 149 | (11)(17)(21) |
|  | Warrant | January 16, 2020 | November 2, 2028 | Preferred Series C | 3850294 | $0.01 |  | 1709 | (11)(17)(21) |
|  | Warrant | November 29, 2021 | November 29, 2031 | Preferred Series D | 154906320 | $0.01 | 7 | 4529 | (17)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Edeniq, Inc. |  |  |  |  |  |  | 7 | 7748 |  |
| &nbsp;&nbsp;&nbsp;Footprint International Holding, Inc. | Warrant | February 14, 2020 | February 14, 2030 | Common Stock | 38171 | $0.31 | $9 | $— |  |
|  | Warrant | February 18, 2022 | February 18, 2032 | Common Stock | 77524 | $0.01 | 4246 |  |  |
|  | Warrant | June 23, 2022 | June 23, 2032 | Common Stock | 14624 | $0.01 | 359 |  |  |
|  | Warrant | October 31, 2024 | October 31, 2034 | Preferred Class F | 250 | $25000.00 |  |  | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Footprint International Holding, Inc. |  |  |  |  |  |  | 4614 |  |  |
| &nbsp;&nbsp;&nbsp;Form Energy Inc. | Warrant | October 21, 2024 | October 21, 2034 | Common Stock | 99287 | $8.03 | $925 | $891 | (19) |
| &nbsp;&nbsp;&nbsp;Mainspring Energy, Inc. | Warrant | January 16, 2020 | July 9, 2029 | Common Stock | 140186 | $1.15 | $283 | $224 |  |
|  | Warrant | November 20, 2020 | November 20, 2030 | Common Stock | 81294 | $1.15 | 226 | 130 |  |
|  | Warrant | March 18, 2022 | March 18, 2032 | Common Stock | 137692 | $1.66 | 344 | 210 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Mainspring Energy, Inc. |  |  |  |  |  |  | 853 | 564 |  |
| &nbsp;&nbsp;&nbsp;RTS Holding, Inc. | Warrant | December 10, 2021 | December 10, 2031 | Preferred Series C | 2314 | $205.28 | $75 | $99 | (9)(17) |
|  | Warrant | October 10, 2022 | October 10, 2032 | Preferred Series D | 917 | $196.50 | 87 | 44 | (9)(17) |
|  | Warrant | January 19, 2024 | January 19, 2034 | Preferred Series D-1 | 2876 | $203.47 | 418 | 137 | (9)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total RTS Holding, Inc. |  |  |  |  |  |  | 580 | 280 |  |
| **Sub-Total: Green Technology (1.2%)\*** |  |  |  |  |  |  | $**7014** | $**9483** |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Dentologie Enterprises, Inc. | Warrant | October 14, 2022 | October 14, 2034 | Common Stock | 51632 | $0.76 | $66 | $147 | (9) |
| &nbsp;&nbsp;&nbsp;Exer Holdings, LLC | Warrant | November 19, 2021 | November 19, 2031 | Common Stock | 281 | $527.51 | $93 | $14 |  |
| &nbsp;&nbsp;&nbsp;Hospitalists Now, Inc. | Warrant | January 16, 2020 | March 30, 2026 | Preferred Series D-2 | 135807 | $5.89 | $71 | $390 | (17) |
|  | Warrant | January 16, 2020 | December 6, 2026 | Preferred Series D-2 | 750000 | $5.89 | 391 | 2152 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Hospitalists Now, Inc. |  |  |  |  |  |  | 462 | 2542 |  |
| &nbsp;&nbsp;&nbsp;Lark Technologies, Inc. | Warrant | September 30, 2020 | September 30, 2030 | Common Stock | 76231 | $1.76 | $177 | $4 |  |
|  | Warrant | June 30, 2021 | June 30, 2031 | Common Stock | 79325 | $1.76 | 258 | 4 |  |
|  | Warrant | December 22, 2022 | December 22, 2032 | Common Stock | 97970 | $2.49 | 58 | 4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Lark Technologies, Inc. |  |  |  |  |  |  | 493 | 12 |  |
| &nbsp;&nbsp;&nbsp;Moxe Health Corporation | Warrant | December 29, 2023 | December 29, 2033 | Preferred Series B | 155438 | $3.62 | $135 | $48 | (17) |
| &nbsp;&nbsp;&nbsp;RXAnte, Inc. | Warrant | November 21, 2022 | November 21, 2032 | Preferred A | 16517 | $10.00 | $89 | $121 | (9)(17)(19) |
|  | Warrant | April 7, 2023 | November 21, 2032 | Preferred A | 5518 | $10.00 | 25 | 41 | (9)(17)(19) |
|  | Warrant | October 17, 2023 | November 21, 2032 | Preferred A | 5506 | $10.00 | 37 | 40 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total RXAnte, Inc. |  |  |  |  |  |  | 151 | 202 |  |
| &nbsp;&nbsp;&nbsp;TMRW Life Sciences, Inc. | Warrant | April 29, 2022 | April 29, 2032 | Preferred Class A | 268983 | $2.09 | $80 | $6 | (17) |
|  | Warrant | March 3, 2023 | April 29, 2032 | Preferred Class A | 268983 | $2.09 | 80 | 6 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total TMRW Life Sciences, Inc. |  |  |  |  |  |  | 160 | 12 |  |
| &nbsp;&nbsp;**Sub-Total: Healthcare Technology (0.4%)\*** |  |  |  |  |  |  | $**1560** | $**2977** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Human Resource Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;BetterLeap, Inc. | Warrant | April 20, 2022 | April 20, 2032 | Common Stock | 88435 | $2.26 | $38 | $6 |  |
| &nbsp;&nbsp;&nbsp;Qwick, Inc. | Warrant | December 31, 2021 | December 31, 2031 | Common Stock | 16964 | $2.79 | $48 | $9 |  |
|  | Warrant | August 8, 2022 | August 8, 2032 | Common Stock | 16964 | $2.79 | 48 | 8 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Qwick, Inc. |  |  |  |  |  |  | 96 | 17 |  |
| **Sub-Total: Human Resource Technology (0.0%)\*** |  |  |  |  |  |  | $**134** | $**23** |  |
| ***<u>Industrials</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;3DEO, Inc. | Warrant | February 23, 2022 | February 23, 2032 | Common Stock | 37218 | $1.81 | $93 | $— |  |
| &nbsp;&nbsp;&nbsp; Digilens, Inc. | Warrant | January 16, 2020 | March 24, 2025 | Preferred Series A-1 | 12155 | $0.70 | $4 | $12 | (17) |
|  | Warrant | January 16, 2020 | March 26, 2025 | Preferred Series A-1 | 200000 | $0.70 | 65 | 204 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Digilens, Inc. |  |  |  |  |  |  | 69 | 216 |  |
| **Sub-total: Industrials (0.0%)\*** |  |  |  |  |  |  | $**162** | $**216** |  |
| ***<u>Marketing, Media, and Entertainment</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Drone Racing League, Inc. | Warrant | October 17, 2022 | October 17, 2032 | Common Stock | 253824 | $6.76 | $375 | $— |  |
| &nbsp;&nbsp;&nbsp;Firefly Systems, Inc. | Warrant | January 31, 2020 | January 29, 2030 | Common Stock | 133147 | $1.14 | $281 | $121 |  |
| &nbsp;&nbsp;&nbsp;Grabit Interactive Media, Inc. | Warrant | April 8, 2022 | April 8, 2034 | Preferred Series A | 142828 | $1.00 | $40 | $28 | (17) |
| &nbsp;&nbsp;&nbsp;Incontext Solutions, Inc. | Warrant | January 16, 2020 | September 28, 2028 | Common Stock | 2219 | $220.82 | $34 | $— |  |
| &nbsp;&nbsp;&nbsp;PebblePost, Inc. | Warrant | May 7, 2021 | May 7, 2031 | Common Stock | 657343 | $0.52 | $68 | $735 |  |
| **Sub-Total: Marketing, Media, and Entertainment (0.1%)\*** | **Sub-Total: Marketing, Media, and Entertainment (0.1%)\*** | **Sub-Total: Marketing, Media, and Entertainment (0.1%)\*** |  |  |  |  | $**798** | $**884** |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Apiject Holdings, Inc. | Warrant | June 24, 2024 | June 24, 2034 | Common Stock | 937604 | $0.99 | $612 | $352 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Convergent Dental, Inc. | Warrant | April 21, 2023 | April 21, 2033 | Preferred Series D | 446982 | $1.61 | $493 | $103 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Delphinus, Inc. | Warrant | June 27, 2023 | June 27, 2033 | Preferred Series E | 294289 | $0.69 | $29 | $19 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Elucent Medical, Inc. | Warrant | October 31, 2024 | October 31, 2034 | Preferred Series C-2 | 1889448 | $0.30 | $167 | $210 | (17)(19) |
| &nbsp;&nbsp;&nbsp;Lightforce Orthodontics, Inc. | Warrant | August 6, 2024 | August 6, 2034 | Preferred Series D | 73065 | $18.01 | $286 | $285 | (17)(19) |
| &nbsp;&nbsp;&nbsp;Neuros Medical, Inc. | Warrant | August 10, 2023 | August 10, 2033 | Preferred Series C | 1197127 | $0.38 | $110 | $100 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Restor3d, Inc. | Warrant | June 4, 2024 | June 4, 2034 | Preferred Series A | 95688 | $5.01 | $51 | $77 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;Shoulder Innovations, Inc. | Warrant | August 7, 2023 | August 7, 2033 | Preferred Series D | 623615 | $0.54 | $120 | $154 | (9)(17) |
| **Sub-Total: Medical Devices (0.2%)\*** |  |  |  |  |  |  | $**1868** | $**1300** |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cellares Corporation | Warrant | August 2, 2024 | August 2, 2034 | Common Stock | 243868 | $4.77 | $841 | $809 | (19) |
| &nbsp;&nbsp;&nbsp;Upward Health, Inc. | Warrant | August 6, 2024 | August 6, 2034 | Preferred Class A Common Stock | 763137 | $0.28 | $251 | $260 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;Metabolon, Inc. | Warrant | March 28, 2024 | March 28, 2034 | Preferred Series 3 | 2288461 | $0.65 | $644 | $245 | (17) |
|  | Warrant | October 1, 2024 | March 28, 2034 | Preferred Series 3 | 384615 | $0.65 | 33 | 41 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Metabolon, Inc. |  |  |  |  |  |  | 677 | 286 |  |
| &nbsp;&nbsp;&nbsp;Velentium, Inc. | Warrant | May 24, 2024 | May 24, 2034 | Preferred Class B | 7958 | $53.40 | $129 | $154 | (9)(17) |
| **Sub-Total: Other Healthcare Services (0.2%)\*** |  |  |  |  |  |  | $**1898** | $**1509** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Real Estate Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Homelight Lending, Inc. | Warrant | June 23, 2022 | June 23, 2032 | Common Stock | 5434 | $18.40 | $1 | $16 |  |
| &nbsp;&nbsp;&nbsp;Knockaway, Inc. | Warrant | January 16, 2020 | May 24, 2029 | Common Stock | 880 | $85.27 | $209 | $— | (21) |
|  | Warrant | November 10, 2021 | November 10, 2031 | Common Stock | 16350 | $2.20 | 265 |  | (21) |
|  | Warrant | September 29, 2023 | September 29, 2033 | Common Stock | 2804355 | $0.01 |  | 18 | (21) |
|  | Warrant | December 6, 2023 | December 6, 2033 | Preferred Series AA | 457778 | $0.01 |  | 6 | (17)(21) |
|  | Warrant | September 16, 2024 | September 16, 2034 | Preferred Series BB | 93951849 | $0.00 | 2391 | 2401 | (17)(21) |
|  | Warrant | September 23, 2023 | September 23, 2033 | Preferred Series AA-1 | 5084804 | $0.09 |  |  | (17)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Knockaway, Inc. |  |  |  |  |  |  | 2865 | 2425 |  |
| &nbsp;&nbsp;&nbsp;Maxwell Financial Labs, Inc. | Warrant | October 7, 2020 | October 7, 2030 | Common Stock | 106735 | $0.29 | $20 | $9 |  |
|  | Warrant | December 22, 2020 | December 22, 2030 | Common Stock | 110860 | $0.29 | 34 | 9 |  |
|  | Warrant | September 30, 2021 | September 30, 2031 | Common Stock | 79135 | $1.04 | 148 | 5 |  |
|  | Warrant | May 10, 2024 | May 10, 2034 | Common Stock | 303562 | $0.27 | 83 | 26 |  |
|  | Warrant | July 1, 2024 | May 10, 2034 | Common Stock | 303562 | $0.27 | 91 | 26 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Maxwell Financial Labs, Inc. |  |  |  |  |  |  | 376 | 75 |  |
| &nbsp;&nbsp;&nbsp;Orchard Technologies, Inc. | Warrant | February 12, 2024 | February 12, 2034 | Preferred Series 1 | 228000 | $0.01 | $— | $111 | (17) |
| **Sub-Total: Real Estate Technology (0.3%)\*** |  |  |  |  |  |  | $**3242** | $**2627** |  |
| ***<u>SaaS</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;All Seated, Inc. | Warrant | February 28, 2022 | February 28, 2032 | Common Stock | 5101 | $15.72 | $20 | $— |  |
| &nbsp;&nbsp;&nbsp;Cart.com, Inc. | Warrant | November 17, 2023 | November 17, 2033 | Common Stock | 31572 | $15.87 | $441 | $697 | (9) |
| &nbsp;&nbsp;&nbsp;Cpacket Networks, Inc. | Warrant | January 29, 2024 | January 29, 2034 | Preferred Class B Common | 499366 | $0.36 | $166 | $133 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Crowdtap, Inc. | Warrant | January 16, 2020 | December 16, 2025 | Preferred Series B | 442233 | $1.09 | $42 | $860 | (17) |
|  | Warrant | January 16, 2020 | December 11, 2027 | Preferred Series B | 100000 | $1.09 | 9 | 194 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Crowdtap, Inc. |  |  |  |  |  |  | 51 | 1054 |  |
| &nbsp;&nbsp;&nbsp;Gtxcel, Inc. | Warrant | January 16, 2020 | September 24, 2025 | Preferred Series C | 1000000 | $0.21 | $83 | $16 | (17) |
|  | Warrant | January 16, 2020 | September 24, 2025 | Preferred Series D | 1000000 | $0.21 | 83 | 22 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Gtxcel, Inc. |  |  |  |  |  |  | 166 | 38 |  |
| &nbsp;&nbsp;&nbsp;Lucidworks, Inc. | Warrant | January 16, 2020 | June 27, 2026 | Preferred Series D | 619435 | $0.77 | $806 | $686 | (17) |
| &nbsp;&nbsp;&nbsp;Reciprocity, Inc. | Warrant | September 25, 2020 | September 25, 2030 | Common Stock | 114678 | $4.17 | $99 | $— |  |
|  | Warrant | April 29, 2021 | April 29, 2031 | Common Stock | 57195 | $4.17 | 54 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Reciprocity, Inc. |  |  |  |  |  |  | 153 |  |  |
| &nbsp;&nbsp;&nbsp;Silk Technologies, Inc. | Warrant | November 4, 2024 | November 4, 2034 | Common Stock | 237623 | $1.98 | $503 | $491 | (19) |
| &nbsp;&nbsp;&nbsp;Smartly, Inc. | Warrant | May 16, 2022 | May 16, 2034 | Common Stock | 48097 | $1.10 | $84 | $90 |  |
| &nbsp;&nbsp;&nbsp;Steno Agency, Inc. | Warrant | June 21, 2024 | June 21, 2034 | Common Stock | 55818 | $1.98 | $136 | $147 | (9)(19) |
| &nbsp;&nbsp;&nbsp;The Tomorrow Companies, Inc. | Warrant | December 14, 2022 | December 14, 2032 | Common Stock | 26124 | $1.70 | $49 | $25 | (9) |
| **Sub-Total: SaaS (0.4%)\*** |  |  |  |  |  |  | $**2575** | $**3361** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- United States, Continued** |  |  |  |  |  |  |  |  |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Astranis Space Technology Corporation | Warrant | April 13, 2023 | April 13, 2033 | Common Stock | 85644 | $7.89 | $83 | $279 | (9)(19) |
|  | Warrant | September 27, 2024 | September 27, 2034 | Common Stock | 156677 | $2.27 | 683 | 683 | (9)(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Astranis Space Technology Corporation |  |  |  |  |  |  | 766 | 962 |  |
| &nbsp;&nbsp;&nbsp;Axiom Space, Inc. | Warrant | May 28, 2021 | May 28, 2031 | Common Stock | 1773 | $169.24 | $121 | $23 |  |
|  | Warrant | May 28, 2021 | May 28, 2031 | Common Stock | 882 | $340.11 | 39 | 4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Axiom Space, Inc. |  |  |  |  |  |  | 160 | 27 |  |
| &nbsp;&nbsp;&nbsp;Hermeus Corporation | Warrant | August 9, 2022 | August 9, 2032 | Common Stock | 19286 | $6.24 | $144 | $47 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Impulse Space, Inc. | Warrant | June 18, 2024 | June 18, 2034 | Common Stock | 64087 | $1.91 | $258 | $564 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Slingshot Aerospace, Inc. | Warrant | July 12, 2024 | July 12, 2034 | Common Stock | 328416 | $0.46 | $400 | $389 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Kymeta Corporation | Warrant | July 3, 2024 | July 3, 2034 | Common Stock | 3995407 | $0.11 | $331 | $354 | (9)(19) |
| &nbsp;&nbsp;&nbsp;Space Perspective, Inc. | Warrant | March 3, 2022 | March 3, 2032 | Preferred Series A | 221280 | $2.75 | $256 | $— | (17) |
| **Sub-Total: Space Technology (0.3%)\*** |  |  |  |  |  |  | $**2315** | $**2343** |  |
| ***<u>Supply Chain Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Macrofab, Inc. | Warrant | July 21, 2023 | July 21, 2033 | Common Stock | 622353 | $2.02 | $332 | $67 |  |
|  | Warrant | April 11, 2024 | April 11, 2034 | Common Stock | 392157 | $0.01 | 254 | 107 |  |
|  | Warrant | January 29, 2024 | January 29, 2034 | Common Stock | 322013 | $2.02 | 128 | 35 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Macrofab, Inc. |  |  |  |  |  |  | 714 | 209 |  |
| &nbsp;&nbsp;&nbsp;Nucleus RadioPharma, Inc. | Warrant | June 4, 2024 | June 4, 2034 | Common Stock | 44303 | $1.99 | $70 | $63 | (9) |
| **Sub-Total: Supply Chain Technology (0.0%)\*** |  |  |  |  |  |  | $**784** | $**272** |  |
| ***<u>Transportation Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Get Spiffy, Inc. | Warrant | July 14, 2023 | July 14, 2033 | Common Stock | 874527 | $0.70 | $408 | $2 | (9) |
| &nbsp;&nbsp;&nbsp;NextCar Holding Company, Inc. | Warrant | December 14, 2021 | December 14, 2026 | Class A Common | 6211 | $64.42 | $35 | $— | (13) |
|  | Warrant | February 23, 2022 | February 23, 2027 | Class A Common | 486 | $64.42 | 3 |  | (13) |
|  | Warrant | March 16, 2022 | March 16, 2027 | Class A Common | 583 | $64.42 | 3 |  | (13) |
|  | Warrant | April 18, 2022 | April 18, 2027 | Class A Common | 5336 | $64.42 | 7 |  | (13) |
|  | Warrant | September 29, 2022 | September 29, 2027 | Preferred Stock | 1224752 | $0.22 | 170 |  | (13)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total NextCar Holding Company, Inc. |  |  |  |  |  |  | 218 |  |  |
| &nbsp;&nbsp;&nbsp;Uveye, Inc. | Warrant | December 26, 2024 | December 26, 2034 | Preferred Ordinary | 476031 | $2.36 | $539 | $523 | (17) |
| &nbsp;&nbsp;&nbsp;Zuum Transportation, Inc. | Warrant | April 30, 2024 | April 30, 2034 | Common Stock | 41271 | $4.34 | $95 | $111 |  |
| **Sub-Total: Transportation Technology (0.1%)\*** |  |  |  |  |  |  | $**1260** | $**636** |  |
| **Total: Warrant Investments- United States (6.1%)\*** |  |  |  |  |  |  | $**39666** | $**50111** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Warrant Investments- Europe** |  |  |  |  |  |  |  |  |  |
| ***<u>Industrials</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Aledia, Inc. | Warrant | March 31, 2022 | March 31, 2032 | Preferred Ordinary | 11771 | 149.02 | $130 | $498 | (17) |
| **Sub-Total: Industrials (0.1%)\*** |  |  |  |  |  |  | $**130** | $**498** |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Zandivio PLC | Warrant | October 29, 2024 | October 29, 2034 | Common Stock | 132042 | 0.01 | $771 | $845 | (19) |
| **Sub-Total: Other Healthcare Services (0.1%)\*** |  |  |  |  |  |  | $**771** | $**845** |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;All.Space Networks, Limited. | Warrant | August 22, 2022 | August 22, 2032 | Common Stock | 71203 | $21.79 | $113 | $— |  |
| **Sub-Total: Space Technology (0.0%)\*** |  |  |  |  |  |  | $**113** | $**—** |  |
| **Total: Warrant Investments- Europe (0.2%)\*** |  |  |  |  |  |  | $**1014** | $**1343** |  |
| **Total: Warrant Investments- (6.3%)\*** |  |  |  |  |  |  | $**40680** | $**51454** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Shares / Principal** | **Series** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Equity Investments- United States** |  |  |  |  |  |  |  |
| ***<u>Connectivity</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tarana Wireless, Inc. | Equity | March 16, 2022 | 611246 | Preferred Series 6 | $500 | $564 | (17) |
| &nbsp;&nbsp;&nbsp;Vertical Communications, Inc. | Equity | January 16, 2020 | 3892485 | Preferred Series 1 | $— | $— | (11)(17)(21) |
|  | Equity | January 16, 2020 | $5500 | Convertible Note | 3966 | 1087 | (16)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Vertical Communications, Inc. |  |  |  |  | 3966 | 1087 |  |
| &nbsp;&nbsp;&nbsp;viaPhoton Inc. | Equity | May 23, 2024 | $740000 | SAFE Note | $370 | $370 |  |
| **Sub-Total: Connectivity (0.2%)\*** |  |  |  |  | $**4836** | $**2021** |  |
| ***<u>Construction Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Project Frog, Inc. | Equity | January 16, 2020 | 4383497 | Preferred Series AA-1 | $351 | $— | (17)(21) |
|  | Equity | January 16, 2020 | 3401678 | Preferred Series BB | 1333 |  | (17)(21) |
|  | Equity | August 3, 2021 | 6633486 | Common Stock | 1684 |  | (21) |
|  | Equity | August 3, 2021 | 3129887 | Preferred Series CC | 1253 | 43 | (17)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Project Frog, Inc. |  |  |  |  | 4621 | 43 |  |
| **Sub-Total: Construction Technology (0.0%)\*** |  |  |  |  | $**4621** | $**43** |  |
| ***<u>Consumer Products & Services</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Portofino Labs, Inc. | Equity | November 1, 2021 | 256291 | Preferred Series B-1 | $500 | $477 | (17) |
| &nbsp;&nbsp;&nbsp;Quip NYC, Inc. | Equity | August 17, 2021 | 3321 | Common Stock | $500 | $1 |  |
| &nbsp;&nbsp;&nbsp;Rinse, Inc. | Equity | December 30, 2024 | 290242 | Preferred Series D | $500 | $496 | (17) |
| **Sub-Total: Consumer Products & Services (0.1%)\*** |  |  |  |  | $**1500** | $**974** |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Busbot, Inc. | Equity | October 18, 2024 | 539490 | Preferred Series B-1 | $500 | $501.000 | (10)(17) |
| &nbsp;&nbsp;&nbsp;Centivo Corporation | Equity | December 20, 2024 | 128393 | Preferred Series B-1 | $375 | $368.000 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;Dynamics, Inc. | Equity | January 16, 2020 | 17726 | Preferred Series A | $390 | $— | (17) |
| &nbsp;&nbsp;&nbsp;Empower Financial, Inc. | Equity | May 15, 2024 | 2810235 | Preferred Series C Preferred | $20000 | $20549 |  |
|  | Equity | May 15, 2024 | 300285 | Common Stock | 4023 | 1424 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Empower Financial, Inc. |  |  |  |  | 24023 | 21973 |  |
| &nbsp;&nbsp;&nbsp;Openly Holdings Corp. | Equity | May 9, 2023 | 44725 | Preferred Series D-1 | $500 | $569 | (17) |
| &nbsp;&nbsp;&nbsp;Slope Tech, Inc. | Equity | June 20, 2023 | 64654 | Preferred Series A-3 | $500 | $520 | (10)(17) |
| **Sub-Total: Finance and Insurance (2.9%)\*** |  |  |  |  | $**26288** | $**23931** |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Emergy, Inc. | Equity | June 28, 2021 | 7595 | Common Stock | $500 | $— |  |
| &nbsp;&nbsp;&nbsp;Athletic Brewing Company, LLC | Equity | August 1, 2024 | 2144 | Preferred Class B | $500 | $501 | (17) |
| **Sub-Total: Food and Agriculture Technologies (0.1%)\*** |  |  |  |  | $**1000** | $**501** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Shares / Principal** | **Series** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Equity Investments- United States, Continued** |  |  |  |  |  |  |  |
| ***<u>Green Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Crusoe Energy Systems LLC | Equity | November 6, 2024 | 11140 | Preferred Series D-1 | $325 | $326 | (9)(17)(19) |
| &nbsp;&nbsp;&nbsp;Edeniq, Inc. | Equity | January 16, 2020 | 7807499 | Preferred Series B | $— | $3129 | (11)(17)(21) |
|  | Equity | January 16, 2020 | 3657487 | Preferred Series C |  | 1658 | (11)(17)(21) |
|  | Equity | January 16, 2020 | 133766138 | Preferred Series D |  | 5569 | (11)(17)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Edeniq, Inc. |  |  |  |  |  | 10356 |  |
| &nbsp;&nbsp;&nbsp;Electric Hydrogen Co. | Equity | April 6, 2023 | 87112 | Preferred Series C | $500 | $304 | (17) |
| &nbsp;&nbsp;&nbsp;Mainspring Energy, Inc. | Equity | March 30, 2022 | 65614 | Preferred Series E-1 | $500 | $291 | (17) |
| &nbsp;&nbsp;&nbsp;RTS Holding, Inc. | Equity | July 5, 2022 | 2035 | Preferred Series D | $334 | $345 | (9)(17) |
|  | Equity | February 15, 2023 | 1966 | Preferred Series D-1 | 405 | 342 | (9)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total RTS Holding, Inc. |  |  |  |  | 739 | 687 |  |
| **Sub-Total: Green Technology (1.5%)\*** |  |  |  |  | $**2064** | $**11964** |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Dentologie Enterprises, Inc. | Equity | August 3, 2023 | 72338 | Preferred Series B-1 | $300 | $302 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Emerald Cloud Lab, Inc. | Equity | June 3, 2022 | 499999 | Preferred Series A | $500 | $103 | (17) |
|  | Equity | April 29, 2024 | 617890 | Preferred Series B-1 | 129 | 116 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Emerald Cloud Lab, Inc. |  |  |  |  | 629 | 219 |  |
| &nbsp;&nbsp;&nbsp;Lark Technologies, Inc. | Equity | August 19, 2021 | 32416 | Preferred Series D | $500 | $54 | (17) |
| &nbsp;&nbsp;&nbsp;WorkWell Prevention & Care Inc. | Equity | January 16, 2020 | 7000000 | Common Stock | $51 | $— | (21) |
|  | Equity | January 16, 2020 | 3450 | Preferred Series P | 3450 |  | (17)(21) |
|  | Equity | January 16, 2020 | $3170 | Convertible Note | 3219 |  | (16)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total WorkWell Prevention & Care Inc. |  |  |  |  | 6720 |  |  |
| **Sub-Total: Healthcare Technology (0.1%)\*** |  |  |  |  | $**8149** | $**575** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Shares / Principal** | **Series** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Equity Investments- United States, Continued** |  |  |  |  |  |  |  |
| ***<u>Human Resource Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Nomad Health, Inc. | Equity | May 27, 2022 | 37920 | Common Stock | $500 | $— |  |
| **Sub-Total: Human Resource Technology (0.0%)\*** |  |  |  |  | $**500** | $**—** |  |
| ***<u>Industrials</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Digilens, Inc. | Equity | July 29, 2023 | 21730 | Preferred Series A-1 | $14 | $26 | (17) |
|  | Equity | September 18, 2024 | 9498 | Preferred Series A-1 | 8 | 12 | (17) |
|  | Equity | October 10, 2023 | 6332 | Preferred Series A-1 | 4 | 8 | (17) |
|  | Equity | January 12, 2024 | 12205 | Preferred Series A-1 | 7 | 15 | (17) |
|  | Equity | May 6, 2024 | 4117 | Preferred Series A-1 | 4 | 5 | (17) |
|  | Equity | June 9, 2024 | 2617 | Preferred Series A-1 | 2 | 3 | (17) |
|  | Equity | May 20, 2024 | 126641 | Preferred Series A-1 | 110 | 154 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Digilens, Inc. |  |  |  |  | 149 | 223 |  |
| **Sub-Total: Industrials (0.0%)\*** |  |  |  |  | $**149** | $**223** |  |
| ***<u>Multi-Sector Holdings</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Senior Credit Corp 2022 LLC | Equity | January 30, 2023 |  | Preferred | $5522 | $6186 | (7)(10)(21) |
| &nbsp;&nbsp;&nbsp;EPT 16 LLC | Equity | June 28, 2024 |  | Preferred | $9215 | $9215 | (7)(10)(17)(21) |
| &nbsp;&nbsp;&nbsp;Trinity Capital Adviser, LLC | Equity | June 28, 2024 |  | Preferred | $1 | $4851 | (10)(17)(21) |
| **Sub-Total: Multi-Sector Holdings (2.5%)\*** |  |  |  |  | $**14738** | $**20252** |  |
| ***<u>Real Estate Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Knockaway, Inc. | Equity | March 30, 2022 | 30458 | Common Stock | $500 | $— | (21) |
|  | Equity | September 29, 2023 | 2956224 | Preferred Series AA | 250 | 45 | (17)(21) |
|  | Equity | September 16, 2024 | 97866510 | Preferred Series BB | 2500 | 2510 | (17)(21) |
|  | Equity | September 7, 2023 | 3409997 | Preferred Series AA-1 |  | 19 | (17)(21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Knockaway Inc. |  |  |  |  | 3250 | 2574 |  |
| &nbsp;&nbsp;&nbsp;Orchard Technologies, Inc. | Equity | August 6, 2021 | 2938 | Preferred Series 2 | $29 | $— | (17) |
|  | Equity | March 16, 2023 | 97060 | Preferred Series 1 | 971 | 50 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Orchard Technologies, Inc. |  |  |  |  | 1000 | 50 |  |
| &nbsp;&nbsp;&nbsp;Maxwell Financial Labs, Inc | Equity | January 22, 2021 | 84998 | Preferred Series B | $313 | $38 | (17) |
|  | Equity | May 10, 2024 | 229972 | Preferred Series B-1 | 365 | 155 | (17) |
|  | Equity | October 2, 2024 | 32839 | Preferred Series B-2 | 121 | 101 | (17) |
|  | Equity | October 2, 2024 | 17804 | Common Stock | 66 | 2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Maxwell Financial Labs, Inc |  |  |  |  | 865 | 296 |  |
| **Sub-Total: Real Estate Technology (0.4%)\*** |  |  |  |  | $**5115** | $**2920** |  |
| ***<u>SaaS</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cart.com, Inc. | Equity | April 17, 2024 | 11533 | Preferred Series C | $500 | $541 | (9)(17) |
| &nbsp;&nbsp;&nbsp;Smartly, Inc. | Equity | March 29, 2023 | 136388 | Preferred Series B | $500 | $689 | (17) |
| &nbsp;&nbsp;&nbsp;The Tomorrow Companies, Inc. | Equity | July 5, 2023 | 108088 | Preferred Series E-1 | $325 | $231 | (9)(17) |
| **Sub-total: SaaS (0.2%)\*** |  |  |  |  | $**1325** | $**1461** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Shares / Principal** | **Series** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Equity Investments- United States, Continued** |  |  |  |  |  |  |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Astranis Space Technology Corporation | Equity | April 5, 2023 | 13685 | Series C Prime Preferred | $300 | $133 | (9)(17) |
|  | Equity | March 19, 2024 | 64223 | Preferred Series D | 600 | 592 | (9)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Astranis Space Technology Corporation |  |  |  |  | 900 | 725 |  |
| &nbsp;&nbsp;&nbsp;Axiom Space, Inc. | Equity | August 11, 2021 | 3624 | Preferred Series C-1 | $521 | $449 |  |
| &nbsp;&nbsp;&nbsp;Hadrian Automation, Inc. | Equity | March 29, 2022 | 53154 | Preferred A-4 | $500 | $570 | (17) |
|  | Equity | December 11, 2023 | 31831 | Preferred B-1 | 300 | 341 | (9)(17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Hadrian Automation, Inc. |  |  |  |  | 800 | 911 |  |
| &nbsp;&nbsp;&nbsp;Impulse Space, Inc. | Equity | August 30, 2024 | 35754 | Preferred Series B | $500 | $492 | (17) |
| **Sub-total: Space Technology (0.3%)\*** |  |  |  |  | $**2721** | $**2577** |  |
| ***<u>Supply Chain Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Macrofab, Inc. | Equity | January 30, 2024 | 247173 | Preferred C-1 Preferred | $500 | $248 | (17) |
| **Sub-total: Supply Chain Technology (0.0%)\*** |  |  |  |  | $**500** | $**248** |  |
| ***<u>Transportation Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;NextCar Holding Company, Inc. | Equity | April 18, 2023 | 2688971 | Preferred Series A-6 | $— | $— | (17) |
| **Sub-total: Transportation Technology (0.0%)\*** |  |  |  |  | $**—** | $**—** |  |
| **Total: Equity Investments- United States (8.2%)\*** |  |  |  |  | $**73506** | $**67690** |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of <br>Investment** <sup>(2)</sup> | **Investment Date** <sup>(3)</sup> | **Shares / Principal** | **Series** | **Cost** | **Fair Value** <sup>(6)</sup> | **Footnotes** |
| **Equity Investments- Canada** |  |  |  |  |  |  |  |
| ***<u>Construction Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Nexii, Inc. | Equity | July 24, 2024 | 250 | Preferred Series A | $3049 | $2614 | (10)(17) |
|  | Equity | July 24, 2024 | 50000 | Common Stock | 1370 | 1008 | (10) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Nexii, Inc. |  |  |  |  | 4419 | 3622 |  |
| **Sub-Total: Construction Technology (0.4%)\*** |  |  |  |  | $**4419** | $**3622** |  |
| ***<u>Supply Chain Technology</u>*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;GoFor Delivers, Inc. | Equity | June 28, 2024 | 194329 | Series 2 Seed | $660 | $673 | (10)(21) |
| **Sub-total: Supply Chain Technology (0.1%)\*** |  |  |  |  | $**660** | $**673** |  |
| **Total: Equity Investments- Canada (0.5%)\*** |  |  |  |  | $**5079** | $**4295** |  |
| **Total: Equity Investments (8.7%)\*** |  |  |  |  | $**78585** | $**71985** |  |
| **Total Investment in Securities (209.7%)\*** |  |  |  |  | $**1760226** | $**1725570** |  |
| **Cash and Cash Equivalents** |  |  |  |  |  |  |  |
| Goldman Sachs Financial Square Government Institutional Fund |  |  |  |  | $3750 | $3750 |  |
| Other cash accounts |  |  |  |  | 5877 | 5877 |  |
| **Cash and Cash Equivalents (1.2%)\*** |  |  |  |  | 9627 | 9627 |  |
| ***Total Portfolio Investments and Cash and Cash Equivalents (210.8%) of net assets)*** |  |  |  |  | $**1769853** | $**1735197** |  |

---

\* Value as a percent of net assets

<sup>(1)</sup> All portfolio companies are located in North America or Europe. As of December 31, 2024, Trinity Capital Inc. (the "Company") had five foreign domiciled portfolio companies, two of which are based in Canada and three of which are based in Europe. In total, these foreign domiciled portfolio investments represent 6.3% of total net asset value based on fair value. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the "Securities Act"). These investments are generally subject to certain limitations on resale and may be deemed to be "restricted securities" under the Securities Act.

<sup>(2)</sup> All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted.

<sup>(3)</sup> Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds as part of the Formation Transactions (both terms as defined in "Note 1 – Organization and Basis of Presentation"), the investment date is January 16, 2020, the date of the Formation Transactions.

<sup>(4)</sup> Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term ("EOT") payment, or additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair value, generally subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the term of the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Company's current debt securities.

<sup>(5)</sup> Principal is net of repayments, if any, as per the terms of the debt instrument's contract.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

<sup>(6)</sup> Except as noted, all investments were valued at fair value as determined in good faith by the Company's Board of Directors (the "Board") using Level 3 inputs.

<sup>(7)</sup> Asset is valued at fair value as determined in good faith by the Company's Board using Level 1 and Level 2 inputs.

<sup>(8)</sup> The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. As of December 31, 2024, the U.S. Prime Rate ("Prime") was 7.50% and the Secured Overnight Financing Rate ("SOFR") 30 Day Forward Rate and 3-Month Term Rate were 4.33% and 4.31%, respectively.

<sup>(9)</sup> Senior Credit Corp 2022 LLC owns an additional portion of this security. See "Note 12 – Related Party Transactions" for further discussion.

<sup>(10)</sup> Indicates a "non-qualifying asset" under section 55(a) of the Investment Company Act of 1940, as amended (the "1940 Act"). The Company's percentage of non-qualifying assets at fair value represents 14.6% of the Company's total assets as of December 31, 2024. Qualifying assets must represent at least 70% of the Company's total assets at the time of acquisition of any additional non-qualifying assets.

<sup>(11)</sup> Investment has zero cost basis as it was purchased at a fair value of zero as part of the Formation Transactions (as defined in "Note 1 – Organization and Basis of Presentation").

<sup>(12)</sup> Investment is a secured loan warehouse facility collateralized by interest in specific assets that meet the eligibility requirements under the facility during the warehouse period. Repayment of the facility will occur over the amortizing period unless otherwise prepaid.

<sup>(13)</sup> Company has been issued warrants with pricing and number of shares dependent upon a future round of equity issuance by the portfolio company.

<sup>(14)</sup> Investment is pledged as collateral supporting amounts outstanding under the Company's credit facility with KeyBank, National Association (the "KeyBank Credit Facility"). See "Note 5 – Borrowings" for more information.

<sup>(15)</sup> Interest on this loan includes a payment-in-kind ("PIK") provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally collected through amortization, is recorded on an accrual basis to the extent such amounts are expected to be collected.

<sup>(16)</sup> Convertible notes represent investments through which the Company will participate in future equity rounds at preferential rates. There are no principal or interest payments made against the note unless conversion does not occur.

<sup>(17)</sup> Preferred stock represents investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.

<sup>(18)</sup> Investment is on non-accrual status as of December 31, 2024, and is therefore considered non-income producing.

<sup>(19)</sup> EPT 16 LLC owns an additional portion of this security. See "Note 12 – Related Party Transactions" for further discussion.

<sup>(20)</sup> Investment has an unfunded commitment as of December 31, 2024 (see "Note 6 – Commitments and Contingencies"). The fair value of the investment includes the impact of the fair value of any unfunded commitments.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**Consolidated Schedule of Investments**

**December 31, 2024**

**(In thousands, except share and per share data)**

<sup>(21)</sup> This investment is deemed to be a "Control Investment" or an "Affiliate Investment." The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. The 1940 Act defines Control Investments as investments in companies in which the Company owns beneficially, either directly or indirectly, more than 25% of the voting securities, or maintains greater than 50% of the board representation. Affiliate Investments are defined by the 1940 Act as investments in companies in which the Company owns beneficially, either directly or indirectly, between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. Fair value as of December 31, 2024, along with transactions during the year ended December 31, 2024 in these control and affiliate investments are as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  | **Net change in** |  |  |
|  |  |  |  |  | **Unrealized** |  |  |
|  | **Fair Value at** | **Gross** | **Gross** | **Realized** | **(Depreciation)/** | **Fair Value at** | **Interest and** |
|  | **December 31, 2023** | **Additions** <sup>(1)</sup> | **Reductions** <sup>(2)</sup> | **Gain/(Loss)** | **Appreciation** | **December 31, 2024** | **Dividend Income** |
| ***For the Year Ended December 31, 2024*** |  |  |  |  |  |  |  |
| **Control Investments** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Edeniq, Inc. | $11386 | $873 | $(3036) | $— | $8882 | $18105 | $1075 |
| &nbsp;&nbsp;&nbsp;3Q GoFor Holdings, LP | 4222 | 988 | (7148) | (4226) | 6164 |  |  |
| &nbsp;&nbsp;&nbsp;Project Frog, Inc. | 8 |  |  |  | 36 | 44 |  |
| &nbsp;&nbsp;&nbsp;Vertical Communications, Inc. | 16745 | 264 | (150) |  | (251) | 16608 | 1819 |
| &nbsp;&nbsp;&nbsp;WorkWell Prevention and Care Inc. | 500 |  |  |  |  | 500 | 67 |
| &nbsp;&nbsp;&nbsp;Knockaway, Inc. | 22989 | 29252 | (2416) |  | (684) | 49141 | 5803 |
| &nbsp;&nbsp;&nbsp;Trinity Capital Adviser, LLC |  | 1 |  |  | 4850 | 4851 |  |
| **Total Control Investments** | $55850 | $31378 | $(12750) | $(4226) | $18997 | $89249 | $8764 |
| **Affiliate Investments** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;EPT 16 LLC | $— | $9215 | $— | $— | $— | $9215 | $— |
| &nbsp;&nbsp;&nbsp;GoFor Delivers, Inc. |  | 6687 |  |  | (246) | 6441 | 393 |
| &nbsp;&nbsp;&nbsp;Senior Credit Corp 2022 LLC | 11335 | 7401 |  |  | 335 | 19071 | 2510 |
| **Total Affiliate Investments** | $11335 | $23303 | $— | $— | $89 | $34727 | $2903 |
| **Total Control and Affiliate Investments** | $67185 | $54681 | $(12750) | $(4226) | $19086 | $123976 | $11667 |

---

------

<sup>(1)</sup> Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.

<sup>(2)</sup> Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TRINITY CAPITAL INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

# Note 1. Organization and Basis of Presentation
Trinity Capital Inc. ("Trinity Capital" and, together with its subsidiaries, the "Company") is a specialty lending company focused on providing debt, including loans, equipment financings and asset based lending, to growth-oriented companies, including institutional investor-backed companies. Trinity Capital was formed on August 12, 2019 as a Maryland corporation and commenced operations on January 16, 2020. Prior to January 16, 2020, Trinity Capital had no operations, except for matters relating to its formation and organization as a business development company ("BDC").

Trinity Capital is an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the "1940 Act"). Trinity Capital has elected to be treated, currently qualifies, and intends to continue to qualify annually as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes.

On September 27, 2019, Trinity Capital was initially capitalized with the issuance of 10 shares of its common stock for $150 to its sole stockholder.

On January 16, 2020, Trinity Capital completed a private offering of shares of its common stock (the "Private Common Stock Offering") pursuant to which it issued and sold 8,333,333 shares of its common stock for total aggregate gross proceeds of approximately $125.0 million, inclusive of an over-allotment option that was exercised in full on January 29, 2020.

Concurrent with the initial closing of the Private Common Stock Offering, the Company completed a private debt offering (the "144A Note Offering" and together with the Private Common Stock Offering, the "Private Offerings"), pursuant to which it issued and sold $125.0 million in aggregate principal amount of the Company's unsecured 7.00% Notes due 2025 (the "2025 Notes"), inclusive of the over-allotment option that was exercised in full on January 29, 2020.

On January 16, 2020, Trinity Capital completed a series of transactions, the Private Offerings, and the acquisition of Trinity Capital Investment, LLC, Trinity Capital Fund II, L.P. ("Fund II"), Trinity Capital Fund III, L.P., Trinity Capital Fund IV, L.P., and Trinity Sidecar Income Fund, L.P. (collectively, the "Legacy Funds") through mergers of the Legacy Funds with and into Trinity Capital as well as Trinity Capital's acquisition of Trinity Capital Holdings, LLC ("Trinity Capital Holdings") (collectively, the "Formation Transactions").

Trinity Capital's common stock began trading on the Nasdaq Global Select Market on January 29, 2021, under the symbol "TRIN" in connection with its initial public offering of shares of its common stock ("IPO").

On December 5, 2022, the Company entered into a joint venture agreement with certain funds and accounts managed by a specialty credit manager to co-manage Senior Credit Corp 2022 LLC (the "Senior Credit Corp"), a Delaware limited liability company. Senior Credit Corp invests in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. Refer to "Note 12 – Related Party Transactions" for additional information.

On March 16, 2023, the Company formed an unconsolidated wholly owned subsidiary, Trinity Capital Adviser LLC ("Adviser Sub"), a Delaware limited liability company. The Company was granted exemptive relief by the SEC that permits the Company to organize, acquire, wholly own and operate the Adviser Sub as an investment adviser registered under the Investment Advisers Act of 1940, as amended (the "Adviser Act"). The Adviser Sub may provide investment advisory and related services to one or more investment vehicles (the "Adviser Funds") with ownership by one or more unrelated third-party investors and receive fee income for such services. Refer to "Note 12 – Related Party Transactions" for additional information.

------

[**<u>**Table of Contents**</u>**](#toc_page)

On June 28, 2024, the Company and a specialty credit manager funded a portion of their respective capital commitments to commence operations of a credit fund, EPT 16 LLC, a Delaware limited liability company. On August 28, 2025, EPT 16 LLC converted into a Delaware statutory trust named Eagle Point Trinity Senior Secured Lending Company ("EPT") and elected to be regulated as a BDC under the 1940 Act. EPT has acquired and intends to acquire, hold and, as applicable, dispose of investments that have been originated by the Company. Refer to "Note 12 – Related Party Transactions" for additional information.

On September 24, 2025, the Company entered into a joint venture agreement with a credit financing platform to co-manage Direct Lending 2025 LLC ("Direct Lending"), a Delaware limited liability company. Direct Lending has acquired loans originated by the Company and intends to acquire, hold and, as applicable, dispose of investments as co-investments alongside the Company. Refer to "Note 12 – Related Party Transactions" for additional information.

## *Basis of Presentation* 
The Company's interim consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Articles 6, 10 and 12 of Regulation S-X. Accordingly, certain disclosures accompanying annual financial statements prepared in accordance with GAAP are omitted. In the opinion of management, the unaudited financial results included herein contain all adjustments, consisting solely of normal accruals, considered necessary for the fair statement of the results for the interim period included herein. The current period's consolidated results of operations are not necessarily indicative of results that may be achieved for the year. The interim consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission ("SEC") on February 26, 2025. As an investment company, the Company follows accounting and reporting guidance determined by the Financial Accounting Standards Board ("FASB"), in Accounting Standards Codification, as amended ("ASC") 946, *Financial Services – Investment Companies* ("ASC 946").

## *Principles of Consolidation* 
Under ASC 946, the Company is precluded from consolidating portfolio company investments, including those in which it has a controlling interest, unless the portfolio company is another investment company. An exception to this general principle occurs if the Company holds a controlling interest in an operating company that provides all or substantially all of its services directly to the Company or to its portfolio companies. None of the portfolio investments made by the Company qualify for this exception. Therefore, the Company's investment portfolio is carried on the Consolidated Statements of Assets and Liabilities at fair value, as discussed further in "Note 3 - Investments," with any adjustments to fair value recognized as "Net change in unrealized appreciation/(depreciation) from investments" on the Consolidated Statements of Operations.

The Company's consolidated operations include the activities of its wholly owned subsidiaries, Trinity Funding 1, LLC ("TF1") and TrinCap Funding, LLC ("TCF"). TF1 was formed on August 14, 2019, as a Delaware limited liability company with Fund II as its sole equity member. On January 16, 2020, in connection with the Formation Transactions, Trinity Capital acquired TF1 through Fund II and became a party to, and assumed, a credit agreement with Credit Suisse AG (the "Credit Suisse Credit Facility") through TF1 which matured on January 8, 2022 in accordance with its terms. TCF was formed on August 5, 2021, as a Delaware limited liability company with Trinity Capital as its sole equity member for purposes of securing lending in conjunction with a credit agreement with KeyBank National Association ("KeyBank") (such credit facility, as amended, the "KeyBank Credit Facility"). TF1 and TCF are special purpose bankruptcy-remote entities and are separate legal entities from Trinity Capital. Any assets conveyed to TF1 or TCF are not available to creditors of the Company or any other entity other than TF1's or TCF's respective lenders. TF1 and TCF are consolidated for financial reporting purposes and in accordance with GAAP, and the portfolio investments held by these subsidiaries, if any, are included in the Company's consolidated financial statements and recorded at fair value. All intercompany balances and transactions have been eliminated. As part of the Formation Transactions, Trinity Capital acquired 100% of the equity interests of Trinity Capital Holdings. There has been no activity in Trinity Capital Holdings since acquisition.

------

[**<u>**Table of Contents**</u>**](#toc_page)

As permitted under Regulation S-X and consistent with the guidance in ASC 946-810-45-3, the Company will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. The Company does not consolidate the Adviser Sub because it is not an investment company as defined in ASC 946 and provides investment advisory services exclusively to the Adviser Funds with ownership by one or more unrelated third-party investors ("External Parties"). The Company does not consolidate the Senior Credit Corp, EPT or Direct Lending as the Company does not hold a majority of the ownership or economic interests of such entities, and the Company's representatives do not comprise the majority of the board of managers or board of trustees, as applicable, of Senior Credit Corp, EPT or Direct Lending. Pursuant to ASC 946, Senior Credit Corp, the Adviser Sub, EPT and Direct Lending are each accounted for as a portfolio investment of the Company held at fair value and are not included as a consolidated subsidiary in the Company's financial statements. Refer to "Note 12 – Related Party Transactions" for additional information.

In accordance with Rule 10-01(b)(1) of Regulation S-X, as amended, the Company must determine which of its unconsolidated controlled subsidiaries, if any, are considered "significant subsidiaries." In evaluating these unconsolidated controlled subsidiaries, there are two significance tests utilized per Rule 1-02(w) of Regulation S-X to determine if any of the Company's investments or unconsolidated controlled subsidiaries are considered significant: the investment test and the income test. As of September 30, 2025 and December 31, 2024, none of the Company's investments or unconsolidated controlled subsidiaries met either of these two significance tests.

# Note 2. Summary of Significant Accounting Policies

# *Use of Estimates* 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ materially from these estimates.

## *Investment Transactions* 
Loan originations are recorded on the date of the legally binding commitment. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received, excluding prepayment fees, if any, and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last business day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.

## *Valuation of Investments* 
The most significant estimate inherent in the preparation of the Company's consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded.

The Company's investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, *Fair Value Measurements and Disclosures* ("ASC 820"). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith pursuant to a consistent valuation policy by the Company's Board of Directors (the "Board") in accordance with the provisions of ASC 820 and the 1940 Act.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The SEC adopted Rule 2a-5 under the 1940 Act ("Rule 2a-5"), which establishes a framework for determining fair value in good faith for purposes of the 1940 Act. As adopted, Rule 2a-5 permits boards of directors to designate certain parties to perform fair value determinations, subject to board oversight and certain other conditions. The SEC also adopted Rule 31a-4 under the 1940 Act ("Rule 31a-4"), which provides the recordkeeping requirements associated with fair value determinations. While the Company's Board has not elected to designate a valuation designee, the Company has adopted certain revisions to its valuation policies and procedures to comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.

While the Board is ultimately and solely responsible for determining the fair value of the Company's investments, the Company has engaged independent valuation firms, on a discretionary basis, to provide the Company with valuation assistance with respect to its investments. Specifically, on a quarterly basis, the Company identifies portfolio investments with respect to which an independent valuation firm assists in valuing such investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on the Company's Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management's own assumptions about the assumptions a market participant would use in pricing the investment.

Given the nature of lending to venture capital-backed growth-oriented companies, 98.2%, based on fair value, of the Company's investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market index for these investment securities to be traded or exchanged. Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis, and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company's investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

*Debt Securities*

The debt securities identified on the Consolidated Schedule of Investments are secured loans and equipment financings made to growth-oriented companies. For portfolio investments in debt securities for which the Company has determined that third-party quotes or other independent pricing are not available, the Company generally estimates the fair value based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.

------

[**<u>**Table of Contents**</u>**](#toc_page)

In its application of the income approach to determine the fair value of debt securities, the Company bases its assessment of fair value on projections of the discounted future free cash flows that the security will likely generate, including analyzing the discounted cash flows of interest and principal amounts for the security, as set forth in the associated loan and equipment financing agreements, as well as market yields and the financial position and credit risk of the portfolio company (the "Hypothetical Market Yield Method"). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Company's investment adjusted for changes in market yields and performance of the subject company. The Company's estimate of the expected repayment date of its loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, the Company may consider other factors in determining the fair value of the security, including, but not limited to, the value attributable to the security from the enterprise value of the portfolio company or the proceeds that would most likely be received in a liquidation analysis.

*Equity Securities and Warrants*

Often the Company is issued warrants by issuers as yield enhancements. These warrants are recorded as assets at estimated fair value on the grant date. The Company determines the cost basis of the warrants or other equity securities received based upon their respective fair values on the date of receipt in proportion to the total fair value of the debt and warrants or other equity securities received. Depending on the facts and circumstances, the Company generally utilizes a combination of one or several forms of the market approach and contingent claim analyses (a form of option analysis) to estimate the fair value of the securities as of the measurement date and determines the cost basis using a relative fair value methodology. As part of its application of the market approach, the Company estimates the enterprise value of a portfolio company utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio company. If appropriate, based on the facts and circumstances, the Company performs an allocation of the enterprise value to the equity securities utilizing a contingent claim analysis and/or other waterfall calculation by which it allocates the enterprise value across the portfolio company's securities in order of their preference relative to one another.

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company's financial instruments, consisting of cash, investments, receivables, payables, and other liabilities, approximate the fair values of such items due to the short-term nature of these instruments. Refer to "Note 4 – Fair Value of Financial Instruments" for further discussion.

## *Cash and Cash Equivalents* 
Cash, cash equivalents and restricted cash consist of funds deposited with financial institutions and short-term (original maturity of three months or less) liquid investments in money market deposit accounts. Cash equivalents are classified as Level 1 assets and are valued using the net asset value ("NAV") per share of the money market fund. As of September 30, 2025 and December 31, 2024, cash and cash equivalents consisted of $9.5 million and $9.6 million, respectively, of which $0.2 million and $3.8 million, respectively, was held in the Goldman Sachs Financial Square Government Institutional Fund with a yield between 3% - 6%. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") insured limit and therefore is subject to credit risk. All of the Company's cash deposits are held at large, established, high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of September 30, 2025 and December 31, 2024, the Company did not have any restricted cash.

## *Other Assets* 
Other assets generally consist of fixed assets net of accumulated depreciation, leasehold improvements net of accumulated depreciation, right-of-use assets, prepaid expenses, deferred offering costs, unsettled receivables, and security deposits for operating leases.

------

[**<u>**Table of Contents**</u>**](#toc_page)

***Foreign Currency Transactions***

The accounting records of the Company are maintained in U.S. dollars. Amounts denominated in foreign currencies are translated into U.S. dollars on the following basis: (i) investments and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates effective on the last business day of the period; and (ii) purchases and sales of investments, income, and expenses denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates prevailing on the transaction dates.

The Company includes net realized gains (losses) and net change in unrealized appreciation (depreciation) on investments held resulting from foreign exchange rate fluctuations in foreign currency and other transactions in its Consolidated Statements of Operations, if any.

Foreign securities and currency transactions may involve certain considerations and risks not typically associated with investing in U.S. companies and U.S. government securities. These risks include, but are not limited to, currency fluctuations and revaluations and future adverse political, social and economic developments, which could cause investments in foreign markets to be less liquid and prices more volatile than those of comparable U.S. companies or U.S. government securities.

***Derivative Instruments***

The Company's derivative instruments include foreign currency forward contracts. The Company recognizes all derivative instruments as assets or liabilities at fair value in its consolidated financial statements. Derivative contracts entered into by the Company are not designated as hedging instruments, and as a result, the Company presents changes in fair value through net change in unrealized appreciation (depreciation) on non-control/non-affiliate investments in the Consolidated Statements of Operations. Realized gains and losses of the derivative instruments are included in net realized gains (losses) on non-control/non-affiliate investments in the Consolidated Statements of Operations. The net cash flows realized on settlement of derivatives are included in realized (gain) loss in the Consolidated Statements of Cash Flows.

***Equity Offering Costs***

Equity offering costs consist of fees and costs incurred in connection with the sale of the Company's common stock, including legal, accounting and printing fees. These costs are deferred at the time of incurrence and are subsequently charged as a reduction to capital when the offering takes place or as shares are issued. Equity offering costs are periodically reviewed and expensed if the related registration is no longer active.

***Security Deposits***

Security deposits are collected upon funding equipment financings and are applied in lieu of regular payments at the end of the term.

***Debt Financing Costs***

The Company records costs related to the issuance of debt obligations as deferred debt financing costs. These costs are deferred and amortized using the straight-line method over the stated maturity life of the obligations. Debt financing costs related to secured or unsecured notes are netted with the outstanding principal balance on the Company's Consolidated Statements of Assets and Liabilities. Debt financing costs related to the KeyBank Credit Facility are recorded as deferred credit facility costs on the Company's Consolidated Statements of Assets and Liabilities.

------

[**<u>**Table of Contents**</u>**](#toc_page)

***Income Recognition***

*Interest and Dividend Income*

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount ("OID") initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Company may also be entitled to an end-of-term ("EOT") payment. EOT payments to be paid at the termination of the debt agreements are accreted into interest income over the contractual life of the debt based on the effective yield method. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT payment is recognized as interest income.

The Company has a limited number of debt investments in its portfolio that contain a payment-in-kind ("PIK") provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company will generally cease accruing PIK interest if there is insufficient value to support the accrual or management does not expect the portfolio company to be able to pay all principal and interest due. The Company recorded $0.7 million and $3.7 million in PIK interest income during the three and nine months ended September 30, 2025, respectively, and $1.6 million and $7.4 million in PIK interest income during the three and nine months ended September 30, 2024, respectively.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, is amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT payment received in consideration for contract modifications commencing in the quarter relating to the specific modification.

The Company records dividend income on an accrual basis to the extent amounts are expected to be collected. Dividend income is recorded when dividends are declared by the portfolio company or at such other time that an obligation exists for the portfolio company to make a distribution. During the three and nine months ended September 30, 2025, the Company recorded $1.4 million and $2.7 million in dividend income, respectively. During the three and nine months ended September 30, 2024, the Company recorded $0.5 million and $1.0 million in dividend income, respectively.

*Fee and Other Income*

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity. In addition, fee income may include fees for originations and administrative agent services rendered by the Company to Senior Credit Corp. Such fees are earned in the period that the services are rendered.

*Non-Accrual Policy*

When a debt security becomes 90 days or more past due, or if management otherwise does not expect that principal, interest, and other obligations due will be collected in full, the Company will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or the Company believes the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, the Company may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

------

[**<u>**Table of Contents**</u>**](#toc_page)

As of September 30, 2025, loans to three portfolio companies and equipment financings to one portfolio company were on non-accrual status, with a total cost of approximately $56.2 million, and a total fair value of approximately $20.7 million, or 1.0%, of the fair value of the Company's debt investment portfolio. As of December 31, 2024, loans to three portfolio companies and equipment financings to two portfolio companies were on non-accrual status, with a total cost of approximately $43.3 million, and a total fair value of approximately $12.7 million, or 0.8%, of the fair value of the Company's debt investment portfolio.

*Net Realized Gains / (Losses)*

Realized gains / (losses) are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written off during the period net of recoveries and realized gains or losses from in-kind redemptions. Net proceeds exclude any prepayment penalties, exit fees, and OID and EOT acceleration. Prepayment penalties and exit fees received at the time of sale or redemption are included in fee income on the Consolidated Statements of Operations. OID and EOT acceleration is included in interest income on the Consolidated Statements of Operations.

*Net Change in Unrealized Appreciation / (Depreciation)*

Net change in unrealized appreciation / (depreciation) reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

## *Stock-Based Compensation* 
The Company has issued and may, from time to time, issue restricted stock, incentive stock options and non-statutory stock options to its officers and employees under the 2019 Trinity Capital Inc. Long Term Incentive Plan, as amended, and to its non-employee directors under the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan, as amended. The Company accounts for its stock-based compensation plans using the fair value method, as prescribed by ASC 718, *Compensation – Stock Compensation*. Accordingly, for restricted stock awards, the Company measures the grant date fair value based upon the market price of its common stock on the date of the grant. For stock option awards, the Company estimates fair value using the Monte Carlo model, which requires the use of subjective assumptions such as expected stock price volatility, expected term of the option, risk-free interest rate, and expected dividend yield. The Company does not estimate forfeitures, and reverses all unvested costs associated with the stock option awards in the period they are forfeited. The Company amortizes the fair value of the awards as stock-based compensation expense over the requisite service period, which is generally the vesting term.

The Company has also adopted Accounting Standards Update ("ASU") 2016-09, *Compensation—Stock Compensation: Improvements to Employee Share-Based Payment Accounting*, which requires that all excess tax benefits and tax deficiencies (including tax benefits of dividends on stock-based payment awards) be recognized as income tax expense or benefit in the income statement and not delay recognition of a tax benefit until the tax benefit is realized through a reduction to taxes payable. Accordingly, the tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. Additionally, the Company has elected to account for forfeitures as they occur.

------

[**<u>**Table of Contents**</u>**](#toc_page)

***Earnings Per Share***

The Company's earnings per share ("EPS") amounts have been computed based on the weighted-average number of shares of common stock outstanding for the period. Basic earnings per share is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted-average number of common shares outstanding for the period. In accordance with ASC 260, *Earnings Per Share*, the unvested shares of restricted stock awarded pursuant to Trinity Capital's equity compensation plans are participating securities and, therefore, are included in the basic earnings per share calculation. Diluted EPS is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average number of shares of common stock assuming all potential shares had been issued and the additional shares of common stock were dilutive. Diluted EPS, if any, during the fiscal year ending December 31, 2025 will reflect the dilutive effect of common stock deliverable pursuant to stock options which are subject to certain time-based and market-based vesting conditions before the delivery of the underlying common stock. Diluted EPS, if any, during the fiscal year ending December 31, 2024 reflects the potential dilution from the assumed conversion of the Company's 6.00% Convertible Notes due 2025 (the "Convertible Notes").

## *Income Taxes* 
The Company has elected to be treated, currently qualifies, and intends to continue to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Company is generally required to distribute at least annually to its stockholders at least the sum of 90% of its investment company taxable income (which generally includes its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and 90% of its net tax-exempt income (if any). The Company generally will not be subject to U.S. federal income tax on these distributed amounts but will pay U.S. federal income tax at corporate rates on any retained amounts.

The Company evaluates tax positions taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" to be sustained by the applicable tax authority in accordance with ASC 740, *Income Taxes* ("ASC 740")*,* as modified by ASC 946. Tax benefits of positions not deemed to meet the more-likely-than-not threshold, or uncertain tax positions, would be recorded as tax expense in the current year. It is the Company's policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense. The Company has no material uncertain tax positions as of September 30, 2025 and December 31, 2024. All the Company's tax returns remain subject to examination by U.S. federal and state tax authorities.

Based on federal excise distribution requirements applicable to RICs, the Company will be subject to a 4% nondeductible federal excise tax on undistributed taxable income and gains unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income or gain realized, but not distributed, in the preceding years. For this purpose, however, any ordinary income or capital gain net income retained by the Company and on which the Company paid corporate income tax is considered to have been distributed. The Company, at its discretion, may determine to carry forward taxable income or gain and pay a 4% excise tax on the amount by which it falls short of this calendar-year distribution requirement. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income and capital gains as required on an annual basis.

## *Distributions* 
Distributions to common stockholders are recorded on the record date. The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by management. Capital gains, if any, are distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay U.S. federal income tax at corporate rates on those retained amounts. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders.

------

[**<u>**Table of Contents**</u>**](#toc_page)

# Note 3. Investments
The Company provides debt, including loans, equipment financings and asset based lending to growth-oriented companies, including institutional investor-backed companies, primarily in the United States. The Company's investment strategy includes making investments consisting primarily of term loans and equipment financings, and, to a lesser extent, working capital loans, equity, and equity-related investments. In addition, the Company may obtain warrants or contingent exit fees at funding from many of its portfolio companies.

## *Debt Securities* 
The Company's debt securities primarily consist of direct investments in interest-bearing secured loans and equipment financings to privately held companies based in the United States. Secured loans are generally secured by a blanket first lien or a blanket second lien on the assets of the portfolio company. Equipment financings typically include a specific asset lien on mission-critical assets as well as a second lien on the assets of the portfolio company. These debt securities typically have a term of between three and five years from the original investment date. Certain of the debt securities are "covenant-lite" loans, which generally are loans that do not have a complete set of financial maintenance covenants and have covenants that are incurrence-based, meaning they are only tested and can only be breached following an affirmative action of the borrower rather than by a deterioration in the borrower's financial condition. The equipment financings in the investment portfolio generally have fixed interest rates. The secured loans in the investment portfolio generally have floating interest rates subject to interest rate floors. Both equipment financings and secured loans generally include an EOT payment.

The specific terms of each debt security vary depending on the creditworthiness of the portfolio company and the projected value of the financed assets. Companies with stronger creditworthiness may receive an initial period of lower financing factor, which is analogous to an interest-only period on a traditional term loan. Equipment financings may include upfront interim payments and security deposits. Equipment financing arrangements have various structural protections, including customary default penalties, information and reporting rights, material adverse change or investor abandonment provisions, consent rights for any additions or changes to senior debt, and, as needed, intercreditor agreements with cross-default provisions to protect the Company's second lien positions.

## *Warrant Investments* 
In connection with the Company's debt investments, the Company may receive warrants in the portfolio company. Warrants received in connection with a debt investment typically include a potentially discounted contract price to exercise, and thus, as a portfolio company appreciates in value, the Company may achieve additional investment return from this equity interest. The warrants typically contain provisions that protect the Company as a minority-interest holder, as well as secured or unsecured put rights, or rights to sell such securities back to the portfolio company, upon the occurrence of specified events. In certain cases, the Company may also obtain follow-up rights in connection with these equity interests, which allow the Company to participate in future financing rounds.

## *Equity Investments* 
In specific circumstances, the Company may seek to make direct equity investments in situations where it is appropriate to align the interests of the Company with key management and stockholders of the portfolio company, and to allow for participation in the appreciation in the equity values of the portfolio company. These equity investments are generally made in connection with debt investments. The Company seeks to maintain fully diluted equity positions in its portfolio companies of 5% to 50% and may have controlling equity interests in some instances.

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *Portfolio Composition* 
The Company's portfolio investments are in companies conducting business in a variety of industries. Industry classifications have been updated to a preferred presentation and the prior year has been amended to conform with the new preferred presentation. The following table summarizes the composition of the Company's portfolio investments by industry at cost and fair value and as a percentage of the total portfolio as of September 30, 2025 and December 31, 2024 (dollars in thousands):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Cost** | **Cost** | **Fair Value** | **Fair Value** | **Cost** | **Cost** | **Fair Value** | **Fair Value** |
| **Industry** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** |
| Finance and Insurance | $333992 | 15.3% | $348594 | 15.8% | $319278 | 18.1% | $322735 | 18.7% |
| SaaS | 222143 | 10.1% | 224837 | 10.3% | 144896 | 8.2% | 146778 | 8.5% |
| Other Healthcare Services | 218387 | 9.9% | 221041 | 10.1% | 142430 | 8.1% | 143186 | 8.3% |
| Medical Devices | 215526 | 9.8% | 218005 | 9.9% | 170923 | 9.7% | 172395 | 10.0% |
| Space Technology | 185006 | 8.4% | 188311 | 8.6% | 141163 | 8.0% | 142034 | 8.2% |
| Healthcare Technology | 134980 | 6.1% | 125019 | 5.7% | 78381 | 4.5% | 71853 | 4.2% |
| Artificial Intelligence & Automation | 119822 | 5.4% | 120839 | 5.5% | 83505 | 4.7% | 84448 | 4.9% |
| Green Technology | 99402 | 4.5% | 119586 | 5.5% | 146851 | 8.3% | 158852 | 9.2% |
| Real Estate Technology | 116655 | 5.3% | 105504 | 4.8% | 101825 | 5.8% | 93587 | 5.4% |
| Marketing, Media, and Entertainment | 102537 | 4.7% | 100860 | 4.6% | 38749 | 2.2% | 38479 | 2.2% |
| Biotechnology | 75565 | 3.4% | 76836 | 3.5% | 56547 | 3.2% | 57836 | 3.4% |
| Transportation Technology | 86843 | 3.9% | 64099 | 2.9% | 62735 | 3.6% | 41547 | 2.4% |
| Multi-Sector Holdings <sup>(1)</sup> | 51328 | 2.3% | 61446 | 2.8% | 27623 | 1.6% | 33137 | 1.9% |
| Connectivity | 62133 | 2.8% | 57688 | 2.6% | 36099 | 2.1% | 35249 | 2.0% |
| Consumer Products & Services | 49889 | 2.3% | 51773 | 2.4% | 56210 | 3.2% | 54607 | 3.2% |
| Supply Chain Technology | 31714 | 1.4% | 29801 | 1.4% | 29765 | 1.7% | 28535 | 1.7% |
| Education Technology | 33440 | 1.5% | 27702 | 1.3% | 33275 | 1.9% | 29740 | 1.7% |
| Diagnostics & Tools | 18060 | 0.8% | 18063 | 0.8% | 3511 | 0.2% | 3493 | 0.2% |
| Food and Agriculture Technologies | 18347 | 0.8% | 15915 | 0.7% | 31824 | 1.8% | 24469 | 1.4% |
| Human Resource Technology | 17220 | 0.8% | 12360 | 0.6% | 33421 | 1.9% | 28891 | 1.7% |
| Industrials | 2330 | 0.1% | 2213 | 0.1% | 11772 | 0.7% | 9677 | 0.6% |
| Construction Technology | 9444 | 0.4% | 1869 | 0.1% | 9443 | 0.5% | 4042 | 0.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $2204763 | 100.0% | $2192361 | 100.0% | $1760226 | 100.0% | $1725570 | 100.0% |

---

------

<sup>(1)</sup> Multi-Sector Holdings generally invest or manage investments in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. The portfolio companies held by the Multi-Sector Holdings represent a diverse set of industry classifications, which are similar to those in which the Company invests directly.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The geographic composition of the Company's investment portfolio is determined by the location of the corporate headquarters of the portfolio company. The following table summarizes the composition of the Company's portfolio investments by geographic region of the United States and other countries at cost and fair value and as a percentage of the total portfolio as of September 30, 2025 and December 31, 2024 (dollars in thousands):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Cost** | **Cost** | **Fair Value** | **Fair Value** | **Cost** | **Cost** | **Fair Value** | **Fair Value** |
| **Geographic Region** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** |
| United States: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;West | $692812 | 31.4% | $701602 | 32.1% | $543501 | 30.7% | $543102 | 31.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Northeast | 520998 | 23.6% | 513510 | 23.4% | 494131 | 28.1% | 475944 | 27.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;South | 224102 | 10.2% | 224730 | 10.3% | 162180 | 9.2% | 164654 | 9.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Mountain | 229474 | 10.4% | 220302 | 10.0% | 191244 | 10.9% | 180644 | 10.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Midwest | 176464 | 8.0% | 168561 | 7.7% | 104074 | 5.9% | 96193 | 5.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Southeast | 171788 | 7.8% | 165338 | 7.5% | 184636 | 10.5% | 180002 | 10.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-Sector Holdings <sup>(1)</sup> | 50758 | 2.3% | 60875 | 2.8% | 27623 | 1.6% | 33137 | 1.9% |
| International: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Western Europe | 85731 | 3.9% | 86281 | 3.9% | 41366 | 2.4% | 41455 | 2.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Canada | 52636 | 2.4% | 51162 | 2.3% | 11471 | 0.7% | 10439 | 0.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $2204763 | 100.0% | $2192361 | 100.0% | $1760226 | 100.0% | $1725570 | 100.0% |

---

------

<sup>(1)</sup> Multi-Sector Holdings generally invest or manage investments in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. The portfolio companies held by the Multi-Sector Holdings represent a diverse set of geographical classifications, which are similar to those in which the Company invests directly.

The following table summarizes the composition of the Company's portfolio investments by investment type at cost and fair value and as a percentage of the total portfolio as of September 30, 2025 and December 31, 2024 (dollars in thousands):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Cost** | **Cost** | **Fair Value** | **Fair Value** | **Cost** | **Cost** | **Fair Value** | **Fair Value** |
| **Investment** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** |
| Secured Loans | $1709394 | 77.6% | $1678348 | 76.6% | $1322999 | 75.1% | $1286668 | 74.5% |
| Equipment Financings | 324641 | 14.7% | 318193 | 14.5% | 317962 | 18.1% | 315463 | 18.3% |
| Equity | 117313 | 5.3% | 125737 | 5.7% | 78585 | 4.5% | 71985 | 4.2% |
| Warrants | 53415 | 2.4% | 70083 | 3.2% | 40680 | 2.3% | 51454 | 3.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $2204763 | 100.0% | $2192361 | 100.0% | $1760226 | 100.0% | $1725570 | 100.0% |

---

## *Certain Risk Factors* 
In the ordinary course of business, the Company manages a variety of risks, including market risk, credit risk and liquidity risk. The Company identifies, measures and monitors risk through various control mechanisms, including investment limits and diversifying exposures and activities across a variety of instruments, markets and counterparties.

Market risk is the risk of potential adverse changes to the value of financial instruments because of changes in market conditions, including as a result of changes in the credit quality of a particular issuer, credit spreads, interest rates, and other movements and volatility in security prices or commodities. In particular, the Company may invest in issuers that are experiencing or have experienced financial or business difficulties (including difficulties resulting from the initiation or prospect of significant litigation or bankruptcy proceedings), which involves significant risks. The Company manages its exposure to market risk through the use of risk management strategies and various analytical monitoring techniques.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The Company's investments are generally comprised of securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.

The Company's investments consist of growth-oriented companies, many of which have relatively limited operating histories and may experience variation in operating results. Many of these companies conduct business in regulated industries and could be affected by changes in government regulations. Most of the Company's borrowers will need additional capital to satisfy their continuing working capital needs and other requirements, and in many instances, to service the interest and principal payments on the debt.

***Derivative Instruments***

The Company enters into forward currency contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company's investments denominated in foreign currencies.

The following is a summary of the fair value and location of the Company's derivative instruments in the Consolidated Statements of Assets and Liabilities held as of September 30, 2025 and December 31, 2024:

---

| | | | |
|:---|:---|:---|:---|
|  |  | **Fair Value** | **Fair Value** |
| **Derivative Instrument** | **Statement Location** | **September 30, 2025** | **December 31, 2024** |
| Foreign currency forward contract | Other assets | $181 | $— |
| **Total** |  | $181 | $— |

---

Net realized and unrealized gains and losses on derivative instruments recorded by the Company during the three and nine months ended September 30, 2025 and 2024 is in the following location in the Consolidated Statements of Operations:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| **Derivative Instrument** | **Statement Location** | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Foreign currency forward contract | Net change in unrealized appreciation/(depreciation) from investments | $499 | $— | $181 | $— |
| **Total** |  | $499 | $— | $181 | $— |

---

# Note 4. Fair Value of Financial Instruments
ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. The Company accounts for its investments at fair value in accordance with ASC 820. As of September 30, 2025 and December 31, 2024, the Company's portfolio investments consisted primarily of investments in secured loans and equipment financings. The fair value amounts have been measured as of the reporting date and have not been reevaluated or updated for purposes of these financial statements subsequent to that date. As such, the fair values of these financial instruments subsequent to the reporting date may be different than amounts reported.

In accordance with ASC 820, the Company has categorized its investments based on the priority of the inputs to the valuation technique into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical investments (Level 1) and the lowest priority to unobservable inputs (Level 3). See "Note 2 – Summary of Significant Accounting Policies."

------

[**<u>**Table of Contents**</u>**](#toc_page)

As required by ASC 820, when the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized within the Level 3 tables below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

The fair value determination of each portfolio investment categorized as Level 3 requires one or more of the following unobservable inputs:

• Financial information obtained from each portfolio company, including unaudited statements of operations and balance sheets for the most recent period available as compared to budgeted numbers;

• Current and projected financial condition of the portfolio company;

• Current and projected ability of the portfolio company to service its debt obligations;

• Type and amount of collateral, if any, underlying the investment;

• Current financial ratios (e.g., fixed charge coverage ratio, interest coverage ratio and net debt/EBITDA ratio) applicable to the investment;

• Current liquidity of the investment and related financial ratios (e.g., current ratio and quick ratio);

• Pending debt or capital restructuring of the portfolio company;

• Projected operating results of the portfolio company;

• Current information regarding any offers to purchase the investment;

• Current ability of the portfolio company to raise any additional financing as needed;

• Changes in the economic environment, which may have a material impact on the operating results of the portfolio company;

• Internal occurrences that may have an impact (both positive and negative) on the operating performance of the portfolio company;

• Qualitative assessment of key management;

• Contractual rights, obligations or restrictions associated with the investment; and

• Time to exit.

The use of significant unobservable inputs creates uncertainty in the measurement of fair value as of the reporting date. The significant unobservable inputs used in the fair value measurement of the Company's investments, are (i) earnings before interest, tax, depreciation, and amortization ("EBITDA") and revenue multiples (both projected and historic), and (ii) volatility assumptions. Significant increases (decreases) in EBITDA and revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Similarly, significant increases (decreases) in volatility inputs in isolation would result in a significantly higher (lower) fair value assessment. Conversely, significant increases (decreases) in weighted average cost of capital inputs in isolation would result in a significantly lower (higher) fair value measurement. However, due to the nature of certain investments, fair value measurements may be based on other criteria, such as third-party appraisals of collateral and fair values as determined by independent third parties, which are not presented in the tables below.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The Company's assets measured at fair value by investment type on a recurring basis as of September 30, 2025 were as follows (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Fair Value Measurements at Reporting Date Using** | **Fair Value Measurements at Reporting Date Using** | **Fair Value Measurements at Reporting Date Using** |  |  |
|  | **Quoted Prices** | **Significant** |  |  |  |
|  | **in Active** | **Other** | **Significant** |  |  |
|  | **Markets for** | **Observable** | **Unobservable** |  |  |
|  | **Identical Assets** | **Inputs** | **Inputs** | **Measured at** |  |
| **Assets** | **(Level 1)** | **(Level 2)** | **(Level 3)** | **Net Asset Value**<sup>(1)</sup> | **Total** |
| Secured Loans | $— | $— | $1678348 | $— | $1678348 |
| Equipment Financings |  |  | 318193 |  | 318193 |
| Warrants |  |  | 70083 |  | 70083 |
| Equity |  |  | 86763 | 38974 | 125737 |
| **Total Investments at fair value** |  |  | 2153387 | 38974 | 2192361 |
| Cash and cash equivalents | 9467 |  |  |  | 9467 |
| Derivative Instruments |  | 181 |  |  | 181 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Investments including cash and cash equivalents and derivative instruments** | $9467 | $181 | $2153387 | $38974 | $2202009 |

---

------

<sup>(1)</sup> In accordance with ASC 820, the Company's equity investments in Senior Credit Corp 2022 LLC, Trinity Capital Adviser LLC, Eagle Point Trinity Senior Secured Lending Company, AZ-VC Fund I, LLC and Direct Lending 2025 LLC are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value, and thus have not been classified in the fair value hierarchy.

The Company's assets measured at fair value by investment type on a recurring basis as of December 31, 2024 were as follows (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Fair Value Measurements at Reporting Date Using** | **Fair Value Measurements at Reporting Date Using** | **Fair Value Measurements at Reporting Date Using** |  |  |
|  | **Quoted Prices** | **Significant** |  |  |  |
|  | **in Active** | **Other** | **Significant** |  |  |
|  | **Markets for** | **Observable** | **Unobservable** |  |  |
|  | **Identical Assets** | **Inputs** | **Inputs** | **Measured at** |  |
| **Assets** | **(Level 1)** | **(Level 2)** | **(Level 3)** | **Net Asset Value**<sup>(1)</sup> | **Total** |
| Secured Loans | $— | $— | $1286668 | $— | $1286668 |
| Equipment Financings |  |  | 315463 |  | 315463 |
| Warrants |  |  | 51454 |  | 51454 |
| Equity |  |  | 56584 | 15401 | 71985 |
| **Total Investments at fair value** |  |  | 1710169 | 15401 | 1725570 |
| Cash and cash equivalents | 9627 |  |  |  | 9627 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Investments including cash and cash equivalents** | $9627 | $— | $1710169 | $15401 | $1735197 |

---

------

<sup>(1)</sup> In accordance with ASC 820, the Company's equity investments in Senior Credit Corp 2022 LLC and Eagle Point Trinity Senior Secured Lending Company are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value, and thus have not been classified in the fair value hierarchy.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The methodology for determining the fair value of the Company's investments is discussed in "Note 2 – Summary of Significant Accounting Policies". The following table provides a summary of the significant unobservable inputs used to measure the fair value of the Level 3 portfolio investments as of September 30, 2025.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Fair Value as of** |  |  |  |  |  |
|  | **September 30, 2025** | **Valuation Techniques/** | **Unobservable** |  | **Weighted** |  |
| **Investment Type** | **(in thousands)** | **Methodologies** | **Inputs** <sup>(1)</sup> | **Range** | **Average** <sup>(2)</sup> |  |
| Debt investments | $1541059 | Discounted Cash Flows | Hypothetical Market Yield | 3.4% - 37.8% | 15.0 | % |
|  | 405936 | Cost approximates fair value <sup>(6)</sup> | n/a | n/a | n/a |  |
|  | 36661 | Scenario Analysis | Probability Weighting of Alternative Outcomes | 10.0% - 90.0% | n/a |  |
| Debt investment in Senior Credit Corp 2022 LLC | 12885 | Enterprise Value <sup>(7)</sup> | n/a | n/a | n/a |  |
| Equity investments | 78887 | Market Approach | Revenue Multiple <sup>(3)</sup> | 0.3x - 30.2x | 3.2 | x |
|  |  |  | Volatility <sup>(5)</sup> | 38.6% - 111.7% | 52.7 | % |
|  |  |  | Risk-Free Interest Rate | 3.6% - 3.7% | 3.6 | % |
|  |  |  | Estimated Time to Exit (in years) | 1.0 - 4.3 | 2.5 |  |
|  | 7876 | Cost approximates fair value <sup>(6)</sup> | n/a | n/a | n/a |  |
| Warrants | 67042 | Market Approach | Revenue Multiple <sup>(3)</sup> | 0.1x - 30.2x | 4.4 | x |
|  |  |  | Company Specific Adjustment <sup>(4)</sup> | n/a | n/a |  |
|  |  |  | Volatility <sup>(5)</sup> | 36.1% - 140.0% | 60.2 | % |
|  |  |  | Risk-Free Interest Rate | 3.6% - 3.9% | 3.6 | % |
|  |  |  | Estimated Time to Exit (in years) | 0.8 - 4.8 | 2.5 |  |
|  | 306 | Transaction Precedent <sup>(7)</sup> | Transaction Price | n/a | n/a |  |
|  | 2735 | Black Scholes | Volatility <sup>(5)</sup> | 58.2% - 77.5% | 68.2 | % |
|  |  |  | Discount for Lack of Marketability | n/a | n/a |  |
|  |  |  | Risk-Free Interest Rate | 3.7% - 4.1% | 3.9 | % |
|  |  |  | Estimated Time to Exit (in years) | 4.9 - 9.9 | 6.6 |  |
| &nbsp;&nbsp;&nbsp;**Total Level 3 Investments** | $2153387 |  |  |  |  |  |

---

------

<sup>(1)</sup> The significant unobservable inputs used in the fair value measurement of the Company's debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Company's equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model ("OPM") include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing, merger or acquisition events near the measurement date.

<sup>(2)</sup> Weighted averages are calculated based on the fair value of each investment.

<sup>(3)</sup> Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.

<sup>(4)</sup> Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

<sup>(5)</sup> Represents the range of industry volatility used by market participants when pricing the investment.

<sup>(6)</sup> Includes debt investments originated within the past three months, for which cost approximates fair value, unless events have occurred during the period that would indicate a different valuation is warranted.

<sup>(7)</sup> The Company determined the value of its subordinated note of Senior Credit Corp 2022 LLC based on the total assets less the total liabilities senior to the subordinated notes held at Senior Credit Corp 2022 LLC in an amount not exceeding par under the Enterprise Value technique.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of December 31, 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Fair Value as of** |  |  |  |  |  |
|  | **December 31, 2024** | **Valuation Techniques/** | **Unobservable** |  | **Weighted** |  |
| **Investment Type** | **(in thousands)** | **Methodologies** | **Inputs** <sup>(1)</sup> | **Range** | **Average** <sup>(2)</sup> |  |
| Debt investments | 1206947 | Discounted Cash Flows | Hypothetical Market Yield | 9.6% - 56.3% | 16.3 | % |
|  | 369600 | Cost approximates fair value <sup>(6)</sup> | n/a | n/a | n/a |  |
|  | 12699 | Scenario Analysis | Probability Weighting of Alternative Outcomes | 1.0% - 100.0% | n/a |  |
| Debt investment in Senior Credit Corp 2022 LLC | 12885 | Enterprise Value <sup>(7)</sup> | n/a | n/a | n/a |  |
| Equity investments | 56584 | Market Approach | Revenue Multiple <sup>(3)</sup> | 0.5x - 34.9x | 3.4 | x |
|  |  |  | Volatility <sup>(5)</sup> | 40.1% - 118.8% | 55.4 | % |
|  |  |  | Risk-Free Interest Rate | 4.2% - 4.3% | 4.3 | % |
|  |  |  | Estimated Time to Exit (in years) | 1.0 - 4.5 | 2.8 |  |
| Warrants | 51454 | Market Approach | Revenue Multiple <sup>(3)</sup> | 0.2x - 34.9x | 4.1 | x |
|  |  |  | Company Specific Adjustment <sup>(4)</sup> | n/a | n/a |  |
|  |  |  | Volatility <sup>(5)</sup> | 35.4% - 127.9% | 61.0 | % |
|  |  |  | Risk-Free Interest Rate | 4.2% - 4.4% | 4.3 | % |
|  |  |  | Estimated Time to Exit (in years) | 0.7 - 5.0 | 2.4 |  |
| &nbsp;&nbsp;&nbsp;**Total Level 3 Investments** | $1710169 |  |  |  |  |  |

---

------

<sup>(1)</sup> The significant unobservable inputs used in the fair value measurement of the Company's debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Company's equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the OPM include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing, merger or acquisition events near the measurement date.

<sup>(2)</sup> Weighted averages are calculated based on the fair value of each investment.

<sup>(3)</sup> Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.

<sup>(4)</sup> Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

<sup>(5)</sup> Represents the range of industry volatility used by market participants when pricing the investment.

<sup>(6)</sup> Includes debt investments originated within the past three months, for which cost approximates fair value, unless events have occurred during the period that would indicate a different valuation is warranted.

<sup>(7)</sup> Under the enterprise value technique, the significant unobservable inputs used in the fair value measurement of the Company's investment in debt or equity securities are: (i) EBITDA, (ii) revenue or (iii) asset multiple; as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The following table provides a summary of changes in the fair value of the Company's Level 3 debt, including loans and equipment financings (collectively "Debt"), equity and warrant portfolio investments for the nine months ended September 30, 2025 (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Type of Investment** | **Type of Investment** | **Type of Investment** | **Type of Investment** |
|  | **Debt** | **Equity** | **Warrants** | **Total** |
| Fair Value as of December 31, 2024 | $1602131 | $56584 | $51454 | $1710169 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases, net of deferred fees | 991986 | 12457 | 18246 | 1022689 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash conversions <sup>(1)</sup> | (3781) | 3850 | (69) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales and paydowns | (602814) | (981) | (4050) | (607845) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accretion of OID, EOT, and PIK payments | 36431 |  |  | 36431 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain/(loss) | (28747) | (303) | (1178) | (30228) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation/(depreciation) | 1335 | 15156 | 5680 | 22171 |
| Fair Value as of September 30, 2025 | $1996541 | $86763 | $70083 | $2153387 |
| Net change in unrealized appreciation/(depreciation) on Level 3 investments still held as of September 30, 2025 | $(14750) | $15157 | $4005 | $4412 |

---

------

<sup>(1)</sup> The non-cash conversion includes an exercise of a warrant to an equity position.

\* During the nine months ended September 30, 2025, there were no transfers into or out of Level 3.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The following table provides a summary of changes in the fair value of the Company's Level 3 Debt, equity, warrant and escrow receivables portfolio investments for the year ended December 31, 2024 (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Type of Investment** | **Type of Investment** | **Type of Investment** | **Type of Investment** | **Type of Investment** |
|  | **Debt** | **Equity** | **Warrants** | **Escrow Receivables** | **Total** |
| Fair Value as of December 31, 2023 | $1222077 | $15150 | $31201 | $2441 | $1270869 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases, net of deferred fees | 1180013 | 6709 | 20774 |  | 1207496 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash conversion <sup>(1)</sup> | (25674) | 31802 | (6128) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Transfers into/(out of) of Level 3 <sup>(2)</sup> | (28315) |  |  |  | (28315) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales and paydowns | (759113) | (11477) | 8006 | (2441) | (765025) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accretion of OID and EOT payments | 39574 |  |  |  | 39574 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain/(loss) | (21294) | 7826 | (9962) |  | (23430) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation/(depreciation) | (5137) | 6574 | 7563 |  | 9000 |
| Fair Value as of December 31, 2024 | $1602131 | $56584 | $51454 | $— | $1710169 |
| Net change in unrealized appreciation/(depreciation) on Level 3 investments still held as of December 31, 2024 | $(24105) | $4631 | $1996 | $— | $(17478) |

---

------

<sup>(1)</sup> The non-cash conversion includes the exercise of debt and warrant positions to equity positions during the period.

<sup>(2)</sup> Transfers out of Level 3 during the year ended December 31, 2024, were related to the conversion of debt to equity in one publicly-traded portfolio company. During the year ended December 31, 2024, there were no transfers into Level 3.

*Fair Value of Financial Instruments Carried at Cost*

As of September 30, 2025 and December 31, 2024, the carrying value of the KeyBank Credit Facility was approximately $481.6 million and $113.0 million, respectively. The carrying value of the KeyBank Credit Facility as of September 30, 2025 and December 31, 2024 approximates the fair value, which was estimated using a relative market yield approach with Level 3 inputs.

As of September 30, 2025 and December 31, 2024, the carrying value of the 4.375% Notes due 2026 (the "August 2026 Notes") was approximately $124.5 million and $124.1 million, respectively, net of unamortized deferred financing costs of $0.5 million and $1.0 million, respectively. The August 2026 Notes have a fixed interest rate as discussed in "Note 5 – Borrowings." The fair value of the Company's August 2026 Notes as of September 30, 2025, and December 31, 2024, was approximately $116.6 million and $114.1 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of September 30, 2025, and December 31, 2024, the carrying value of the Company's 4.25% Notes due 2026 (the "December 2026 Notes") was approximately $74.6 million and $74.3 million, respectively, net of unamortized deferred financing fees of $0.4 million and $0.7 million, respectively. The December 2026 Notes have a fixed interest rate as discussed in "Note 5 – Borrowings." The fair value of the Company's December 2026 Notes as of September 30, 2025 and December 31, 2024 was approximately $70.2 million and $68.6 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

------

[**<u>**Table of Contents**</u>**](#toc_page)

As of September 30, 2025 and December 31, 2024, the carrying value of the Company's 7.875% Notes due March 2029 (the "March 2029 Notes") was approximately $114.3 million and $112.1 million, respectively, net of unamortized deferred financing fees and premium of $2.5 million and $2.9 million, respectively. The March 2029 Notes have a fixed interest rate as discussed in "Note 5 – Borrowings." The fair value of the Company's March 2029 Notes as of September 30, 2025 and December 31, 2024 was approximately $117.6 million and $116.2 million, respectively, based on the market closing price of the March 2029 Notes, which trade on the Nasdaq Global Select Market under the symbol "TRINZ".

As of September 30, 2025 and December 31, 2024, the carrying value of the Company's 7.875% Notes due September 2029 (the "September 2029 Notes") was approximately $116.6 million and $111.6 million, respectively, net of unamortized deferred financing fees and premium of $3.0 million and $3.4 million, respectively. The September 2029 Notes have a fixed interest rate as discussed in "Note 5 – Borrowings." The fair value of the Company's September 2029 Notes as of September 30, 2025 and December 31, 2024 was approximately $120.3 million and $118.0 million, respectively, based on the market closing price of the September 2029 Notes, which trade on the Nasdaq Global Select Market under the symbol "TRINI".

As of September 30, 2025 and December 31, 2024, the carrying value of the Series A Senior Notes (the "Series A Notes") was approximately $141.2 million and $140.9 million, respectively, net of unamortized deferred financing costs of $1.3 million and $1.7 million, respectively. The Series A Notes have a fixed interest rate as discussed in "Note 5 – Borrowings." The fair value of the Company's Series A Notes as of September 30, 2025 and December 31, 2024 was approximately $144.0 million and $142.5 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of September 30, 2025, the carrying value of the Company's 6.750% Notes due July 2030 (the "July 2030 Notes") was approximately $122.0 million, net of unamortized deferred financing costs and discount of $3.0 million. The July 2030 Notes have a fixed interest rate as discussed in "Note 5 – Borrowings." The fair value of the Company's July 2030 Notes as of September 30, 2025 was approximately $125.0 million, which was estimated using a relative market yield approach with Level 3 inputs.

# Note 5. Borrowings

## *KeyBank Credit Facility* 
On October 27, 2021, TCF, a wholly owned subsidiary of the Company, as borrower, and the Company, as servicer, entered into a credit agreement (as amended, the "KeyBank Credit Agreement") with the lenders from time-to-time party thereto, KeyBank, as administrative agent and syndication agent, and Wells Fargo, National Association, as collateral custodian and paying agent.

The KeyBank Credit Facility includes a commitment of $690.0 million from KeyBank and other banks. Borrowings under the KeyBank Credit Agreement generally bear interest at a rate equal to Adjusted Term SOFR plus 2.85% to 3.25%, subject to the number of eligible loans in the collateral pool. The KeyBank Credit Facility provides for a variable advance rate of up to 62% on eligible first lien loans and up to 47% on eligible second lien loans.

The KeyBank Credit Facility includes a three-year revolving period and a two-year amortization period and matures on July 27, 2029, unless extended. Such credit facility is collateralized by all investment assets held by TCF. The KeyBank Credit Agreement contains representations and warranties and affirmative and negative covenants customary for secured financings of this type, including certain financial covenants such as a consolidated tangible net worth requirement and a required asset coverage ratio.

The KeyBank Credit Agreement also contains customary events of default (subject to certain grace periods, as applicable), including but not limited to the nonpayment of principal, interest or fees; breach of covenants; inaccuracy of representations or warranties in any material respect; voluntary or involuntary bankruptcy proceedings; and change of control of the borrower without the prior written consent of KeyBank.

During the three months ended September 30, 2025, the Company borrowed $437.0 million and made repayments of $438.4 million under the KeyBank Credit Facility. During the nine months ended September 30, 2025, the Company borrowed $1,164.2 million and made repayments of $795.6 million under the KeyBank Credit Facility.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The Company incurred approximately $9.8 million of initial and additional financing costs in connection with the KeyBank Credit Facility that were capitalized and deferred using the straight-line method over the life of the facility. As of September 30, 2025 and December 31, 2024, unamortized deferred financing costs related to the KeyBank Credit Facility were $6.3 million and $6.6 million, respectively. As of September 30, 2025 and December 31, 2024, the Company had a borrowing availability of approximately $208.4 million and $487.0 million, respectively.

The summary information regarding the KeyBank Credit Facility is as follows (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Stated interest expense | 8132 | 5731 | 21731 | 15081 |
| Amortization of deferred financing costs | 402 | 284 | 1172 | 703 |
| &nbsp;&nbsp;Total interest and amortization of deferred financing costs | $8534 | $6015 | $22903 | $15784 |
| Weighted average effective interest rate | 7.8% | 9.2% | 8.0% | 9.2% |
| Weighted average outstanding balance | 434826 | 262174 | 381433 | 228029 |

---

# *Unsecured Notes* 
As of September 30, 2025 and December 31, 2024, the Company had the following outstanding Unsecured Notes (dollars in thousands):

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Series A Notes, net of $1,289 and $1,650, respectively, of unamortized deferred financing costs | $141211 | $140850 |
| August 2026 Notes, net of $517 and $950, respectively, of unamortized deferred financing costs | 124483 | 124050 |
| July 2030 Notes, net of $3,049 and $0, respectively, of unamortized deferred financing costs and discount | 121951 |  |
| September 2029 Notes, net of $3,036 and $3,433, respectively, of unamortized deferred financing costs and premium | 116593 | 111567 |
| March 2029 Notes, net of $2,518 and $2,879, respectively, of unamortized deferred financing costs and premium | 114252 | 112121 |
| December 2026 Notes, net of $449 and $729, respectively, of unamortized deferred financing costs | 74551 | 74271 |
| 2025 Notes, net of $0 and $81, respectively, of unamortized deferred financing costs and discount |  | 152419 |
| Convertible Notes, net of $0 and $605, respectively, of unamortized deferred financing costs and discount |  | 49395 |
| &nbsp;&nbsp;Total Unsecured Notes, net of $10,858 and $10,327, respectively, of unamortized deferred financing costs and premium/discount | $693041 | $764673 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *2025 Notes* 
Concurrent with the completion of the Private Common Stock Offering, on January 16, 2020, the Company completed its offering of $105.0 million in aggregate principal amount of the unsecured 2025 Notes in reliance upon the available exemptions from the registration requirements of the Securities Act (the "144A Note Offering"). Keefe, Bruyette & Woods, Inc. ("KBW"), as the initial purchaser, exercised in full its option to purchase or place additional 2025 Notes and on January 29, 2020, the Company issued and sold an additional $20.0 million in aggregate principal amount of the 2025 Notes. As a result, the Company issued and sold a total of $125.0 million in aggregate principal amount of the 2025 Notes pursuant to the 144A Note Offering.

Concurrent with the closing of the 144A Note Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of the 2025 Notes in the 144A Note Offering. Pursuant to the terms of this registration rights agreement, the Company filed with the SEC a registration statement, which was initially declared effective on October 20, 2020, registering the public resale of the 2025 Notes by the holders thereof that elected to include their 2025 Notes in such registration statement.

The 2025 Notes were issued pursuant to an Indenture dated as of January 16, 2020 (the "Base Indenture"), between the Company and U.S. Bank National Association, as trustee (together with its successor in interest, U.S. Bank Trust Company, National Association, the "Trustee"), and a First Supplemental Indenture, dated as of January 16, 2020 (the "First Supplemental Indenture" and together with the Base Indenture, the "2025 Notes Indenture"), between the Company and the Trustee.

On July 22, 2022, the Company issued $50.0 million in aggregate principal amount of the 2025 Notes in an additional issuance of such 2025 Notes. On July 27, 2022, the underwriters exercised, in full, their option to purchase from the Company an additional $7.5 million in aggregate principal amount of the 2025 Notes solely to cover over-allotments in accordance with the Underwriting Agreement. The 2025 Notes issued pursuant to July 2022 offering were treated as a single series with the then-existing 2025 Notes under the 2025 Notes Indenture (the "Then-Existing 2025 Notes") and had the same terms as the Then-Existing 2025 Notes (other than issue date and issue price). The 2025 Notes had the same CUSIP number and were fungible and ranked equally.

In connection with the additional issuance of the 2025 Notes, the 2025 Notes began trading on the Nasdaq Global Select Market under the symbol "TRINL" on July 29, 2022.

The 2025 Notes bore interest at a fixed rate of 7.00% per year that was payable quarterly on March 15, June 15, September 15, and December 15 of each year, commencing on March 15, 2020. The 2025 Notes were the direct, general unsecured obligations of the Company and ranked pari passu, or equal in right of payment, with all of the Company's existing and future unsecured indebtedness or other obligations that were not so subordinated.

On May 17, 2024, the Company redeemed $30.0 million in aggregate principal amount of the $182.5 million in aggregate principal amount of then outstanding 2025 Notes.

On January 16, 2025, the 2025 Notes matured pursuant to their terms and were repaid in full. The 2025 Notes are no longer outstanding or listed on Nasdaq Global Select Market.

Aggregate offering costs in connection with the 2025 Notes issuance, including the underwriters' discount and commissions, were approximately $7.8 million, which were capitalized and deferred. As of September 30, 2025, there were no unamortized deferred financing costs related to the 2025 Notes. As of December 31, 2024, unamortized deferred financing costs related to the 2025 Notes was $0.1 million.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The components of interest expense and related fees for the 2025 Notes are as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Stated interest expense |  | 2669 | 445 | 8800 |
| Amortization of deferred financing costs |  | 483 | 81 | 1465 |
| &nbsp;&nbsp;Total interest and amortization of deferred financing costs | $— | $3152 | $526 | $10265 |
| Weighted average effective interest rate | —% | 8.3% | 8.4% | 8.2% |
| Weighted average outstanding balance |  | 152500 | 8379 | 167500 |

---

## *6.00% Convertible Notes due 2025* 
On December 11, 2020, the Company completed a private offering (the "Private Convertible Note Offering") of $50.0 million in aggregate principal amount of its unsecured Convertible Notes in reliance upon the available exemptions from the registration requirements of the Securities Act. KBW acted as the initial purchaser and placement agent in connection with the Private Convertible Note Offering pursuant to a purchase/placement agreement dated December 4, 2020, by and between the Company and KBW.

The Convertible Notes were issued pursuant to the Base Indenture and a Second Supplemental Indenture, dated as of December 11, 2020 (the "Second Supplemental Indenture" and together with the Base Indenture, the "Convertible Notes Indenture"), between the Company and the Trustee. Concurrent with the closing of the Convertible Note Offering, on December 11, 2020, the Company entered into a registration rights agreement for the benefit of the holders of the Convertible Notes and the shares of common stock issuable upon conversion thereof. Aggregate offering costs in connection with the Convertible Note Offering, including the initial purchaser and placement agent discount and commissions, were approximately $1.9 million, which were capitalized and deferred.

The Convertible Notes bore interest at a fixed rate of 6.00% per year, subject to additional interest upon certain events, payable semiannually in arrears on May 1 and November 1 of each year, beginning on May 1, 2021. Had an investment grade rating not been maintained with respect to the Convertible Notes, additional interest of 0.75% per annum would have accrued on the Convertible Notes until such time as the Convertible Notes received an investment grade rating of "BBB-" (or its equivalent) or better. The Convertible Notes rating remained at investment grade through the conversion date. The Convertible Notes would have matured on December 11, 2025.

On February 20, 2025, the holders of the Convertible Notes exercised their right to convert all of the outstanding principal amount of the Convertible Notes, pursuant to the terms of conditions of the Convertible Notes. At its election, the Company paid $66.2 million in cash to satisfy in full its obligation to pay the principal amount of the Convertible Notes and any accrued interest, such settlement amount being determined based on the then existing conversion rate of 81.6439 per $1,000 principal amount of the Convertible Notes. The net amount of the carrying value of the Convertible Notes and cash paid of $15.8 million was recorded in Paid-In Capital in Excess of Par Value on the Consolidated Statements of Assets and Liabilities, and as such, no realized gain/loss was recorded. As of September 30, 2025, the Convertible Notes are no longer outstanding.

The Convertible Notes were direct unsecured obligations of the Company and ranked pari passu, or equal in right of payment, with all of the Company's then-existing and future unsecured indebtedness or other obligations that were not so subordinated, and senior in right of payment to all of the Company's future indebtedness or other obligations that were expressly subordinated, or junior, in right of payment to the Convertible Notes.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The Convertible Notes were accounted for in accordance with ASC 470-20, *Debt Instruments with Conversion and Other Options*. In accounting for the Convertible Notes, the Company estimated at the time of issuance that the values of the debt and the embedded conversion feature of the Convertible Notes were approximately 99.1% and 0.9%, respectively. The original issue discount of 0.9%, or approximately $0.5 million, attributable to the conversion feature of the Convertible Notes was recorded in "capital in excess of par value" in the Consolidated Statements of Assets and Liabilities as of December 31, 2020.

The components of the carrying value of the Convertible Notes were as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Principal amount of debt | $— | $50000 |
| Unamortized debt financing cost |  | (356) |
| Original issue discount, net of accretion |  | (249) |
| Carrying value of Convertible Notes | $— | $49395 |

---

The components of interest expense and related fees for the Convertible Notes were as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Stated interest expense |  | 750 | 417 | 2250 |
| Amortization of deferred financing costs and original issue discount |  | 160 | 89 | 485 |
| &nbsp;&nbsp;Total interest and amortization of deferred financing costs and original issue discount | $— | $910 | $506 | $2735 |
| Weighted average effective interest rate | —% | 7.3% | 7.2% | 7.3% |
| Weighted average outstanding balance |  | 50000 | 9341 | 50000 |

---

## *August 2026 Notes* 
On August 24, 2021, the Company issued and sold $125.0 million in aggregate principal amount of its unsecured August 2026 Notes under its shelf Registration Statement on Form N-2. The August 2026 Notes were issued pursuant to the Base Indenture and a Third Supplemental Indenture, dated as of August 24, 2021 (together with the Base Indenture, the "August 2026 Notes Indenture"), between the Company and the Trustee. The August 2026 Notes mature on August 24, 2026, unless repurchased or redeemed in accordance with their terms prior to such date. The August 2026 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company's option, at a redemption price equal to the greater of (1) 100% of the principal amount of the August 2026 Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the August 2026 Notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable treasury rate plus 50 basis points, plus, in each case, accrued and unpaid interest to the redemption date; provided, however, that if the Company redeems any August 2026 Notes on or after July 24, 2026, the redemption price for the August 2026 Notes will be equal to 100% of the principal amount of the August 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. In addition, if a change of control repurchase event (as defined in the August 2026 Notes Indenture) occurs prior to the maturity date of the August 2026 Notes or the Company's redemption of all outstanding August 2026 Notes, the Company will be required, subject to certain conditions, to make an offer to the holders thereof to repurchase for cash some or all of the August 2026 Notes at a repurchase price equal to 100% of the principal amount of the August 2026 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The August 2026 Notes bear interest at a fixed rate of 4.375% per year payable semiannually on February 15 and August 15 of each year, commencing on February 15, 2022. The August 2026 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company's existing and future unsecured indebtedness or other obligations that are not so subordinated.

Aggregate offering costs in connection with the August 2026 Notes issuance, including the underwriters' discount and commissions, were approximately $2.9 million, which were capitalized and deferred. As of September 30, 2025 and December 31, 2024, unamortized deferred financing costs related to the August 2026 Notes were $0.5 million and $1.0 million, respectively.

The components of interest expense and related fees for the 2026 Notes are as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Stated interest expense | 1367 | 1367 | 4102 | 4102 |
| Amortization of deferred financing costs | 150 | 149 | 438 | 437 |
| &nbsp;&nbsp;Total interest and amortization of deferred financing costs | $1517 | $1516 | $4540 | $4539 |
| Weighted average effective interest rate | 4.9% | 4.9% | 4.8% | 4.8% |
| Weighted average outstanding balance | 125000 | 125000 | 125000 | 125000 |

---

## *December 2026 Notes* 
On December 15, 2021, the Company issued and sold $75.0 million in aggregate principal amount of its unsecured December 2026 Notes under its shelf Registration Statement on Form N-2. The December 2026 Notes were issued pursuant to the Base Indenture and a Fourth Supplemental Indenture, dated as of December 15, 2021 (together with the Base Indenture, the "December 2026 Notes Indenture"), between the Company and the Trustee. The December 2026 Notes mature on December 15, 2026, unless repurchased or redeemed in accordance with their terms prior to such date. The December 2026 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company's option, at a redemption price equal to the greater of (1) 100% of the principal amount of the December 2026 Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the December 2026 Notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable treasury rate plus 50 basis points, plus, in each case, accrued and unpaid interest to the redemption date; provided, however, that if the Company redeems any December 2026 Notes on or after November 15, 2026, the redemption price for the December 2026 Notes will be equal to 100% of the principal amount of the December 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. In addition, if a change of control repurchase event (as defined in the December 2026 Notes Indenture) occurs prior to the maturity date of the December 2026 Notes or the Company's redemption of all outstanding December 2026 Notes, the Company will be required, subject to certain conditions, to make an offer to the holders thereof to repurchase for cash some or all of the December 2026 Notes at a repurchase price equal to 100% of the principal amount of the December 2026 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.

The December 2026 Notes bear interest at a fixed rate of 4.25% per year payable semiannually on June 15 and December 15 of each year, commencing on June 15, 2022. The December 2026 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company's existing and future unsecured indebtedness or other obligations that are not so subordinated.

Aggregate offering costs in connection with the December 2026 Notes issuance, including the underwriters' discount and commissions, were approximately $1.9 million, which were capitalized and deferred. As of September 30, 2025 and December 31, 2024, unamortized deferred financing costs related to the December 2026 Notes were $0.4 million and $0.7 million, respectively.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The components of interest expense and related fees for the December 2026 Notes are as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Stated interest expense | 797 | 797 | 2391 | 2391 |
| Amortization of deferred financing costs | 93 | 93 | 286 | 286 |
| &nbsp;&nbsp;Total interest and amortization of deferred financing costs | $890 | $890 | $2677 | $2677 |
| Weighted average effective interest rate | 4.7% | 4.7% | 4.8% | 4.8% |
| Weighted average outstanding balance | 75000 | 75000 | 75000 | 75000 |

---

## *March 2029 Notes* 
On March 28, 2024, the Company issued and sold $115.0 million in aggregate principal amount of its unsecured March 2029 Notes under its shelf Registration Statement on Form N-2, which amount includes the underwriters' exercise, in full, of their option to purchase an additional $15.0 million in aggregate principal amount of the March 2029 Notes.

The March 2029 Notes were issued pursuant to the Base Indenture and a Fifth Supplemental Indenture, dated as of March 28, 2024 (together with the Base Indenture, the "March 2029 Notes Indenture"), between the Company and the Trustee. The March 2029 Notes mature on March 30, 2029, unless repurchased or redeemed in accordance with their terms prior to such date. The March 2029 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company's option on or after March 30, 2026 upon not less than 30 days' nor more than 60 days' written notice prior to the date fixed for redemption thereof, at a redemption price equal to 100% of the outstanding principal amount of the March 2029 Notes, plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to, but excluding, the date fixed for redemption. In addition, if a change of control repurchase event (as defined in the March 2029 Notes Indenture) occurs prior to the maturity date of the March 2029 Notes, unless the Company has exercised its right to redeem the March 2029 Notes in full, holders will have the right, at their option, to require the Company to repurchase for cash some or all of the March 2029 Notes at a repurchase price equal to 100% of the principal amount of the March 2029 Notes being repurchased, plus accrued and unpaid interest, if any, to, but not including, the repurchase date.

The March 2029 Notes bear interest at a fixed rate of 7.875% per year payable quarterly on March 30, June 30, September 30 and December 30 of each year, commencing on June 30, 2024. The March 2029 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company's existing and future unsecured indebtedness or other obligations that are not so subordinated.

The March 2029 Notes began trading on the Nasdaq Global Select Market under the symbol "TRINZ" on April 1, 2024.

On February 10, 2025, the Company entered into an open market sale agreement (the "Sales Agreement") with B. Riley Securities, Inc. (the "Sales Agent"), as sales agent and/or principal thereunder. Under the Sales Agreement, the Company may, but has no obligation to, issue and sell, from time to time, up to $100,000,000 aggregate principal amount of the March 2029 Notes (the "ATM March 2029 Notes") through the Sales Agent or to the Sale Agent, as principal for its own account. The ATM March 2029 Notes are treated as a single series with the existing March 2029 Notes and have the same terms as the existing March 2029 Notes (other than the issue date and issue price). The March 2029 Notes have the same CUSIP number and are fungible and ranked equally. Any ATM March 2029 Notes issued in the future will be issued pursuant to the March 2029 Notes Indenture.

------

[**<u>**Table of Contents**</u>**](#toc_page)

During the three months ended September 30, 2025, the Company issued and sold $0.1 million in aggregate principal amount of its ATM March 2029 Notes and raised $0.1 million of net proceeds after deducting deferred offering costs and commissions to the Sales Agent on notes sold under the Sales Agreement. During the nine months ended September 30, 2025, the Company issued and sold $1.8 million in aggregate principal amount of its ATM March 2029 Notes and raised $1.8 million of net proceeds after deducting deferred offering costs and commissions to the Sales Agent on notes sold under the Sales Agreement. For additional information regarding the March 2029 Notes, see "Note 15 – Subsequent Events."

The components of the carrying value of the March 2029 Notes were as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Principal amount of debt | $116770 | $115000 |
| Unamortized deferred financing cost | (2534) | (2879) |
| Issuance premium and/or (discount), net of accretion | 16 |  |
| Carrying value of March 2029 Notes | $114252 | $112121 |

---

Aggregate offering costs in connection with the March 2029 Notes issuance, including the underwriters' discount and commissions, were approximately $3.6 million, which were capitalized and deferred.

The components of interest expense and related fees for the March 2029 Notes are as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Stated interest expense | 2299 | 2264 | 6834 | 4604 |
| Amortization of deferred financing costs | 180 | 170 | 532 | 341 |
| &nbsp;&nbsp;Total interest and amortization of deferred financing costs | $2479 | $2434 | $7366 | $4945 |
| Weighted average effective interest rate | 8.5% | 8.5% | 8.5% | 8.4% |
| Weighted average outstanding balance | 116703 | 115000 | 115910 | 78066 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *September 2029 Notes* 
On July 19, 2024, the Company issued and sold $115.0 million in aggregate principal amount of the September 2029 Notes under its shelf Registration Statement on Form N-2, which amount includes the underwriters' exercise, in full, of their option to purchase an additional $15.0 million in aggregate principal amount of additional September 2029 Notes.

The September 2029 Notes were issued pursuant to the Base Indenture and a Sixth Supplemental Indenture, dated as of July 19, 2024, between the Company and the Trustee (together with the Base Indenture, the "September 2029 Notes Indenture"). The September 2029 Notes mature on September 30, 2029, unless repurchased or redeemed in accordance with their terms prior to such date. The September 2029 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company's option on or after September 30, 2026 upon not less than 30 days' nor more than 60 days' written notice prior to the date fixed for redemption thereof, at a redemption price equal to 100% of the outstanding principal amount of the September 2029 Notes, plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to, but excluding, the date fixed for redemption. In addition, if a change of control repurchase event (as defined in the September 2029 Notes Indenture) occurs prior to maturity date of the September 2029 Notes, unless the Company has exercised its right to redeem the September 2029 Notes in full, holders will have the right, at their option, to require the Company to repurchase for cash some or all of the September 2029 Notes at a repurchase price equal to 100% of the principal amount of the September 2029 Notes being repurchased, plus accrued and unpaid interest, if any, to, but not including, the repurchase date.

The September 2029 Notes bear interest at a fixed rate of 7.875% per year payable quarterly on March 30, June 30, September 30 and December 30 of each year, commencing on September 30, 2024. The September 2029 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company's existing and future unsecured indebtedness or other obligations that are not so subordinated.

The September 2029 Notes began trading on the Nasdaq Global Select Market under the symbol "TRINI" on July 22, 2024.

On February 10, 2025, the Company entered into the Sales Agreement with the Sales Agent. Under the Sales Agreement, the Company may, but has no obligation to, issue and sell, from time to time, up to $100,000,000 aggregate principal amount of the September 2029 Notes (the "ATM September 2029 Notes") through the Sales Agent or to the Sale Agent, as principal for its own account. The ATM September 2029 Notes are treated as a single series with the existing September 2029 Notes and have the same terms as the existing September 2029 Notes (other than the issue date and issue price). The September 2029 Notes have the same CUSIP number and are fungible and ranked equally. Any ATM September 2029 Notes issued in the future will be issued pursuant to the September 2029 Notes Indenture.

During the three months ended September 30, 2025, the Company issued and sold $0.4 million in aggregate principal amount of its ATM September 2029 Notes and raised $0.4 million of net proceeds after deducting deferred offering costs and commissions to the Sales Agent on notes sold under the Sales Agreement. During the nine months ended September 30, 2025, the Company issued and sold $4.6 million in aggregate principal amount of its ATM September 2029 Notes and raised $4.6 million of net proceeds after deducting deferred offering costs and commissions to the Sales Agent on notes sold under the Sales Agreement. For additional information regarding the September 2029 Notes, see "Note 15 – Subsequent Events."

The components of the carrying value of the September 2029 Notes were as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Principal amount of debt | $119628 | $115000 |
| Unamortized deferred financing cost | (3079) | (3433) |
| Issuance premium and/or (discount), net of accretion | 44 |  |
| Carrying value of September 2029 Notes | $116593 | $111567 |

---

Aggregate offering costs in connection with the September 2029 Notes issuance, including the underwriters' discount and commissions, were approximately $4.0 million, which were capitalized and deferred.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The components of interest expense and related fees for the September 2029 Notes are as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Stated interest expense | 2355 | 1811 | 6941 | 1811 |
| Amortization of deferred financing costs | 190 | 140 | 562 | 140 |
| &nbsp;&nbsp;Total interest and amortization of deferred financing costs | $2545 | $1951 | $7503 | $1951 |
| Weighted average effective interest rate | 8.5% | 8.6% | 8.5% | 8.5% |
| Weighted average outstanding balance | 119373 | 91250 | 117893 | 30639 |

---

*Series A Notes* 

On October 29, 2024, the Company entered into a note purchase agreement (the "Note Purchase Agreement") governing the issuance of (i) $55.5 million in aggregate principal amount of Series A Senior Notes, Tranche A, due October 29, 2027 (the "Series A 2027 Notes"), (ii) $73.0 million in aggregate principal amount of Series A Senior Notes, Tranche B, due October 29, 2028 (the "Series A 2028 Notes") and (iii) $14.0 million in aggregate principal amount of Series A Senior Notes, Tranche C, due October 29, 2029 (the "Series A 2029 Notes" and, together with the Series A 2027 Notes and Series A 2028 Notes, collectively, the "Series A Notes") to certain qualified institutional investors in a private placement.

The Series A Notes were delivered and paid for on October 29, 2024, subject to certain customary closing conditions. The Series A 2027 Notes have a fixed interest rate of 7.54% per year, the Series A 2028 Notes have a fixed interest rate of 7.60% per year and the Series A 2029 Notes have a fixed interest rate of 7.66% per year, subject to a step up to the extent a Below Investment Grade Event (as defined in the Note Purchase Agreement) or a Secured Debt Ratio Event (as defined in the Note Purchase Agreement) occurs. The Series A 2027 Notes will mature on October 29, 2027, the Series A 2028 Notes will mature on October 29, 2028 and the Series A 2029 Notes will mature on October 29, 2029, unless redeemed, purchased or prepaid prior to such date by us in accordance with the terms of the Note Purchase Agreement. Interest on the Series A Notes will be due semiannually in April and October of each year, beginning in April 2025. In addition, the Company is obligated to offer to repay the Series A Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the Note Purchase Agreement, the Company may redeem the Series A Notes in whole or in part at any time or from time to time at our option at par plus accrued interest to the prepayment date and, if the Series A 2027 Notes are redeemed on or before August 31, 2027, the Series A 2028 Notes are redeemed on or before August 31, 2028 or the Series A 2029 Notes are redeemed on or before August 1, 2029, a make-whole premium.

The Series A Notes were offered in reliance on Section 4(a)(2) of the Securities Act. The Series A Notes have not and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable.

Aggregate offering costs in connection with the Series A Notes issuance, including the underwriters' discount and commissions, were approximately $1.7 million, which were capitalized and deferred. As of September 30, 2025 and December 31, 2024, unamortized deferred financing costs related to the Series A Notes were $1.3 million and $1.7 million, respectively.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The components of interest expense and related fees for the Series A Notes are as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Stated interest expense | 2701 |  | 8104 |  |
| Amortization of deferred financing costs | 120 |  | 361 |  |
| &nbsp;&nbsp;Total interest and amortization of deferred financing costs | $2821 | $— | $8465 | $— |
| Weighted average effective interest rate | 7.9% | —% | 7.9% | —% |
| Weighted average outstanding balance | 142500 |  | 142500 |  |

---

*July 2030 Notes*

On July 3, 2025, the Company issued and sold $125.0 million in aggregate principal amount of the July 2030 Notes under its shelf Registration Statement on Form N-2.

The July 2030 Notes were issued pursuant to the Base Indenture and a Seventh Supplemental Indenture, dated as of July 3, 2025, between the Company and the Trustee (together with the Base Indenture, the "July 2030 Notes Indenture"). The July 2030 Notes mature on July 3, 2030, unless repurchased or redeemed in accordance with their terms prior to such date. The July 2030 Notes are redeemable, in whole or in part at the Company's option at any time prior to June 3, 2030 at par value plus a "make-whole" premium calculated in accordance with terms under the July 2030 Notes Indenture and at par on June 3, 2030 or thereafter.

The July 2030 Notes bear interest at a fixed rate of 6.750% per year payable semi-annually on January 3 and July 3 of each year, commencing on January 3, 2026. The July 2030 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company's existing and future unsecured indebtedness or other obligations that are not so subordinated.

The components of the carrying value of the July 2030 Notes were as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Principal amount of debt | $125000 | $— |
| Unamortized deferred financing cost | (1814) |  |
| Issuance premium and/or (discount), net of accretion | (1235) |  |
| Carrying value of July 2030 Notes | $121951 | $— |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

Aggregate offering costs in connection with the July 2030 Notes issuance, including the underwriters' discount and commissions, were approximately $1.9 million, which were capitalized and deferred.

The components of interest expense and related fees for the July 2030 Notes are as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Stated interest expense | 2039 |  | 2039 |  |
| Amortization of deferred financing costs | 156 |  | 156 |  |
| &nbsp;&nbsp;Total interest and amortization of deferred financing costs | $2195 | $— | $2195 | $— |
| Weighted average effective interest rate | 7.2% | —% | 7.2% | —% |
| Weighted average outstanding balance | 120924 |  | 40751 |  |

---

As of September 30, 2025, the Company was in compliance with the terms of the KeyBank Credit Agreement, the August 2026 Notes Indenture, the December 2026 Notes Indenture, the March 2029 Notes Indenture, the September 2029 Notes Indenture, the Note Purchase Agreement and the July 2030 Notes Indenture. As of December 31, 2024, the Company was in compliance with the terms of the KeyBank Credit Agreement, the 2025 Notes Indenture, the Convertible Notes Indenture, the August 2026 Notes Indenture, the December 2026 Notes Indenture, the March 2029 Notes Indenture, the September 2029 Notes Indenture and the Note Purchase Agreement.

# Note 6. Commitments and Contingencies

## *Unfunded Commitments* 
The Company's commitments and contingencies consist primarily of unused commitments to extend credit in the form of loans or equipment financings to the Company's portfolio companies. A portion of these unfunded contractual commitments as of September 30, 2025 and December 31, 2024 are generally dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company's credit agreements contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the Company. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company's disclosure of unfunded contractual commitments as of September 30, 2025 and December 31, 2024 includes only those commitments that are available at the request of the portfolio company and are unencumbered by milestones or additional lending provisions.

The Company has entered into a capital commitment with the Senior Credit Corp, EPT and Direct Lending in the amount of $21.4 million, $10.0 million and $100.0 million, respectively.

As of September 30, 2025, the Company had unfunded commitments of $3.0 million and $77.7 million for the Senior Credit Corp and Direct Lending, respectively. As of September 30, 2025, there were no unfunded commitments for EPT. As of September 30, 2025, the Company had aggregate unfunded commitments of $70.8 million to eight portfolio companies. The Company did not have any other off-balance sheet financings or liabilities as of September 30, 2025.

As of December 31, 2024, the Company had unfunded commitments of $3.0 million and $0.8 million for the Senior Credit Corp and EPT, respectively. As of December 31, 2024, the Company had aggregate unfunded commitments of $31.2 million to two portfolio companies. The Company did not have any other off-balance sheet financings or liabilities as of December 31, 2024.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The Company will fund its unfunded commitments, if any, from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under its KeyBank Credit Facility) and maintains adequate liquidity to fund its unfunded commitments through these sources.

In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company's experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

## *Leases* 
ASU No. 2016-02, *Leases (Topic 842)* ("ASU 2016-02") requires that a lessee evaluate its leases to determine whether they should be classified as operating or finance leases. The Company classified the leases for its headquarters and other administrative office spaces as operating leases.

The total lease expense incurred for the three and nine months ended September 30, 2025 was $0.5 million and $1.2 million, respectively, and for the three and nine months ended September 30, 2024 was approximately $0.4 million and $1.0 million, respectively. As of September 30, 2025 and December 31, 2024, the right of use assets related to the office operating leases were $5.0 million and $5.4 million, respectively, and the lease liabilities were $5.3 million and $5.7 million, respectively.

As of September 30, 2025 and December 31, 2024, the weighted-average discount rate determined for the operating lease liabilities was 8.50% and 8.53%, respectively. As of September 30, 2025 and December 31, 2024, the weighted-average remaining lease term for the operating leases was 5.4 years and 6.1 years, respectively.

The following table shows future minimum payments under the Company's operating leases as of September 30, 2025 (in thousands):

---

| | |
|:---|:---|
| **For the Years Ended December 31,** | **Total** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | $354 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2026 | 1144 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2027 | 1066 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2028 | 1051 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2029 | 1080 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Thereafter | 1565 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $6260 |

---

## *Legal Proceedings* 
The Company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise. Furthermore, third parties may try to seek to impose liability on the Company in connection with the activities of its portfolio companies. As of September 30, 2025, there were no material legal matters or material litigation pending of which the Company is aware.

# Note 7. Stockholders' Equity
The Company authorized 200,000,000 shares of its common stock with a par value of $0.001 per share. On September 27, 2019, the Company was initially capitalized by the issuance of 10 shares of its common stock for an aggregate purchase price of $150 to its sole stockholder.

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *Private Common Stock Offerings* 
On January 16, 2020, the Company completed the Private Common Stock Offering in reliance upon the available exemptions from the registration requirements of the Securities Act. As a result, the Company issued and sold a total of 7,000,000 shares of its common stock for aggregate net proceeds of approximately $105.0 million. The related over-allotment option was exercised in full on January 29, 2020, pursuant to which the Company issued and sold an additional 1,333,333 shares of its common stock for gross proceeds of approximately $20.0 million. As a result, the Company issued and sold a total of 8,333,333 shares of its common stock pursuant to the Private Common Stock Offering for aggregate net proceeds of approximately $114.4 million, net of offering costs of approximately $10.6 million.

Concurrent with the closing of the Private Common Stock Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of shares of its common stock in such offering and the certain of the investors in the Legacy Funds (the "Legacy Investors") that received shares of its common stock in connection with the Formation Transactions that were not the Company's directors, officers and affiliates. Pursuant to the terms of this registration rights agreement, the Company no longer has any registration obligations with respect to such shares because (i) such shares may be sold by any such stockholder in a single transaction without registration pursuant to Rule 144 under the Securities Act, (ii) the Company has been subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), for a period of at least 90 days and is current in the filing of all such required reports and (iii) such shares have been listed for trading on the Nasdaq Global Select Market.

## *Formation Transactions* 
On January 16, 2020, immediately following the initial closings of the Private Offerings, the Company used the proceeds from the Private Offerings to complete the Formation Transactions, pursuant to which the Company acquired the Legacy Funds and Trinity Capital Holdings. As consideration for the Legacy Funds, the Company issued 9,183,185 shares of common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to certain of the Legacy Investors. As consideration for all of the equity interests in Trinity Capital Holdings, the Company issued 533,332 shares of its common stock at $15.00 per share for a total value of approximately $8.0 million and paid approximately $2.0 million in cash.

## *Initial Public Offering* 
On February 2, 2021, the Company completed its initial public offering of 8,006,291 shares of common stock at a price of $14.00 per share, inclusive of the underwriters' option to purchase additional shares, which was exercised in full. The Company's common stock began trading on the Nasdaq Global Select Market on January 29, 2021, under the symbol "TRIN."

## *Equity ATM Program* 
On November 9, 2021, the Company established an at-the-market equity program (the "ATM Program"), pursuant to which the Company can issue and sell, from time to time, up to $50.0 million in aggregate offering price of shares of its common stock by any method permitted by law and deemed to be part of an "at-the-market" offering (as defined in Rule 415 under the Securities Act). On December 1, 2023, the Company entered into new equity distribution agreements to (i) increase the maximum aggregate offering price of shares of its common stock to be sold through the ATM Program to $145.7 million and (ii) add one additional sales agent to the ATM Program. On August 23, 2024, the Company entered into new equity distribution agreements to (i) increase the maximum aggregate offering price of shares of its common stock to be sold through the ATM Program to $250.0 million and (ii) add one additional sales agent to the ATM Program.

The Company generally uses net proceeds from the ATM Program to make investments in accordance with its investment objective and investment strategy and for general corporate purposes.

------

[**<u>**Table of Contents**</u>**](#toc_page)

During the three months ended September 30, 2025, the Company issued and sold 5,318,978 shares of its common stock at a weighted-average price of $15.78 per share and raised $83.0 million of net proceeds after deducting deferred offering costs and commissions to the sales agents on shares sold under the ATM Program.

During the nine months ended September 30, 2025, the Company issued and sold 13,013,562 shares of its common stock at a weighted-average price of $15.16 per share and raised $194.9 million of net proceeds after deducting deferred offering costs and commissions to the sales agents on shares sold under the ATM Program.

During the year ended December 31, 2024, the Company issued and sold 14,161,064 shares of its common stock at a weighted-average price of $14.35 per share and raised $200.2 million of net proceeds after deducting deferred offering costs and commissions to the sales agents on shares sold under the ATM Program.

For additional information regarding the ATM Program, see "Note 15 – Subsequent Events."

## *Stock Repurchase Program* 
On November 7, 2024, the Board authorized a program permitting the Company to repurchase up to $30.0 million of the Company's common stock (the "2024 Repurchase Program"). Under the 2024 Repurchase Program, the Company may, but is not obligated to, repurchase its outstanding common stock in the open market from time to time, provided that the Company complies with guidelines specified in Rule 10b-18 of the Exchange Act, including certain price, market, volume, and timing constraints. The 2024 Share Repurchase Program is expected to be in effect until November 7, 2025, unless extended or until the aggregate repurchase amount that has been approved by the Board has been expended.

The Board authorized the 2024 Repurchase Program because it believes sustained macroeconomic pressures and other market factors may cause the Company's common stock to be undervalued from time to time, especially relative to the Company's performance and its peers, and that such repurchase demonstrates the Company's stability and strength, including the resilience and creditworthiness of its portfolio. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions and alternative investment opportunities. In addition, any repurchases will be conducted in accordance with the 1940 Act.

The Company did not repurchase shares of its outstanding common stock during the three and nine months ended September 30, 2025 or during the year ended December 31, 2024.

## *Equity Offerings* 
On April 7, 2022, the Company issued 2,754,840 shares of the Company's common stock, par value $0.001 per share, at a public offering price of $18.15 per share, resulting in net proceeds to the Company of approximately $47.9 million, after deducting discounts and commissions and offering expenses. In addition, the underwriters exercised their option to purchase an additional 413,226 shares of common stock, resulting in additional net proceeds to the Company of $7.2 million, after deducting discounts, commissions and offering expenses.

On August 18, 2022, the Company issued 3,587,736 shares of the Company's common stock, par value $0.001 per share, at a public offering price of $15.33 per share, resulting in net proceeds to the Company of approximately $53.3 million, after deducting discounts and commissions and offering expenses. In addition, the underwriters exercised their option in part to purchase an additional 132,168 shares of common stock, resulting in additional net proceeds to the Company of $2.0 million, after deducting discounts, commissions and offering expenses.

On August 8, 2023, the Company issued 5,190,312 shares of the Company's common stock, par value $0.001 per share, at a public offering price of $14.45 per share, resulting in net proceeds to the Company of approximately $72.5 million, after deducting discounts and commissions and offering expenses. In addition, the underwriters exercised their option in part to purchase an additional 500,000 shares of common stock, resulting in additional net proceeds to the Company of $6.9 million, after deducting discounts, commissions and offering expenses.

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *Distribution Reinvestment Plan* 
The Company's amended and restated distribution reinvestment plan ("DRIP") provides for the reinvestment of distributions in the form of common stock on behalf of its stockholders, unless a stockholder has elected to receive distributions in cash. As a result, if the Company declares a cash distribution, its stockholders who have not "opted out" of the DRIP by the opt out date will have their cash distribution automatically reinvested into additional shares of the Company's common stock. The share requirements of the DRIP may be satisfied through the issuance of common shares or through open market purchases of common shares by the DRIP plan administrator. Newly issued shares will be valued based upon the final closing price of the Company's common stock on the valuation date determined for each distribution by the Board.

The Company's DRIP is administered by its transfer agent on behalf of the Company's record holders and participating brokerage firms. Brokerage firms and other financial intermediaries may decide not to participate in the Company's DRIP but may provide a similar distribution reinvestment plan for their clients. During the three months ended September 30, 2025, the Company issued 22,729 shares of common stock for a total of approximately $0.3 million under the DRIP. During the nine months ended September 30, 2025, the Company issued 64,150 shares of common stock for a total of approximately $0.9 million under the DRIP.

During the year ended December 31, 2024, the Company issued 90,245 shares of common stock for a total of approximately $1.3 million under the DRIP.

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *Distributions* 
The following table summarizes distributions declared and/or paid by the Company since inception:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Declaration<br>Date** | **Type** | **Record<br>Date** | **Payment<br>Date** | **Per Share<br>Amount** |
| May 7, 2020 | Quarterly | May 29, 2020 | June 5, 2020 | $0.22 |
| August 10, 2020 | Quarterly | August 21, 2020 | September 4, 2020 | 0.27 |
| November 9, 2020 | Quarterly | November 20, 2020 | December 4, 2020 | 0.27 |
| December 22, 2020 | Quarterly | December 30, 2020 | January 15, 2021 | 0.27 |
| March 23, 2021 | Quarterly | March 31, 2021 | April 16, 2021 | 0.28 |
| June 15, 2021 | Quarterly | June 30, 2021 | July 15, 2021 | 0.29 |
| September 13, 2021 | Quarterly | September 30, 2021 | October 15, 2021 | 0.33 |
| December 16, 2021 | Quarterly | December 31, 2021 | January 14, 2022 | 0.36 |
| March 15, 2022 | Quarterly | March 31, 2022 | April 15, 2022 | 0.40 |
| March 15, 2022 | Supplemental | March 31, 2022 | April 15, 2022 | 0.15 |
| June 15, 2022 | Quarterly | June 30, 2022 | July 15, 2022 | 0.42 |
| June 15, 2022 | Supplemental | June 30, 2022 | July 15, 2022 | 0.15 |
| September 15, 2022 | Quarterly | September 30, 2022 | October 14, 2022 | 0.45 |
| September 15, 2022 | Supplemental | September 30, 2022 | October 14, 2022 | 0.15 |
| December 15, 2022 | Quarterly | December 30, 2022 | January 13, 2023 | 0.46 |
| December 15, 2022 | Supplemental | December 30, 2022 | January 13, 2023 | 0.15 |
| March 14, 2023 | Quarterly | March 31, 2023 | April 14, 2023 | 0.47 |
| June 14, 2023 | Quarterly | June 30, 2023 | July 14, 2023 | 0.48 |
| June 14, 2023 | Supplemental | June 30, 2023 | July 14, 2023 | 0.05 |
| September 13, 2023 | Quarterly | September 30, 2023 | October 13, 2023 | 0.49 |
| September 13, 2023 | Supplemental | September 30, 2023 | October 13, 2023 | 0.05 |
| December 14, 2023 | Quarterly | December 29, 2023 | January 12, 2024 | 0.50 |
| March 14, 2024 | Quarterly | March 28, 2024 | April 15, 2024 | 0.51 |
| June 13, 2024 | Quarterly | June 28, 2024 | July 15, 2024 | 0.51 |
| September 18, 2024 | Quarterly | September 30, 2024 | October 15, 2024 | 0.51 |
| December 12, 2024 | Quarterly | December 31, 2024 | January 15, 2025 | 0.51 |
| March 19, 2025 | Quarterly | March 31, 2025 | April 15, 2025 | 0.51 |
| June 18, 2025 | Quarterly | June 30, 2025 | July 15, 2025 | 0.51 |
| September 17, 2025 | Quarterly | September 30, 2025 | October 15, 2025 | 0.51 |
|  |  |  | **Total** | $10.23 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

# Note 8. Equity Incentive Plans
***2019 Long Term Incentive Plan***

The Company's Board initially adopted and approved the 2019 Trinity Capital Inc. Long Term Incentive Plan (as amended, the "2019 Long Term Incentive Plan") on October 17, 2019 and the Company's stockholders approved the 2019 Long Term Incentive Plan on June 17, 2021 at the Company's 2021 Annual Meeting of Stockholders, with the 2019 Long Term Incentive Plan becoming effective on June 17, 2021. The Company's Board adopted and approved Amendment No. 1 to the 2019 Trinity Capital Inc. Long-Term Incentive Plan on April 23, 2024 to, among other things, increase the total number of shares available for issuance under the 2019 Long Term Incentive Plan by 5,800,000 shares (from 3,600,000 shares to 9,400,000 shares) and the Company's stockholders approved such amendment on June 12, 2024 at the Company's 2024 Annual Meeting of Stockholders, with such amendment becoming effective on June 12, 2024.

Under the 2019 Long Term Incentive Plan, awards of restricted stock, incentive stock options and non-statutory stock options (together with incentive stock options, "Options") may be granted to certain of the Company's executive officers, employee directors and other employees (collectively, the "Employee Participants") in accordance with the SEC exemptive order the Company received on May 27, 2021 (the "SEC Exemptive Order"). While the 2019 Long Term Incentive Plan contemplates grants of restricted stock, restricted stock units, Options, dividend equivalent rights, performance awards and other stock-based awards to the Employee Participants, the Company only sought and received exemptive relief from the SEC pursuant to the SEC Exemptive Order to grant awards of restricted stock and Options. As a result, the Company will only grant awards of such securities under the 2019 Long Term Incentive Plan. The Employee Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.

Subject to certain adjustments under the 2019 Long Term Incentive Plan, the maximum aggregate number of shares of the Company's common stock authorized for issuance under the 2019 Long Term Incentive Plan is 9,400,000 shares. The 2019 Long Term Incentive Plan is to be administered by the Compensation Committee of the Board (the "Compensation Committee") in accordance with the terms of the 2019 Long Term Incentive Plan. The 2019 Long Term Incentive Plan will terminate on the day prior to the tenth anniversary of the date it was initially adopted by the Board, unless terminated sooner by action of the Board or the Compensation Committee, as applicable.

For additional information regarding the 2019 Long Term Incentive Plan, please refer to the Company's Current Reports on Form 8-K filed with the SEC on June 23, 2021 and June 14, 2024, and the Company's definitive proxy statement for the 2025 Annual Meeting of Stockholders.

The following table summarizes issuances, vesting, and retirement of shares under the plan as well as the fair value of granted stock for the nine months ended September 30, 2025 and 2024 (dollars in thousands).

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** | **Weighted Average** | **Nine Months Ended** | **Nine Months Ended** | **Weighted Average** |
|  | **September 30, 2025** | **September 30, 2025** | **Grant Date Fair Value** | **September 30, 2024** | **September 30, 2024** | **Grant Date Fair Value** |
| Unvested as of Beginning of Period |  | 1993459 | $14.53 |  | 1326891 | $14.56 |
| Shares Granted |  | 471322 | 15.89 |  | 856407 | 14.70 |
| Shares Vested and Forfeited |  | (613049) | 14.81 |  | (575887) | 14.77 |
| Unvested as of Ending of Period |  | 1851732 | $14.78 |  | 1607411 | $14.56 |
| Fair Value of Granted Stock | $— | 7490 |  | $— | 12590 |  |
| Compensation Cost Recognized | $— | 8489 |  | $— | 8027 |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

As of September 30, 2025, there was approximately $25.0 million of total unrecognized compensation costs related to the non-vested restricted stock awards. These costs are expected to be recognized over a weighted average period of 2.8 years. As of December 31, 2024, there was approximately $26.3 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs were expected to be recognized over a weighted average period of 3.0 years. Shares vested and forfeited primarily relate to shares acquired of common stock held by employees who tendered owned shares to satisfy tax withholding obligations.

*Option Awards*

On March 14, 2025 (the "Option Awards Grant Date"), the Company's Board approved grants of non-statutory stock options to certain executive officers of the Company each to purchase up to 300,000 shares of the Company's common stock pursuant to the 2019 Long Term Incentive Plan (the "Option Awards") for a total of 1,500,000 shares. Each Option Award is subject to certain time-based and market-based vesting conditions, which are set forth in the Company's Non-Statutory Stock Option Award Agreement.

Within four years following the Option Awards Grant Date, the volume weighted average trading price ("VWAP") per share of the Company's common stock on any established stock exchange or national market system for ninety (90) consecutive calendar days ending on the last trading day preceding the applicable day must be equal to or greater than $23.75. If the VWAP condition is satisfied, and the applicable recipient of the Option Award remains in the continuous employment of the Company through the applicable vesting date (subject to certain limited exceptions), the stock option will vest as follows: 25% on March 14, 2026 with the remaining 75% vesting pro rata over the twelve (12) full calendar quarters immediately following March 14, 2026. The Option Awards expire on March 14, 2035.

The $15.83 exercise price of the Option Awards was calculated based on the closing stock price on the Option Awards Grant Date. As of September 30, 2025, there were no Option Awards exercised as time-based and market-based vesting conditions have not been met.

During the three and nine months ended September 30, 2025, there was $0.1 million and $0.2 million, respectively, of total compensation costs related to the Option Awards. As of September 30, 2025, there was approximately $1.5 million of total unrecognized compensation costs expected to be recognized over a weighted average period of 3.5 years. The fair value of the Option Awards as of September 30, 2025 was approximately $1.7 million.

***2019 Restricted Stock Plan***

The Company's Board initially adopted and approved the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (as amended, the "2019 Restricted Stock Plan") on October 17, 2019 and the Company's stockholders approved the 2019 Restricted Stock Plan on June 17, 2021 at the Company's 2021 Annual Meeting of Stockholders, with the 2019 Restricted Stock Plan becoming effecting on June 17, 2021. The Company's Board adopted and approved Amendment No. 1 to the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan on April 23, 2024 to increase the total number of shares available for issuance under the 2019 Restricted Stock Plan by 60,000 shares (from 60,000 shares to 120,000 shares) and the Company's stockholders approved such amendment on June 12, 2024 at the Company's 2024 Annual Meeting of Stockholders, with such amendment becoming effective on June 12, 2024.

The 2019 Restricted Stock Plan provides for grants of restricted stock awards ("Non-Employee Director Awards") to the Company's non-employee directors (the "Non-Employee Director Participants"), which are directors who are not "interested persons" of the Company (as such term is defined in Section 2(a)(19) of the 1940 Act) in accordance with the SEC Exemptive Order. The Non-Employee Director Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.

Subject to certain adjustments under the 2019 Restricted Stock Plan, the total number of shares of the Company's common stock that may be subject to Non-Employee Director Awards is 120,000 shares. The 2019 Restricted Stock Plan is to be administered by the Compensation Committee, subject to the discretion of the Board. The 2019 Restricted Stock Plan will terminate on the day prior to the tenth anniversary of the date it was approved by the Company's stockholders, unless terminated sooner by action of the Board.

------

[**<u>**Table of Contents**</u>**](#toc_page)

For additional information regarding the 2019 Restricted Stock Plan, please refer to the Company's Current Reports on Form 8-K, filed with the SEC on June 23, 2021 and June 14, 2024, and the Company's definitive proxy statement for the 2025 Annual Meeting of Stockholders.

The following table summarizes issuances, vesting, and retirement of shares under the plan as well as the fair value of granted stock for the nine months ended September 30, 2025 and 2024 (dollars in thousands).

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** | **Weighted Average** | **Nine Months Ended** | **Nine Months Ended** | **Weighted Average** |
|  | **September 30, 2025** | **September 30, 2025** | **Grant Date Fair Value** | **September 30, 2024** | **September 30, 2024** | **Grant Date Fair Value** |
| Unvested as of Beginning of Period, |  | 13340 | $14.99 |  | 15196 | $13.16 |
| Shares Granted |  | 13772 | 14.52 |  | 13340 | 14.99 |
| Shares Vested and Forfeited |  | (13340) | 14.99 |  | (15196) | 13.16 |
| Unvested as of Ending of Period, |  | 13772 | $14.52 |  | 13340 | $14.99 |
| Fair Value of Granted Stock | $— | 200 |  | $— | 200 |  |
| Compensation Cost Recognized | $— | 150 |  | $— | 151 |  |

---

As of September 30, 2025, there was $0.1 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs are expected to be recognized over a nine-month period. As of December 31, 2024, there was approximately $0.1 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs were expected to be recognized over a six-month period.

# Note 9. Earnings Per Share
The following table sets forth the computation of the basic and diluted earnings per common share for the three and nine months ended September 30, 2025 and 2024 (in thousands except shares and per share information):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| **Earnings per common share - basic** |  |  |  |  |
| Numerator for basic earnings per share | $27645 | $24400 | $96144 | $69738 |
| Denominator for basic weighted average shares | 71467831 | 54412566 | 66677623 | 50455373 |
| Earnings/(Loss) per common share - basic | $0.39 | $0.45 | $1.44 | $1.38 |
| **Earnings per common share - diluted** |  |  |  |  |
| Numerator for increase in net assets per share | 27645 | 24400 | 96144 | 69738 |
| Adjustment for dilutive effect of Option Awards and Convertible Notes |  | 910 |  | 2735 |
| Numerator for diluted earnings per share | 27645 | 25310 | 96144 | 72473 |
| Denominator for basic weighted average shares | 71467831 | 54412566 | 66677623 | 50455373 |
| Adjustment for dilutive effect of Option Awards and Convertible Notes |  | 3961130 |  | 3961130 |
| Denominator for diluted weighted average shares | 71467831 | 58373696 | 66677623 | 54416503 |
| Earnings/(Loss) per common share - diluted | $0.39 | $0.43 | $1.44 | $1.33 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

Diluted earnings (loss) available to each share of common stock outstanding during the reporting period included any additional shares of common stock that would be issued if all potentially dilutive securities were exercised. In accordance with ASU 2020-06, the Company is required to disclose diluted EPS using (i) the treasury stock method for Option Awards that assumes shares were exercised at the beginning of the reporting period (or at time of issuance, if later) and is intended to show the dilution effect to common stockholders and (ii) the if-converted method for the Convertible Notes that assumes the conversion of convertible securities at the beginning of the reporting period and is intended to show the maximum dilution effect to common stockholders regardless of how the conversion can occur. During the three and nine months ended September 30, 2025, the market-based conditions for the Option Awards were not met and the Convertible Notes were converted in full and are no longer outstanding, as such, both were not considered in the calculation of diluted EPS. During the three and nine months ended September 30, 2024, the adjustments for diluted EPS included additional effects for the Convertible Notes.

# Note 10. Income Taxes
The Company has elected to be treated, currently qualifies, and intends to continue to qualify annually as, a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Company is generally required to distribute at least annually to its stockholders at least the sum of 90% of its investment company taxable income (which generally includes its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and 90% of its net tax-exempt income (if any). The Company generally will not be subject to U.S. federal income tax on these distributed amounts, but will pay U.S. federal income tax at corporate rates on any retained amounts.

The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the annual earnings estimated by management of the Company. Net capital gains, if any, are distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay U.S. federal income tax at corporate rates on those retained amounts. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders. In the event the Company's taxable income (including any net capital gains) for a fiscal year falls below the amount of distributions declared and paid with respect to that year, however, a portion of the total amount of those distributions may be deemed a return of capital for tax purposes to the Company's stockholders.

Because federal income tax regulations differ from GAAP, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their appropriate tax character. Temporary differences arise when certain items of income, expense, gain or loss are recognized at some time in the future.

For the three and nine months ended September 30, 2025, $0.6 million and $1.9 million, respectively, was recorded for U.S. federal excise tax. For the three and nine months ended September 30, 2024, $0.6 million and $1.9 million, respectively, was recorded for U.S. federal excise tax.

The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of September 30, 2025 and December 31, 2024 (in thousands):

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Tax Cost of Investments | $2207721 | $1763183 |

---

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Unrealized appreciation | $90281 | $60872 |
| Unrealized depreciation | (105640) | (113528) |
| Net change in unrealized appreciation/(depreciation) from investments | $(15359) | $(52656) |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

# Note 11. Financial Highlights
The following presents financial highlights (in thousands except share and per share information):

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** |
| Per Share Data: <sup>(1)</sup> |  |  |
| Net asset value, beginning of period | $13.35 | $13.19 |
| Net investment income | 1.56 | 1.61 |
| Net realized and unrealized gains/(losses) on investments <sup>(2)</sup> | (0.12) | (0.23) |
| Net increase/(decrease) in net assets resulting from operations | 1.44 | 1.38 |
| Offering costs | (0.03) | (0.04) |
| Effect of shares issued and repurchased <sup>(3)</sup> | 0.08 | 0.13 |
| Distributions <sup>(4)</sup> | (1.53) | (1.53) |
| Total increase/(decrease) in net assets | (0.04) | (0.06) |
| **Net asset value, end of period** | $**13.31** | $**13.13** |
| Shares outstanding, end of period | 74988962 | 57642040 |
| Weighted average shares outstanding | 66677623 | 50455373 |
| Total return based on net asset value <sup>(5)(9)</sup> | 11.2% | 11.1% |
| Total return based on market value <sup>(6)(9)</sup> | 18.7% | 3.7% |
| **Ratio/Supplemental Data:** |  |  |
| Per share market value at end of period | $15.48 | $13.57 |
| Net assets, end of period | $998264 | $756795 |
| Ratio of total expenses to average net assets <sup>(10)</sup> | 16.0% | 17.2% |
| Ratio of net investment income to average net assets <sup>(10)</sup> | 15.7% | 16.3% |
| Ratio of interest and credit facility expenses to average net assets <sup>(10)</sup> | 8.5% | 8.6% |
| Portfolio turnover rate <sup>(7)(9)</sup> | 31.9% | 37.3% |
| Asset coverage ratio <sup>(8)</sup> | 184.2% | 182.0% |

---

------

<sup>(1)</sup> Based on actual number of shares outstanding at the end of the corresponding period or the weighted average shares outstanding for the period, unless otherwise noted, as appropriate.

<sup>(2)</sup> Net realized and unrealized gains/(losses) on investments include rounding adjustments to reconcile the change in net asset value per share.

<sup>(3)</sup> Includes the impact of the different share amounts as a result of calculating certain per share data based on the weighted-average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. Also includes the impact of the issuance of shares related to the equity incentive plans, the accretive effect of DRIP issuance and stock offerings (issuing shares above NAV per share), and the impact of share repurchases under the 2024 Repurchase Program.

<sup>(4)</sup> The per share data reflects the actual amount of distributions declared per share for the applicable period.

<sup>(5)</sup> Total return based on net asset value is calculated as the change in net asset value per share during the period plus declared distributions per share during the period, divided by the beginning net asset value per share.

<sup>(6)</sup> Total return based on market value is calculated as the change in market value per share during the period, taking into account dividends.

<sup>(7)</sup> Portfolio turnover rate is calculated using the lesser of year-to-date cash sales/repayments or year-to-date cash purchases over the average of the total investments at fair value.

<sup>(8)</sup> Based on outstanding debt of $1,185.5 million and $922.5 million as of September 30, 2025 and 2024, respectively.

<sup>(9)</sup> Not annualized.

<sup>(10)</sup> Annualized.

------

[**<u>**Table of Contents**</u>**](#toc_page)

*Senior Securities*

Information about the Company's senior securities (including debt securities and other indebtedness) is shown in the following table as of September 30, 2025, and December 31, 2024, 2023, 2022, 2021 and 2020. No senior securities were outstanding as of December 31, 2019.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Class and Period** | **Total <br>Amount <br>Outstanding <br>Exclusive of <br>Treasury<br>Securities** <sup>(1)</sup> **(in thousands)** | **Asset <br>Coverage <br>per Unit** <sup>(2)</sup> | **Involuntary <br>Liquidating <br>Preference <br>per Unit** <sup>(3)</sup> | **Average <br>Market Value <br>per Unit** <sup>(4)</sup> |
| **Credit Suisse Credit Facility** |  |  |  |  |
| September 30, 2025 (Unaudited)<sup>(5)</sup> | $— |  |  | $— |
| December 31, 2024<sup>(5)</sup> |  |  |  |  |
| December 31, 2023<sup>(5)</sup> |  |  |  |  |
| December 31, 2022<sup>(5)</sup> |  |  |  |  |
| December 31, 2021 | 10000 | 1958 |  |  |
| December 31, 2020 | 135000 | 1770 |  |  |
| **KeyBank Credit Facility** |  |  |  |  |
| September 30, 2025 (Unaudited) | $481600 | 1842 |  | $— |
| December 31, 2024 | 113000 | 1927 |  |  |
| December 31, 2023 | 213000 | 1947 |  |  |
| December 31, 2022 | 187500 | 1741 |  |  |
| December 31, 2021 | 81000 | 1958 |  |  |
| December 31, 2020 |  |  |  |  |
| **2025 Notes** |  |  |  |  |
| September 30, 2025 (Unaudited)<sup>(6)</sup> | $— |  |  | $— |
| December 31, 2024 | 152500 | 1927 |  | 1009 |
| December 31, 2023 | 182500 | 1947 |  | 1006 |
| December 31, 2022 | 182500 | 1741 |  | 1006 |
| December 31, 2021 | 125000 | 1958 |  |  |
| December 31, 2020 | 125000 | 1770 |  |  |
| **Convertible Notes** |  |  |  |  |
| September 30, 2025 (Unaudited)<sup>(7)</sup> | $— |  |  | $— |
| December 31, 2024 | 50000 | 1927 |  |  |
| December 31, 2023 | 50000 | 1947 |  |  |
| December 31, 2022 | 50000 | 1741 |  |  |
| December 31, 2021 | 50000 | 1958 |  |  |
| December 31, 2020 | 50000 | 1770 |  |  |
| **August 2026 Notes** |  |  |  |  |
| September 30, 2025 (Unaudited) | $125000 | 1842 |  | $— |
| December 31, 2024 | 125000 | 1927 |  |  |
| December 31, 2023 | 125000 | 1947 |  |  |
| December 31, 2022 | 125000 | 1741 |  |  |
| December 31, 2021 | 125000 | 1958 |  |  |
| December 31, 2020 |  |  |  |  |
| **December 2026 Notes** |  |  |  |  |
| September 30, 2025 (Unaudited) | $75000 | 1842 |  | $— |
| December 31, 2024 | 75000 | 1927 |  |  |
| December 31, 2023 | 75000 | 1947 |  |  |
| December 31, 2022 | 75000 | 1741 |  |  |
| December 31, 2021 | 75000 | 1958 |  |  |
| December 31, 2020 |  |  |  |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Class and Period, Continued** | **Total <br>Amount <br>Outstanding <br>Exclusive of <br>Treasury<br>Securities** <sup>(1)</sup> **(in thousands)** | **Asset <br>Coverage <br>per Unit** <sup>(2)</sup> | **Involuntary <br>Liquidating <br>Preference <br>per Unit** <sup>(3)</sup> | **Average <br>Market Value <br>per Unit** <sup>(4)</sup> |
| **March 2029 Notes** |  |  |  |  |
| September 30, 2025 (Unaudited) | $116770 | 1842 |  | $1011 |
| December 31, 2024 | 115000 | 1927 |  | 1012 |
| December 31, 2023 |  |  |  |  |
| December 31, 2022 |  |  |  |  |
| December 31, 2021 |  |  |  |  |
| December 31, 2020 |  |  |  |  |
| **September 2029 Notes** |  |  |  |  |
| September 30, 2025 (Unaudited) | $119628 | 1842 |  | $1013 |
| December 31, 2024 | 115000 | 1927 |  | 1014 |
| December 31, 2023 |  |  |  |  |
| December 31, 2022 |  |  |  |  |
| December 31, 2021 |  |  |  |  |
| December 31, 2020 |  |  |  |  |
| **Series A Notes** |  |  |  |  |
| September 30, 2025 (Unaudited) | $142500 | 1842 |  | $— |
| December 31, 2024 | 142500 | 1927 |  |  |
| December 31, 2023 |  |  |  |  |
| December 31, 2022 |  |  |  |  |
| December 31, 2021 |  |  |  |  |
| December 31, 2020 |  |  |  |  |
| **July 2030 Notes** |  |  |  |  |
| September 30, 2025 (Unaudited) | $125000 | 1842 |  | $— |
| December 31, 2024 |  |  |  |  |
| December 31, 2023 |  |  |  |  |
| December 31, 2022 |  |  |  |  |
| December 31, 2021 |  |  |  |  |
| December 31, 2020 |  |  |  |  |
| **Total** |  |  |  |  |
| September 30, 2025 (Unaudited) | $1185498 | 1842 |  | $— |
| December 31, 2024 | 888000 | 1927 |  |  |
| December 31, 2023 | 645500 | 1947 |  |  |
| December 31, 2022 | 620000 | 1741 |  |  |
| December 31, 2021 | 466000 | 1958 |  |  |
| December 31, 2020 | 310000 | 1770 |  |  |

---

------

<sup>(1)</sup> Total amount of each class of senior securities outstanding at the end of the period presented.

<sup>(2)</sup> Asset coverage per unit is the ratio of the carrying value of total assets, less all liabilities excluding indebtedness represented by senior securities in this table to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.

<sup>(3)</sup> The amount to which such class of senior security would be entitled upon the Company's involuntary liquidation in preference to any security junior to it. The "—" in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.

<sup>(4)</sup> Not applicable because the senior securities are not registered for public trading, with the exception of the 2025 Notes, March 2029 Notes and September 2029 Notes. The average market value per unit calculated for the 2025 Notes, March 2029 Notes and September 2029 Notes are based on the average daily price of such notes and are expressed in terms of dollar amounts per $1,000 of indebtedness.

<sup>(5)</sup> The Credit Suisse Credit Facility matured on January 8, 2022, in accordance with its terms, and all outstanding indebtedness thereunder was repaid.

<sup>(6)</sup> The 2025 Notes matured on January 16, 2025 pursuant to their terms and were repaid in full.

<sup>(7)</sup> The Convertible Notes were converted on February 20, 2025 and repaid in full pursuant to their terms and conditions.

------

[**<u>**Table of Contents**</u>**](#toc_page)

# Note 12. Related Party Transactions
During the three and nine months ended September 30, 2025 and the year ended December 31, 2024, certain related parties received distributions from the Company relating to their shares held. Refer to "Note 7 – Stockholder's Equity" for further details on the Company's DRIP and the distributions declared.

During the three and nine months ended September 30, 2025 and the year ended December 31, 2024, the Company's directors and executive officers and certain employees received restricted stock awards under the 2019 Long Term Incentive Plan and the 2019 Restricted Stock Plan. Refer to "Note 8 – Equity Incentive Plans" for further details on the Company's stock-based compensation plans.

The Company has entered into indemnification agreements with its directors and executive officers. The indemnification agreements are intended to provide the Company's directors and executive officers the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that the Company shall indemnify the director or executive officer who is a party to the agreement, or an "Indemnitee," including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

The Company and its executives and directors are covered by directors and officers insurance. In addition, each of our directors and officers have entered into an indemnification agreement with us pursuant to which our directors and officers are indemnified by us to the maximum extent permitted by Maryland law subject to the restrictions of the 1940 Act.

*Senior Credit Corp 2022 LLC*

As disclosed in "Note 1 - Organization and Basis of Presentation", the Company entered into a joint venture agreement with certain funds and accounts managed by a specialty credit manager (collectively, the "Senior Credit Corp JV Partner") on December 5, 2022 to co-manage Senior Credit Corp. Senior Credit Corp invests in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. The Company and the Senior Credit Corp JV Partner committed to initially contribute $21.4 million and $150.0 million, respectively, of capital in the form of 8.5% notes and preferred equity in Senior Credit Corp. Senior Credit Corp is capitalized as investment transactions are completed and all portfolio decisions and generally all other actions in respect of Senior Credit Corp must be approved by the board of managers of Senior Credit Corp consisting of an equal number of representatives of the Company and the Senior Credit Corp JV Partner. Capital contributions are called from each JV member on a pro-rata basis based on their total capital commitments, with 70% of each such capital contribution invested in Senior Credit Corp's 8.5% notes and the remaining 30% invested in Senior Credit Corp's preferred equity. As of September 30, 2025, the Company's and Senior Credit Corp JV Partner's ownership of Senior Credit Corp was 12.5% and 87.5%, respectively.

The Company has agreed to offer Senior Credit Corp the opportunity to purchase a percentage of each secured loan and equipment financing advance originated by the Company during the period commencing on September 1, 2022 and ending on June 5, 2026. Senior Credit Corp is required to pay the Company a fee equal to 100 basis points of the total principal amount of each loan or equipment financing advance acquired by Senior Credit Corp from the Company, with 50% of the fee for each such particular loan or advance payable by Senior Credit Corp to the Company within two business days of the date of such acquisition or advance and the remaining 50% payable in equal monthly installments over 24 months following the date of such acquisition or advance. In addition, Senior Credit Corp is required to pay the Company an administrative agent fee equal to 75 basis points of the daily average aggregate value of Senior Credit Corp's outstanding loans and equipment financings.

As of September 30, 2025, the Company contributed $18.4 million of capital to Senior Credit Corp, which consisted of a debt investment of $12.9 million and an equity investment of $5.5 million. As of December 31, 2024, the Company contributed $18.4 million of capital to Senior Credit Corp, which consisted of a debt investment of $12.9 million and an equity investment of $5.5 million. As of September 30, 2025 and December 31, 2024, the Company's unfunded commitment of capital to Senior Credit Corp was $3.0 million and $3.0 million, respectively.

------

[**<u>**Table of Contents**</u>**](#toc_page)

As of September 30, 2025 and December 31, 2024, Senior Credit Corp's total investment portfolio on a fair value basis was $239.2 million and $219.1 million, respectively. During the three and nine months ended September 30, 2025, the Company received $33.2 million and $79.8 million, respectively, in net proceeds from the sale of investments to Senior Credit Corp. During the year ended December 31, 2024, the Company received $157.3 million in net proceeds from the sale of investments to Senior Credit Corp.

During the three and nine months ended September 30, 2025, the Company earned approximately $0.7 million and $2.0 million, respectively, for originations and administrative agent fees which are recognized as fee income on the Consolidated Statements of Operations. During the three and nine months ended September 30, 2024, the Company earned approximately $0.8 million and $2.5 million, respectively, for originations and administrative agent fees which are recognized as fee income on the Consolidated Statements of Operations. As of September 30, 2025 and December 31, 2024, the Company had approximately $1.0 million and $1.1 million, respectively, in unsettled receivables due from Senior Credit Corp that were included in other assets in the accompanying Consolidated Statements of Assets and Liabilities.

*Trinity Capital Adviser LLC*

As disclosed in "Note 1 - Organization and Basis of Presentation", the Company formed the Adviser Sub on March 16, 2023 as a wholly owned subsidiary of the Company. The Company was granted exemptive relief by the SEC that permits the Company to organize, acquire, wholly own and operate the Adviser Sub as an investment adviser registered under the Advisers Act. The Adviser Sub may provide investment advisory and related services to the Adviser Funds with ownership by one or more External Parties and receives fee income for such services. The Adviser Sub commenced operations on June 28, 2024.

The Company has entered into a resource sharing agreement ("Sharing Agreement") with the Adviser Sub, through which the Adviser Sub has access to the Company's human capital resources, facilities and systems. Under the terms of Sharing Agreement, the Company allocates the related expenses of such shared resources to the Adviser Sub pro rata based on total assets under management by the Adviser Sub and the Company. The Company's total expenses are net of such expenses allocated to the Adviser Sub of $1.0 million and $1.9 million for the three and nine months ended September 30, 2025, respectively. The Company's total expenses are net of such expenses allocated to the Adviser Sub of $0.1 million for the three and nine months ended September 30, 2024. As of September 30, 2025 and December 31, 2024, there were $3.3 million and $1.8 million, respectively, receivable from the Adviser Sub.

The Adviser Sub has entered into an investment management agreement with the Adviser Funds and may enter into additional investment management agreements with other Adviser Funds in the future, pursuant to which the Adviser Sub receives management fees and/or incentive fees based on the assets under management and the performance of the Adviser Funds, respectively. With respect to such fee income, the Adviser Sub expects to declare and pay dividend distributions to the Company. During the three and nine months ended September 30, 2025 and 2024, no dividend distributions were declared and paid by the Adviser Sub to the Company.

*Eagle Point Trinity Senior Secured Lending Company*

As disclosed in "Note 1 - Organization and Basis of Presentation", the Company and a specialty credit manager (the "Class A Member") funded a portion of their respective capital commitments on June 28, 2024 to commence the operations of a credit fund, EPT 16 LLC. On August 28, 2025, EPT 16 LLC converted into a Delaware statutory trust named Eagle Point Trinity Senior Secured Lending Company ("EPT") and elected to be regulated as a BDC under the 1940 Act. EPT has acquired and intends to acquire, hold and, as applicable, dispose of investments that have been originated by the Company. The Company and the Class A Member had capital commitments to EPT in the amount of $10.0 million and $50.0 million, respectively. As of September 30, 2025, the Company's and the Class A Member's ownership percentages were 16.7% and 83.3%, respectively. EPT has entered into an investment management agreement with the Adviser Sub, pursuant to which the Adviser Sub will earn certain base management and incentive fees in exchange for providing advisory services to EPT.

As of September 30, 2025 and December 31, 2024, the Company had contributed $10.0 million of capital to EPT. As of September 30, 2025, there were no unfunded commitments for EPT. As of December 31, 2024, the Company's unfunded commitment was $0.8 million.

------

[**<u>**Table of Contents**</u>**](#toc_page)

As of September 30, 2025 and December 31, 2024, EPT's total investment portfolio on a fair value basis was $118.4 million and $66.9 million, respectively. During the three and nine months ended September 30, 2025, the Company received $40.5 million and $61.6 million, respectively, in net proceeds from the sale of investments to EPT. During the year ended December 31, 2024, the Company received $74.7 million in net proceeds from the sale of investments to EPT. During the three and nine months ended September 30, 2025, $0.8 million dividend distributions were declared and paid by EPT to the Company. During the three and nine months ended September 30, 2024, no dividend distributions were declared and paid by EPT to the Company.

*Co-Investment Exemptive Relief* 

On July 8, 2025, the Company and certain of its affiliates were granted an exemptive relief order (the "Order") from the SEC that permits the Company to enter into certain negotiated co-investment transactions alongside certain of its affiliates in a manner consistent with its investment objective, positions, policies, strategies, and restrictions as well as regulatory requirements and other pertinent factors, subject to compliance with the Order. The Order contains certain conditions and requires the Board to maintain oversight of the Company's participation in the co-investment program. The Order also requires a "required majority" (as defined in Section 57(o) of the 1940 Act) of the Company's eligible directors to make certain conclusions pursuant to Section 57(f) of the 1940 Act in connection with certain co-investment transactions, including co-investment transactions in which an affiliate of the Company is an existing investor in the portfolio company, non-pro rata follow on investments and non-pro rata dispositions of investments.

*Direct Lending 2025 LLC*

As disclosed in "Note 1 – Organization and Basis of Presentation," on September 24, 2025, the Company entered into a joint venture agreement with a credit financing platform ("Direct Lending JV Partner") to co-manage Direct Lending. Direct Lending has acquired loans originated by the Company and intends to acquire, hold and, as applicable, dispose of investments as co-investments alongside the Company. The Company and Direct Lending JV Partner each hold equal ownership interests in Direct Lending and committed capital contributions of $100.0 million. Direct Lending is capitalized as investment transactions are completed, with contributions called from each member on a pro rata basis relative to each member's total commitments.

All portfolio decisions, as well as substantially all other actions relating to Direct Lending, require approval by its board of managers, which is composed of an equal number of representatives from the Company and Direct Lending JV Partner. Direct Lending has entered into an investment services agreement with the Adviser Sub, pursuant to which the Adviser Sub earns base management and incentive fees for providing advisory and management services to Direct Lending. Direct Lending has also entered into an administration agreement with the Adviser Sub, pursuant to which the Adviser Sub is reimbursed for its costs and expenses incurred in connection with providing administrative services thereunder.

As of September 30, 2025, the Company had contributed $22.4 million of capital to Direct Lending and had an unfunded capital commitment of $77.7 million. As of September 30, 2025, Direct Lending's total investment portfolio on a fair value basis was $44.5 million. During the three and nine months ended September 30, 2025, the Company received net proceeds of $44.6 million from the sale of investments to Direct Lending.

**Note 13. Segment Reporting**

The Company has determined that is has a single operating segment in accordance with Topic 280, Segment Reporting ("ASC 280"). The Company's Chief Operating Decision Maker ("CODM") is the Chief Executive Officer ("CEO"). While the Company derives income and capital appreciation by providing debt to growth-oriented companies across various industries, the Company and the CODM evaluate and monitor performance of the business on a consolidated basis. Further, each investment is evaluated and managed using similar processes and shared operations support functions such as deal origination, underwriting, loan servicing in addition to the administrative functions of human resources, legal, finance and information technology. The accounting policies of the segment align with those outlined in "Note 2 - Summary of Significant Accounting Policies" included in the notes of the consolidated financial statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The CODM uses consolidated net investment income and net increase/(decrease) in net assets resulting from operations when allocating resources and assessing the Company's performance. Net investment income is comprised of consolidated total investment income ("segment revenues") and consolidated total net operating expenses ("significant segment expenses"). The net increase/(decrease) in net assets is comprised of consolidated net investment income and consolidated net realized gain/(loss) from investments and consolidated net change in unrealized appreciation/(depreciation) from investments. These performance metrics are considered the key segment measure of profit or loss received by the CODM. As the Company's operations comprise of a single reporting segment, the segment assets are reflected on the accompanying Consolidated Statements of Assets and Liabilities as Total Assets, investments held on the Consolidated Statements of Investments, and the significant segment expenses are listed on the accompanying Consolidated Statements of Operations.

# Note 14. Recent Accounting Pronouncements
In December 2023, the Financial Accounting Standards Board ("FASB") issued *ASU 2023-09—Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09")* related to income tax disclosures. ASU 2023-09 requires additional disaggregated disclosures on the entity's effective tax rate reconciliation and additional details on income taxes paid. ASU 2023-09 is effective on a prospective basis, with the option for retrospective application, for annual periods beginning after December 15, 2024 and early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.

In November 2024, the Financial Accounting Standards Board ("FASB") issued *ASU 2024-03—Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses* ("ASU 2024-03") related to expense disclosures. The amendments in ASU 2024-03 require public entities to provide disaggregated disclosure of expenses included within relevant income statement expense captions, as well as additional disclosures about selling expenses. This update will become effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact of adopting this guidance with respect to the consolidated financial statements.

# Note 15. Subse quent Events
The Company's management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. Except as noted below, there have been no subsequent events that occurred during such period that would require recognition or disclosure.

*Equity ATM Program*

For the period from October 1, 2025 to November 3, 2025, the Company issued and sold 663,974 shares of its common stock at a weighted-average price of $14.99 per share and raised $9.9 million of net proceeds after deducting commissions to the sales agents on shares sold under the Equity ATM Program.

*Debt ATM Program*

For the period from October 1, 2025 to November 3, 2025, the Company issued and sold $25.4 million in aggregate principal amount of its ATM March 2029 Notes and $2.6 million in aggregate principal amount of its ATM September 2029 Notes and raised $25.3 million and $2.6 million, respectively, of net proceeds after deducting deferred offering costs and commissions to the sales agents on such notes sold under the Sales Agreement.

------

[**<u>**Table of Contents**</u>**](#toc_page)

# Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
*Except where the context suggests otherwise, the terms "we," "us," "our," and "the Company" refer to Trinity Capital Inc. and its consolidated subsidiaries. The information contained in this section should be read in conjunction with our consolidated financial statements and related notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q.* 

## Forward-Looking Statements
This quarterly report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Any statements about our expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as "anticipate," "believes," "can," "could," "may," "predicts," "potential," "should," "will," "estimate," "plans," "projects," "continuing," "ongoing," "expects," "intends" and similar words or phrases. Accordingly, these statements are only predictions and involve estimates, known and unknown risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Our actual results could differ materially from those anticipated in such forward-looking statements as a result of several factors discussed under Item 1A. "Risk Factors" of Part II of this quarterly report and Item 1A. "Risk Factors" of Part I of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission ("SEC") on February 26, 2025, including but not limited to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•our future operating results;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•our dependence upon our management team and key investment professionals;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•our ability to manage our business and future growth;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•risks related to investments in growth-oriented companies, other venture capital-backed companies and generally U.S. companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the ability of our portfolio companies to achieve their objectives;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the use of leverage;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•risks related to the uncertainty of the value of our portfolio investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•changes in political, economic or industry conditions, including as a result of prolonged governmental shutdowns, supply chain disruptions, disruptions related to tariffs or other trade or sanction related issues, the interest rate and inflation rate environments or conditions affecting the financial and capital markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•uncertainty surrounding domestic and/or global financial and/or political stability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the dependence of our future success on the general economy and its impact on the industries in which we invest;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•risks related to changes in interest rates and inflation rates, our expenses, and other general economic conditions and the effect on our net investment income;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the impact of changes in laws or regulations (including the interpretation thereof), including tax laws, on our operations and/or the operations of our portfolio companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•risks related to market volatility, including general price and volume fluctuations in stock markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•our ability to make distributions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•our ability to maintain our status as a business development company ("BDC") under the Investment Company Act of 1940, as amended (the "1940 Act"), and qualify annually for tax treatment as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code").

------

[**<u>**Table of Contents**</u>**](#toc_page)

Additionally, there may be other risks that are otherwise described from time to time in the reports that we file with the SEC. Any forward-looking statements in this Quarterly Report on Form 10-Q should be considered in light of various important factors, including the risks and uncertainties listed above, as well as others. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this quarterly report. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as may be required by law. Because we are an investment company, the forward-looking statements and projections contained in this quarterly report are excluded from the safe harbor protections provided by Section 27A(b)(2)(B) of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Exchange Act (the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995).

***Overview***

We are a specialty lending company providing debt, including loans, equipment financings and asset based lending, to growth-oriented companies, including institutional investor-backed companies. We are an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the 1940 Act. We have elected to be treated, and intend to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As a BDC and a RIC, we are required to comply with certain regulatory requirements.

Our investment objective is to generate current income and, to a lesser extent, capital appreciation through our investments across five distinct vertical markets. We seek to achieve our investment objective by making investments consisting primarily of term loans, equipment financings, and asset based lending and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, we may obtain warrants or contingent exit fees at funding from many of our portfolio companies, providing an additional potential source of investment returns. We generally are required to invest at least 70% of our total assets in qualifying assets in accordance with the 1940 Act but may invest up to 30% of our total assets in non-qualifying assets, as permitted by the 1940 Act.

We target investments in growth-oriented companies, which are typically private companies, including institutional investor-based companies. We define "growth-oriented companies" as companies that have significant ownership and active participation by sponsors, such as institutional investors or private equity firms, and expected annual revenues of up to $100 million. Subject to the requirements of the 1940 Act, we are not limited to investing in any particular industry or geographic area and seek to invest in under-financed segments of the private credit markets.

Our loans generally may have initial interest-only periods of up to 24 months, and our equipment financings generally begin amortizing immediately. Our loans and equipment financings generally have a total term of up to 60 months. These investments are typically secured by a blanket first position lien, a specific asset lien on mission-critical assets and/or a blanket second position lien. We may also make a limited number of direct equity and equity-related investments in conjunction with our debt investments. We target growth-oriented companies that have recently issued equity to raise cash to offset potential cash flow needs related to projected growth, have achieved positive cash flow to cover debt service, or have institutional investors committed to providing additional funding. A loan or equipment financing may be structured to tie the amortization of the loan or equipment financing to the portfolio company's projected cash balances while cash is still available for operations. As such, the loan or equipment financing may have a reduced risk of default. We believe that the amortizing nature of our investments will mitigate risk and significantly reduce the risk of our investments over a relatively short period. We focus on protecting and recovering principal in each investment and structure our investments to provide downside protection.

## *Our History* 
Trinity Capital Inc. was incorporated under the general corporation laws of the State of Maryland on August 12, 2019 and commenced operations on January 16, 2020. Prior to January 16, 2020, we had no operations, except for matters relating to our formation and organization as a BDC.

------

[**<u>**Table of Contents**</u>**](#toc_page)

On January 16, 2020, through a series of transactions, we acquired Trinity Capital Investment, LLC, Trinity Capital Fund II, L.P., Trinity Capital Fund III, L.P., Trinity Capital Fund IV, L.P., and Trinity Sidecar Income Fund, L.P. (collectively, the "Legacy Funds") and all of their respective assets, including their respective investment portfolios (the "Legacy Portfolio"), as well as Trinity Capital Holdings, LLC, a holding company whose subsidiaries managed and/or had the right to receive fees from certain of the Legacy Funds. In order to complete these transactions, we used a portion of the proceeds from our private equity offering and private debt offering that occurred on January 16, 2020 (the "Private Offerings").

On February 2, 2021, we completed our initial public offering of 8,006,291 shares of our common stock at a price of $14.00 per share, inclusive of the underwriters' option to purchase additional shares, which was exercised in full. Our common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol "TRIN."

On December 5, 2022, we entered into a joint venture agreement with certain funds and accounts managed by a specialty credit manager to co-manage Senior Credit Corp 2022 LLC, a Delaware limited liability company ("Senior Credit Corp"). Senior Credit Corp invests in secured loans and equipment financings to growth-oriented companies that have been originated by us.

On March 16, 2023, we formed an unconsolidated wholly owned subsidiary, Trinity Capital Adviser LLC, a Delaware limited liability company ("Adviser Sub"). We were granted exemptive relief by the SEC that permits us to organize, acquire, wholly own and operate the Adviser Sub as an investment adviser registered under the Investment Advisers Act of 1940, as amended (the "Adviser Act"). The Adviser Sub may provide investment advisory and related services to one or more investment vehicles (the "Adviser Funds") with ownership by one or more unrelated third-party investors and receive fee income for such services.

On June 28, 2024, we and a specialty credit manager funded a portion of their respective capital commitments to commence operations of a credit fund, EPT 16 LLC, a Delaware limited liability company. On August 28, 2025, EPT 16 LLC converted into a Delaware statutory trust named Eagle Point Trinity Senior Secured Lending Company ("EPT") and elected to be regulated as a BDC under the 1940 Act. EPT has acquired and intends to acquire, hold and, as applicable, dispose of investments that have been originated by us.

On September 24, 2025, the Company entered into a joint venture agreement with a specialty credit manager to co-manage Direct Lending 2025 LLC ("Direct Lending"), a Delaware limited liability company. Direct Lending has acquired loans originated by the Company and intends to acquire, hold and, as applicable, dispose of investments as a co-investment alongside us.

## *Critical Accounting Estimates and Policies* 
The preparation of our financial statements in accordance with U.S. generally accepted accounting principles ("GAAP") requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially. Our critical accounting estimates, including those relating to valuation of investments and income recognition, are described below. Please refer to "Note 2 – Summary of Significant Accounting Policies" in the notes to the consolidated financial statements included in this Quarterly Report on Form 10-Q for a discussion of our significant accounting policies.

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *Valuation of Investments* 
The most significant estimate inherent in the preparation of the Company's consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded. The Company's investments are carried at fair value in accordance with the 1940 Act and Accounting Standards Codification ("ASC") 946, *Financial Services — Investment Companies* ("ASC 946") and measured in accordance with ASC 820, *Fair Value Measurements and Disclosures* ("ASC 820"). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith by the Company's Board of Directors (the "Board") in accordance with the provisions of ASC 820 and the 1940 Act.

The SEC adopted Rule 2a-5 under the 1940 Act ("Rule 2a-5"), which establishes a framework for determining fair value in good faith for purposes of the 1940 Act. As adopted, Rule 2a-5 permits boards of directors to designate certain parties to perform fair value determinations, subject to board oversight and certain other conditions. The SEC also adopted Rule 31a-4 under the 1940 Act ("Rule 31a-4"), which provides the recordkeeping requirements associated with fair value determinations. While the Company's Board has not elected to designate a valuation designee, the Company has adopted certain revisions to its valuation policies and procedures to comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.

While the Board is ultimately and solely responsible for determining the fair value of the Company's investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company identifies portfolio investments with respect to which an independent valuation firm assists in valuing certain investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on our Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management's own assumptions about the assumptions a market participant would use in pricing the investment.

Given the nature of lending to venture capital-backed growth-oriented companies, substantially all of the Company's investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company's investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

------

[**<u>**Table of Contents**</u>**](#toc_page)

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company's financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments.

## *Income Recognition* 
The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount ("OID") initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. Interest income from payment-in-kind ("PIK") represents contractually deferred interest added to the loan balance recorded on an accrual basis to the extent such amounts are expected to be collected.

In addition, the Company may also be entitled to an end-of-term ("EOT") payment. EOT payments to be paid at the termination of the debt agreement are accreted into interest income over the contractual life of the debt based on the effective yield method. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT is recognized as interest income.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are accreted into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

The Company records dividend income on an accrual basis to the extent amounts are expected to be collected. Dividend income is recorded when dividends are declared by the portfolio company or at such other time that an obligation exists for the portfolio company to make a distribution. During three and nine months ended September 30, 2025, the Company recorded $1.4 million and $2.7 million, respectively, in dividend income. During the three and nine months ended September 30, 2024, the Company recorded $0.5 million and $1.0 million, respectively, in dividend income.

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity. In addition, fee income may include fees for originations and administrative agent services rendered by the Company to Senior Credit Corp. Such fees are earned in the period that the services are rendered.

## *Portfolio Composition and Investment Activity* 
*Portfolio Composition*

As of September 30, 2025, our investment portfolio had an aggregate fair value of approximately $2,192.4 million and was comprised of approximately $1,678.3 million in secured loans, $318.2 million in equipment financings, and $195.9 million in equity and warrants, across 178 portfolio companies. As of December 31, 2024, our investment portfolio had an aggregate fair value of approximately $1,725.6 million and was comprised of approximately $1,286.7 million in secured loans, $315.5 million in equipment financings, and $123.4 million in equity and warrants, across 151 portfolio companies.

------

[**<u>**Table of Contents**</u>**](#toc_page)

A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments are shown in the following table as of September 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| **Type** | **Cost** | **Fair Value** | **Cost** | **Fair Value** |
| Secured Loans | 77.6% | 76.6% | 75.1% | 74.5% |
| Equipment Financings | 14.7% | 14.5% | 18.1% | 18.3% |
| Equity | 5.3% | 5.7% | 4.5% | 4.2% |
| Warrants | 2.4% | 3.2% | 2.3% | 3.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% | 100.0% | 100.0% | 100.0% |

---

The following table shows the composition of our investment portfolio by geographic region at cost and fair value as a percentage of total investments as of September 30, 2025 and December 31, 2024. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| **Geographic Region** | **Cost** | **Fair Value** | **Cost** | **Fair Value** |
| United States |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;West | 31.4% | 32.1% | 30.7% | 31.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Northeast | 23.6% | 23.4% | 28.1% | 27.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;South | 10.2% | 10.3% | 9.2% | 9.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Mountain | 10.4% | 10.0% | 10.9% | 10.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Midwest | 8.0% | 7.7% | 5.9% | 5.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Southeast | 7.8% | 7.5% | 10.5% | 10.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-Sector Holdings <sup>(1)</sup> | 2.3% | 2.8% | 1.6% | 1.9% |
| International: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Western Europe | 3.9% | 3.9% | 2.4% | 2.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Canada | 2.4% | 2.3% | 0.7% | 0.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% | 100.0% | 100.0% | 100.0% |

---

------

<sup>(1)</sup> Multi-Sector Holdings generally invest or manage investments in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. The portfolio companies held by the Multi-Sector Holdings represent a diverse set of geographical classifications, which are similar to those in which the Company invests directly.

------

[**<u>**Table of Contents**</u>**](#toc_page)

Set forth below is a table showing the industry composition of our investment portfolio at cost and fair value as a percentage of total investments as of September 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| **Industry** | **Cost** | **Fair Value** | **Cost** | **Fair Value** |
| Finance and Insurance | 15.3% | 15.8% | 18.1% | 18.7% |
| SaaS | 10.1% | 10.3% | 8.2% | 8.5% |
| Other Healthcare Services | 9.9% | 10.1% | 8.1% | 8.3% |
| Medical Devices | 9.8% | 9.9% | 9.7% | 10.0% |
| Space Technology | 8.4% | 8.6% | 8.0% | 8.2% |
| Healthcare Technology | 6.1% | 5.7% | 4.5% | 4.2% |
| Artificial Intelligence & Automation | 5.4% | 5.5% | 4.7% | 4.9% |
| Green Technology | 4.5% | 5.5% | 8.3% | 9.2% |
| Real Estate Technology | 5.3% | 4.8% | 5.8% | 5.4% |
| Marketing, Media, and Entertainment | 4.7% | 4.6% | 2.2% | 2.2% |
| Biotechnology | 3.4% | 3.5% | 3.2% | 3.4% |
| Transportation Technology | 3.9% | 2.9% | 3.6% | 2.4% |
| Multi-Sector Holdings <sup>(1)</sup> | 2.3% | 2.8% | 1.6% | 1.9% |
| Connectivity | 2.8% | 2.6% | 2.1% | 2.0% |
| Consumer Products & Services | 2.3% | 2.4% | 3.2% | 3.2% |
| Supply Chain Technology | 1.4% | 1.4% | 1.7% | 1.7% |
| Education Technology | 1.5% | 1.3% | 1.9% | 1.7% |
| Diagnostics & Tools | 0.8% | 0.8% | 0.2% | 0.2% |
| Food and Agriculture Technologies | 0.8% | 0.7% | 1.8% | 1.4% |
| Human Resource Technology | 0.8% | 0.6% | 1.9% | 1.7% |
| Industrials | 0.1% | 0.1% | 0.7% | 0.6% |
| Construction Technology | 0.4% | 0.1% | 0.5% | 0.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% | 100.0% | 100.0% | 100.0% |

---

------

<sup>(1)</sup> Multi-Sector Holdings invest or manage investments in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. The portfolio companies held by the Multi-Sector Holdings represent a diverse set of industry classifications, which are similar to those in which the Company invests directly.

As of September 30, 2025 and December 31, 2024, the debt, including loans and equipment financings, in our portfolio had a weighted average time to maturity of approximately 3.3 and 3.2 years, respectively. Additional information regarding our portfolio is set forth in the Consolidated Schedule of Investments and the related notes thereto included with this Quarterly Report on Form 10-Q.

*Concentrations of Credit Risk*

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment's carrying amount. Industry and sector concentrations will vary from period to period based on portfolio activity.

As of September 30, 2025 and December 31, 2024, the Company's ten largest portfolio companies represented approximately 24.6% and 26.7%, respectively, of the total fair value of the Company's investments in portfolio companies. As of September 30, 2025 and December 31, 2024, the Company had five and seven portfolio companies, respectively, that represented 5% or more of the Company's net assets.

------

[**<u>**Table of Contents**</u>**](#toc_page)

*Investment Activity*

During the nine months ended September 30, 2025, we invested approximately $669.0 million in 38 new portfolio companies, approximately $364.3 million in 32 existing portfolio companies and approximately $23.1 million in the Multi-Sector Holdings, excluding deferred fees. During the nine months ended September 30, 2025, we received an aggregate of $607.8 million in proceeds from repayments and sales of our investments, including proceeds of approximately $224.3 million from early repayments on our debt investments, $192.8 million from scheduled/amortizing debt payments, $190.0 million from investments sold primarily to Multi-Sector Holdings and $0.7 million from warrant and equity exits.

During the year ended December 31, 2024, we invested approximately $969.1 million in 39 new portfolio companies, approximately $244.1 million in 28 existing portfolio companies, and approximately $16.6 million in the Multi-Sector Holdings, excluding deferred fees. During the year ended December 31, 2024, we received an aggregate of $807.9 million in proceeds from repayments and sales of our investments, including proceeds of approximately $313.2 million from early repayments on our debt investments, $45.7 million from warrant and equity exits, $207.3 million from scheduled/amortizing debt payments and $241.7 million from investments sold primarily to Multi-Sector Holdings.

The following table provides a summary of the changes in the investment portfolio for the nine months ended September 30, 2025 and the year ended December 31, 2024 (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended** | **Year Ended** |
|  | **September 30, 2025** | **December 31, 2024** |
| **Beginning Portfolio, at fair value** | $1725570 | $1275180 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases, net of deferred fees | 1046394 | 1218931 |
| &nbsp;&nbsp;&nbsp;&nbsp;Principal payments received on investments | (192796) | (207328) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from early debt repayments | (224322) | (313207) |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales of investments | (190728) | (287331) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accretion of OID, EOT, and PIK payments | 36431 | 39574 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gain/(loss) | (30441) | (9730) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized appreciation/(depreciation) | 22253 | 9481 |
| **Ending Portfolio, at fair value** | $2192361 | $1725570 |

---

The level of our investment activity can vary substantially from period to period depending on many factors, including the amount of debt, including loans and equipment financings, and equity capital required by growth-oriented companies, the general economic environment and market conditions and the competitive environment for the types of investments we make.

*Portfolio Asset Quality*

Our portfolio management team uses an ongoing investment risk rating system to characterize and monitor our outstanding loans and equipment financings. Our portfolio management team monitors and, when appropriate, recommends changes to the investment risk ratings. Our investment committee reviews the recommendations and/or changes to the investment risk ratings, which are submitted on a quarterly basis to the Board and its audit committee.

------

[**<u>**Table of Contents**</u>**](#toc_page)

For our investment risk rating system, we review seven different criteria and, based on our review of such criteria, we assign a risk rating on a scale of 1 to 5, as set forth in the following illustration.

![img123191569_0.jpg](img123191569_0.jpg)

The following table shows the distribution of our secured loan and equipment financing investments on the 1 to 5 investment risk rating scale range at fair value as of September 30, 2025 and December 31, 2024 (dollars in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| **Investment Risk Rating** |  | **Investments at** | **Percentage of** | **Investments at** | **Percentage of** |
| **Scale Range** | **Designation** | **Fair Value** | **Total Portfolio** | **Fair Value** | **Total Portfolio** |
| 4.0 - 5.0 | Very Strong Performance | $102624 | 5.3% | $89716 | 5.6% |
| 3.0 - 3.9 | Strong Performance | 668545 | 33.5% | 453584 | 28.3% |
| 2.0 - 2.9 | Performing | 1148937 | 57.5% | 972001 | 60.7% |
| 1.6 - 1.9 | Watch | 42811 | 2.1% | 62883 | 3.9% |
| 1.0 - 1.5 | Default/Workout | 20739 | 1.0% | 11062 | 0.7% |
| &nbsp;&nbsp;Total Debt Investments excluding Senior Credit Corp 2022 LLC |  | 1983656 | 99.4% | 1589246 | 99.2% |
| . | Senior Credit Corp 2022 LLC <sup>(1)</sup> | 12885 | 0.6% | 12885 | 0.8% |
| &nbsp;&nbsp;Total Debt Investments |  | $1996541 | 100.0% | $1602131 | 100.0% |

---

------

<sup>(1)</sup> An investment risk rating is not applied to Senior Credit Corp 2022 LLC.

As of both September 30, 2025 and December 31, 2024, our debt investments had a weighted average risk rating score of 2.9.

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *Debt Investments on Non-Accrual Status* 
When a debt security becomes 90 days or more past due, or if our management otherwise does not expect that principal, interest, and other obligations due will be collected in full, we will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or we believe the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, we may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of September 30, 2025, loans to three portfolio companies and equipment financings to one portfolio company were on non-accrual status with a total cost of approximately $56.2 million, and a total fair value of approximately $20.7 million, or 1.0%, of the fair value of the Company's debt investment portfolio. As of December 31, 2024, loans to three portfolio companies and equipment financings to two portfolio companies were on non-accrual status with a total cost of approximately $43.3 million, and a total fair value of approximately $12.7 million, or 0.8%, of the fair value of the Company's debt investment portfolio.

## *Results of Operations* 
The following discussion and analysis of our results of operations encompasses our consolidated results for the three and nine months ended September 30, 2025 and 2024.

*Investment Income*

The following table sets forth the components of investment income (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Stated interest income | $59421 | $47555 | $161517 | $126952 |
| Amortization of OID and EOT | 8767 | 6930 | 22804 | 19304 |
| Acceleration of OID and EOT | 2312 | 2629 | 11272 | 5823 |
| PIK interest income | 692 | 1576 | 3685 | 7389 |
| Prepayment penalty and related fees | 354 | 880 | 1536 | 1375 |
| Dividend income | 1383 | 500 | 2683 | 950 |
| Other fee income | 2621 | 1696 | 6920 | 5066 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment income | $75550 | $61766 | $210417 | $166859 |

---

For the three and nine months ended September 30, 2025, total investment income was approximately $75.6 million and $210.4 million, respectively, which represents an approximate effective yield of 15.0% and 15.3%, respectively, on the average investments during the year. For the three and nine months ended September 30, 2024, total investment income was approximately $61.8 million and $166.9 million, respectively, which represents an approximate effective yield of 16.1% and 16.0%, respectively, on the average investments during the year. The increase in investment income for the three and nine months ended September 30, 2025 is due to higher interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments.

*Net Operating Expenses and Excise Taxes*

Our operating expenses are comprised of interest and fees on our borrowings, employee compensation, professional fees, general and administrative expenses, and excise taxes. Our operating expenses totaled approximately $38.6 million and $106.3 million, respectively, for the three and nine months ended September 30, 2025 and $32.4 million and $85.6 million, respectively, for the three and nine months ended September 30, 2024. The increase in our operating expenses for the three and nine months ended September 30, 2025 is discussed with respect to each component of such expenses below.

------

[**<u>**Table of Contents**</u>**](#toc_page)

*Interest Expense and Other Debt Financing Costs*

Our interest expense and other debt financing costs are primarily comprised of interest and fees related to our secured borrowings, the 4.375% Notes due 2026 (the "August 2026 Notes"), the 4.25% Notes due 2026 (the "December 2026 Notes"), the 7.875% Notes due March 2029 (the "March 2029 Notes"), the 7.875% Notes due September 2029 (the "September 2029 Notes"), the 7.54% Notes due 2027 (the "Series A 2027 Notes"), the 7.60% Notes due 2028 (the "Series A 2028 Notes"), the 7.66% Notes due 2029 (the "Series A 2029 Notes" and together with the Series A 2027 Notes and Series A 2028 Notes, the "Series A Notes") and the 6.750% Notes due 2030 (the "July 2030 Notes"). Interest expense and other debt financing costs on our borrowings totaled approximately $21.0 million and $56.7 million, respectively, for the three and nine months ended September 30, 2025, and $16.9 million and $42.9 million, respectively, for the three and nine months ended September 30, 2024. Our weighted average effective interest rate, comprised of interest and amortization of fees and discount, was approximately 7.3% and 7.5%, respectively, for the three and nine months ended September 30, 2025, and 7.7% and 7.6%, respectively, for the three and nine months ended September 30, 2024. The increase in interest expense for the three and nine months ended September 30, 2025 was primarily due to the increased borrowings under our credit facility with KeyBank, National Association (the "KeyBank Credit Facility") and the addition of the July 2030 Notes.

*Employee Compensation and Benefits*

Employee compensation and benefits totaled approximately $13.4 million and $36.5 million, respectively, for the three and nine months ended September 30, 2025, and $11.5 million and $31.3 million, respectively, for the three and nine months ended September 30, 2024. The increase in employee compensation expenses for the three and nine months ended September 30, 2025 relates primarily to the increased compensation related to a higher headcount and stock-based compensation. As of September 30, 2025 and 2024, the Company had 107 and 86 employees, respectively.

*Professional Fees Expenses*

Professional fees expenses, consisting of legal fees, accounting fees, third-party valuation fees, and talent acquisition fees, totaled approximately $1.9 million and $5.8 million, respectively, for the three and nine months ended September 30, 2025, and $1.3 million and $3.4 million, respectively, for the three and nine months ended September 30, 2024. The increase in professional fees expenses for the three and nine months ended September 30, 2025 resulted primarily from an increase in legal fees, third-party valuation fees and other consulting fees.

*General and Administrative Expenses*

General and administrative expenses include insurance premiums, rent, state taxes and various other expenses related to our ongoing operations. Our general and administrative expenses totaled approximately $2.6 million and $7.3 million, respectively, for the three and nine months ended September 30, 2025, and $2.2 million and $6.2 million, respectively, for the three and nine months ended September 30, 2024. The increase in general and administrative expenses for the three and nine months ended September 30, 2025 was primarily due to additional office rent and related expenses.

*Allocated Expenses to Trinity Capital Adviser, LLC*

The resource sharing agreement (the "Sharing Agreement") with the Adviser Sub provides the Adviser Sub with access to the Company's human capital resources, facilities and systems. Under the terms of the Sharing Agreement, we allocate the related expenses of such shared resources to the Adviser Sub based on total assets under management by the Adviser Sub and us. The Company's total expenses are net of $1.0 million and $1.9 million of expenses allocated to the Adviser Sub for the three and nine months ended September 30, 2025, respectively. The Company's total expenses are net of $0.1 million of expenses allocated to the Adviser Sub for the three and nine months ended September 30, 2024. The increase in allocated expenses for the three and nine months ended September 30, 2025 was primarily due to additional assets managed by the Adviser Sub.

------

[**<u>**Table of Contents**</u>**](#toc_page)

*Excise Taxes*

Our excise taxes totaled approximately $0.6 million and $1.9 million for the three and nine months ended September 30, 2025, respectively, and $0.6 million and $1.9 million for the three and nine months ended September 30, 2024, respectively.

*Net Investment Income*

For the three months ended September 30, 2025 and 2024, we recognized approximately $75.6 million and $61.8 million, respectively, in total investment income as compared to approximately $38.6 million and $32.4 million, respectively, in total expenses, including excise tax expense, resulting in net investment income of $37.0 million and $29.4 million, respectively. For the nine months ended September 30, 2025 and 2024, we recognized approximately $210.4 million and $166.9 million, respectively, in total investment income as compared to approximately $106.3 million and $85.6 million, respectively, in total expenses, including excise tax expense, resulting in net investment income of $104.2 million and $81.3 million, respectively.

*Net Realized Gains and Losses*

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written off during the period.

During the nine months ended September 30, 2025, our gross realized gains primarily consisted of the repayment of two equipment financing positions and the repayment of one warrant position. Our gross realized losses primarily consisted of the sale of one equipment financing position, the conversion of one debt position, the extinguishment of two debt positions and one receivable associated with a loan position. During the nine months ended September 30, 2024, our gross realized gains primarily consisted of the repayment of two equipment financing positions and the sale of one equity position. Our gross realized losses primarily consisted of the sale of one equity position, the sale of one debt position, the repayment of one debt position and the conversion of debt positions in four portfolio companies.

The net realized gains (losses) from the sales, repayments, or exits of investments for the three and nine months ended September 30, 2025 and 2024 were comprised of the following (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Net realized gain/(loss) on investments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross realized gains | 3332 | 1877 | 5939 | 10436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross realized losses | (23357) | (15757) | (36381) | (29452) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net realized gains/(losses) on investments | $(20025) | $(13880) | $(30441) | $(19016) |

---

*Net Change in Unrealized Appreciation / (Depreciation) from Investments*

Net change in unrealized appreciation/(depreciation) from investments primarily reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

------

[**<u>**Table of Contents**</u>**](#toc_page)

Net unrealized appreciation and depreciation on investments for the three and nine months ended September 30, 2025 and 2024 is comprised of the following (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Gross unrealized appreciation | $25033 | $15186 | $51086 | $28780 |
| Gross unrealized depreciation | (25347) | (20713) | (46806) | (48725) |
| Net unrealized appreciation/(depreciation) reclassified related to net realized gains or losses | 10519 | 14447 | 17973 | 27438 |
| Net change in unrealized appreciation/(depreciation) on portfolio investments | 10205 | 8920 | 22253 | 7493 |
| Other net changes in unrealized appreciation/(depreciation)<sup>(1)</sup> | 499 |  | 181 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net unrealized gains/(losses) on investments | $10704 | $8920 | $22434 | $7493 |

---

------

<sup>(1)</sup> Includes the net change in unrealized appreciation/(depreciation) related to derivative instruments.

During the three months ended September 30, 2025, our net unrealized appreciation on portfolio investments totaled approximately $10.2 million, which included net unrealized appreciation of $8.2 million from our equity investments, net unrealized appreciation of $3.1 million from our debt investments and net unrealized depreciation of $1.1 million from our warrant investments.

During the nine months ended September 30, 2025, our net unrealized appreciation on portfolio investments totaled approximately $22.3 million, which included net unrealized appreciation of $15.1 million from our equity investments, net unrealized appreciation of $5.9 million from our warrant investments and net unrealized appreciation of $1.3 million from our debt investments.

During the three months ended September 30, 2024, our net unrealized appreciation on portfolio investments totaled approximately $8.9 million, which included net unrealized appreciation of $3.0 million from our warrant investments, net unrealized appreciation of $2.0 million from our equity investments and net unrealized appreciation of $4.0 million from our debt investments.

During the nine months ended September 30, 2024, our net unrealized appreciation on portfolio investments totaled approximately $7.5 million, which included net unrealized appreciation of $6.6 million from our warrant investments, net unrealized appreciation of $2.7 million from our equity investments and net unrealized depreciation of $1.8 million from our debt investments.

*Net Increase (Decrease) in Net Assets Resulting from Operations* 

Net increase in net assets resulting from operations during the three and nine months ended September 30, 2025, totaled approximately $27.6 million and $96.1 million, respectively. Net increase in net assets resulting from operations during the three and nine months ended September 30, 2024, totaled approximately $24.4 million and $69.7 million, respectively.

*Net Increase (Decrease) in Net Assets Resulting from Operations and Earnings Per Share*

For the three months ended September 30, 2025, basic and diluted net increase in net assets per common share were $0.39 and $0.39, respectively. For the nine months ended September 30, 2025, basic and diluted net increase in net assets per common share were $1.44 and $1.44, respectively.

For the three months ended September 30, 2024, basic and diluted net decrease in net assets per common share were $0.45 and $0.43, respectively. For the nine months ended September 30, 2024, basic and diluted net increase in net assets per common share were $1.38 and $1.33, respectively.

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *Financial Condition, Liquidity and Capital Resources* 
Our liquidity and capital resources are generated primarily from the net proceeds of offerings of our securities, including our "at-the-market" offering, the August 2026 Notes offering, the December 2026 Notes offering, the March 2029 Notes offering, the September 2029 Notes offering, the Series A Notes offering and the July 2030 Notes offering and borrowings under the KeyBank Credit Facility, each of which were outstanding as of September 30, 2025, as well as cash flows from our operations, including investment sales and repayments and income earned on investments and cash equivalents. Our primary use of our funds includes investments in portfolio companies, payments of interest on our outstanding debt, and payments of fees and other operating expenses we incur. We also expect to use our funds to pay distributions to our stockholders. We have used, and expect to continue to use, our borrowings, including under the KeyBank Credit Facility or any future credit facility, as well as proceeds from the turnover of our portfolio, to finance our investment objectives and activities.

From time to time, we may enter into additional credit facilities, increase the size of our existing KeyBank Credit Facility, or issue additional securities in private or public offerings. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions, and other factors.

During the nine months ended September 30, 2025, we experienced a net decrease in cash and cash equivalents in the amount of $0.2 million, which is the net result of $370.7 million of cash provided by financing activities, offset by $370.5 million of cash used in operating activities and $0.4 million of cash used in investing activities. During the nine months ended September 30, 2024, we experienced a net increase in cash and cash equivalents in the amount of $3.8 million, which is the net result of $339.4 million of cash provided by financing activities, offset by $335.3 million of cash used in operating activities and $0.3 million of cash used in investing activities.

As of September 30, 2025 and December 31, 2024, we had cash and cash equivalents of $9.5 million and $9.6 million, respectively, of which $0.2 million and $3.8 million, respectively, was held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") insured limit and therefore is subject to credit risk. All of the Company's cash deposits are held at large established high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote.

As of September 30, 2025 and December 31, 2024, we had approximately $208.4 million and $487.0 million, respectively, of available borrowings under the KeyBank Credit Facility, subject to its terms and regulatory requirements. Cash and cash equivalents, taken together with available borrowings under the KeyBank Credit Facility, as of September 30, 2025, are expected to be sufficient for our investing activities and to conduct our operations in the near term and long term.

Refer to "Note 5 – Borrowings" in the notes to our consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information, including a discussion of our borrowings.

## *Asset Coverage Requirements* 
In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. On September 27, 2019, the Board, including a "required majority" (as such term is defined in Section 57(o) of the 1940 Act) and our initial stockholder approved the application to us of the 150% minimum asset coverage ratio set forth in Section 61(a)(2) of the 1940 Act. As a result, we are permitted to potentially borrow $2 for investment purposes of every $1 of investor equity. As of September 30, 2025, our asset coverage ratio was approximately 184.2% and our asset coverage ratio per unit was approximately $1,842. As of December 31, 2024, our asset coverage ratio was approximately 192.7% and our asset coverage ratio per unit was approximately $1,927.

## *Commitments and Off-Balance Sheet Arrangements* 
The Company has entered into a capital commitment with Senior Credit Corp, EPT and Direct Lending in the amount of $21.4 million, $10.0 million and $100.0 million, respectively.

------

[**<u>**Table of Contents**</u>**](#toc_page)

As of September 30, 2025, unfunded commitments were $3.0 million and $77.7 million for Senior Credit Corp and Direct Lending, respectively. As of September 30, 2025, there were no unfunded commitments for EPT. As of September 30, 2025, the Company also had unfunded commitments of approximately $70.8 million to eight portfolio companies. The Company did not have any other off-balance sheet financings or liabilities as of September 30, 2025.

As of December 31, 2024, unfunded commitments were $3.0 million for Senior Credit Corp and $0.8 million for EPT, respectively. As of December 31, 2024, the Company also had unfunded commitments of $31.2 million to two portfolio companies. The Company did not have any other off-balance sheet financings or liabilities as of December 31, 2024.

The Company's commitments and contingencies consist primarily of unfunded commitments to extend credit in the form of loans to the Company's portfolio companies. A portion of these unfunded contractual commitments as of September 30, 2025 and December 31, 2024 are dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company's credit agreements with its portfolio companies generally contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the company. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company's disclosure of unfunded contractual commitments includes only those which are available at the request of the portfolio company and unencumbered by milestones. The Company will fund future unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under the KeyBank Credit Facility).

In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company's experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

## *Contractual Obligations* 
A summary of our contractual payment obligations as of September 30, 2025, is as follows (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** |  |
|  | **Less than 1** |  |  |  |  |
|  | **year** | **1 - 3 years** | **4 - 5 years** | **After 5 years** | **Total** |
| KeyBank Credit Facility | $— | $— | $481600 | $— | $481600 |
| August 2026 Notes | 125000 |  |  |  | 125000 |
| December 2026 Notes |  | 75000 |  |  | 75000 |
| March 2029 Notes |  |  | 116770 |  | 116770 |
| September 2029 Notes |  |  | 119628 |  | 119628 |
| Series A Notes |  | 55500 | 87000 |  | 142500 |
| July 2030 Notes |  |  | 125000 |  | 125000 |
| Operating Leases | 354 | 2210 | 2131 | 1565 | 6260 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Contractual Obligations | $125354 | $132710 | $932129 | $1565 | $1191758 |

---

## *Distributions* 
We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. All distributions will be paid at the discretion of the Board and will depend on our earnings, financial condition, maintenance of our tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The following table summarizes distributions declared and/or paid by the Company since inception:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Declaration<br>Date** | **Type** | **Record<br>Date** | **Payment<br>Date** | **Per Share<br>Amount** |
| May 7, 2020 | Quarterly | May 29, 2020 | June 5, 2020 | $0.22 |
| August 10, 2020 | Quarterly | August 21, 2020 | September 4, 2020 | 0.27 |
| November 9, 2020 | Quarterly | November 20, 2020 | December 4, 2020 | 0.27 |
| December 22, 2020 | Quarterly | December 30, 2020 | January 15, 2021 | 0.27 |
| March 23, 2021 | Quarterly | March 31, 2021 | April 16, 2021 | 0.28 |
| June 15, 2021 | Quarterly | June 30, 2021 | July 15, 2021 | 0.29 |
| September 13, 2021 | Quarterly | September 30, 2021 | October 15, 2021 | 0.33 |
| December 16, 2021 | Quarterly | December 31, 2021 | January 14, 2022 | 0.36 |
| March 15, 2022 | Quarterly | March 31, 2022 | April 15, 2022 | 0.40 |
| March 15, 2022 | Supplemental | March 31, 2022 | April 15, 2022 | 0.15 |
| June 15, 2022 | Quarterly | June 30, 2022 | July 15, 2022 | 0.42 |
| June 15, 2022 | Supplemental | June 30, 2022 | July 15, 2022 | 0.15 |
| September 15, 2022 | Quarterly | September 30, 2022 | October 14, 2022 | 0.45 |
| September 15, 2022 | Supplemental | September 30, 2022 | October 14, 2022 | 0.15 |
| December 15, 2022 | Quarterly | December 30, 2022 | January 13, 2023 | 0.46 |
| December 15, 2022 | Supplemental | December 30, 2022 | January 13, 2023 | 0.15 |
| March 14, 2023 | Quarterly | March 31, 2023 | April 14, 2023 | 0.47 |
| June 14, 2023 | Quarterly | June 30, 2023 | July 14, 2023 | 0.48 |
| June 14, 2023 | Supplemental | June 30, 2023 | July 14, 2023 | 0.05 |
| September 13, 2023 | Quarterly | September 30, 2023 | October 13, 2023 | 0.49 |
| September 13, 2023 | Supplemental | September 30, 2023 | October 13, 2023 | 0.05 |
| December 14, 2023 | Quarterly | December 29, 2023 | January 12, 2024 | 0.50 |
| March 14, 2024 | Quarterly | March 28, 2024 | April 15, 2024 | 0.51 |
| June 13, 2024 | Quarterly | June 28, 2024 | July 15, 2024 | 0.51 |
| September 18, 2024 | Quarterly | September 30, 2024 | October 15, 2024 | 0.51 |
| December 12, 2024 | Quarterly | December 31, 2024 | January 15, 2025 | 0.51 |
| March 19, 2025 | Quarterly | March 31, 2025 | April 15, 2025 | 0.51 |
| June 18, 2025 | Quarterly | June 30, 2025 | July 15, 2025 | 0.51 |
| September 17, 2025 | Quarterly | September 30, 2025 | October 15, 2025 | 0.51 |
|  |  |  | **Total** | $10.23 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *Price Range of Common Stock* 
Our common stock began trading on the Nasdaq Global Select Market ("Nasdaq") on January 29, 2021 under the symbol "TRIN" in connection with our IPO, which closed on February 2, 2021. Prior to our IPO, the shares of our common stock were offered and sold in transactions exempt from registration under the Securities Act. As such, there was no public market for shares of our common stock during year ended December 31, 2020. Since our IPO, our common stock has traded at prices both above and below our net asset value per share.

The following table sets forth the net asset value per share of our common stock, the range of high and low closing sales prices of our common stock reported on Nasdaq, the closing sales price as a premium (discount) to net asset value and the dividends declared by us in each fiscal quarter since we began trading on Nasdaq. On November 3, 2025, the last reported closing sales price of our common stock on Nasdaq was $15.12 per share, which represented a premium of approximately 13.6% to our net asset value per share of $13.31 as of September 30, 2025. As of November 3, 2025, we had approximately 45 stockholders of record, which does not include stockholders for whom shares are held in nominee or "street" name.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  | **Price Range** | **Price Range** |  |  |  |
| **Class and Period** | **Net Asset Value**<sup>(1)</sup> | **High** | **Low** | **High Sales Price Premium (Discount) to Net Asset Value**<sup>(2)</sup> | **Low Sales Price Premium (Discount) to Net Asset Value**<sup>(2)</sup> | **Cash Dividend Per Share**<sup>(3)</sup> |
| **Year Ending December 31, 2025** |  |  |  |  |  |  |
| Fourth Quarter (through November 3, 2025) | **\*** | $15.56 | $14.44 | **\*** | **\*** | **\*** |
| Third Quarter | $13.31 | $16.47 | $14.04 | 23.7% | 5.5% | $0.51 |
| Second Quarter | $13.27 | $15.52 | $13.53 | 16.9% | 1.9% | $0.51 |
| First Quarter | $13.05 | $16.56 | $14.26 | 26.9% | 9.3% | $0.51 |
| **Year Ending December 31, 2024** |  |  |  |  |  |  |
| Fourth Quarter | $13.35 | $14.87 | $13.11 | 11.4% | (1.8)% | $0.51 |
| Third Quarter | $13.13 | $14.74 | $13.57 | 12.3% | 3.4% | $0.51 |
| Second Quarter | $13.12 | $15.26 | $14.03 | 16.3% | 7.0% | $0.51 |
| First Quarter | $12.88 | $15.08 | $13.68 | 17.1% | 6.2% | $0.51 |
| **Year Ending December 31, 2023** |  |  |  |  |  |  |
| Fourth Quarter | $13.19 | $15.40 | $13.33 | 16.7% | 1.0% | $0.50 |
| Third Quarter | $13.17 | $15.29 | $13.75 | 16.1% | 4.4% | $0.54<br><sup>(4)</sup> |
| Second Quarter | $13.15 | $13.91 | $11.36 | 5.8% | (13.6)% | $0.53<br><sup>(4)</sup> |
| First Quarter | $13.07 | $14.26 | $10.91 | 9.1% | (16.5)% | $0.47 |

---

------

<sup>(1)</sup> Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low closing sales prices. The net asset values shown are based on outstanding shares at the end of the relevant quarter.

<sup>(2)</sup> Calculated as the respective high or low closing sales price less net asset value, divided by net asset value (in each case, as of the applicable quarter).

<sup>(3)</sup> Represents the dividend or distribution declared in the relevant quarter.

<sup>(4)</sup> Consists of a quarterly dividend and a supplemental dividend.

\* &nbsp;&nbsp;&nbsp;&nbsp;Not determined at time of filing.

------

[**<u>**Table of Contents**</u>**](#toc_page)

Shares of BDCs may trade at a market price that is less than the value of the net assets attributable to those shares. At times, our shares of common stock have traded at prices both above and below our net asset value per share. The possibility that our shares of common stock will trade at a discount from net asset value per share or at premiums that are unsustainable over the long term are separate and distinct from the risk that our net asset value per share will decrease. It is not possible to predict whether our common stock will trade at, above, or below net asset value per share.

## *Related Party Transactions* 
Certain members of management as well as employees of the Company hold shares of the Company's stock.

We have entered into indemnification agreements with our directors and executive officers. The indemnification agreements are intended to provide our directors and executive officers with the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that we shall indemnify the director or executive officer who is a party to the agreement, or an "Indemnitee," including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

Refer to "Note 12 – Related Party Transactions" included in the notes to our consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information.

 ***Recent Developments***

*Equity ATM Program*

For the period from October 1, 2025 to November 3, 2025, the Company issued and sold 663,974 shares of its common stock at a weighted-average price of $14.99 per share and raised $9.9 million of net proceeds after deducting commissions to the sales agents on shares sold under the Equity ATM Program.

*Debt ATM Program*

For the period from October 1, 2025 to November 3, 2025, the Company issued and sold $25.4 million in aggregate principal amount of its ATM March 2029 Notes and $2.6 million in aggregate principal amount of its ATM September 2029 Notes and raised $25.3 million and $2.6 million, respectively, of net proceeds after deducting deferred offering costs and commissions to the sales agents on such notes sold under the Sales Agreement.

------

[**<u>**Table of Contents**</u>**](#toc_page)

# Item 3. Quantitative a nd Qualitative Disclosures About Market Risk
We are subject to financial market risks, including valuation risk and interest rate risk. Uncertainty with respect to the economic effects of the overall market conditions has introduced significant volatility in the financial markets, and the effect of the volatility could materially impact our market risks, including those listed below.

## *Valuation Risk* 
Our investments may not have readily available market quotations (as such term is defined in Rule 2a-5), and those investments which do not have readily available market quotations are valued at fair value as determined in good faith by our Board of Directors in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is possible that the difference could be material.

In accordance with Rule 2a-5, our Board periodically assesses and manages material risks associated with the determination of the fair value of our investments.

## *Interest Rate Risk* 
Interest rate sensitivity and risk refer to the change in earnings that may result from changes in the level of interest rates. To the extent that we borrow money to make investments, including under the KeyBank Credit Facility or any future financing arrangement, our net investment income will be affected by the difference between the rate at which we borrow funds and the rate at which we invest these funds. In periods of rising interest rates, our cost of borrowing funds would increase, which may reduce our net investment income. As a result, there can be no assurance that a significant change in market interest rates, including as a result of inflation, will not have a material adverse effect on our net investment income. Inflation is likely to continue in the near to medium-term, particularly in the United States and Europe, with the possibility that monetary policy may tighten in response. Persistent inflationary pressures could affect our portfolio companies' profit margins.

As of September 30, 2025, approximately 82.4% of our debt investments based on outstanding principal balance represented floating-rate investments based on U.S. Prime Rate ("Prime"), Secured Overnight Financing Rate ("SOFR") or Canadian Overnight Repo Rate Average ("CORRA"), and approximately 17.6% of our debt investments based on outstanding principal balance represented fixed rate investments. In addition, borrowings under the KeyBank Credit Facility are subject to floating interest rates based on SOFR, generally bearing interest at a rate of the Adjusted Term SOFR Reference Rate plus 2.85% to 3.25%, subject to the number of eligible debt investments in the collateral pool.

Based on our Consolidated Statements of Operations as of September 30, 2025, the following table shows the annualized impact on net income of hypothetical base rate changes in the Prime Rate on our debt investments (considering interest rate floors for floating-rate instruments) and the hypothetical base rate changes in the SOFR on our KeyBank Credit Facility, assuming that there are no changes in our investment and borrowing structure (in thousands):

---

| | | | |
|:---|:---|:---|:---|
|  | **Interest** | **Interest** | **Net** |
|  | **Income** | **Expense** | **Income/(Loss)** |
| Up 300 basis points | $49379 | $14448 | $34931 |
| Up 200 basis points | 32919 | 9632 | 23287 |
| Up 100 basis points | 14562 | 4816 | 9746 |
| Down 100 basis points | (5247) | (4816) | (431) |
| Down 200 basis points | (8900) | (9632) | 732 |
| Down 300 basis points | (8131) | (14448) | 6317 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

## *Currency Risk* 
Any investments we make that are denominated in a foreign currency will be subject to risks associated with changes in currency exchange rates. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved. As of September 30, 2025, we had nine foreign domiciled portfolio companies. Our exposure to currency risk related to these debt investments is minimal as payments from such portfolio companies are primarily received in U.S. dollars. No other investments as of September 30, 2025 were subject to currency risk.

## *Hedging* 
We currently, and may in the future, hedge against interest rate and currency exchange rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in benefits of lower interest rates with respect to our portfolio of investments with fixed interest rates. We may also borrow funds in local currency as a way to hedge our non-U.S. denominated investments.

## Item 4. Controls and Procedures
***Evaluation of Disclosure Controls and Procedures***

In accordance with Rules 13a-15(b) and 15d-15(b) under the Exchange Act, we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q and determined that our disclosure controls and procedures are effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

***Changes in Internal Control Over Financial Reporting***

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three months ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II: OTHER INFORMATION**

**Item 1. Legal Proceedings**

We are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Furthermore, third parties may seek to impose liability on us in connection with the activities of our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of any future legal or regulatory proceedings cannot be predicted with certainty, we do not expect that any such future proceedings will have a material effect upon our financial condition or results of operations.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Item 1A. Risk Factors**

Investing in our securities involves a number of significant risks. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors discussed in "Item 1A. Risk Factors" of our Annual Report on Form 10-K filed with the SEC on February 26, 2025, all of which could materially affect our business, financial condition and/or results of operations. Although the risks described in our other SEC filings referenced above represent the principal risks associated with an investment in us, they are not the only risks we face. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, might materially and adversely affect our business, financial condition and/or results of operations.

During the nine months ended September 30, 2025, there have been no material changes to the risk factors discussed in our SEC filings referenced above, except as provided below.

***Global economic, political and market conditions, including uncertainty about the financial stability of the United States, could have a significant adverse effect on our business, financial condition and results of operations.***

Downgrades by rating agencies to the U.S. government's credit rating or concerns about its credit and deficit levels in general could cause interest rates and borrowing costs to rise, which may negatively impact both the perception of credit risk associated with our debt portfolio and our ability to access the debt markets on favorable terms. In addition, a decreased U.S. government credit rating, any default by the U.S. government on its obligations, or any prolonged U.S. government shutdown could create broader financial turmoil and uncertainty, which may weigh heavily on our financial performance and the value of our common stock.

Deterioration in the economic conditions in the Eurozone and other regions or countries globally and the resulting instability in global financial markets may pose a risk to our business. Financial markets have been affected at times by a number of global macroeconomic events. Several European Union countries have faced budget issues, some of which may have negative long-term effects for the economies of those countries and other EU countries. In addition, the fiscal policy of large foreign nations, may have a severe impact on the worldwide and U.S. financial markets. Additionally, trade wars and volatility in the U.S. repo market, the U.S. high yield bond markets, the global stock markets and global markets for commodities may affect other financial markets worldwide. In addition, while governments worldwide may use stimulus measures to reduce volatility in the financial markets, volatility may return as such measures phase out, and the long-term impacts of such stimulus on fiscal policy and inflation remain unknown. We cannot predict the effects of these or similar events in the future on the U.S. and global economies and securities markets or on our investments. We monitor developments in economic, political and market conditions and seek to manage our investments in a manner consistent with achieving our investment objective, but there can be no assurance that we will be successful in doing so.

The conflict between Russia and Ukraine and in the Middle East, and resulting market volatility, could also adversely affect the Company's business, operating results, and financial condition. The extent and duration or escalation of such conflicts, resulting sanctions and resulting future market disruptions are impossible to predict, but could be significant. Any disruptions resulting from such conflicts and any future conflict (including cyberattacks, espionage or the use or threatened use of nuclear weapons) or resulting from actual or threatened responses to such actions could cause disruptions to any of our portfolio companies located in Europe or the Middle East or that have substantial business relationships with companies in affected regions. It is not possible to predict the duration or extent of longer-term consequences of these conflicts, which could include further sanctions, retaliatory and escalating measures, embargoes, regional instability, geopolitical shifts and adverse effects on or involving macroeconomic conditions, the energy sector, supply chains, inflation, security conditions, currency exchange rates and financial markets around the globe. Any such market disruptions could affect our portfolio companies' operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

***Dividend Reinvestment Plan***

On October 15, 2025, pursuant to its amended and restated distribution reinvestment plan, the Company issued 30,419 shares of its common stock, at a price of $15.14 per share, to stockholders of record as of September 30, 2025 that did not opt out of the Company's amended and restated distribution reinvestment plan in order to satisfy the reinvestment portion of the Company's distribution. This issuance was not subject to the registration requirements of the Securities Act. See "Item 1. Consolidated Financial Statements – Note 7. Stockholder's Equity – Distribution Reinvestment Plan" for more information.

# Item 3. Defaults Upon Senior Securities
None.

# Item 4. Mine Safety Disclosures
Not Applicable.

# Item 5. Other Information
***Rule 10b5-1 Trading Plans*** 

During the fiscal quarter ended September 30, 2025, none of the Company's directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement."

# Item 6. Exhibits
The following exhibits are filed as part of this Quarterly Report on Form 10-Q or hereby incorporated by reference to exhibits previously filed with the SEC:

---

| | |
|:---|:---|
| **Exhibit<br>Number** | **Description of Exhibits** |
| 3.1 | [<u>Articles of Amendment and Restatement (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed June 30, 2023).</u>](https://www.sec.gov/Archives/edgar/data/1786108/000121390023053521/ea157258_ex3-1.htm) |
| 3.2 | [<u>Bylaws (incorporated by reference to Exhibit 3.2 to the Company's Registration Statement on Form 10 filed on January 16, 2020).</u>](https://www.sec.gov/Archives/edgar/data/1786108/000110465920004792/tv534325_ex3-2.htm) |
| 10.1\* | [<u>Joinder Agreement, dated September 4, 2025, by and between TrinCap Funding, LLC, as Borrower, Trinity Capital Inc., as Servicer, KeyBank National Association, as the Administrative Agent, and the Lenders party thereto.</u>](trin-ex10_1.htm) |
| 10.2 | [<u>Open Market Sale Agreement, dated August 29, 2025, by and between Trinity Capital Inc. and Jefferies LLC (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on August 29, 2025).</u>](https://www.sec.gov/Archives/edgar/data/1786108/000121390025082060/ea025496101ex10-1_trinity.htm) |
| 10.3 | [<u>Open Market Sale Agreement, dated August 29, 2025, by and between Trinity Capital Inc. and B. Riley Securities, Inc. (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on August 29, 2025).</u>](https://www.sec.gov/Archives/edgar/data/1786108/000121390025082060/ea025496101ex10-2_trinity.htm) |
| 10.4 | [<u>Open Market Sale Agreement, dated August 29, 2025, by and between Trinity Capital Inc. and Keefe, Bruyette & Woods, Inc. (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed on August 29, 2025).</u>](https://www.sec.gov/Archives/edgar/data/1786108/000121390025082060/ea025496101ex10-3_trinity.htm) |
| 10.5 | [<u>Open Market Sale Agreement, dated August 29, 2025, by and between Trinity Capital Inc. and Compass Point Research & Trading, LLC (incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K filed on August 29, 2025).</u>](https://www.sec.gov/Archives/edgar/data/1786108/000121390025082060/ea025496101ex10-4_trinity.htm) |
| 31.1\* | [<u>Certification of Principal Executive Officer Pursuant to Rules 13a 14(a) and 15d 14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</u>](trin-ex31_1.htm) |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

---

| | |
|:---|:---|
| 31.2\* | [<u>Certification of Principal Financial Officer Pursuant to Rules 13a 14(a) and 15d 14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</u>](trin-ex31_2.htm) |
| 32.1\*\* | [<u>Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</u>](trin-ex32_1.htm) |
| 32.2\*\* | [<u>Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</u>](trin-ex32_2.htm) |
| 101.INS | Inline XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document with Embedded Linkbase Documents |
| 104 | Cover Page formatted as Inline XBRL and contained in Exhibit 101 |

---

------

\* Filed herewith

\*\* Furnished herewith

------

[**<u>**Table of Contents**</u>**](#toc_page)

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **TRINITY CAPITAL INC.** | **TRINITY CAPITAL INC.** |
| Dated: November 5, 2025 | By: | /s/ Kyle Brown |
|  |  | Kyle Brown |
|  |  | Chief Executive Officer, President and Chief |
|  |  | Investment Officer<br>(Principal Executive Officer) |

---

---

| | | |
|:---|:---|:---|
| Dated: November 5, 2025 | By: | /s/ Michael Testa |
|  |  | Michael Testa |
|  |  | Chief Financial Officer and Treasurer |
|  |  | (Principal Financial and Accounting Officer) |

---

------

## Exhibit 10.1

**Exhibit 10.1**

EXECUTION VERSION

INCREASE AGREEMENT

Reference is made to the that certain Credit Agreement dated as of October 27, 2021 (as the same may be amended, supplemented, restated or otherwise modified from time to time, the "Credit Agreement"), by and among TrinCap Funding, LLC, as Borrower (the "Borrower"), Trinity Capital Inc., as Servicer (the "Servicer"), the Lenders from time to time party thereto, KeyBank National Association, as the Administrative Agent (the "Administrative Agent") and Syndication Agent and Computershare Trust Company, N.A., as Collateral Custodian. Capitalized terms used and not otherwise defined herein are used with the meanings set forth or incorporated by reference in the Credit Agreement.

Zions Bancorporation, N.A. dba California Bank & Trust (the "Zions Increasing Managing Agent"), Zions Bancorporation, N.A. dba California Bank & Trust (the "Zions Increasing Lender"; and together with the Zions Increasing Managing Agent, the "Zions Increasing Lender Group"), Hancock Whitney Bank (the "Hancock Increasing Managing Agent"), Hancock Whitney Bank (the "Hancock Increasing Lender"; and together with the Hancock Increasing Managing Agent, the "Hancock Increasing Lender Group"), Live Oak Banking Company (the "Live Oak Increasing Managing Agent"), Live Oak Banking Company (the "Live Oak Increasing Lender"; and together with the Live Oak Increasing Managing Agent, the "Live Oak Increasing Lender Group"), Customers Bank (the "Customers Increasing Managing Agent"), Customers Bank (the "Customers Increasing Lender"; and together with the Customers Increasing Managing Agent, the "Customers Increasing Lender Group"), Axos Bank (the "Axos Increasing Managing Agent"), Axos Bank (the "Axos Increasing Lender"; and together with the Axos Increasing Managing Agent, the "Axos Increasing Lender Group"), MUFG Bank, Ltd. (the "MUFG Increasing Managing Agent"), MUFG Bank, Ltd. (the "MUFG Increasing Lender"; and together with the MUFG Increasing Managing Agent, the "MUFG Increasing Lender Group"), City National Bank (the "City National Increasing Managing Agent"), City National Bank (the "City National Increasing Lender"; and together with the City National Increasing Managing Agent, the "City National Increasing Lender Group"), Columbia Bank (f/k/a Umpqua Bank) (the "Columbia Increasing Managing Agent"), Columbia Bank (f/k/a Umpqua Bank) (the "Columbia Increasing Lender"; and together with the Columbia Increasing Managing Agent, the "Columbia Increasing Lender Group"), Western Alliance Bank (the "Western Alliance Increasing Managing Agent"; and collectively with the Zions Increasing Managing Agent, the Hancock Increasing Managing Agent, the Live Oak Increasing Managing Agent, the Customers Increasing Managing Agent, the Axos Increasing Managing Agent, the MUFG Increasing Managing Agent, the City National Increasing Managing Agent and the Columbia Increasing Managing Agent, the "Increasing Managing Agents", and each, an "Increasing Managing Agent"), Western Alliance Bank (the "Western Alliance Increasing Lender"; and together with the Western Alliance Increasing Managing Agent, the "Western Alliance Increasing Lender Group"; the Zions Increasing Lender, the Hancock Increasing Lender, the Live Oak Increasing Lender, the Customers Increasing Lender, the Axos Increasing Lender, the MUFG Increasing Lender, the City National Increasing Lender, the Columbia Increasing Lender and the Western Alliance Increasing Lender collectively, the "Increasing Lenders", and each, an "Increasing Lender"; the Zions Increasing Lender Group, the Hancock Increasing Lender Group, the Live Oak

------

Increasing Lender Group, the Customers Increasing Lender Group, the Axos Increasing Lender Group, the MUFG Increasing Lender Group, the City National Increasing Lender Group, the Columbia Increasing Lender Group and the Western Alliance Increasing Lender Group collectively, the "Increasing Lender Groups", and each, an "Increasing Lender Group"), the Administrative Agent, the Borrower and the Servicer agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Borrower has requested that (i) the Zions Increasing Lender increase its Commitment under the Credit Agreement by $4,210,526.32 (the "Zions Increase"), (ii) the Hancock Increasing Lender increase its Commitment under the Credit Agreement by $4,210,526.32 (the "Hancock Increase"), (iii) the Live Oak Increasing Lender increase its Commitment under the Credit Agreement by $8,421,052.63 (the "Live Oak Increase"), (iv) the Customers Increasing Lender increase its Commitment under the Credit Agreement by $16,842,105.26 (the "Customers Increase"), (v) the Axos Increasing Lender increase its Commitment under the Credit Agreement by $7,894,736.84 (the "Axos Increase"), (vi) the MUFG Increasing Lender increase its Commitment under the Credit Agreement by $21,052,631.58 (the "MUFG Increase"), (vii) the City National Increasing Lender increase its Commitment under the Credit Agreement by $4,210,526.32 (the "City National Increase"), (viii) the Columbia Increasing Lender increase its Commitment under the Credit Agreement by $21,052,631.58 (the "Columbia Increase") and (ix) the Western Alliance Increasing Lender increase its Commitment under the Credit Agreement by $2,105,263.15 (the "Western Alliance Increase"; and collectively with the Zions Increase, the Hancock Increase, the Live Oak Increase, the Customers Increase, the Axos Increase, the MUFG Increase, the City National Increase and the Columbia Increase, the "Increases", and each, an "Increase").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The effective date (the "Increase Date") of the Increases shall be the date on which (i) a fully executed copy of this Increase Agreement is delivered to, and consented to by, the Administrative Agent and (ii) the conditions set forth in Section 2.3(c) of the Credit Agreement have been satisfied, the Borrower's executed consent to this Increase Agreement being a representation and warranty of the Borrower that such conditions set forth in Section 2.3(c) of the Credit Agreement have been satisfied.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.By executing and delivering this Increase Agreement, each Increasing Managing Agent and each Increasing Lender (i) confirms that it has received a copy of the Credit Agreement and such Transaction Documents and other documents and information requested by it, and that it has, independently and without reliance upon the Borrower, the Servicer, any other Lender, any other Managing Agent or the Administrative Agent, and based on such documentation and information as it has deemed appropriate, made its own decision to enter into this Increase Agreement; (ii) agrees that it shall, independently and without reliance upon the Borrower, the Servicer, any other Lender, any other Managing Agent or the Administrative Agent, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement and any of the Transaction Documents; (iii) acknowledges that it has appointed and authorized the Administrative Agent to take such action on its behalf and to exercise such powers and discretion under the Credit Agreement and the Transaction Documents as are delegated to the Administrative Agent by the terms hereof and thereof, together with such powers and discretion as are reasonably incidental thereto; and (iv) agrees that it shall continue to perform in accordance with their terms all of the obligations that by the terms of the Credit Agreement are required to be performed by it as a Managing Agent and a Lender, respectively, after giving effect to this Increase Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.On the Increase Date of this Increase Agreement, (i) the Commitment of the Zions Increasing Lender shall be increased by $4,210,526.32, (ii) the Commitment of the Hancock Increasing Lender shall be increased by $4,210,526.32, (iii) the Commitment of the Live Oak Increasing Lender shall be increased by $8,421,052.63, (iv) the Commitment of the Customers Increasing Lender shall be increased by $16,842,105.26, (v) the Commitment of the Axos Increasing Lender shall be increased by $7,894,736.84, (vi) the Commitment of the MUFG Increasing Lender shall be increased by $21,052,631.58, (vii) the Commitment of the City National Increasing Lender shall be increased by $4,210,526.32, (viii) the Commitment of the Columbia Increasing Lender shall be increased by $21,052,631.58 and (ix) the Commitment of the Western Alliance Increasing Lender shall be increased by $2,105,263.15.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.This Increase Agreement may be executed by one or more of the parties on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.This Increase Agreement shall be governed by, and construed in accordance with, the laws of the State of New York.

IN WITNESS WHEREOF, the parties hereto have caused this Increase Agreement to be executed by their respective officers thereunto duly authorized, as of the date first below written, such execution being made on Schedule I hereto.

\* \* \* \* \*

------

Schedule I

to

Increase Agreement

Dated September 4, 2025

<u>Section 1.</u> 

The "Commitment" with respect to the Zions Increasing Lender after giving effect to the Zions Increase is $34,210,526.32.

The "Commitment" with respect to the Hancock Increasing Lender after giving effect to the Hancock Increase is $39,210,526.32.

The "Commitment" with respect to the Live Oak Increasing Lender after giving effect to the Live Oak Increase is $48,421,052.63.

The "Commitment" with respect to the Customers Increasing Lender after giving effect to the Customers Increase is $96,842,105.26.

The "Commitment" with respect to the Axos Increasing Lender after giving effect to the Axos Increase is $82,894,736.84.

The "Commitment" with respect to the MUFG Increasing Lender after giving effect to the MUFG Increase is $96,052,631.58.

The "Commitment" with respect to the City National Increasing Lender after giving effect to the City National Increase is $44,210,526.32.

The "Commitment" with respect to the Columbia Increasing Lender after giving effect to the Columbia Increase is $56,052,631.58.

The "Commitment" with respect to the Western Alliance Increasing Lender after giving effect to the Western Alliance Increase is $22,105,263.15.

------

<u>Section 2.</u> 

The "Group Advance Limit" with respect to the Zions Increasing Lender Group after giving effect to the Zions Increase is $34,210,526.32.

The "Group Advance Limit" with respect to the Hancock Increasing Lender Group after giving effect to the Hancock Increase is $39,210,526.32.

The "Group Advance Limit" with respect to the Live Oak Increasing Lender Group after giving effect to the Live Oak Increase is $48,421,052.63.

The "Group Advance Limit" with respect to the Customers Increasing Lender Group after giving effect to the Customers Increase is $96,842,105.26.

The "Group Advance Limit" with respect to the Axos Increasing Lender Group after giving effect to the Axos Increase is $82,894,736.84.

The "Group Advance Limit" with respect to the MUFG Increasing Lender Group after giving effect to the MUFG Increase is $96,052,631.58.

The "Group Advance Limit" with respect to the City National Increasing Lender Group after giving effect to the City National Increase is $44,210,526.32.

The "Group Advance Limit" with respect to the Columbia Increasing Lender Group after giving effect to the Columbia Increase is $56,052,631.58.

The "Group Advance Limit" with respect to the Western Alliance Increasing Lender Group after giving effect to the Western Alliance Increase is $22,105,263.15.

------

ZIONS INCREASING LENDER AND ZIONS INCREASING MANAGING AGENT: <br>

ZIONS BANCORPORATION, N.A. DBA CALIFORNIA BANK & TRUST<br>

---

| | |
|:---|:---|
| By: | /s/ Peter Drees |
|  | Name: Peter Drees |
|  | Title: Senior Vice President |

---

HANCOCK INCREASING LENDER AND HANCOCK INCREASING MANAGING AGENT:

HANCOCK WHITNEY BANK <br>

---

| | |
|:---|:---|
| By: | /s/ Thomas Pericak |
|  | Name: Thomas Pericak |
|  | Title: Senior Vice President |

---

LIVE OAK INCREASING LENDER AND LIVE OAK INCREASING MANAGING AGENT:

LIVE OAK BANKING COMPANY <br>

---

| | |
|:---|:---|
| By: | /s/ Robert Riesen |
|  | Name: Robert Riesen  |
|  | Title: Director |

---

CUSTOMERS INCREASING LENDER AND CUSTOMERS INCREASING MANAGING AGENT:

CUSTOMERS BANK

---

| | |
|:---|:---|
| By: | /s/ Scott Gates |
|  | Name: Scott Gates |
|  | Title: Senior Vice President |

---

AXOS INCREASING LENDER AND AXOS INCREASING MANAGING AGENT:

AXOS BANK <br>

---

| | |
|:---|:---|
| By: | /s/ David Park |
|  | Name: David Park |
|  | Title: President |

---

------

MUFG INCREASING LENDER AND MUFG INCREASING MANAGING AGENT:

MUFG BANK, LTD. <br>

---

| | |
|:---|:---|
| By: | /s/ Ted Polito |
|  | Name: Ted Polito |
|  | Title: Vice President |

---

CITY NATIONAL INCREASING LENDER AND CITY NATIONAL INCREASING MANAGING AGENT:

CITY NATIONAL BANK <br>

---

| | |
|:---|:---|
| By: | /s/ Lee Merkle-Raymond |
|  | Name: Lee Merkle-Raymond |
|  | Title: Managing Director |

---

COLUMBIA INCREASING LENDER AND COLUMBIA INCREASING MANAGING AGENT:

COLUMBIA BANK (F/K/A UMPQUA BANK)<br>

---

| | |
|:---|:---|
| By: | /s/ Daniel Dominguez |
|  | Name: Daniel Dominguez |
|  | Title: Senior Vice President |

---

WESTERN ALLIANCE INCREASING LENDER AND WESTERN ALLIANCE INCREASING MANAGING AGENT:

WESTERN ALLIANCE BANK<br>

---

| | |
|:---|:---|
| By: | /s/ Francesco Corradino |
|  | Name: Francesco Corradino |
|  | Title: Director |

---

------

Consented to this 4th day of September 2025 by:

KEYBANK NATIONAL ASSOCIATION,

as Administrative Agent

---

| | |
|:---|:---|
| By: | /s/ Richard Andersen |
|  | Name: Richard Andersen |
|  | Title: Senior Vice President  |

---

TRINCAP FUNDING, LLC,

as Borrower

By: Trinity Capital Inc., its sole and managing member

---

| | |
|:---|:---|
| By: | /s/ Sarah Stanton |
|  | Name: Sarah Stanton |
|  | Title: General Counsel and Secretary |

---

TRINITY CAPITAL INC.,

as Servicer

---

| | |
|:---|:---|
| By: | /s/ Sarah Stanton |
|  | Name: Sarah Stanton |
|  | Title: General Counsel and Secretary |

---

------

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Kyle Brown, Chief Executive Officer of Trinity Capital Inc., certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Trinity Capital Inc. (the "registrant") for the quarter ended September 30, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this Quarterly Report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*a)*Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*b)*Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*c)*Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*d)*Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*a)*All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*b)*Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: November 5, 2025 | By: | /s/ Kyle Brown |
|  |  | **Kyle Brown** |
|  |  | **Chief Executive Officer** |

---

------

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Michael Testa, Chief Financial Officer of Trinity Capital Inc., certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Trinity Capital Inc. (the "registrant") for the quarter ended September 30, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this Quarterly Report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*a)*All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*b)*Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: November 5, 2025 | By: | /s/ Michael Testa |
|  |  | **Michael Testa** |
|  |  | **Chief Financial Officer and Treasurer** |

---

------

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Executive Officer of Trinity Capital Inc. (the "Company"), does hereby certify that to the undersigned's knowledge:

1)the Company's Form 10-Q for the quarter ended September 30, 2025 fully complies with the requirements of Section 13(a) or 15(d) as applicable of the Securities Exchange Act of 1934, as amended; and

2)the information contained in the Company's Form 10-Q for the quarter ended September 30, 2025 fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: November 5, 2025 | By: | /s/ Kyle Brown |
|  |  | **Kyle Brown** |
|  |  | **Chief Executive Officer** |

---

------

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Financial Officer of Trinity Capital Inc. (the "Company"), does hereby certify that to the undersigned's knowledge:

1)the Company's Form 10-Q for the quarter ended September 30, 2025 fully complies with the requirements of Section 13(a) or 15(d) as applicable of the Securities Exchange Act of 1934, as amended; and

2)the information contained in the Company's Form 10-Q for the quarter ended September 30, 2025 fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: November 5, 2025 | By: | /s/ Michael Testa |
|  |  | **Michael Testa** |
|  |  | **Chief Financial Officer and Treasurer** |

---

------